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ABSTRACT
The Schwann cell is the major glial cell of the vertebrate peripheral nervous
system (PNS) where its prime function is to ensheathe and myelinate nerve fibers.
Although axons promote the differentiation of Schwann cells, the identity of the
signalling molecules responsible is unknown. It is likely that the cytoskeleton plays
a vital role in regulating both the changes in cell shape and the expression of myelin
protein genes that are required for myelination. Hence the discovery of L- and S-
periaxin, putative cytoskeletal-associated proteins of myelinating Schwann cells,
has prompted a detailed examination of their localization and developmental
expression in differentiating Schwann cells. In this work, in a search for protein-
binding domains which might help elucidate the function of the periaxin isoforms, a
single modular PDZ protein-binding domain was identified at the extreme N-
terminus. This strongly suggests that these proteins play a role in signalling axon-
glial interactions.
The localization of L- and S-periaxin was studied in the developing axon-
Schwann cell unit where both proteins were localized exclusively to myelin-forming
cells. During initial axonal ensheathment L-periaxin was detected at the Schwann
cell plasma membrane and in uncompacted myelin whorls. In early postnatal nerve
it was concentrated in the adaxonal (apposing the axon) and abaxonal (apposing
the basal lamina) membranes, but as the myelin sheath matures, L-periaxin became
predominantly localized to the abaxonal Schwann cell membrane demonstrating a
dynamic change in localization during development and ensheathment. This shift in
localization of the protein after completion of the spiralization phase of myelination
suggests that it participates in stabilizing the mature mmyelin sheath. In contrast,
S-periaxin was not associated with membranes but appeared to be present
throughout the Schwann cell cytoplasm. Both proteins were excluded from compact
myelin.
xv
During embryogenesis, Schwann cell precursor cells develop from migrating
neural crest cells. At around E14.5 in the mouse sciatic nerve, the precursor cells
differentiate to form embryonic Schwann cells which in turn become either myelin-
forming or non-myelin-forming Schwann cells in the mature PNS. In contrast to the
gene encoding the major myelin protein PO, which is expressed in neural crest cells,
Schwann cell precursor cells and embryonic Schwann cells, L-periaxin mRNA and
protein were first detected in embryonic Schwann cells. S-periaxin was detectable
somewhat later at post-natal day 1.
L-periaxin was initially detected in the nuclei of embryonic Schwann cells;
however it was predominantly localized to the plasma membrane by E17.5. To
investigate the embryonic nuclear expression further, transfection experiments of full
length and various deletion constructs of L-periaxin cDNA were undertaken which
indicated that the basic domain in the N-terminus of L-periaxin was responsible for
nuclear localization.
The regulation of the periaxin gene was investigated by transgenesis. It was
shown that a region of 5.5 kb upstream from the transcription initiation site along
with the first intron could direct expression to myelinating Schwann cells as well as
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The vertebrate nervous system develops from a dorsal specialization of the
embryonic ectoderm. During neurulation the ectoderm at the midline thickens to
form the neural plate. This region of dorsal ectoderm invaginates to give rise to the
neural tube which develops into the brain and spinal cord. At the end of
neurulation a population of cells emerges bilaterally from the dorsal regions of the
neural folds, emigrates from the neural tube and initiates a program of migration,
proliferation and finally differentiation (Fig. 1). These cells are the neural crest cells
and they give rise to diverse cell types in the developing embryo including the
neurons and glia of the peripheral nervous system (PNS), melanocytes, endocrine
cells, smooth muscle, and cells that contribute to cranio-facial structures. These
crest derivatives were identified by LeDouarin and co-workers using quail-chick
embryonic chimaeras in which they could precisely map the fate of neural crest cells
at every axial level (LeDouarin, 1982). By this means, sensory and autonomic
neurons, neurons and glial cells of the enteric nervous system, Schwann cells in
peripheral nerves, and ganglionic satellite cells were shown to originate from the
neural crest (Dupin et al., 1998; LeDouarin, 1993; LeDouarin and Smith, 1988;
Weston, 1991). However, not all glial cells in the PNS originate from the neural
crest. Some Schwann cells in the spinal ventral roots may arise from the ventral
neural tube (LeDouarin, 1982; Lunn et al., 1887) and some satellite cells of dorsal
root ganglia originate from spinal cord neuroepithelia after crest migration has taken
place (Sharma et al., 1995).
In the vertebrate PNS the major glial cell is the cell named after Theodor
Schwann (Schwann, 1839) first noted surrounding nerve fibers by Virchow
(Virchow, 1854). The Schwann cell is responsible for elaborating and maintaining
the myelin sheath. Intercellular interactions between neurons and Schwann cells
direct development of both the Schwann cell and the neuron and are responsible for
1




Figure 1. Diagrammatic representation of neurulation. (A) The ectoderm lying
above the notochord (No) and paraxial mesoderm (Pa) thickens to form the neural
plate. The cells which will become the neural crest originate from the lateral regions
of the neural plate. (B) The neural plate invaginates to form the neural tube. (C) the
neural tube (NT) fuses at the dorsal midline and separates from the overlying
ectoderm which will form the epidermis. Neural crest cells then migrate ventrally
and laterally. The paraxial mesoderm forms the somites, SOM.
From Selleck et al., 1993.
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maintenance as well as repair of peripheral nerves. Axonal signals regulate the
expression of myelin-specific genes (Jessen and Mirsky, 1992) and Schwann cells
can in turn influence the phosphorylation state of neurofilaments and axonal calibre
(DeWaegh et al., 1992), the segregation of Na+ and K+ channels, and the velocity of
nerve conduction by the production of the myelin sheath (Joe and Angelides, 1992;
Vabnick et al., 1997). In spite of the importance of these interactions between the
Schwann cell and the axon that it ensheathes we still know little about the
molecular basis of this signalling. It is therefore of great importance to identify the
molecules that are involved in the process of myelination in order to shed light on
the mechanisms that permit the glial cell and the neuron to communicate.
1.2 THE DEVELOPMENT OF THE SCHWANN CELL
1.2.1 Neural crest cells are multipotent
An important question in embryonic development is whether individual
neural crest cells are precommitted to a specific lineage or whether they are
multipotent (reviewed in, Selleck et al., 1993; Stemple and Anderson, 1993). To
address this question, lineage tracing studies have been conducted in vivo by
marking individual trunk neural crest cells with dye or recombinant retrovirus and
by tracing their fates within the embryo. These experiments have shown that neural
crest cells are multipotent and that they can give rise to multiple crest derivatives
(Frank and Sanes, 1991; Fraser and Bronner-Fraser, 1991). Similar results have
been obtained by growing avian neural crest cells in clonal cultures (Baroffio et al.,
1988; Dupin et al., 1990; Sieber-Blum and Cohen, 1980). The in vivo studies
showed some cells which exhibited multipotency but others generated a subset of
the possible lineages indicating that there may be subpopulations of crest cells with
a restricted potential or which do not encounter the environment necessary to
3
develop to their full potential. Transplantation of crest cells to different locations
or exposure of these cells to different environments in vitro has indeed
demonstrated that environmental cues can influence lineage fate (see section
1.2..4.1) (for review, LeDouarin et al., 1993).
1.2.2 The Schwann cell precursor
It has been shown by ablation experiments that neural crest cells and axons
migrate to form nerves independently of each other (Loring and Erickson, 1987;
Rickmann et al., 1985). In the rat embryo the period of nerve development in the
limb begins at E13/14 and spans a week until birth (Jessen et al., 1994). Cells
isolated from newly formed nerves have a different phenotype from neural crest
cells (Stewart et al., 1996) and are distinct from neonatal Schwann cells (Jessen et
al., 1994). These Schwann cell precursors represent an intermediate stage in
Schwann cell differentiation from the neural crest. Precursor cells differ from
Schwann cells in that they are flattened rather than bipolar in vitro and they do not
express S100 protein. They also undergo programmed cell death when removed
from axonal contact and placed in high density cultures whereas Schwann cells do
not, and they are not induced to synthesize DNA by Schwann cell mitogens
(Gavrilovic et al., 1995; Jessen et al., 1994). In the rat hindlimb, the switch from
precursor phenotype to embryonic Schwann cell phenotype occurs at E16 (Jessen et
al., 1994).
The embryonic Schwann cell displays some of the same molecular markers
as the precursor cell, growth-associated protein-43 (GAP-43), the neural cell
adhesion molecules (N-CAM) and LI but they can be distinguished from precursors







Figure 2. Diagrammatic representation of murine Schwann cell development
with stage specific molecular markers. Schwann cell precursors differentiate to
embryonic Schwann cells. Embryonic Schwann cells will become either
promyelinating or non-myelinating. The promyelinating Schwann cell becomes a
myelinating cell and forms a myelin sheath. GAP-43, growth associated protein 43;
NCAM, neural cell adhesion molecule; NGFR, nerve growth factor receptor; MAG,
myelin-associated glycoprotein; GalC, galactocerebroside; MBP, myelin basic
protein; PMP22, peripheral myelin protein 22.
Modified from Scherer, 1997.
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1.2.3 Two forms of Schwann cells arise from embryonic Schwann cells
There are of two types of Schwann cells in normal peripheral nerves, a cell
which forms a myelin sheath and ensheathes a single axon and a non-myelin-
forming cell that ensheathes multiple smaller calibre axons (Fig. 3) (Ochoa, 1976;
Webster and Favilla, 1984). They both arise from the same pool of embryonic cells.
Non-myelin-forming cells retain many of the characteristics of embryonic Schwann
cells in that they associate with multiple axons and express some of the same
phenotypic markers. Myelin-forming and non-myelin-forming Schwann cells each
display a distinct complement of genes. Non-myelin-forming Schwann cells express
the cell adhesion molecules LI and neural cell adhesion molecule (NCAM), nerve
growth factor receptor (NGFR), growth-associated protein 43 (GAP-43) and glial
fibrillary acidic protein (GFAP) while myelin-forming cells express protein 0 (PO),
myelin basic protein (MBP), myelin-associated protein (MAG), and peripheral
myelin protein 22 (PMP22), some of which are structural components of the myelin
sheath (Scherer and Salzer, 1996). Schwann cells can exhibit a third phenotype
when deprived of axonal contact, either following nerve injury or when cultured
alone in vitro (Curtis et al., 1992; Daniloff et al., 1986; Lemke and Chao, 1988;
Martini and Schachner, 1988; Scherer et al., 1994; Taniuchi et al., 1986; Taniuchi et
al., 1988). Both myelin-forming and non-myelin-forming Schwann cells can become
denervated or dedifferentiated. The myelin-forming cell reverts to the LI, NCAM,
NGFR, GAP-43 expressing cell and down-regulates the synthesis of myelin proteins
and the glycolipids. After the loss of axonal contact the mature non-myelin-forming
Schwann cell also down-regulates the glycolipids galactocerebroside and sulfatide
(Jessen et al., 1987). The dedifferentiated Schwann cell can also express proteins
which are unique to its phenotype such as the neurofilament proteins NF-M and
NF-L which are not normally expressed (Fabrizi et al., 1997). Although certain
aspects of dedifferentiation may represent the reversal of differentiation and the
loss of proteins they no longer require, it is likely that the denervated Schwann cell
6
Figure 3. Two types of Schwann cell are found in the peripheral nervous
system. (A) Electron micrograph of a non-myelin-forming Schwann cell with
cytoplasmic processes surrounding multiple small diameter axons. (B) An electron
micrograph of a myelin-forming Schwann cell which has formed a compact myelin
sheath. The inner mesaxon and outer mesaxon (large arrow) are visible with an
electron dense plaque along the outer mesaxon (small arrow). N, nucleus. Bar in B,
0.5 gm.
From (A) Peters et al., 1991; (B) Raine, 1994.
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expresses proteins which relate to promoting axonal regeneration and hence
constitutes a third phenotype (Scherer and Salzer, 1996).
The striking changes that Schwann cells undergo when removed from axons
indicates that axonal signals are required to maintain the Schwann cell phenotype.
This was first shown (Langley and Anderson, 1903) in experiments where axons
from a myelinated nerve were forced to regenerate into the distal stump of an
unmyelinated nerve. This induced Schwann cells from the unmyelinated nerve to
myelinate indicating that axons destined to be myelinated induced Schwann cells to
form a myelin sheath. The potential for Schwann cells from unmyelinated nerves to
produce myelin was confirmed by other studies (Aguayo et al., 1976; Weinberg and
Spencer, 1976). Thus, Schwann cells are adaptable and depend on signals from
axons to exhibit the phenotype required for myelination. The nature of the axonal
signal or signals which induce myelination remain elusive. They may include axonal
calibre as shown in experiments where postganglionic sympathetic non-myelinated
axons were induced to myelinate as a result of increased target size (Voyvodic,
1989).
1.2.4 Regulation of Schwann cell development by neuregulins
Neuregulins are a group of structurally related proteins that are alternatively
spliced products of a single gene, neuregulin 1 (Burden and Yarden, 1997). These
proteins are known to regulate cell survival, proliferation and differentiation in
different tissues. Neuregulin is the consensus name for the isoforms (Marchionni et
al., 1993) although they were independently identified as glial growth factor (GGF),
Neu differentiation factor (NDF), heregulin, acetylcholine receptor inducing activity
(ARIA), and sensory and motor neuron-derived factor (SMDF) (for reviews Lemke,
1996; Gassmann and Lemke, 1997). The neuregulin isoforms have been recently
classified into three types (Fig. 4): type I isoforms (originally identified as NDF,
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Figure 4. Schematic representation of the three types of neuregulin and the
neuregulin gene. (A) The structure of type I neuregulins (NDF/heregulin and
ARIA), type II (GGF), and type III (SMDF). The EGF-like domain is present in all
isoforms; the Ig-like domain is present in type I and II isoforms; a signal peptide
(SP) is present in type II neuregulin; kringle-like domain is present in type II
neuregulin; Hy-I and Hy-III are internal hydrophobic stretches in type I and type III
isoforms; N-III is the unique cysteine-rich N-terminal domain in type III; C-l is the
unique C-terminal domain of type I. (B) Hypothetical structure of the neuregulin
gene. Domains encoded by different exons are indicated.
Modified from Meyer et al., 1997.
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and a glycosylation domain; type II isoforms (originally identified as GGF) contain
an EGF-like domain (P-variant), an Ig-like domain but no glycosylation domain;
type III isoforms (originally identified as SMDF) contain an EGF-like domain (P-
variant) and a cysteine-rich domain (Burden and Yarden, 1997; Meyer et al., 1997).
1.2.4.1 Glial growth factor can influence fate determination of neural crest cells
towards a glial lineage.
GGF was originally identified and purified as a Schwann cell mitogen
(Brockes et al., 1980; Lemke and Brockes, 1984) because it stimulates their
proliferation and survival in vitro. GGF was the first extrinsic signal shown to alter
choice towards a glial lineage in neural crest cells. GGF was used in clonal cultures
ofmultipotent rat neural crest cells to determine its effect on lineage determination.
In standard media, the majority of the clones contained neurons and glia while 10%
of the clones contained only glia. After the addition of GGF, 95% of the clones
contained only glia indicating that GGF had a dramatic effect on crest cells to
suppress neuronal differentiation and promote or allow glial differentiation (Shah
et al., 1994).
1.2.4.2 Neuregulin receptors
Neuregulin-induced cellular responses are mediated by tyrosine kinase
receptors of the ErbB family which are structurally related to the EGF receptor
(ErbBl) (Carraway and Burden, 1995). These receptors include three closely
related proteins ErbB2, ErbB3, and ErbB4 (Fig. 5). Neuregulin isoforms bind
directly to ErbB3 and ErbB4 with high affinity but recruit ErbBl and ErbB2 as co-
receptors (Burden and Yarden, 1997; Peles and Yarden, 1993). A functional
neuregulin receptor complex with the highest affinity for neuregulins is the result of
ligand-induced heterodimerization of ErbB2 with ErbB3 or ErbB4 and subsequent














Figure 5. The structure and sequence identity of ErbB2, ErbB3 and ErbB4
receptors. The extracellular domains of the ErbB receptors contain two cysteine-
rich boxes (ovals, Cys Box 1 and 2) which exhibit 40 to 50% sequence identity. The
receptors exhibit 60 to 80% sequence identity in their intracellular kinase domains.
The cytoplasmic tails of the three receptors are divergent with very little identity.
From Lemke, 1996.
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formation of homo- and heterodimers can produce 10 possible receptor
combinations and most, but not all, become tyrosine phosphorylated upon ligand-
binding and initiate signaling cascades. The mechanism for the promotion of
different receptor combinations by ligand-binding is still unclear (Burden and
Yarden, 1997).
1.2.4.3 Expression and activities of neuregulin and the ErbB receptors
Recent studies have shown that in addition to their role in neural crest cell
differentiation (see section 1.2.4.1), ErbB receptors and their ligands have a crucial
role in Schwann cell development. The activity of neuregulin has been shown to
regulate DNA synthesis of Schwann cell precursors and support lineage progression
in vitro in a time course which parallels in vivo progression (Dong et al., 1995). No
other known growth factor is capable of this activity.
Axonal contact has been shown to induce proliferation of Schwann cells in
vitro (Wood and Bunge, 1975) and it has more recently been shown that neuregulin
and its receptor ErbB2 are components of the Schwann cell mitogenic activity
provided by axonal contact (Morrissey et al., 1995). Neuregulins synthesized by
PNS neurons are axonally transported and biologically active (Marchionni et al.,
1993; Sandrock et al., 1995; Vartanian et al., 1997).
In addition to the activity of neuregulins in Schwann cell proliferation and
development they can regulate survival. Neuregulins can rescue Schwann cell
precursors from the dramatic programmed cell death they undergo in vitro (Dong et
al., 1995; Murphy et al., 1996). The survival activity of neuregulins is not restricted
to precursor cells since they has been shown to regulate programmed cell death in
Schwann cells in vitro induced by serum withdrawal in cultured cells (Syroid et al.,
1995), in vivo after nerve transection in early postnatal sciatic nerve (Grinspan et
al., 1996; Syroid et al., 1995) and at the neuromuscular junction (Trachtenberg and
Thompson, 1996).
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Numerous studies have defined the embryonic expression pattern of
neuregulins (reviewed in Gassmann and Lemke, 1997) which are expressed widely
but most recently using isoform specific probes for in situ hybridization studies it
was shown that the isoforms have distinct expression patterns: type I neuregulins
are the only isoforms detected in the early embryo and are predominantly
expressed in cephalic mesenchyme, neural crest-derived neurons in cranial ganglia
and endocardium; type II neuregulins are the major isoforms expressed in embryonic
muscle; type III neuregulin is expressed in sympathetic, sensory and motor neurons
whereas all isoforms are expressed in the ventricular zone of the telencephalon
(Burden and Yarden, 1997; Meyer et al., 1997).
ErbB2 and ErbB3 mRNA and protein are expressed by neonatal Schwann
cells and phosphorylated in vivo indicating that they are active (Grinspan et al.,
1996; Jin et al., 1993; Levi et al., 1995; Meyer and Birchmeier, 1995; Morrissey et al.,
1995). In vitro studies showed that the heterodimerization of ErbB2 and ErbB3 in
Schwann cells was ligand-induced with subsequent tyrosine phosphorylation of
both subunits (Vartanian et al., 1997). The fact that neuregulins are expressed by
neurons in the right place combined with the presence of the appropriate receptors
on Schwann cells indicates that this ligand-receptor system is responsible for the
regulation of Schwann cell development..
1.2.4.4 Targeted mutation of neuregulin and the ErbB receptors
Targeted deletion in mice of neuregulin (Meyer and Birchmeier, 1995), ErbB2
(Lee et al., 1995), ErbB3 (Riethmacher et al., 1997), and ErbBi genes (Gassmann et
al., 1995) have indicated that neuregulins and their receptors have multiple
independent and essential functions in embryonic development particularly in the
nervous system and heart. Analysis of E10.5 mouse embryos with the neuregulin
null mutation show that ErbB3-expressing cranial ganglia and Schwann cell
precursors fail to develop normally and are reduced in number while sensory
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neurons of the dorsal root ganglia are normal. These results demonstrate that
neuregulins are essential for the neurogenic lineage in cranial neural crest whereas in
trunk neural crest they only affect early Schwann cell development consistent with
earlier studies on Schwann cell precursor survival (Meyer and Birchmeier, 1995).
The neuregulin and ErbB2 mutant mice display similar defects in cranial neural crest
derived sensory ganglia development. Most neural crest derived portions of these
ganglia are missing (Lee et al., 1995). Analysis of the phenotype of mice with a
targeted mutation in the neuregulin Ig-like domain (neuregulin1!?) which causes
premature translational termination of neuregulin isoforms containing the Ig domain
(types I and II), demonstates that Schwann cell precursors develop normally,
indicating that Schwann cells do not depend on the Ig-like isoforms of neuregulins
for their development (Meyer et al., 1997).
Most recently Birchmeier and co-workers generated mice lacking the ErbB3
receptor (Riethmacher et al., 1997). Most homozygous null embryos died before
E13.5. The most striking feature of the E12.5 mutant embryos was the complete
absence of Schwann cell precursors in sensory and motor peripheral nerves and a
complete absence of Schwann cells in older embryos of E18.5. These results
demonstrate that ErbB3 is essential for the development of Schwann cells. Enteric
glial cells were also absent but satellite cells in dorsal root ganglia and CNS glia
were normal. The appearence of normal glial cells in the CNS is consistentwith the
fact that oligodendrocytes have been shown to express the neuregulin receptors
ErbB2 and ErbB4 but not ErbB3 (Vartanian et al., 1997). On the other hand it is
surprising that the supporting cells in the dorsal root ganglia are not affected in the
mutant embryos because their phenotype is very like Schwann cell precursors.
Another very interesting finding by Birchmeier and co-workers was that
sensory and motor neurons are formed in the mutant embryos but subsequently
degenerate by programmed cell death. The dorsal root ganglion neurons were of a
similar number to wild type on E12.5 but by E14.5 and E18.5 they were reduced by
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70% and 82% respectively. The loss of motor neurons takes place 2 days later in
mutant embryos, the number was normal at E16.5 but drastically reduced by E18.5.
To distinguish whether this neuronal loss in mutant embryos was a consequence of
the role of ErbB3 in mediating trophic signals directly to neurons or indirectly
through the loss of Schwann cells, chimaeric embryos were generated by injection of
ErbB3 ' embryonic stem cells into wild-type blastocysts (Riethmacher et al.,
1997). While the contribution of mutant and wild type cells from chimaeric pups
was similar in dorsal root ganglia, spinal cord and other tissues, there was no
contribution of mutant cells to Schwann cell precursors. This important experiment
demonstrates that ErbB3 functions in a cell autonomous fashion in Schwann cell
development but acts indirectly in the survival of sensory and motor neurons.
The loss of motor and sensory neurons in the ErbB3 mutant embryos is most
likely due to the complete loss of trophic support provided by Schwann cells and
their precursor cells. Schwann cells have been reported to produce many
neurotrophic factors such as CNTF, GDNF, BDNF, LIF, NT-3, and HGF which are
all capable of promoting sensory and motor neuron survival in vitro (Davies, 1998).
The fact that more neurons die in the ErbB3 mutant embryos than in any single
neurotrophic factor-null mouse, suggests that Schwann cells and their precursors
provide multiple survival factors for early sensory and motor neurons which
probably include as yet uncharacterized neurotrophic factors (Davies, 1998).
1.2.5 Transcriptional regulation during Schwann cell development
Schwann cells have been shown to express many transcription factors
(reviewed in Stewart et al., 1996) but so far only two, Krox-20 and Oct-6, have
been shown to be important for the development of the myelinating Schwann cell
lineage.
The Jun family of leucine zipper transcription factors, c-Jun, Jun B, and Jun
D, are expressed in Schwann cells in vitro and at low levels in vivo. Expression of
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c-Jun is associated with the non-myelin-forming phenotype and is regulated by
axonal contact in that it is increased in the distal stump after nerve crush and
rapidly decreases when axons re-grow (Shy et al., 1996; Stewart, 1995). Another
leucine zipper transcription factor, cAMP response element binding protein (CREB),
which mediates the actions of cAMP, is expressed during all stages of Schwann cell
development (Stewart, 1995). It was thought that CREB may be important in
regulating myelin-forming cells since up-regulation of cAMP in vitro can reproduce
the myelinating Schwann cell phenotype induced by axonal contact (Lemke and
Chao, 1988; Morgan et al., 1991), but cAMP response element (CRE) sites have not
been found in any of the Schwann cell myelin genes (Lemke and Chao, 1988;
Stewart et al., 1996). The zinc finger transcription factor Krox-24 is expressed by
immature and non-myelin-forming Schwann cells but not by myelin-forming cells
(Nikam et al., 1995). Several basic helix-loop-helix (bHLH) transcription factors
are found in the Schwann cell lineage but their mRNAs are not strongly regulated
during development (Stewart et al., 1997).
1.2.5.1 Pax3
Pax3 is a paired box gene expressed in craniofacial neural crest cells
derivatives and in the spinal ganglia (Goulding et al., 1991). Expression is
maintained in Schwann cell precursors but is down-regulated in embryonic Schwann
cells (Kioussi and Gruss, 1996). Homozygous Splotch mutant mice which have a
mutation resulting in a truncated Pax3 protein die at E13.5 and lack Schwann cell
precursors. In contrast, a point mutation in the paired domain of Pax3, splotch
delayed, causes a decrease in the number of Schwann cells in the sciatic nerve
(Kioussi et al., 1995). A second wave of high level Pax3 expression occurs at E18.5
to postnatal-day 5. Pax3 levels remain high in the non-myelin-forming Schwann
cells but Pax3 expression is down-regulated as Schwann cells begin to myelinate.
Myelin-specific genes may be negatively related targets of Pax3. In vitro
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experiments have shown that Pax3 expression in Schwann cells results in repression
of Mbp promoter activity and activation of GFAP, NCAM, LI and NGFR promoters
(Kioussi et al., 1995). Therefore Pax3 expression may be involved in maintaining
gene expression in non-myelin-forming cells.
1.2.5.2 SCIP/Tst-l/Oct-6
SCIP (suppressed-cyclic AMP-inducible protein) is a member of the POU-
homeo-domain family of proteins which are expressed in the nervous system and
other tissues (He et al., 1989; Meijer et al., 1989; Monuki et al., 1989; Suzuki et al.,
1990). SCIP is strongly induced by elevating cAMP in Schwann cells in vitro
(Monuki et al., 1990; Monuki et al., 1989) and can also act as a repressor of P0 and
MBP expression in transfection studies (He et al., 1991; Monuki et al., 1993). SCIP
protein is present in the sciatic nerve in Schwann cell precursors, embryonic
Schwann cells, and myelin-forming Schwann cells until postnatal-day 12, and in
many non-myelin-forming Schwann cells in the adult (Blanchard et al., 1996;
Scherer et al., 1994) and demonstrates a transient expression pattern in the myelin-
forming lineage (Zorick et al., 1996). Targeted deletion of the SCIP gene in mice
delays the appearance of myelin-forming Schwann cells by 1 to 2 weeks so that
they are arrested at the stage when there is a 1:1 relationship between Schwann cell
and axon prior to myelin sheath formation (Bermingham et al., 1996; Jaegle et al.,
1996). The levels of P0 and MBP mRNAs in SCIP null mice were not reduced
(Bermingham et al., 1996) indicating that SCIP does not regulate these genes.
Therefore SCIP acts to regulate genes in embryonic Schwann cells that are involved
in the transition to a myelin-forming phenotype.
1.2.5.3 Krox-20
The expression pattern of the zinc-finger transcription factor Krox-20 has
been described by 2 groups using different methods of analysis. Topilko and co-
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workers used (3-galactosidase histochemistry in mice carrying a lacZ pgk-neo gene
inserted into the Krox-20 locus (Topilko et ah, 1994) whereas Zorick and co¬
workers used Northern analysis to examine mRNA expression and
immunohistochemistry with an antibody to Krox-20 to localize protein in rats
(Zorick et al., 1996). Rats are delayed in the maturation of the PNS by 1 to 2 days
when compared to mice. The difference in the sensitivity of the detection methods
used could account for the different results. Topilko and co-workers first detected
Krox-20 at El 1.5 in the dorsal and ventral spinal roots but the gene is not expressed
in distal peripheral nerves until E16.5. Zorick and co-workers showed that Krox-20
appears in the dorsal root Schwann cells at PI in the rat 24 to 36 h after they
become SCIP+. A third group demonstrated Krox-20 mRNA by RT-PCR in mice
after the transition from precursor cell to embryonic Schwann cell while SCIP is
expressed in precursor cells (Blanchard et al., 1996). Therefore SCIP expression
precedes Krox-20 expression during Schwann cell development. Krox-20 is never
expressed in non-myelin-forming cells but its expression is maintained in myelin-
forming Schwann cells in the adult (Zorick et al., 1996) where it requires axonal
contact in vitro and in vivo (Murphy et al., 1996; Zorick et al., 1996).
Mutant mice homozygous for a null allele in the Krox-20 gene are never able
to myelinate axons. The Schwann cells spiral just one and a half turns around an
axon and the only myelin protein they express is MAG (Topilko et al., 1994) an
early marker of myelination. The phenotype observed in Krox-20 null mice, the
absence of myelination and of myelin gene products, suggests that Krox-20 may be




1.3.1 The myelination process
Embryonic Schwann cells migrate along axons in developing peripheral
nerves and loosely ensheath bundles of axons. Over time their processes extend
into the bundles and gradually segregate smaller bundles of axons until only one
axon is surrounded by Schwann cell cytoplasm (Webster, 1971; Webster and
Favilla, 1984). The process of spiralization of the Schwann cell plasma membrane
around the axon begins with the inner mesaxon spiraling under the outer mesaxon
when axonal diameter reaches approximately 1 to 1.6 |xm (Fraher, 1978; Peters and
Vaughn, 1970; Voyvodic, 1989; Webster, 1971). The spiralization process
continues and the cytoplasm within the spirals is extruded after 3 to 4 complete
turns thus forming the compact myelin sheath (Fig. 6). Even after sheath formation
there remains some uncompacted membranes containing cytoplasm on the external
mesaxon side which eventually decrease in size and disappear as the turns
increase. This process of spiralization to produce a myelin sheath was first
described by Geren (Geren, 1954).
Like other epithelial cells Schwann cells synthesize a basal lamina which is
composed of laminin, nidogen, type IV collagen, heparin sulfate proteoglycan, and
fibronectin and is characteristic of the axon-Schwann cell unit. The basal lamina is
formed when Schwann cells first associate with axons (Billings-Gagliardi et al.,
1974). Studies using an in vitro co-culture system of dorsal root ganglion neurons
with Schwann cells has provided evidence that in addition to axonal contact, the
deposition of a basal lamina is necessary for myelination (Bunge, 1993; Bunge et al.,
1990).
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Figure 6. Schematic representation of myelination in the peripheral nervous
system. The process of ensheathment and spiralization is depicted with the inner
mesaxon wrapping around the axon. Compaction of the lamellae forms the
multilamellar myelin sheath composed of the major dense lines and the thinner
intraperiod lines. From Raine, 1984.
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1.3.2 The domain structure of a myelinated fiber
The myelinated peripheral nerve fiber has a distinctive morphology with the
myelin sheath appearing as a segmented tube surrounding the axon. As first
described by Ranvier, (Ranvier, 1871), the interruptions in the sheath causing the
segmental appearance are the nodes of Ranvier and the segments of myelin between
nodes are the internodes formed by the acquisition of a length of axon by a single
Schwann cell with its spindle-shaped nucleus located in the approximate center of
the internode. The length of an internode increases proportionally to axon diameter
and internodal segments can range from 200 to 2000 pm (Hiscoe, 1947; Schlaepfer
and Myers, 1973; Vizoso and Young, 1948).
Schwann cells like other epithelial cells polarize their surfaces thereby
creating distinct domains: compact myelin, uncompacted regions or cytoplasmic
channels, and plasma membrane (Trapp et al., 1995).
1.3.2.1 Cytoplasmic channels within the internode
All myelin-forming Schwann cells have a network of cytoplasmic channels
that are precisely organized in the internode. After myelin sheath formation,
Schwann cell cytoplasm is retained on the inside of the sheath (the periaxonal
region), the outside of the sheath where the bulk of the cell body is located, channels
within the sheath, and at the paranodes (Fig. 7). The thin cytoplasmic periaxonal
domain, enclosed by periaxonal membrane on one side and sheath on the other, is
separated by a 12 to 14 nm gap or periaxonal space from the axolemma (Trapp
and Quarles, 1982).
Within the internode are the cytoplasmic channels that traverse the myelin
sheath known as Schmidt-Lanterman incisures (Fig. 7 ). They were described over a
century ago as a series of funnel-shaped clefts in the myelin sheath (Boll, 1877;
Lanterman, 1877; Schmidt, 1874; Zawerthal, 1874). These channels provide a
direct connection from the perinuclear to the periaxonal cytoplasm apposing the
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(
Figure 7. Diagram of an "unrolled" Schwann cell. When the Schwann is viewed
"unrolled" the cytoplasmic network is more clearly visible. The Schmidt-Lanterman
channels which traverse the sheath are distinguished from the outer boundaries of
the cell which include the lateral paranodal channel or loops and the inner and outer
mesaxons.









axon. The Schmidt-Lanterman incisures have been implicated in the metabolic
maintenance of the myelin sheath (Ghabriel and Allt, 1981) but their function
remains unclear. The cytoplasm of the incisure usually contains a single
microtubule, microfilaments, mitochondria and smooth endoplasmic reticulum but
no Golgi vesicles, rough ER or free polysomes thereby unable to participate in
protein synthesis and processing (Gould and Mattingly, 1990; Hall and Williams,
1970; Rosenbluth, 1980). Electron densities within the incisures have been
described (Hall and Williams, 1970) and it is now known that these densities are
components of adherens-like junctions (Fannon et al., 1995).
The paranode is the region of the internode where the myelin sheath
terminates close to the node of Ranvier. When viewed in a longitudinal section by
electron microscopy it is clear that the major dense line of the compacted sheath
opens in these regions and the resulting loops, which abut each side of the axon, are
filled with cytoplasmic components (Fig, 8A). The loop from the outer most myelin
lamellae is closest to the node. Within the cytoplasm of paranodes there are
abundant microtubules which are suggested to be involved in myelin protein
transport (Kidd et al., 1994; Peters et al., 1991; Trapp et al., 1995). Covering the
node, in close contact with the axolemma are interdigitating microvilli extending
from each Schwann cell plasma membrane at each end of the internode. If the
myelin sheath was unrolled as seen in Fig 7, the paranodal loops would be seen to
form a continuous channel at the lateral boundary of the cell.
1.3.2.2 Molecular and structural organization of the node of Ranvier and
paranode
Originally described as desmosomes (Harkin, 1964), a series of helically
arranged densities are seen that traverse the cytoplasm between the paranodal
loops. It is now clear that these electron densities are components of an adherens-
type junction which contains the adhesion molecule E-cadherin (epithelial cadherin)
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basal paranodal loops
node of myelin sheath
Figure 8. Diagram of a node of Ranvier (A) and an electron micrograph of a
node of Ranvier from a large diameter axon (B). The ends of the cytoplasmic-
filled paranodal loops directly appose the axon. Interdigitating Schwann cell
microvilli are visible at the node (B, arrow) and a basal lamina can be seen. In (B)
the axonal narrowing at the node is evident as well as the condensation of axonal
organelles and neurofilaments. Bar, 2 |im.
From Raine, 1984.
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and its associated protein [3-catenin (Fannon et al., 1995) and which serves to
anchor adjacent membranes. E-cadherin adhesion plaques are restricted to the
uncompacted channel networks in the Schwann cell: paranodes, Schmidt-
Lanterman incisures, and mesaxons. In other epithelial cells E-cadherin mediates
intercellular adhesion. Thus the Schwann cell provides a novel role for E-cadherin
in mediating adhesion within the membrane system of a single cell.
The gap junction protein connexin32 (Cx32) has been localized to the same
Schwann cell regions as E-cadherin; paranodes, Schmidt-Lanterman incisures and
mesaxons (Scherer et al., 1995). Mutations affecting the CX32 gene are associated
with the X-linked form of the hereditary peripheral neuropathy Charcot-Marie-
Tooth disease (CMTX) in humans (Bergoffen et al., 1993; Ionasescu et al., 1994).
Some Cx32 mutations lack the ability to form functional gap junctions when tested
by transfection in vitro (Bruzzone et al., 1994; Omori et al., 1996) which may
restrict diffusion within the cytoplasmic channels in the myelin sheath leading to
pathology. A null mutation of the Cx32 gene has been generated in mice resulting in
a late-onset progressive neuropathy with morphological abnormalities comparable
to CMTX (Anzini et al., 1997; Nelles et al., 1996). The striking difference between
the null mutant and CMTX is the absence of a behavioral phenotype in the mutant
mice which have normal nerve conduction compared to CMTX patients with
impaired nerve conduction.
The organization of the paranodal and nodal regions contain many cellular
specializations to aid nerve conduction. At the internode the axolemma and
Schwann cell periaxonal membrane are separated by a gap of approximately 12 nm
which narrows at the node to 2.5 to 3.0 nm (Peters et al., 1991). The axonal
diameter is also reduced at the node compared with the internode and has a higher
density of neurofilaments (DeWaegh et al., 1992) (Fig. 8B).
The specialization of a myelin sheath allows for the propagation of faster
nerve impulses which travel down the fiber from node to node by a process called
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saltatory conduction. For a given conduction velocity myelination reduces the size
of the axon required by a factor of ten (Ritchie, 1984). Hence the acquisition of a
myelin sheath has played a key role in the evolution of complex nervous systems.
The nerve impulse or action potential in a peripheral myelinated fiber is generated
by the activation of voltage-gated sodium channels (Ritchie, 1984). At the node
there is a vast increase in clusters of voltage-dependent sodium channels by
comparison with the internode, ~1500/mm2 compared with <25 mm2 (Salzer,
1997). The Schwann cell has been shown to be essential for the clustering of sodium
channels at the node and the clustering only takes place with the concurrent
commitment of Schwann cells to a myelin-forming phenotype (Dugandzija-
Novakovic et al., 1995; Joe and Angelides, 1992; Vabnick et al., 1997; Vabnick et
al., 1996). Oligodendrocytes, the myelin-forming cell in the CNS, have also been
shown to induce Na+ channel clustering in vitro and in vivo (Kaplan et al., 1997).
Other molecules which may have a function in channel clustering include two
components of the actin cytoskeleton, spectrin and ankyrin, which are concentrated
at the nodal subaxolemma (Kordeli et al., 1995). Ankyrinc colocalizes with Na+
channels at the node as well as with the cell adhesion molecules (CAMs)
neurofascin and NrCAM, members of the LI family of CAMS (Davis et al., 1996).
The function of these molecules in sodium channel clustering is as yet unknown.
Interestingly, voltage-gated K+ channels are absent at the node and
electrophysiological studies have suggested that K+ channels are present in
paranodal and internodal regions and that they do not contribute to the action
potential but play a role in stabilizing action potential discharge at the node (Chiu
and Richie, 1980). Recent immunolocalization studies of three K+ channel subunits,
Kvl.l, Kvl.2 (members of the Shaker gene subfamily) and Kv(32, demonstrate that
the channels are located in the juxtaparanodal regions (Mi et al., 1995; Rasband et
al., 1998; Wang et al., 1993). Therefore there is a channel-free gap between the
precise localization of Na+ channels at the node and the K+ channels on the other
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side of the paranode leaving the paranodal region where the Schwann cell
paranodal loops are in close apposition to the axolemma free of channels perhaps
for a specialized axon-glial interaction. Rasband and co-workers have shown by
using a demyelination and remyelination paradigm that Schwann cells are
important for K+ channel clustering and redistribution (Rasband et al., 1998).
The axolemma and Schwann cell plasma membrane are tightly apposed at
the paranode where electron microscopic studies have shown rows of regularly
spaced particles in the membranes of both the axon and Schwann cell (Ichimura
and Ellisman, 1991; Wiley and Ellisman, 1980). This close association between the
membranes of both cells in the paranodal region may be functionally very significant
since it is found to be a site for disruption in peripheral neuropathy (Griffin et al.,
1996). This junctional specialization of intermittent densities has been described as
being similar to septate junctions. Recently a component of the paranodal septate-
like junction has been identified by two groups. Paranodin (Menegoz et al., 1997)
also called Caspr (Peles et al., 1997) is a transmembrane protein expressed by
neurons in the PNS and CNS and is developmentally regulated distributing to the
paranodes of mature myelinated axons (Einheber et al., 1997). Paranodin/Caspr
appears to interactwith the cytoskeleton through a region in its intracellular domain
which is capable of binding the erythrocyte protein 4.1 which links the erythrocyte
plasma membrane to cortical actin and spectrin. Thus Caspr has been implicated
as a potential candidate to mediate axon-glial interactions at the paranodes.
In spite of the functional importance the node of Ranvier and paranodal
regions have in impulse conduction, the molecules which play important roles in







Diagrammatic representation of a node of Ranvier and paranode indicating the
locations of E-cadherin, CASPR, Na+ and K+ channels. Modified from Einheber
et al., 1997.
1.4 THE MOLECULAR ORGANIZATION OF COMPACT MYELIN
After spiralization the compact myelin sheath is formed by the simultaneous
loss of cytoplasm within the spirals bringing the cytoplasmic faces of the plasma
membrane together to fuse forming the major dense line and the closing of the 12-14
nm gap in the outer faces of the plasma membrane of the mesaxon to 2.0-2.5 nm
thereby forming the intraperiod line (Peters et al., 1991) (Fig. 9A). It appears that
myelin sheath thickness is directly related to axonal calibre with larger diameter
axons possessing thicker sheaths (Fraher, 1978; Friede and Samorajski, 1967; Hahn
et al., 1987). Therefore axonal calibre regulates whether a Schwann cell will
myelinate or not as well as how much myelin itwill produce which again implicates
neuronal regulatory influences on Schwann cells.
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Figure 9. Multilamellar structure of the compact myelin sheath (A) and topology
of myelin components in the compact and non-compact myelin sheath (B). (A)
A high magnification electron micrograph of the myelin sheath demonstrates the
fused cytoplasmic membranes which form the major dense line (MDL) and the
intraperiod line (IPL) formed by the close apposition of the outer faces of the
plasma membrane. (B) The myelin proteins PO, PMP22, and MBP are present in
compact myelin and MAG, Cx32, and E-cadherin are in uncompacted regions of the
Schwann cell cytoplasmic channel network.
From (A) Raine, 1984; (B) Scherer, 1997.
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1.4.1 The lipid composition of the myelin membrane
The elaboration of a myelin sheath requires an enormous increase in the
biosynthesis of lipids and membrane-associated proteins which compose the
bilayer and which play a role in generating this crystalline multilammelar structure
(Fig. 9B). It is not surprising that the myelin membrane has a high lipid content due
to its specialized function as an insulator of nerve fibers essential for saltatory
conduction (Ritchie, 1984). Myelin has an extremely high ratio of lipid to protein,
80% to 20% respectively, in comparison with equal amounts of lipid and protein in
most plasma membranes. As in all plasma membranes the lipid content in myelin
membranes consists of cholesterol, glycolipids and phospholipids differing only in
that it has a higher cholesterol content (Stoffel and Bosio, 1997) than other
membranes, less phosphatidylcholine, and an abundance of the glycolipids
galactocerebroside and galactosulfatide (Kirschner et al., 1984). Cholesterol is the
most abundant single lipid comprising 25% of the dry weight of PNS myelin,
whereas the phospholipids as a group comprise 50% of the dry weight of myelin
(Norton and Cammer, 1984). Of the phospholipid species, there is about twice as
much by weight of phosphatidylethanolamine as the other species
(phosphatidylcholine, phosphatidylserine, phosphatidylinositol, and
sphingomyelin). The phospholipids and glycolipids are asymmetrically arranged in
the bilayer. Phosphatidylethanolamine, phosphatidylcholine, phosphatidylserine
and phosphatidylinositol are predominantly found in the inner leaflet whereas the
outer extracellular leaflet contains sphingomyelin and the glycolipids (Kirschner and
Ganser, 1982; Stoffel and Bosio, 1997). The unique lipid composition of myelin is
predominantly due to its enrichment of galactocerebroside (GalC) and
galactosulfatide (sulfatide).
The expression of GalC and sulfatide are have been shown to be
developmentally regulated in both the oligodendrocyte lineage and the Schwann cell
lineage (Jessen et al., 1985; Mirsky et al., 1990; Mirsky et al., 1980; Raff et al., 1978;
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Ranscht et al., 1982) and in Schwann cells expression of both glycolipids is up-
regulated by axonal contact (Mirsky et al., 1990; Mirsky et al., 1980). Using the
monoclonal antibodies Ol for GalC and 04 for sulfatide (amongst other species)
the developmental stage of expression of each lipid antigen was determined
demonstrating that in the Schwann cell lineage 04 is expressed in embryonic
Schwann cells and GalC expression parallels the expression of myelin proteins
(Mirsky et al., 1990; Schachner et al., 1981; Sommer and Schachner, 1981). GalC is
also expressed by non-myelin-forming Schwann cells showing that the plasma
membranes of myelin-forming and non-myelin-forming Schwann cells differ less in
lipid than protein composition (Jessen et al., 1985).
Studies using dorsal root ganglion neuron and Schwann cell co-cultures grown
in the presence of saturating levels of the Ranscht anti-GalC monoclonal antibody
to deplete surface GalC indicated that GalC was essential for the formation of
myelin even though these Schwann cells did form 1:1 relationships with axons
(Owens and Bunge, 1990; Ranscht et al., 1987). This suggests that GalC depletion
may alter the physical properties of the membrane resulting in the inhibition of
myelination. It should be noted that the Ranscht monoclonal antibody is not
specific for GalC and also recognizes monogalactosyldiglyceride, sulfatide,
seminolipid and psychosine whereas the Ol antibody recognizes GalC,
monogalactosyldiglyceride, and psychosine, and the 04 antibody recognizes
sulfatide and seminolipid (Bansal et al., 1990).
Two groups have generated a null mutant in which the UDP-galactose-
ceramide galactosyltransferase gene (cgt), the key enzyme in glycolipid synthesis,
has been ablated by gene targeting (Bosio et al., 1996; Coetzee et al., 1996). GalC,
sulfatide and galactodiglyceride were completely absent in the CNS and PNS of the
mutant mice resulting in dysmyelinosis at around postnatal-day 10 to death after 3
weeks. Nerve conduction velocity was drastically reduced. Interestingly, in spite of
the severe phenotype of the mutant mice expression of the genes for the myelin
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proteins Mbp, Pip, Mag and PO were normal and the ultrastructure of myelin
appeared normal in the PNS but in the CNS the periaxonal space was enlarged and
the paranodal loops and nodes were disorganized and lost contact with the
axolemma (Stoffel and Bosio, 1997). The lipid bilayers of the mutants have an
altered lipid composition which leads to increased fluidity, permeability, and
impaired packing (Bosio et al., 1998). It appears that the main function of GalC
and sulfatide is in their contribution to an ion-permeable bilayer necessary for
impulse propagation.
1.4.2 PNS myelin proteins
As lipids play a necessary role in myelination the less abundant protein
constituents of myelin also play an important role in the architecture of the myelin
sheath. The proteins are largely specific to myelin-forming cells in the PNS and
CNS. Early studies at the protein level has shown that many of the myelin proteins
have a role in myelin sheath structure but cloning of the major myelin genes has led
to functional studies in vivo by targeted deletion of each gene through homologous
recombination.
1.4.2.1 PO
PO is the most abundant protein of PNS myelin and accounts for over 50% of
the total protein in compact myelin (Greenfield et al., 1973; Ishaque et al., 1980). It
is a glycoprotein with a molecular weight of 28,500 originally identified by lectin
binding studies (Brostoff et al., 1975; Everly et al., 1973; Kitamura et al., 1976;
Wood and Dawson, 1973). The nucleotide sequence of PO as deduced from the
cDNA sequence and by the direct protein sequence depicts an integral membrane
protein with a single transmembrane domain, an N-terminal extracellular domain
and a C-terminal cytoplasmic domain (Barbu, 1990; Hayasaka et al., 1991; Lemke
and Axel, 1985; Sakamoto et al., 1987). X-ray crystallography of the extracellular
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domain of PO has revealed that PO forms tetramers in the plane of the membrane
which interact with tetramers in the apposing membrane forming a lattice that holds
myelin together (Shapiro et al., 1996).
The primary structure of PO reveals a signal sequence comprising the first 28
amino acids of the open reading frame which is necessary for protein translocation
and membrane insertion. The extracellular domain contains one site for N-linked
glycosylation. PO has previously been shown to be N-glycosylated at a single
position with an extracellularly positioned oligosaccharide chain (Ishaque et al.,
1980; Peterson and Grevner, 1978; Wood and McLaughlin, 1975). Two
carbohydrate epitopes, L2/HNK-1 and L3, which are found in neural cell adhesion
molecules (CAMs) are present on the chain (Bollensen and Schachner, 1987;
Edelman, 1983). The carbohydrates may be important for PO by influencing the
conformation of the extracellular domain, but they are unlikely to participate in the
homophilic adhesion of the extracellular myelin membranes (Filbin and Tennekoon,
1993; Filbin and Tennekoon, 1991). The homophilic adhesive properties of PO are
more likely due to the presence of a single immunoglobulin-like (Ig-like) domain in
its extracellular region (Filbin et al., 1990). Thus PO is a member of the
immunoglobulin gene superfamily (Lai et al., 1987; Salzer and Colman, 1989) a
large family of proteins known to mediate cell-cell interactions in the nervous and
immune systems but unlike most members of this family which possess multiple Ig-
like domains (Williams and Barclay, 1988). Transfection studies have provided
direct evidence that PO functions homotypically to adhere plasma membranes of
adjacent cells (D'Urso et al., 1990; Filbin and Tennekoon, 1990; Schneider-Schaulies
et al., 1990). Zones of cell-cell contact in transfected cells expressing P0 were
shown to contain high concentrations of the protein. Transfection studies also
show that formation of a disulfide bond in the Ig domain is essential for its
homophilic adhesion (Zhang and Filbin, 1994) and site-directed mutagenesis
studies demonstrated that both molecules of P0 in the homophilic pair must be
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glycosylated for adhesion to occur (Filbin and Tennekoon, 1993). Although one
adhesive domain in the protein has been mapped to amino acids 91-95 there is an
indication that there is more than one domain responsible for cell adhesion (Zhang
et al., 1996). Transfection studies have shown that the adhesive properties of the
extracellular domain depends on the intact cytoplasmic domain (Wong and Filbin,
1994) and the interaction of PO with microtubules was important for this adhesion
(Wong and Filbin, 1996).
Myelin basic proteins (MBPs) have been postulated to be involved in myelin
compaction based on studies of the shiverer mouse mutant. In the shiverer mutant
there is a deletion of a large part of the Mbp gene resulting in a severe CNS
phenotype (Kirschner and Ganser, 1980). In the fibres where myelin has formed,
the major dense line is missing which implies that MBPs function in compaction of
the apposed cytoplasmic faces of myelin to form the major dense line (Privat et al.,
1979). Although MBP is normally expressed in the CNS and the PNS, the mutant
mice have functionally normal myelin with little structural abnormality in peripheral
nerves (Kirschner and Ganser, 1980; Rosenbluth, 1980). Since PO, which is specific
to PNS myelin, has a basic C-terminal tail, it has been suggested that PO takes the
place of MBP in the PNS since PO is expressed exclusively in the PNS (Lemke and
Axel, 1985).
The cytoplasmic domain of PO has been postulated to interact
electrostatically with acidic lipids present in the cytoplasmic face of the bilayer to
form the major dense line of the myelin sheath. When PO is purified from myelin it
is complexed with tightly bound acidic lipids of which the most abundant is
phosphatidylserine (Ishaque et al., 1980). Phosphorylation by protein kinase C
regulates the strength of the electrostatic interaction between PO and negatively
charged phospholipids and alters myelin compaction. Dephosphorylation of PO is
known to occur during compaction when the major dense line forms (Eichberg and
Iyer, 1996; Hilmi et al., 1995; Rowe-Rendleman and Eichberg, 1994; Suzuki et al.,
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1990). A peptide fragment containing the cytoplasmic region of P0 was found to
bind and aggregate phospholipid vesicles by ionic interactions providing further
evidence that the cytoplasmic domain of P0 may be responsible for the formation
and maintenance of the major dense line (Ding and Brunden, 1994).
Earlier studies have shown that P0 is expressed exclusively in the PNS in
myelin-forming Schwann cells and localized to compact myelin (Brockes et ah,
1980; Trapp et al., 1981). P0 mRNA levels rise dramatically from birth and peak in
actively myelinating Schwann cells (Stahl et al., 1990; Trapp et al., 1988). Axonal
contact regulates P0 expression since levels fall sharply in transected nerve or when
Schwann cells are removed from axonal contact and placed in culture (Lemke et al.,
1988; Mirsky et al., 1980; Politis et al., 1982). Some studies have shown that even
after permanent nerve transection a basal level of P0 mRNA and protein remain
(LeBlanc and Poduslo, 1990; Poduslo et al., 1984; Poduslo et al., 1985; Poduslo
and Windebank, 1985). In addition Po mRNA and protein is expressed long before
myelination during embryogenesis in the neural crest, Schwann cell precursors and
embryonic Schwann cells indicating an early role for P0 in Schwann cell
development (Bhattacharyya et al., 1991; Lee et al., 1997; Zhang et al., 1995).
When Schwann cells myelinate, there is a dramatic up-regulation of P0 basal level
expression and the basal expression down-regulates in Schwann cells that do not
myelinate indicating that there is both positive and negative regulation of P0 gene
expression.
The P0 gene has been isolated and consists of 6 exons distributed over 7 kb
and is located on mouse chromosome 1 (Lemke et al., 1988; You et al., 1991).
Evidence that P0 expression is important for myelination came from experiments
using a retrovirus-mediated antisense mRNA strategy which suppressed P0 protein
synthesis and thereby inhibited spiralization and compaction (Owens and Boyd,
1991).
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Mice with a null mutation of the PO gene have been generated by homologous
recombination (Giese et al., 1992). Homozygous null mice exhibit a behavioral
phenotype first evident at 2 to 4 weeks of age with progressive disturbances in
motor coordination, tremors, and eventually occasional convulsions but not death.
At the cellular level, peripheral nerves were severely hypomyelinated with a
majority of fibers containing fewer spirals around axons, non-compacted regions,
and fewer compacted regions with widened intraperiod lines in support of the role
of PO as a mediator of intracellular and extracellular membrane adhesion. The loss
of PO did not prevent the segregation of axons in a 1:1 relationship or
ensheathment. Interestingly, there was some axonal degeneration and an up-
regulation of several proteins, LI, NCAM, NGFR, MAG, PLP, and tenascin. Some
sheaths were observed with normal periodicity and a normal major dense line
suggesting that other proteins may compensate for the lack of PO or membrane
adhesion can be mediated by other proteins. Double mutants generated by crossing
the PO null mutant with the shiverer mutant have peripheral nerve myelin devoid of
both the major dense line and the intraperiod line implicating MBP as the mediator
of intracellular adhesion in the PO null mutants (Martini et al., 1995). Therefore
both PO and MBP contribute to the formation of the major dense line. The
phenotype of the double mutant mice also revealed that not only are MBP and PO
involved in compaction but also regulate myelin thickness (Martini et al., 1995).
The PO gene does not show linkage with any spontaneous mutations in the
mouse. Point mutations in the human PO gene have been linked to the peripheral
neuropathy Charcot-Marie Tooth neuropathy type IB (CMT1B), Dejerine-Sottas
syndrome, and congenital hypomyelination (Hayasaka et al., 1993; Kulkens et al.,
1993; Warner et al., 1996). These mutations are dominant because individuals with
CMT1B are heterozygous for the normal and mutant alleles whereas heterozygous
mice for the PO null allele have a normal phenotype.
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Transgenic mouse studies have indicated that the transcriptional regulation of
the PO gene is controlled by a 1.1 kb region flanking the transcription start site.
When linked to reporter genes this fragment drives developmental stage and
Schwann cell specific expression in transgenic mice (Hayasaka et al., 1993; Kulkens
et al., 1993; Messing et al., 1992; Messing et al., 1994; Warner et al., 1996). Further
dissection of the regulatory elements in the core PO promoter has identified two
regulatory elements, a G/C-rich element that binds nuclear factor Spl and a CAAT
box that binds NF-Y. These elements were shown to be essential for transcription
in transfected Schwann cells (Brown and Lemke, 1997).
1.4.2.2 Myelin Basic Proteins
The myelin basic proteins (MBPs) are a group of small, peripheral membrane
proteins synthesized on free polysomes, whose mRNAs originate from a single gene
by alternative splicing of the primary transcript (Aruga et al., 1991; de Ferra et al.,
1985; Kitamura et al., 1990; Newman et al., 1987; Takahashi et al., 1985).
Although the MBPs are quite abundant proteins in CNS myelin, in PNS myelin they
comprise less than 15% of the total protein (Greenfield et al., 1973). They are
thought to bring about the apposition of the cytoplasmic membrane leaflets that
form the major dense line of the myelin sheath. The MBPs are positively charged
molecules which exhibit a high affinity for acidic lipids in the bilayer (Maggio and
Yu, 1992; Mendz, 1992; Ong and Yu, 1984). It has been suggested that this affinity
for membranes is non-specific and a mechanism for MBP mRNA transport has
evolved which targets these proteins to regions where myelin compaction occurs
(Brophy et al., 1993; Colman et al., 1982; Gould and G., 1990; Griffiths et al., 1989;
Trapp et al., 1987; Verity and Campagnoni, 1988). The transport of MBP mRNA
requires microtubules and kinesin as demonstrated in culture studies using anti-
sense oligonucleotides to suppress kinesin expression and agents to depolymerize
microtubules (Carson et al., 1997).
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The mouse Mbp gene is 32 kb in size comprising seven exons and maps to
chromosome 18 (Roach et al., 1985; Takahashi et al., 1985). The MBP isoforms
which range in size from 14 kDa to 21.5 kDa differ by the presence or absence of
sequences encoded by exons 2, 5, and 6 (de Ferra et al., 1985; Newman et al., 1987;
Roach et al., 1985; Takahashi et al., 1985). Although functional differences
between the isoforms are not apparent, when MBP isoforms are expressed in
heterologous cells and shiverer oligodendrocytes, the exon 2 containing isoforms, 17
kDa and 21.5 kDa, have a diffuse cytoplasmic and nuclear distribution whereas the
14 kDa and 18.5 kDa isoforms are membrane-associated (Allinquant et al., 1991;
Pedraza et al., 1997; Staugaitis et al., 1990). The isoforms are developmentally
regulated with exon 2 containing isoforms appearing earlier (Barbarese et al., 1978;
Carson et al., 1983).
Recently the 32 kb Mbp gene has been found to part of a larger gene called
golli-mbp (gene in the oligodendrocyte lineage) which spans over 100 kb in length
(Campagnoni et al., 1993; Pribyl et al., 1993). The golli-mbp gene includes 5
additional exons with an additional transcription initiation site far upstream of the
myelin-specific site and encodes at least three alternatively spliced golli mRNAs.
The golli-mbp gene is expressed early during development in CNS neurons as well as
other tissues (Landry et al., 1996).
As mentioned in the previous section, the shiverer mutant has a deletion in
the Mbp gene which encompasses exon 3 to 7 resulting in the complete absence of all
the MBP isoforms (Molineaux et al., 1986; Roach et al., 1985). Homozygotes for
the mutation display a tremor or "shivering" phenotype, convulsions and early
death. The PNS of shiverer mice is functionally normal and few structural
abnormalities are found. These include reduction in axon calibre and myelin sheath
thickness and an increase in the number of Schmidt-Lanterman incisures to more
than double (Gould et al., 1995; Peterson and Bray, 1984). The wild type Mbp gene
introduced by transgenesis can rescue the shiverer phenotype both behaviorally and
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structurally (Readhead et al., 1987). Interestingly, when transgenic shiverer mice
were generated using a construct which encoded the 14 kDa isoform only, the
mutant phenotype was also rescued indicating that just one MBP isoform is
sufficient for normal myelin compaction (Kimura et al., 1989).
The Mbp gene contains separate enhancers for CNS and PNS expression
(Gow et al., 1992). The regulatory elements for Schwann cell specific expression are
still unknown but a 1.9 kb sequence upstream of the myelin transcription initiation
site of the Mbp gene can direct transcription in oligodendrocytes at the correct
developmental stage but not in Schwann cells.
1.4.2.3 Peripheral Myelin Protein 22
The glycoprotein peripheral myelin protein 22 (PMP22) accounts for 2 to 5%
of total protein from rat PNS myelin (Suter and Snipes, 1995b). Although PMP22
is most abundant in peripheral nerve its expression is not restricted to the PNS;
there are low levels of mRNA expression in lung, intestine, heart, brain, skeletal
muscle, testis, and liver (Baechner et al., 1995; Manfioletti et al., 1990; Spreyer et
al., 1991; Suter and Snipes, 1995b; Welcher et al., 1991). PMP22 is identical to the
growth arrest-specific mRNA gas-3, periodic acid Schiff protein (PASII), crushed
denervated cDNA 25 (CD25) and sciatic nerve regeneration clone 13 (SR13) but
was finally called PMP22 (Kitamura et al., 1976; Manfioletti et al., 1990; Snipes et
al., 1992; Spreyer et al., 1991; Welcher et al., 1991). The identification of gas-3 was
based on its upregulation in growth-arrested NIH 3T3 fibroblasts indicating that
PMP22 may be involved in cell cycle regulation in non-neural tissue (Suter and
Snipes, 1995b).
The deduced amino acid sequence of PMP22 predicts a protein of 17 kDa
which has one N-linked glycosylation site hence the Mr on SDS-PAGE is 22 kDa
(Manfioletti et al., 1990; Snipes et al., 1992; Spreyer et al., 1991; Welcher et al.,
1991). PMP22 is an extremely hydrophobic protein with four transmembrane
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domains (Spreyer et al., 1991), two extracellular domains and amino- and carboxy-
terminal domains residing in the cytosol (D'Urso and Miiller, 1997). An N-linked
carbohydrate chain carries the L2/HNK-1 adhesion epitope (Snipes et al., 1993)
and is located in the first putative extracellular loop (Pareek et al., 1993). The
protein has a signal sequence at its amino terminus which is not cleaved in the
mature protein (Manfioletti et al., 1990).
PMP22 has been localized to myelin-forming Schwann cells in peripheral
nerve and more specifically to the compact myelin sheath (Haney et al., 1996;
Snipes et al., 1992). In addition, at the ultrastructural level PMP22 was localized
to the membranes of non-myelin-forming Schwann cells in human peripheral nerve
(Haney et al., 1996). In the CNS PMP22 mRNA has been detected in motoneurons
by in situ hybridization (Parmantier et al., 1995). Like other myelin proteins,
Pmp22 gene expression is regulated by axonal contact as shown by sciatic nerve
transection (Snipes et al., 1992; Spreyer et al., 1991) and is also upregulated in
cultured Schwann cells by exposure to agents which elevate intracellular cAMP
(Pareek et al., 1993). Interestingly, PMP22 mRNA in other cell types is not
upregulated by raising intracellular cAMP (Spreyer et al., 1991). This suggests that
cAMP may induce the expression of a Schwann cell specific transcription factor
which influences differentiation specific genes.
The human PMP22 gene spans 40 kb and contains 4 coding exons and two
alternatively spliced 5'-non-coding exons (exon 1A and IB) (Suter et al., 1994). The
gene is regulated by the use of two alternative promoters, one located upstream of
exon 1A and the other upstream of exon IB. The proteins produced from each
mRNA are identical but transcripts containing exon 1A are preferentially expressed
in peripheral nerve while transcripts containing exon IB are preferentially expressed
in other tissues (Suter et al., 1994). It is likely that there may be Schwann cell
specific regulatory elements controlling Schwann cell PMP22 expression.
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Point mutations in the PMP22 gene are responsible for autosomal dominant
peripheral neuropathies in humans and mice. The most common type in humans is
Charcot-Marie-Tooth disease 1A (CMT1A) affecting 1 in 2,500 people (for reviews,
(Suter and Snipes, 1995a; Suter and Snipes, 1995b). The human PMP22 gene was
mapped within a 1.5 Mb duplication on human chromosome 17 associated with the
most common form of CMT1A disease (Lupski et al., 1991; Matsunami et al., 1992;
Timmerman et al., 1992; Valentijn et al., 1992). A smaller number of patients with
CMT1A have a point mutation in the gene but have a similar phenotype as the
increased gene dosage form (Suter and Snipes, 1995a). A more severe peripheral
neuropathy called Dejerine-Sottas syndrome (DSS) is also the result of point
mutations in the PMP22 gene (Roa et al., 1993). Mutations in the PMP22 gene also
result in a disease with a mild phenotype called hereditary neuropathy with
liability to pressure palsies (HNPP) also referred to as tomaculous neuropathy
which is associated with a deletion of the same region of chromosome 17 that is
duplicated in CMT1A (Chance et al., 1993; Nicholson et al., 1994). Thus gene
dosage and mutations in the PMP22 gene give rise to distinct neuropathies
indicating that the correct regulation of the gene is critical for normal function.
The Trembler (Tr) mutation in the mouse is characterized by a severe
peripheral neuropathy with hypomyelination and Schwann cell proliferation into
adulthood (Henry et al., 1983; Henry and Sidman, 1988). Heterozygous mutants
have some axons with thin myelin sheaths but the majority of axons are
unsheathed. The abnormal Schwann cell proliferation is characterized by onion
bulb formation which is indicative of demyelination-induced Schwann cell
hypertrophy (Dyck et al., 1993). Homozygous mutants have almost no myelin.
The Tr) allele has a more severe phenotype and the homozygous mutants are lethal.
It has been shown that both Tr and Tr) have point mutations in the Pmp22 gene in
putative transmembrane domains (Suter et al., 1992). In Tr there is a substitution
of an aspartic acid residue for a glycine residue within the fourth transmembrane
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domain of Pmp22 whereas in the Tr] there is a leucine to proline substitution in the
first putative transmembrane domain (Suter et al., 1992). The same mutation in
PMP22 as in TrJ mutant mice has been found in a family with a severe form of
CMT1A (Valentijn et al., 1992). There is evidence from transfection studies that
the Tr and Tr] mutant proteins are not inserted into the plasma membrane and
accumulate in the ER and Golgi compartments suggesting that impaired trafficking
may contribute to the defect (D'Urso et al., 1998; Naef et al., 1997). One paper
suggests than in Tr] the PMP22 may be in the lysosomal/endosomal compartments
(Notterpek et al., 1997).
Transgenic mice and rats have been generated which overexpress the Pmp22
gene (Magyar et al., 1996; Sereda et al., 1996). Transgenic rats display a
phenotype similar to CMT1A characterized by hypomyelination and Schwann cell
hypertrophy (Sereda et al., 1996). Transgenic mice with a high copy number of
Pmp22 transgenes displayed a severe phenotype with almost a complete lack of
myelin (Magyar et al., 1996). Pmp22 null mutant mice have been generated by
homologous recombination and display a progressive hind limb paralysis (Adlkofer
et al., 1995). At the cellular level there was evidence of demyelination, tomacula,
onion bulb formation and axonal loss. Heterozygous mice Pmp+/~ display a
neuropathy with a late onset and a mild degree of demyelination similar to HNPP
(Adlkofer et al., 1997). Taken together the spontaneous mutations and engineered
mutations and have shown that PMP22 is necessary for normal myelination and
may have a role in cell growth, the regulation of myelin thickness, and maintenance
ofmyelin.
1.4.2.4 Myelin Associated Glycoprotein
Myelin-associated glycoprotein (MAG) is a minor component of PNS and
CNS myelin comprising about 0.1% (Figlewicz et al., 1981; Quarles, 1984). Its
presence was first demonstrated biochemically in CNS myelin (Everly et al., 1973)
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and it was later demonstrated by immunocytochemistry in the PNS where it
specifically localized to the uncompacted regions in Schwann cells which include
periaxonal membranes, Schmidt-Lanterman incisure, paranodal loops, and the
outer mesaxon but was absent from compact myelin (Schober et al., 1981;
Sternberger et al., 1979; Trapp et al., 1982; Trapp et al., 1984a). Based on its
localization it was suggested that MAG had a role in forming and stabilizing the 12
to 14 nm periaxonal space and cytoplasmic collar (Trapp et al., 1984a; Trapp et
al., 1984b). MAG was shown to be expressed early in development when Schwann
cells first ensheathe axons and form a 1:1 relationship (Martini and Schachner,
1986; Owens and Bunge, 1989). MAG co-localizes with the microfilament
components F-actin and spectrin suggesting that MAG may interact with the
cytoskeleton (Trapp et al., 1989b).
The Mr of MAG by SDS-PAGE is 100 kDa but when deglycosylated, two
isoforms of 72 kDa (L-MAG) and 67 kDa (S-MAG) are apparent (Frail and Braun,
1984). Both isoforms are present in the CNS where L-MAG is more abundant than
the smaller isoform (Salzer et al., 1990). In the PNS S-MAG is predominant and
peaks during the most active phase of myelination but, in contrast to the CNS ,the
level of L-MAG is very low (Frail et al., 1985; Tropak et al., 1988). Two MAG
mRNAs as deduced from cDNA clones arise by alternative splicing and differ in
the presence or absence of an insert near the 3' end (Arquint et al., 1987; Lai et al.,
1987; Salzer et al., 1987; Tropak et al., 1988). Both isoforms share an N-terminal
signal sequence, a large extracellular N-terminal domain, a single transmembrane
domain but have different C-terminal cytoplasmic domains (Pedraza et al., 1990).
Analysis of the extracellular domain of MAG revealed five repeats with homology
to each other and with the Ig domain of members of the immunoglobulin gene
superfamily known to mediate cell adhesion which includes the neural cell adhesion
molecules LI, NCAM, P0 (Arquint et al., 1987; Lai et al., 1987; Salzer et al., 1987).
The extracellular region of MAG also has the L2/HNK-1 carbohydrate structure
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which has been shown to be involved in cell-cell interactions (Kruse et ah, 1984;
Ktinemund et ah, 1988; MacGarry et ah, 1983). Based on MAGs structural
similarity to adhesion molecules with Ig domains and its localization to the
periaxonal collar it was thought to have a role in axon-glial interactions through
recognition and adhesion during initial envelopment. In fact when MAG was
overexpressed in vitro it was shown to promote initial investment of axons by
Schwann cells (Owens et al., 1990). Further support that MAG functions in cell
adhesion came from the demonstration that MAG-containing liposomes specifically
bind to axons (Johnson et al., 1989; Poltorak et al., 1987; Sadoul et al., 1990).
MAG has been shown to promote (Johnson et al., 1989) or inhibit neurite outgrowth
from certain neuronal populations (McKerracher et al., 1994; Mukhopadhyay et al.,
1994) and the inhibitory interaction is through a sialoglycoprotein (Debellard et al.,
1996). It has been suggested that MAG is a potent inhibitor of axonal regeneration
in the CNS and could contribute to the absence of regeneration after injury (Tang et
al., 1997).
The Mag gene consists of 13 exons spanning about 16 kb (Lai et al., 1987;
Nakano et al., 1991) and maps to mouse chromosome 7 (D'Eustachio et al., 1988)
and human chromosome 19 (Barton et al., 1987). The transcript which encodes L-
MAG contains all of the exons except exon 12 which is present in S-MAG and
introduces an in frame termination codon. S-MAG lacks the non-coding exon 2. A
third MAG transcript has been identified which lacks exon 2 and 12 (Fujita et al.,
1989).
Further support that MAG was essential for myelination came from in vitro
experiments in which MAG antisense transcripts were constitutively expressed by
retroviral transfection of Schwann cells with antisense oligonucleotides thereby
inhibiting myelin formation (Owens and Bunge, 1991). Therefore it was surprising
when two groups independently generated Mag null mice by homologous
recombination and found that myelin formed normally in the PNS and CNS in the
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absence of MAG (Li et al., 1994; Montag et al., 1994). The behavior of the mutant
mice was normal except for a reduction in fine motor coordination (Li et al., 1994).
On the cellular level there were no significant abnormalities in young animals but
after 8 months of age, peripheral nerves showed signs of axon and myelin
degeneration in about 30% of the fibers (Fruttiger et al., 1995). The phenotype of
the Mag null mutant indicates that MAG is not required for initial ensheathment or
spirialization in the PNS but has a role in maintenance. To test whether N-CAM
may be compensating for MAG in the mutant, double mutants were generated by
crossing N-CAM null mice with Mag null mice. The double mutants had a
phenotype with a slightly earlier onset when compared to the Mag mutant
demonstrating that N-CAM does not compensate for MAG but may have a partial
effect on axon-Schwann cell integrity (Carenini et al., 1997).
1.4.2.5 Proteolipid Protein
Proteolipid protein (PLP) is the major integral membrane protein in CNS
myelin comprising about 50% of total protein (Lees and Brostoff, 1984).
Alternative splicing of the Pip gene results in two isoforms, PLP and the smaller
isoform DM-20 (Nave et al., 1987). The isoforms are developmentally regulated in
the CNS where PLP is a major structural component of myelin in the adult with a
possible role in maintaining the intraperiod line (Duncan et al., 1987). DM-20 is
expressed at lower levels in the adult but predominates during early myelination
and is the only isoform expressed in oligodendrocyte precursors during
embryogenesis suggesting an additional role for PLP (Ikenaka et al., 1992; Timsit et
al., 1992; Timsit et al., 1995). Although PLP is the major component of myelin in
the CNS it accounts for <1% of the total myelin protein in the PNS where DM-20 is
the predominant isoform expressed during development and in the adult (Griffiths
et al., 1995; Lemke, 1992; Pham-Dinh et al., 1991). PLP mRNA and protein have
been detected in both myelin-forming and non-myelin-forming Schwann cells
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(Agrawal and Agrawal, 1991; Griffiths et al., 1995; Griffiths et al., 1989; Puckett et
al., 1987). DM-20 is the isoform which is present in the cytoplasmic regions of the
internode, non-myelin-forming Schwann cells, the satellite cells of spinal, cranial
and autonomic ganglia, and ensheathing cells of the olfactory bulb whereas PLP is
present in the perinuclear region of myelin-forming Schwann cells (Griffiths et al.,
1995). Neither isoform was found in compact myelin. Increasing the level of PLP
and DM-20 expression in transgenic mice leads to the incorporation of PLP but not
DM-20 into compact myelin indicating that each isoform is targeted differently in
the Schwann cell (Anderson et al., 1997). The Pip gene is expressed early during
Schwann cell development demonstrated by analysis of transgenic mice carrying a
transgene composed of the Pip promoter and first intron fused to the LacZ gene
(Wight et al., 1993) and at E12.5 by in situ hybridization using a DM-20 riboprobe
(Peyron et al., 1997).
Although missense mutations in PLP can cause dysmyelination in the CNS
which results in the severe Pelizaeus Merzbacher disease (PMD) and the milder X-
linked spastic paraplegia type 2 in humans, the PNS of these patients remains
normal. In addition the PNS is not affected in the jimpy mouse mutant which
exhibits a severe CNS dysmyelination and death at 3 to 4 weeks of age (Griffiths et
al., 1995; Nave, 1996). Recently, a kindred was described in which a novel single
base-pair deletion resulted in the complete absence of PLP/DM-20 expression
causing a less severe form of PMD with widespread CNS demyelination and
progressive demyelinating peripheral neuropathy (Garbern et al., 1997). Because
peripheral myelin is formed in this kindred and subsequently breaks down it
suggests that PLP is necessary for the maintenance of PNS myelin sheaths in
humans (Garbern et al., 1997). In contrast mice carrying a null allele for Pip as a
result of targeted gene inactivation by homologous recombination do not exhibit
dysmyelination and have normal motor function (Klugmann et al., 1997) but it
remains to be seen if they will exhibit a similar phenotype to the human null
46
mutation at an older age; alternatively PLP may be more important for myelin
stability in humans than in mice.
1.4.2.6 Minor components of the PNS myelin proteins
The protein P2 is a minor constituent of rodent PNS myelin protein
comprising less than 1% of total myelin protein whereas in humans it comprises
14% of total myelin protein (Greenfield et al., 1973). P2 is a member of a large
family of fatty acid binding proteins (FABPs) based on sequence homology with
other family members and is thought to be involved with the transport of
intracellular fatty acids (Martenson and Uyemura, 1992; Narayanan et al., 1988).
Another minor component of PNS myelin proteins is the enzyme 2'/3'-cyclic
nucleotide-3'-phosphodiesterase (CNPase) which comprises 0.5 to 1% of PNS
myelin proteins. CNPase levels are much higher in oligodendrocytes compared to
Schwann cells with even lower abundance in non-neural cells. CNPase was the first
enzyme to be characterized as a component of the myelin membrane (Adams et al.,
1963). Developmental studies have shown that CNPase is an early appearing
myelin-associated protein in the developing nervous system (Braun et al., 1988). In
myelin-forming cells, CNPase is concentrated at the cytoplasmic side of all
membranes except those of compact myelin. The function of this protein in the
myelin-forming cell is still unclear but studies in transgenic mice in which the protein
was overexpressed revealed that CNPase may have a role in membrane expansion
during myelination and may help target MBP to compact myelin (Yin et al., 1997).
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1.5 BACKGROUND TO THE PROJECT
Myelination requires dramatic changes in cell shape which must involve the
cytoskeleton to regulate the extension of myelin processes during axonal
ensheathment. The cytoskeleton of oligodendrocytes has been shown to be
intimately involved in the extension ofmyelin processes in the rat CNS (Wilson and
Brophy, 1989). The Schwann cell cytoskeleton must also play a major role in the
process of myelination because the Schwann cell undergoes dramatic changes in cell
shape during process elongation along axons, in segregation of an individual axon,
and in spiralization around the axon. In fact depolymerization of actin
microfilaments in Schwann cell/neuron co-cultures disrupts myelination and results
in the failure of Schwann cells to form a 1:1 relationship with axons (Fernandez-
Valle et al., 1997).
It is well established that axonal signals are crucial for Schwann cell
differentiation but the precise intracellular events following that interaction remain
elusive. In an attempt to identify molecules that may be involved in the intracellular
mechanism that drives axonal ensheathment and regulates changes in cell shape, a
cytoskeleton-associated protein called periaxin was isolated from the Triton X-100
insoluble fraction of rat PNS myelin (Gillespie et al., 1994). An antibody raised
against the protein (pl70) recognized a relatively abundant protein of Mr 170 kDa
in sciatic nerve homogenate on SDS-polyacrylamide gel electrophoresis.
Immunofluorescence analysis of cultured cells from rat sciatic nerve demonstrated
that periaxin was expressed by Schwann cells.
A full length cDNA was cloned and sequenced and the deduced amino acid
sequence predicted a protein of 147 kDa with no sequence similarity to any other
protein sequence in the database. Periaxin is not an integral membrane protein
based on the absence of transmembrane domains by hydrophobicity plot analysis





Domain structure of L-periaxin
near the N-terminus from amino acid 118 to 196 and an acidic domain between
amino acids 1036 to 1163 near the C-terminus. A unique region of pentamer
repeats was identified which stretches over approximately 300 amino acids from
amino acids 432 to 725 (Fig. 10). This repeat region comprised a consensus
pentapeptide:
aliphatic nonpolar - pro - glu or asp - aliphatic nonpolar - variable
and the tripeptide spacer: leu pro lys.
It was suggested that the repeat region is more inflexible than the rest of the protein
and may serve as an extender between the N and C-terminal domains.
Two other proteins with identical Mr had been isolated from PNS myelin,
Pl70K and Schwann cell associated glycoprotein (SAG) (Dieperink et al., 1992;
Shuman et al., 1988). Both proteins had been characterized as glycoproteins but
based on relative abundance (-5% of total myelin protein), localization by
immunocytochemistry, Triton X-100 insolubility and upregulation by cAMP
analogues (Shuman et al., 1988), they are probably periaxin (Gillespie et al., 1994).
The structure of the murine Prx gene was determined (Dytrych et al., 1998)
and localized to mouse chromosome 7 (Gillespie et al., 1997) which is syntenic with
human chromosome 19. The Prx gene comprises 7 exons and spans approximately
20.6 kb and encodes two mRNAs of 5.2 kb and 4.6 kb (Fig. 11). The two mRNAs
are of approximately equal abundance and are produced by alternative splicing by
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432 GPEVK APK 531 VPEMK 627 IPDMA
440 GPEVK LPK 536 LPDMK LPK 632 VPDVR
448 VPEIK LPK 544 VPEMA 637 LPEVQ LPK
456 APEAA 549 VPDVH 645 VSELK LPK
461 IPDVQ 554 LPDIQ LPK 653 VPEMT
466 LPEVQ LPK 562 VPEMK 658 MPDIR
474 MSDMK LPK 567 LPDMK LPK 663 LPEVQ LPK
482 IPEMA 575 VPEMA 671 VPDIK
487 VPDVH 580 VPDVR 676 LPEIK LPK
492 LPEVK LPK 585 IPEVQ LPK 684 VPEMA
500 VPEMK 593 VSEVK LPK 689 VPDVP
505 VPEMK LPK 601 IPDMA 694 LPELQ LPK
513 IPEMA 606 VPDVR 702 VPQ
518 VPDVH 611 LPELQ LPK 705 VPDVH LPK
523 LPDIQ LPK 619 MSEVK LPK 713 VPEMK LPK
721 VPEAQ
Figure 10. Alignment of the deduced amino acid sequence comprising the
repeat region of L-periaxin. The repeated pentapeptide motifs with the tripeptide
spacers are shown. The underlined sequences contain a serine substitution for
proline.
From Gillespie et al., 1994.
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Figure 11. Schematic representation of the structure of the periaxin gene with
the 5.2 and 4.6 kb mRNAs. The murine periaxin gene spans 20.6 kb and is
comprised of 7 exons (red boxes). Alternative splicing of a retained intron
generates two mRNAs, 5.2 and 4.6 kb. The 4.6 kb mRNA is translated into the 147
kDa protein, L-periaxin. Intron 6 (600 bp) is retained in the larger transcript which
is translated into a 16 kDa protein, S-periaxin. Coding sequences are shown as
filled boxes and non-coding sequences as empty boxes. Spliced sequences from the
primary gene transcript are shown as dashed lines. Intron 6 is depicted as a purple
box.
a rare retained intron mechanism (Dytrych et al., 1998). The 5.2 kb mRNA includes
intron 6 located between exons 6 and 7. The retained intron introduces a stop
codon and encodes a smaller isoform with an intron-encoded C-terminus of 21
amino acids. Therefore the Prx gene encodes two proteins, the larger 147 kDa
protein now called L-periaxin and the truncated isoform of 16 kDa, S-periaxin
(Dytrych et al., 1998).
The core promoter of the Prx gene (Fig. 12) lacks a TATA box but has a GC
rich region between the transcription initiation site and a CAAT box (-86 to -76)
which is common for TATA-less promoters (Dytrych et al., 1998). The presence of
an octomer motif (-236 to -243) which is a potential binding site for POU family
transcription factors may play an important role in cell-specific regulation but it is
unlikely in this case since in the SCIP null mutants L-periaxin was expressed
(Bermingham et al., 1996). A GCRE element (-317 to -306) has been identified in
the promoters of several myelin genes and has been implicated in mediating the
induction of these genes by forskolin (Li et al., 1994). The presence of this element
in the Prx promoter and other myelin genes helps to explain the ability of cAMP to
upregulate myelin gene expression in the absence of axonal contact (Lemke and
Chao, 1988).
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-491 ACAAC CTTCA AGAGG TAAGC
-441 AACTG AGGGC CCAGT GATGC
-391 AATGC CTGAG CTGGG ACTTG
-341 GGTTG TTTTG AGAGT CTCAG
-291 GCCCA GAGAT GATGG GGGTG
SCIP/Oct-6
-241 GCAAA TTCTT GAACT AAGGC
-191 GAGGT TCATG TTTCC ACATC
-141 AGAAG GGGAT GTTTG TTTCC
CAAT BOX
-91 CAGGA CAGCC AATGG CCAGG
-41 TTTTC CCTCC CAGCC CAAGG
+10 TGGAG GTGTC TGGAG GCCCA
ATTCT TACTA CTACT ATTTC AAAGA CAAAG
CCTGT GATTG CTGAA GTTCC CGGAG CCAGG
AACCC AAATT CTCAA GGAGA CAGTG TAAGA
GCRE
GGACT ATGTG GGCTA GGCCT GGGTC CAGGA
GGGTG CTGAG TATTC GAATG GGGGT GGTAT
TGGGG TGGAG GTCTG GGCTC TGGCA AGGGA
CCCAC GCCCT TGCAG ATGGA TGTAG TGCAC
CCACC ACCCA CCCTT TGGGT GACAT CACAG
GTCCC CCTTC TGCCC CCCCC TTCCC ATTCC
+ 1
CTAGG ACTAA ACAGA CAGAC CAAGG AGCTC
CCGgt
Figure 12. Sequence of the murine periaxin core promoter. The putative binding
sites for SCIP and GCRE are underlined. The CAAT box is double underlined and
the transcription initiation site is marked (+1).
From Dytrych et al., 1998.
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1.6 AIMS OF THE PROJECT
In order to gain insight into the role of periaxin in Schwann cells, the first
aim of the project was to investigate the localization of periaxin in peripheral nerve
by immunofluorescence microscopy and immuno-electron microscopy. This was of
particular importance since there was reason to believe that periaxin interacted
with the cytoskeleton of Schwann cells. The second aim of the project was to
determine the developmental stage in which periaxin mRNAs and protein isoforms
are first expressed in developing Schwann cells since the gene encoding PO, the
major protein on PNS myelin, is expressed very early in embryonic development
prior to the appearance of phenotypically distinct Schwann cells (Lee et al., 1997).
Since it was believed that the gene was exclusively expressed in Schwann
cells, the third aim of the project was to identify by trangenesis the regulatory






Fixation was either by immersion, for rat sciatic nerves up to postnatal-day
8, or by perfusion for older animals. Rats were anaesthetized with Sagatal (26
mg/kg) and perfused transcardially by inserting a needle into the left ventricle and
clipping the right atrium. Heparinized (200 U heparin/100 ml) saline (0.89% NaCl)
followed by freshly prepared formaldehyde-lysine-periodate fixative (Mclean and
Nakane, 1974) was perfused through the animal. The sciatic and trigeminal nerves
were removed and placed in fixative for 2-3 hours at room temperature.
Formaldehyde-lysine-periodate fixative
4% paraformaldehyde
0.01 M sodium periodate
0.075 M lysine hydrochloride
0.1 M sodium phosphate buffer, pH 7.4
3% sucrose
An 8% solution of paraformaldehyde (Sigma) in water was heated on a hot
plate to 60°C and the solution was cleared by the dropwise addition of 1 M NaOH.
An equal volume of 0.15 M lysine hydrochloride in 0.2 M sodium phosphate buffer
(prepared by adding 0.2 M NaH2PC>4 to 0.2 M Na2FlP04 to obtain pH 7.4) was
added to the paraformaldehyde. Sodium periodate was added to the fixative to a
final concentration of 0.01 M. The pH was adjusted to 7.4 and sucrose was added
to a final concentration of 3%.
Tissue Processing
The tissue was processed according to the method of (Berryman et al., 1992).
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1. The tissue was washed 3 times for 10 min each in 0.1 M phosphate buffer
pH 7.4 containing 3.5% sucrose (buffer A).
2. Nerves were stained in 0.2% tannic acid (Mallincrodt) in buffer A for 1 h at
4°C. Subsequent steps were performed at 4°C.
3. The tissue was washed 3 times for 10 min each with buffer A.
4. Free aldehydes were quenched by incubating with 50 mM ammonium
chloride in buffer A for 1 h.
5. Phosphate ions were removed by washing the tissue 4 times for 10 min each
with 0.1 M maleate buffer pH 6.2 containing 4% sucrose (buffer B).
6. The tissue was stained en bloc with 1-2% uranyl acetate in buffer B for 1 h.
Uranyl acetate was dissolved in buffer B and the pH was adjusted to 6.5
and then filtered through a 0.2 gmMillipore filter before use.
7. Dehydration through a series of ethanol solutions was performed according to
the following schedule:
50% ethanol 2 times 5 min each 4°C
70% ethanol 1 time 30 min -20°C
90% ethanol 1 time 30 min -20°C
100% ethanol 3 times 5 min each -20°C
8. Infiltration with LR Gold resin (Agar Scientific Ltd.) was performed by
incubating the tissue with LR Gold and ethanol (1:1, v/v) for 1 h at -20°C followed
by LR Gold and ethanol (7:3, v/v) for 1 h at -20°C. The tissue was infiltrated with
LR Gold resin for 1-3 h, followed by overnight infiltration with fresh resin. Two
changes of LR Gold containing 0.5% benzoin methyl ether (Sigma) was performed
for 1-3 h and then overnight. The tissue was then embedded in fresh LR Gold
containing 0.5% benzoin methyl ether in gelatin capsules, size 00 (Agar Scientific




Sections of approximately 70 nm were cut on either a LKB Ultratome III or a
Reichert Ultracut E and collected on coated 200 mesh nickel grids (Agar Scientific
Ltd.). The grids were first coated with formvar (0.5% in ethylene dichloride)
followed by a very thin coat of carbon. The carbon was necessary to prevent the
sections from floating off in buffers containing detergents. The grids were placed
section side down on drops of all the solutions on dental wax in a humidified petri
dish.
Immunostaining
Sections were blocked for 30 min at room temperature in a freshly prepared
blocking buffer composed of 1% BSA, 0.5% fish skin gelatin (Sigma), 0.05% Triton
X-100, 0.05% Tween-20 in a Tris buffer (10 mM Tris, 500 mM NaCl, pH 7.4). The
blocking buffer was filtered (0.2 pm Millipore) before use. The grids were
transferred to drops (-40 pi) of primary antibodies (see Table 1) diluted in blocking
buffer and incubated overnight at 4°C. Controls were performed in which grids
were incubated overnight in blocking buffer without primary antibodies. Grids were
washed four times with the blocking buffer and incubated for 1 h with either goat
anti-rabbit IgG conjugated to 10 nm colloidal gold (Amersham), 1:20 in blocking
buffer or in combination with goat anti-mouse IgG conjugated to 5 nm colloidal gold
(Amersham), 1:20 in blocking buffer. The gold solutions were centrifuged at 5000
rpm for 5 min to pellet any clumps and the supernatants recovered. The grids were
washed by transfer through 6 drops of distilled water, fixed with 2.5 % aqueous
glutaraldehyde for 5 min and rinsed in a stream of distilled water. Postfixation
was performed with 2 % aqueous OsC>4 for 15 min. The grids were washed with
distilled water and air dried. The sections were stained with lead citrate for 3 min
and then rinsed with distilled water and examined at 80 kV with a JEOL 100CX or
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TABLE 1







1 40 for EM P. Brophy affin. purified
pl70 polyclonal 1 200 P. Brophy
SPeri polyclonal 1 2000 P. Brophy affin. purified
NTerm polyclonal 1 2000 P. Brophy
CTerm polyclonal 1 1000 P. Brophy
MAG polyclonal 1 100 D. Colman
MAG monoclonal 1 20 Boehringer
NF-M monoclonal 1 800 V. Lee
MBP monoclonal 1 100 N. Groome
GAP-43 monoclonal 1 500 Boehringer
myosin HC monoclonal 1 400 Sigma
04 monoclonal 1 10 I. Sommer
E-cadherin polyclonal 25 pg/ml D. Colman EcadEC5
PO polyclonal 1 100 D. Colman
S100 monoclonal 1 200 Affiniti
S100 polyclonal 1 1000 Dako





Anti-peptide antibodies were produced in New Zealand white rabbits after
immunization with antigen comprising an emulsion of Freund's adjuvant and
peptide (a kind gift of Prof. N. Groome, Oxford Brookes University) coupled to
Keyhole Limpet Haemocyanin.
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a Phillips 400 electron microscope. Photographs were taken using Kodak electron
microscope film 4489.
Lead citrate stain
0.2% lead citrate in 0.1M NaOH (Venable and Coggeshall, 1965)
0.03 g lead citrate was placed in a 15 ml Falcon centrifuge tube containing 15 mis of
distilled water that was previously boiled for 10 minutes. 150 pi of 10 M NaOH
was added and the tube was mixed until the lead citrate was dissolved.
2.1.2 Electron microscopy of E16.5 and PI sciatic nerves
For dating the embryos, the day of the vaginal plug was 0.5. E16.5 and PI
murine sciatic nerves were removed and placed in a 35 mm petri dish containing
freshly prepared 4% paraformaldehyde, 2% glutaraldehyde in 0.1 M sodium
cacodylate buffer, pH 7.4. After 1 h fixation the tissue was washed twice for 5 min
with 0.1 M sodium cacodylate buffer and postfixed in reduced osmium tetroxide
(1% OSO4 in 0.1 M sodium cacodylate buffer containing 1% potassium
ferrocyanide) for 1 h at 4°C. After one 5 min wash with 0.1 M sodium cacodylate
buffer the nerves were dehydrated through an ascending series of ethanol for 5 min
each (50%, 70%, 90%) and finally three changes of absolute ethanol for 10 min each.
The tissue was infiltrated with Epon 812 (Taab) and ethanol (1:1, v/v) for 1 h
followed by Epon 812 overnight at room temperature. The tissue was transferred
to fresh Epon 812 for 2 h and embedded in Epon 812 in flat silicone moulds. The
resin was polymerized at 60°C for 24-48 h. Silver sections were cut (-70 nm) and
collected on 300 mesh copper grids (Agar Scientific Ltd.). The grids were stained
with 2% uranyl acetate in 50% ethanol for 3 min, washed with distilled water, air
dried and then stained with lead citrate for 3 min followed by washing in a stream
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of distilled water. The grids were examined on a Phillips 400 electron microscope
at 80 kV.
2.2 INDIRECT IMMUNOFLUORESCENCE
2.2.1 General fixation and tissue preparation
Immunofluorescence was performed on teased fibres of sciatic nerve, frozen
sections, and cultured cells. In all cases the fixative was freshly prepared 4%
paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.4. Paraformaldehyde
(8%) in distilled water was heated to 60°C and cleared with 1 M NaOH added
dropwise. An equal volume of 0.2 M sodium phosphate buffer was added and the
pH adjusted to 7.4.
Cryo-sections
a. Sciatic nerves
Sciatic nerves from mice and rats were fixed by immersion for embryonic
nerves and postnatal nerves from young animals and by perfusion at older ages.
Fixation was at room temperature for 2 h. The nerves were washed in 3 changes of
0.1 M phosphate buffer for 10-15 min each and then cryo-protected by infiltrating
the tissue with 5%, followed by 10% sucrose in 0.1 M phosphate buffer. After
incubation in 20- 25% sucrose in 0.1 M phosphate buffer overnight at 4°C the nerves
were frozen by placing them in OCT (Tissue-Tek, Miles Scientific) in a plastic
mould (Polysciences) and the mould was frozen in isopentane cooled in liquid
nitrogen. The blocks were stored at -70°C until needed.
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b. Cervical sympathetic trunks
The rostral halves of E16.5 embryos or postnatal-day 1 mice were placed in
fixative for 2 h at room temperature. The cervical sympathetic trunk was removed
and placed in fixative in a 35 mm petri dish for 1 h. The tissues were washed in 3
changes of 0.1 M phosphate buffer for 10-15 min each and then cryo-protected by
infiltration with 25% sucrose in 0.1 M phosphate buffer overnight at 4°C. The
tissue was placed in OCT in a plastic mould and frozen in isopentane cooled in
liquid nitrogen.
c. Embryos
Mouse embryos were dissected in cold HBSS and cut in half between the
thoracic and lumbar vertebrae. The caudal and rostral halves were placed in
fixative for 3-4 h at room temperature. The embryos were washed in 3 changes of
0.1 M phosphate buffer for 30 min each and then infiltrated with 5% sucrose in 0.1
M phosphate buffer for 30 min, 10% sucrose in 0.1 M phosphate buffer 30 min
followed by 20-25% sucrose in 0.1 M phosphate buffer overnight at 4°C. The
embryos were frozen in cooled isopentane.
Sectioning was performed on a cryostat (Bright OTF/AS) at -15 to -17°C.
Approximately 7 gm sections were cut and collected on TESPA-coated (3-
aminopropyltriethoxy-silane) slides. The sections were allowed to air dry for 1 h
and then either used directly or stored at -40°C.
Preparation of TESPA-coated slides
TESPA-coated glass slides were prepared by dipping pre-cleaned glass
slides in acetone for 1 min, 2% TESPA (Sigma) in acetone for 1 min, followed by
two 30 s washes in acetone, and then air-dried. The slides were stored in a slide
box containing silica gel.
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2.2.2 Immunostaining controls
Controls in which the primary antibodies were omitted were performed for
each experiment. The antibody raised against Speri has been previously
characterized and preincubation of the antisera with 1 mg/ml of peptide abolished
immunolabeling (Dytrych et al., 1998). The L-periaxin antibodies which were used
in the experiments, anti-170pepl, anti-NTerm, and anti-CTerm have been described
previously (Gillespie et al., 1994; Dytrych et al., 1998). Each antibody recognized
one band with a Mr of 170 kDa by Western blotting and all showed the same
staining pattern in rat peripheral nerve sections by immunofluorescence.
2.2.3 Immunostaining of cryo-sections
A ring of rubber cement was placed around the sections on the slides which
produced a well for small volumes of antisera. The rubber cement was allowed to
completely dry before the OCT was removed by rinsing twice with PBS. For all
incubations the slides were placed in a humid chamber. The sections were blocked
with 200 pi blocking buffer consisting of 10% goat serum, 0.2% gelatin, 0.3% Triton
X-100 in PBS. Primary antibodies were diluted in 4% goat serum, 0.2% gelatin,
0.3% Triton X-100 in PBS and left on the sections overnight at room temperature or
4°C (see Table 1, p 58 for antibodies used and dilutions). The slides were washed
in the same buffer 4 times for 5 min each. Secondary antibodies, goat anti-rabbit
IgG coupled to fluorescein isothiocyanate (FITC; Cappel, 1:200) and biotinylated
goat anti-mouse IgG (Kirkegaard and Perry, 1:500), were diluted in the same buffer
and placed on the sections for 1 h at room temperature. The slides were washed
with buffer 3 times for 5 min each and then incubated with streptavidin-Texas Red
(Vector Laboratories, 1:1200). After 4 washes in PBS, coverslips were mounted on
the slides with a drop of Vectashield non-fade mounting medium (Vector
Laboratories). In some experiments propidium iodide binding was performed in
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combination with L-periaxin immunolabelling. Sections were incubated with
propidium iodide (100 pg/ml; Sigma) for 2 min after immunolabelling for L-periaxin
was completed. The slides were viewed on a Olympus BX60 microscope equipped
with a 460-490 excitation filter and 515-550 barrier filter for FITC and for Texas
Red or tetramethylrhodamine isothiocyanate (TRITC) a 530-550 excitation filter
and 590 barrier filter. The images were photographed on Fuji Provia color slide
film. Alternatively, confocal microscopy was performed on a Leica TCS 4D
scanning confocal microscope. A maximum projection was made from a series of
optical scans through the z axis of the tissue. The digitized images were processed
using Adobe Photoshop 3.0 software on a Power Macintosh 8600/200.
2.2.4 Tissue preparation and immunostaining of teased fibres
After fixation for 2 h, the sciatic nerves were washed in PBS several times.
The nerves were placed in a 35 mm petri dish and the epineurium was removed.
The tissue was cut into 3 mm segments and transferred to another petri dish
containing 0.1% Triton X-100 in PBS. The fibres were teased using acupuncture
needles and transferred to a dish containing Triton X-100 for 1 h (Kidd et al.,
1994). The fibres were washed several times in PBS and then blocked with 10%
goat serum, 0.2% gelatin, 0.3% Triton X-100 in PBS for 2 h. The fibres were then
transferred to wells in a 24 well plate containing primary antibodies diluted in 4%
goat serum, 0.2% gelatin, 0.3% Triton X-100 in PBS and incubated overnight at
room temperature in a humid chamber. The rest of the procedure was the same as
for cryosections except to change solutions the fibres were transferred from well to
well with an acupuncture needle and finally placed in a drop of Vectashield
mounting media on a glass slide, re-teased, and coversliped
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2.2.5 Fixation and immunostaining of cultured cells
Monolayers grown on 13 mm glass coverslips (BDH) coated with poly-D-
lysine (100 gg/ml, Sigma) were fixed with 4% paraformaldehyde in 0.1 M sodium
phosphate buffer for 30 min at room temperature. 04 labelling was performed
before fixation. Coverslips were rinsed with PBS and incubated with monoclonal
anti-04 (IgM) diluted with 2% goat serum in PBS for 30 min. For detection of L-
periaxin on the cell surface, immunolabelling with anti-pl70, anti-170pepl, anti-
NTerm, and anti-CTerm was performed prior to fixation as for 04. After three
rinses with PBS, the coverslips were fixed with 4% paraformaldehyde. For S-100
staining, the cells were fixed for 20 min with 4% paraformaldehyde followed by 10
min in cold methanol (-20°C). The cells were washed 4 times for 5 min each with
PBS and blocked with 4% goat serum, 0.2% gelatin, 0.1% Triton X-100 in PBS for 30
min. The coverslips were placed on a piece of parafilm in a humid chamber and 40
pi of the diluted primary antibodies was placed on the coverslip. After 1 h the
coverslips were washed 3 times with blocking buffer and the procedure repeated for
the incubation with goat anti-rabbit FITC IgG (Cappel, 1:200) and goat anti-mouse
TRITC IgG (Jackson Laboratories, 1:100) or donkey anti-mouse TRITC Ig (not type-
specific) (Jackson Laboratories, 1:50) for 04. After 45 min the coverslips were
washed with PBS and mounted on slides with Vectashield. The edges of the
coverslips were sealed with nail varnish.
The numbers of 04 and L-periaxin positive cells were determined in three
experiments, in each of which a minimum total of 400 cells per coverslip were
scored in randomly selected fields. Cell numbers were calculated Mean ±SEM.
2.2.6 Terminal deoxynucleotide transferase mediated UTP nick end-labelling
(TUNEL)
TUNEL combined with immunofluorescence for L-periaxin was performed
on E15 sciatic nerve cryosections according to the method of Grinspan (Grinspan et
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al., 1996).. Following immunostaining for L-periaxin, using 170pepl followed by
goat anti-rabbit FITC IgG, the sections were incubated in PBS containing 0.5%
Triton X-100 for 15 min at room temperature followed by equilibration in TdT
buffer (140 mM sodium cacodylate, 1 mM cobalt chloride, 30 mM Tris-HCl, pH
7.2) for 20 min. The sections were then incubated with 50 pi TdT buffer containing
17.9 U TdT (Gibco BRL) and 10 pM biotinyl-ll-dUTP (Sigma) for 1 h at 37°C.
Biotinyl-ll-dUTP was omitted on a control slide. Room temperature incubation for
15 min with a buffer containing 300 mM NaCl and 30 mM sodium citrate
terminated the reaction. Following a 10 min wash in 2% BSA in PBS, sections were
incubated for 1 h with streptavidin- Texas Red (1:1200) in PBS. The slides were
washed three times with PBS and mounted with Vectashield before examination on
a Leica TCS 4D confocal microscope.
2.3 CELL CULTURE
2.3.1 General cell culture
Cell lines were maintained in complete medium (10% FCS, DMEM [ICN[
containing penicillin (100 IU/ml) and streptomycin (100 pg/ml) (Sigma). When the
cells were confluent they were passaged by washing once with HBSS (Gibco BRL)
and incubating in trypsin-EDTA (Sigma) for 1-3 min. Complete medium was
added and the cells were pelleted by centrifugation (1000 rpm for 3 min). The cells
were resuspended in 1 ml of complete medium and plated in either 25 cm^ flasks,
coverslips or petri dishes at the appropriate densities. Cell were frozen for long-
term storage in 20% FCS and 10% DMSO in DMEM by placing them at -70°C
overnight and then transferring them to liquid nitrogen.
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2.3.2 Schwann cell culture
Dissociation and cytosine arabinoside treatment
Sciatic nerves were removed from P5 rats and placed in a 35 mm petri dish
containing pre-warmed L15 (Sigma). The epineurium was removed by dissection
with fine forceps and the nerve fibres were cut into small pieces and placed in a
bijou containing collagenase (0.24 mg/ml) in 1 ml of L15. The nerves were
incubated for 45 min to 1 h in a 37°C incubator before the addition of trypsin (0.6
mg/ml) for 10 min. The trypsinization was terminated by the addition of 2 ml of
complete medium (DMEM containing 10% FCS, Pen/Strep). The nerves were
titurated using a 3 ml syringe with a 21 gauge needle 6 times, followed by 4 times
with a 25 gauge needle. The cells were transferred to a 15 ml Falcon centrifuge tube
and 5 ml of complete medium was added before centrifugation for 3 min at 1000
rpm. The pellet was resuspended in complete medium and cells were plated in 25
cm^ flasks pre-coated with poly-D-lysine (0.1 mg/ml). The following day the
medium was changed to fresh medium containing 10 fiM cytosine arabinoside (Ara
C, Sigma). The cells were cultured in medium containing Ara C for 7 d.
Complement-mediated lysis with anti-Thyl.l
The cells were trypsinized and centrifuged (1000 rpm for 3 min) after the
addition of DMEM containing 10% FCS. The pellet was resuspended in 1.6 ml of
DMEM and 0.4 ml Thy-1.1 monoclonal antibody diluted 1:10 (a gift of A. F.
Williams, Oxford University) and incubated at 37°C. After 30 min, 0.4 ml baby
rabbit complement (Cedarlane Laboratories Ltd, Canada) was added and
incubated for a further 30 min at 37°C. DMEM containing 10% FCS (8 mis) was
added and the cells were centrifuged at 1000 rpm for 3 min. The pellet was
resuspended with DMEM containing 10% FCS, Pen/Strep, 2 pM forskolin (Sigma),
and GGF (a gift of J. Brockes, Ludwig Institute, London) and seeded in 25 cm^
flasks pre-coated with 0.1 mg/ml poly-D-lysine. After one week, the complement-
66
mediated lysis with anti-Thyl.l was repeated. The pellets were resuspended with
DMEM containing 10% FCS, Pen/Strep, and 2 pM forskolin and seeded in poly-D-
lysine coated flasks. When the cells reached confluency they were passaged and
plated on poly-D-lysine and laminin coated coverslips (see 2.4.2) for transfection.
To coat coverslips with laminin, 50 pi of laminin (10 pg/ml, Sigma) in DMEM was
placed on the coverslip and incubated in a 37°C CO2 incubator for 2 h. The
laminin was aspirated from the coverslips immediately before plating the cells.
2.3.2 Embryonic Schwann cell culture
Sciatic nerves were removed from E16.5 mouse embryos and placed in a
dish containing L15 (Sigma). They were washed once with fresh L15 and cut into
small segments. The nerves were incubated with collagenase (0.21 mg/ml) in L15 at
37°C for 40 min. Hyaluronidase (1 mg/ml, Sigma) was added to the nerve
segments for 15 min after which an additional amount of collagenase was added
(0.08 mg/ml). The nerve segments were triturated using a yellow Gilson pipette tip
followed by glass micro-pipettes to completely dissociate the cells. The cells were
transferred to a centrifuge tube and complete medium (5 mis) containing 10% FCS,
Pen/Strep, 2 mM glutamine, DMEM was added followed by centrifugation at 1000
rpm for 3 min and resuspension in complete medium. Cells were plated on laminin-
coated coverslips that had been pre-coated with poly-D-lysine. The cultures were
incubated for 6.5 h before fixation.
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2.4 TRANSFECTION
2.4.1 Production of 33B cells permanently expressing L-periaxin
DNA preparation
L-periaxin cDNA was directionally subcloned into pCB6 expression vector
(a gift from Dr. David Russell, Southwestern Medical Center, Dallas, TX) at the
Mlul and Xbal sites and transformed into freshly prepared XLl-blue competent
cells (Sambrook et al., 1989).. pCB6 contains the CMV promoter and a neomycin-
resistance gene for selection. The insert was checked by restriction digest. To
prepare DNA for transfection a maxiprep was performed on a 500 ml overnight
culture in LB broth (Gibco BRL) containing ampicillin (0.1 mg/ml) using the
Promega Wizard Maxiprep kit according to the manufacturer's instructions.
Dose response to G418
The Schwann cell line, 33B, was a generous gift from Dr. Eric Blair, Leeds
University. First it was necessary to determine the dose-response of the cells to
geneticin, (G418, Gibco BRL), the neomycin analog, before transfection to identify
the optimum concentration for the cell line used. 33B cells were seeded in a 24 well
plate at low density. A 5 mg/ml stock solution of G418 was prepared in complete
medium (10% FCS, DMEM containing penicillin [100 IU/ml] and streptomycin [100
|ig/ml]). Cells were grown in the presence of increasing concentrations (200 fig/ml,
400 |ig/ml, 600 fig/ml and 800 gg/ml) of G418 or in the absence of G418. After
approximately 10-12 days the wells were assessed for the lowest dose of G418
which produced cell death which for 33B cells was 600 (ig/ml.
Cationic liposome-niediated transfection
33B cells were seeded in two 90 mm petri dishes and allowed to grow
overnight to achieve 50 to 70% confluency. The medium was changed to fresh
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medium for 3 h. DNA (24 |ag) was added to 0.8 ml Optimem (Gibco BRL) and
gently mixed and Lipofectamine (64 pg, Gibco BRL) was added to 0.8 ml Optimem
in a polystyrene Falcon tube (Feigner et al., 1993). The DNA solution was then
added to the Lipofectamine solution and mixed before incubating for 20 min at
room temperature. The volume was brought to 8 ml with Optimem. The cells were
rinsed three times with serum-free Optimem before 4 ml of DNA/Lipofectamine
solution was added to each petri dish. The cells were transfected for 4 h at 37°C in
a humidified CO2 incubator. They were then washed and complete medium was
added. After 48 hrs, 600 gg/ml G418 was added to the medium and the cultures
were maintained until single G418 resistant colonies appeared. These colonies were
isolated with cloning rings and seeded in a 24 well plate. Each clone was passaged
and seeded on poly-D-lysine-coated (100 pg/ml, Sigma) glass coverslips and
screened by indirect immunofluorescence for expression of L-periaxin. Clone 25
was selected for further studies.
Cytoskeleton Preparation
Cells cultures were washed briefly with extraction buffer, 10 mM Pipes, pFl
6.9, 50 mM KC1, 2 mM EGTA, 1 mM MgC^, 2 M glycerol, 10 gg/ml leupeptin
(Sigma) and 10 pg/ml antipain (Sigma), and extracted at room temperature for 3
min with the extraction buffer containing 0.5% Triton X-100 (Wilson and Brophy,
1989). The cytoskeletons were then washed in the same buffer without Triton X-
100 prior to being fixed and processed for indirect immunofluorescence.
2.4.2 Methods for transient transfection
Transient transfection was carried out using either lipid-mediated
transfection or by calcium-phosphate-DNA precipitation. Hela, 33B, NIH 3T3, or
Cos7 cells were transiently transfected using both methods on each cell-line to
obtain the most efficient transfection.
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Liposome-mediated transfection
The same method was used for transient transfection as was used for
permanent transfection except that cells were seeded on poly-D-lysine-coated
coverslips in 35 mm dishes. For each dish 3 pg of plasmid DNA was diluted in 100
pi Optimem and 8 pg Lipofectamine was also diluted in 100 pi Optimem. The two
solutions were mixed and incubated for 20 minutes in a polystyrene Falcon tube
before 800 pi Optimem was added, mixed and then placed on cells that were rinsed
3 times in Optimem to remove the serum. After 4 h the cells were washed once with
either serum-containing medium or HBSS and grown for 24 to 48 h in DMEM with
10% FCS. The cells were processed for immunofluorescence microscopy or for GFP
they were viewed directly.
For Schwann cell cultures, the cells were plated on coverslips coated with
poly-D-lysine and laminin. The cells were grown in the presence of 2 pM forskolin
and when they reached 70-80% confluency they were transfected with
Lipofectamine as above for 3 h. After washing, medium containing 2 pM forskolin
was replaced. Higher concentrations of forskolin (50 pM) were used for Schwann
cell cultures that were transfected with periaxin/LacZ constructs.
Calciurn-phosphate-DNA precipitation
Cells were seeded on coverslips and grown for 17 h to 30-50% confluency.
Fresh medium (2 ml) was added to each 35 mm dish for 1 h. The Stratagene
Mammalian Transfection Kit was used to prepare the precipitate according to the
manufacturer's instructions. Plasmid DNA (1.25 pg) was diluted in sterile distilled
water to a volume of 45 pi. Solution 1 (5 pi: 2.5 M calcium chloride) was added to
the DNA and an equal volume (50 pi) of solution 2 (50 mM BES, 280 mM NaCl, 1.5
mM Na2HPC>4/ pH 6.95) was added and gently mixed. One minute was allowed
for precipitation (Jordan et al., 1996) before quickly adding the 100 pi to the cell
culture. After 6 h the cells were washed with HBSS and changed to fresh medium.
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2.4.3 Preparation of constructs for transfection
Diagrams of the constructs are illustrated in Fig. 13. All PCR reactions were
performed with a proof-reading polymerase and the regions of each construct that
were generated by PCR were sequenced using the Pharmacia T7 sequencing kit
which employs the Sanger dideoxy-mediated chain-termination method (Sanger et
al., 1977). The sequences were analyzed using MacVector sequence analysis
software (Oxford Molecular Group) and the University of Wisconsin GCG package
(Devereaux et al., 1984). Primers for PCR and sequencing were synthesized on an
Applied Biosystems model 391 PCR-MATE and purified by butanol extraction
(Sawadogo and Van Dyke, 1991). A list of all the primers used are listed in Table
2. The PCR reactions were performed on a Hybaid OmniGene Thermal Cycler. To
prevent contamination the reaction was prepared in a hood equipped with UV
illumination and before the template and enzyme were added, the reaction tubes
were incubated for 10 minutes in a Amplirad UV illuminator (Genetic Research
Instruments Ltd.). A typical 50 pi PCR reaction consisted of 10X reaction buffer (5
pi), 5 pM primer 1 (5 pi), 5 pM primer 2 (5 pi), 2 mM dNTPs (5 pi), template and
enzyme. The reaction was overlayed with mineral oil. The cycle conditions were:
94°C for 1 min, 55°C for 1 min, 72°C extension (1 min/ 1 kb product) - 5 cycles;
94°C for 40 s, 55°C for 1 min, 72°C (1 min/ 1 kb product) -28 cycles; 94°C for 40 s,
55°C for 1 min, 72°C for 7 min -1 cycle.
DNA Sequencing
Denaturation of double-strand DNA
Plasmid DNA (1 pg) was denatured with 2 M NaOH (2 pi) in a total
volume of 10 pi for 10 min at room temperature. The DNA was precipitated by the
addition of 0.9 M sodium acetate, pH 5.5 (10 pi) and ethanol (60 pi) and incubated
at -70°C for 30 min. Following a 4°C centrifugation for 30 min at 13000 rpm, the














Figure 13. Schematic representations of L-periaxin deletion mutants. The repeat
region of L-periaxin is depicted as a lined red box, the basic domain (blue box) is in
the N-terminus which is represented by a yellow box, and the C-terminus is
represented by a green box. The deleted regions are either missing or depicted as
lines. PrxA13 has two mutated nts, TT.
TABLE 2
Oligonucleotide primer sequences
Primer 5' to 3' Restrict, sites





DLS19 CATGCCATGGTGGGCCTCCAGACACCTCCAGAGCT R Ncol
DLS21 GGAATTCCATGGTGGGCCTCCAGA R EcoRI, Ncol
DLS25 ACGCGTCGACACAACCTTCAAGAGGTAAGC F Sail
DLS26 CCCTGTGAAGACGACGAAGAT F
DLS27 GAATTCACCATGGAGATGAAGGGCCCGCGGGCCAA F EcoRI, Kozak seq









Labelling using the Pharmacia T7 sequencing kit
The primer was annealed to the template after resuspension with 5 pi
distilled water and the addition of 1 pi annealing buffer and 1 pi sequencing primer
(5 pM) to the DNA pellet and incubation for 20 min at 37°C followed by 10 min at
room temperature. The labelling reaction consisted of a 4 min incubation of the
annealed template (7 pi ), labelling mix A (1.5 pi), [a-^^S] dATP (0.2 pi, ICN),
distilled water (0.3 pi), and T7 DNA polymerase (1 pi of 1:4, v/v, enzyme with
dilution buffer). The termination reaction followed the labelling by the addition of
2.25 pi of the labelling reaction to each of 4 pre-warmed tubes containing 1.25 pi of
A, G, T, and C termination mixes and incubation for 5 min at 39°C. Stop solution
(2.5 ml) was added to each of the 4 tubes.
Electrophoresis
The 4 tubes were incubated at 80°C for 3 min and a 2 pi aliquot of each was
resolved on a sequencing gel in an IBI Base Runner. The pre-set gel consisted of 6%
acrylamide/bisacrylamide (Ambion, 19:1), 42% urea, 0.005% TEMED, 0.025%
ammonium persulfate in TBE (90 mM Tris-HCl, 90 mM boric acid, 2 mM EDTA,
pH 8.0). The gel was fixed with 5% methanol and 5% acetic acid for 20 min and
dried under vacuum for 1 h at 80°C. The gel was exposed to X-ray film (Agfa Curix
RP-1 Plus) for 48 h at room temperature. The film was developed with Kodak
LX24 X-ray developer and fixed with Kodak Industrex fixer.
PrxAl
The repeat region of L-periaxin cDNA was deleted from nt 1408 to nt 2556
using a PCR-ligation-PCR technique (Ali and Steinkasserer, 1995) as illustrated in
Fig. 14. The template for the PCR was L-periaxin cDNA in pSPORT (Gibco BRL).
It was important for the products to have blunt ends therefore pfu polymerase
(Stratagene) was used. The first step was to perform PCR A using the T7
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PCR product A PCR product B
Phosphorylate PCR products A & B
3. Ligation
Y
PCR with T7 and reverse primer M13
Figure 14. Diagrammatic representation of the PCR-ligation-PCR technique
used to construct L-periaxin cDNA lacking the repeat region (yellow). (1) Two
PCR reactions were performed; PCR A using T7 sequencing primer and a L-periaxin
reverse primer which produced PCR product A (red), and PCR B using a L-periaxin
forward primer and M13 reverse which produced PCR product B (blue). It was
essential to use a polymerase which produced blunt ends. (2) An equal amount of
PCR product from each PCR was phosphorylated with T4 kinase. (3) The
phosphorylated PCR products were ligated with T4 DNA ligase. (4) A final PCR
was performed with primers T7 and M13 reverse using 1/10 of the ligation as
template which produced the final product containing the deletion.
sequencing primer and the periaxin reverse primer DLS 8 which produced a 1.4 kb
product and PCR B using the periaxin forward primer DLS 9 and the primer M13
reverse which produced a 2.2 kb product. An equal amount of PCR product from
each PCR was phosphorylated with T4 kinase (Gibco BRL). The reaction contained
10 pi 5X kinase buffer, 10 pi PCR product, 5 pi lOmM dATP, 1 pi T4 kinase (10 U)
in a final volume of 50 pi. After incubation for 30 min at 37°C the enzyme was
inactivated at 70°C for 5 min. After ethanol precipitation the two PCR products
were ligated with T4 DNA ligase (3 U, Promega) for 1 h at room temperature. A
final PCR was performed using l/10th of the ligation as template with the forward
primer T7 and the reverse primer p300. The PCR product was run on a 1% agarose
gel, the bands were excised, the DNA was extracted from the gel using the Qiaex II
gel extraction kit (Qiagen) according to the manufacturer's instructions, digested
with EcoRI and Xhol, and subcloned into EcoRI/XhoI cut L-periaxin in pSV-SPORT
by ligation with 1-2 U T4 DNA ligase (Fermentas) for 3 h at room temperature.
Competent XLl-blue cells were transformed and plated on LB agar (Gibco BRL)
containing 0.1 mg/ml ampicillin. Minipreps were performed by alkaline lysis
(Sambrook et ah, 1989) on 4 ml overnight cultures from individual colonies.
Restriction digest followed by electrophoresis on 1% agarose gel revealed if the
insert was present. The construct was checked by sequencing (Pharmacia). DNA
for transfection was prepared using the Promega Maxi-prep kit on a 500 ml
overnight culture.
PrxA2
The 3' end of L-periaxin cDNA was deleted from nt 2576 and a termination
codon and Xbal site was introduced by PCR. The template was L-periaxin cDNA
in pSPORT using the primers DLS 10 (reverse) and T7. The PCR reaction had an
annealing temperature of 55°C and a 2.5 min extension at 72°C and used pfu
polymerase. The PCR product was gel purified and restriction digested with EcoRI
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and Xbal and cloned into pBlueScript KS (BS; Stratagene) which contained the first
2 kb of L-periaxin cDNA and the sequences generated by PCR were checked by
DNA sequencing. The construct was released from the BS polylinker by digestion
with Sail and NotI and cloned into pSV-SPORT. DNA for transfection was
prepared from a 30 ml overnight culture using the Qiagen midi-prep kit.
PrxA3
The 5' end of L-periaxin cDNA was deleted up to nt 1562 and an initiation
codon with a strong Kozak consensus sequence (Kozak, 1996) as well as a Kpnl
site was introduced by PCR. The template was L-periaxin cDNA in pSPORT using
the primers DLS 11 (forward) and M13 forward sequencing primer. The PCR
reaction had an annealing temperature of 60°C and a 3 min extension at 72°C and
used pfu polymerase. The PCR product was gel purified and restriction digested
with EcoRI and Kpnl and cloned into EcoRI/Kpnl digested L-periaxin in
pSV SPORT. The resulting construct was sequenced to check for fidelity of the PCR
generated region. DNA for transfection was prepared from a 30 ml overnight
culture using the Qiagen midi-prep kit.
PrxA12
A similar strategy was used to delete the basic domain (nt 622 to 859) as
was used for PrxAl. The enzyme pfu polymerase (Stratagene) was used for all the
PCRs. For PCR A the primers used were T7 and the periaxin reverse primer DLS
17. For PCR B the periaxin forward primer DLS 18 and the periaxin reverse primer
CSG1 were used. The annealing temperature was 55°C with a 1 min extension at
72°C. The products were phosphorylated and ligated. The primers for the final
PCR were T7 and CSG1 with an extension time of 1.5 min. The PCR product was
Qiaex purified, digested with BstBI and Sail and subcloned into L-periaxin in
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pSVSPORT. DNA for transfection was prepared from 30 ml overnight cultures
using the Qiagen midi-prep kit.
PrxA13
Two of the lysine residues (nt 137 and 138) in the basic domain of L-
periaxin were mutated to threonine residues. K fi T
GAA fi GAC
Again the same strategy was used for the mutagenesis as for PrxAl and PrxA12.
PCR A used the forward primer DLS 26 5' CCCTGTGAAGACGACGAAGAT 3'
K T T K
and the periaxin reverse primer CSG 1 5' GGAAGTTTCATGTCTGACAT 3' while
the primers for PCR B were LMD 2 (forward) and LMD 56 (reverse). The products
were phosphorylated and ligated. The primers for the final PCR were LMD 6
(forward) and CSG 1 (reverse). The PCR product was digested with BstBI and Sfil
and subcloned into L-periaxin in pSV-SPORT. Plasmid DNA for transfection was
prepared using the Qiagen midi-prep kit.
BD-GFP
The basic domain (244 bp) of L-periaxin which comprises nt 616 to 860 was
generated by PCR. The forward primer DLS 27 was designed with an EcoRI site
followed by an initiation codon with a strong Kozak consensus sequence. The
reverse primer DLS 28 contained a BamHI site. The PCR product that was
generated was digested with EcoRI and BamHI and cloned into pIBI30 in order to
check the sequence. Several clones were sequenced with T3 and T7 sequencing
primers. The basic domain was released from the pIBI30 polylinker by restriction
digest with EcoRI and BamHI then cloned into the expression vector pEGFP-Nl
(Clontech) in frame at the EcoRI and BamHI sites. pEGFP encodes a red-shifted
variant of wild-type green fluorescent protein which has thirty times the
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fluorescence intensity. The basic domain of L-periaxin will be expressed as an N-
terminal fusion of EGFP. To obtain DNA for transfection Qiagen midi-preps were
performed on 30 ml overnight cultures of BD-GFP and pEGFP.
2.4.4 Energy depletion
33B cells, Hela cells, and Schwann cells were transiently transfected with
BD-GFP for 4 h using Lipofectamine. After 24 h, the cells were washed twice with
glucose-free MEM (Gibco BRL) containing 10% dialysed FCS, penicillin (100 IU/ml)
and streptomycin (100 pg/ml) and 2 mM glutamine. and then incubated with 6 mM
2-deoxyglucose (Sigma) and 10 mM sodium azide in glucose-free medium
containing dialysed FCS for 1 h and 2 h. Some transfected cells were allowed to
recover for 2 h in complete medium at 37°C. At the end of the incubation times the
cells were fixed with 4% paraformaldehyde for 20 min, washed with PBS, mounted
with Vectashield, and viewed on a fluorescence microscope and optical images
were captured on a Leica TCS 4D scanning confocal microscope.
2.4.5 Cell surface biotinylation
Biotinylation of cell surface proteins was performed according to (Rosen et
al., 1992). Permanently transfected 33B cells (clone 25) were grown in 35 mm petri
dishes to confluency. The cells were washed twice with HBSS. For cell surface
biotinylation, the cells were incubated with 0.5 mg/ml sulfo-NHS-biotin (Pierce
Chemical Co.) in HBSS twice for 15 min at room temperature. Sulfo-NHS-biotin
was diluted from a 200 mg/ml stock dissolved in DMSO. The cells were rinsed
once with DMEM and twice with HBSS before the addition of 1 ml of solution A
(2.5% (v/v) Triton X-100, 150 mM NaCl, 4 mM EDTA, 50 mM Tris HC1 pH 7.4)
containing the proteinase inhibitors, leupeptin (10 pg/ml), antipain (10 pg/ml),
TLCK (1 mM), PMSF (200 gg/ml), chymostatin (660 gg/ml), and benzamidine
(10pM). As a control, cells were permeabilized with 2% Triton X-100 in HBSS
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containing proteinase inhibitors for 5 min prior to the addition of 0.5 mg/ml sulfo-
NHS-biotin for 30 min. Glycine was added to a final concentration of 100 mM and
Tris HC1 pH 8 was added to a final concentration of 50 mM. The cells were
removed by scraping, centrifuged and the supernatant was taken for
immuneprecipitation.
2.5 METABOLIC LABELLING, IMMUNEPRECIPITATION, SDS PAGE
AND WESTERN BLOTTING
2.5.1 Metabolic labelling with [3®S] methionine
Labelling was performed on 33B cells (clone 25) grown in 4 x 35 mm petri
dishes. The cells were washed twice with HBSS and once with methionine and
cysteine-free DMEM (ICN) containing 10% dialysed serum and 2 mM glutamine
and incubated for 15 min. Fresh medium (1.2 ml) and 12 pi of Trans [^^S] label
(ICN) were added to each dish and incubated for 3 h at 37°C with 95% C02- A 35
mm petri dish containing charcoal was placed with the dishes. The supernatant
was removed and the cells were washed twice with complete medium and twice
with HBSS. A solution of 2% SDS (200 pi) containing proteinase inhibitors,
leupeptin (10 pg/ml), antipain (10 pg/ml), TLCK (1 mM), PMSF (200 pg/ml),
chymostatin (660 pg/ml), and benzamidine (lOpM), was added to each dish, the
cells were scraped, centrifuged, and the supernatants were removed and placed in a
microfuge tube for immuneprecipitation. Alternatively sciatic nerves were removed
from postnatal-day 6 rats and placed in L15 medium in a 35 mm petri dish. The
nerves were teased and placed into wells in a 24 well plate (6 nerves/well). The
nerves were washed twice with methionine and cysteine-free DMEM containing
10% dialysed FCS and 2 mM glutamine and incubated in fresh medium. After 15
min, fresh medium (750 pi) and Trans [3^S] label (7.5 pi) were added to each well
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and incubated for a further 3 h at 37°C. After washing twice with complete medium
and twice with HBSS, the nerves were placed in a microfuge tube with 200 pi 2%
SDS containing proteinase inhibitors and boiled for 2.5 min. Solution A containing
2.5% Triton X-100 and proteinase inhibitors was added to the tube, centrifuged,
and the supernatant taken for immuneprecipitation.
2.5.2 Immuneprecipitation
Preparation ofprotein A agarose
Protein A agarose (Sigma) was swollen in an excess of distilled water for 1
hour at room temperature. The protein A agarose was washed twice with 2
volumes of solution A (as described in section 2.4.5) to 1 volume of agarose and
resuspended in 2 volumes of solution A containing proteinase inhibitors and kept at
0°C until use.
Immuneprecipitation
Protein A agarose (60 pi) was added to the solublized pellet or supernatant
and incubated for 1 hour at room temperature. All incubations were performed on
a rotator. The sample was centrifuged and the supernatant was transferred to
another microfuge tube. Rabbit polyclonal anti-170pepl (10 pi) was added and
incubated for 2 h at room temperature after which 60 pi of protein A agarose was
added and incubated for 2 h. After centrifugation the pellet was washed three
times with solution A containing proteinase inhibitors followed by one wash with
solution A without Triton X-100. The pellet was resuspended in 80 pi SDS-PAGE
sample buffer containing 62.5 mM dithiothreitol (DTT; Sigma) and boiled for 3 min.
After centrifugation for 5 min, the supernatant was resolved by electrophoresis on a
4-20% gradient SDS-polyacrylamide gel. Gels were stained with 0.2% Coomassie
blue (PAGE Blue 83, BDH), destained, and dried under vacuum. The dried gel was
exposed to X-ray film (Agfa Curix RP-1 Plus) at room temperature and the
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autoradiograph was developed using Kodak X-ray developer (LX24) and fixer
(Industrex).
2.5.3 Western Blotting
Following SDS-PAGE electrophoresis, proteins were transferred to
nitrocellulose (0.45 |xm, Schleicher and Schuell) using a Hoefer Mighty Small
Transphor Unit (Pharmacia Biotech) in a buffer containing 25 mM Tris HCL pH
8.3, 192 mM glycine, and 20% methanol (Towbin et al., 1979). The nitrocellulose
was rinsed in PBS and blocked for 3 h with 0.2% gelatin, 0.1% Triton X-100 in PBS
followed by a 1 hour incubation with primary antibody in blocking buffer. After 3
washes of 5 min each the membrane was incubated with donkey anti-rabbit IgG
HRP conjugate (1:500, Scottish Antibody Production Unit) in blocking buffer for 1
hour. Following four washes in PBS (5 min each) the peroxidase was visualized by
incubation first with 1 mg/ml 3,3'-diaminobenzidine tetrahydrochloride (DAB,
Sigma) in 50 mM Tris HC1 pH 7.4 and then initiating the reaction by the addition of
H2O2 to a final concentration of 0.3%. When the color was sufficiently developed,
the reaction was stopped by the addition of SDS.
For the surface biotinylation and biotinylation of total cellular proteins, the
immuneprecipitated protein was probed with streptavidin-HRP (1:10,000). As a
control, one lane was probed with anti-170pep (1:1000) followed by donkey anti-
rabbit-IgG HRP conjugate (1:500).
2.5.4 SDS-PAGE of sciatic nerves
Sciatic nerves were removed from E15.5 mouse embryos and P3 mice,
placed in 0.5 ml microfuge tubes and stored at -80°C. Boiling sample buffer
containing 62.5 mM DTT was placed in the tube with the nerves and immediately
boiled for 3 min. Following centrifugation the samples were loaded on a 10% SDS-
polyacrylamide gel and resolved by electrophoresis using the Hoefer Mighty Small
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Unit (Pharmacia Biotech). Following electrophoresis the proteins were transferred
to PVDF (polyvinylidene difluoride) protein sequencing membrane (Bio-Rad). For
the Western blot, the PVDF was blocked with 5% non-fat milk in PBS containing
0.1% Tween-20 overnight at 4°C. The membrane was incubated with anti-170pepl
(1:20,000) in 0.2% gelatin in PBS containing 0.1% Tween-20 for 1 h at room
temperature. Following 6 washes in gelatin/PBS/Tween-20, the blot was incubated
with donkey anti-rabbit IgG conjugated to HRP (1:500) for 1 h. After prolonged
washing with PBS containing 0.1% Tween-20, enhanced chemiluminescence (ECL)
was performed using the ECL Plus Kit (Amersham) according to the manufacturer's
instructions. The excess buffer was drained from the PVDF membrane and the
membrane was placed on Saran Wrap and overlayed with 2 mis of ECL detection
reagent (2 mis of solution A + 40 pi solution B) for 5 minutes. Excess reagent was
removed and the membrane was wrapped in Saran Wrap. The chemiluminescence
was detected on X-ray film (Agfa Curix RP-1 Plus).
2.6 IN SITU HYBRIDIZATION
The method used for in situ hybridization (Griffiths et al., 1989; Wilkinson
et al., 1987), was an adaptation of the original method of (Cox et al., 1984). The
method of (Carrasco and Bravo, 1994) for frozen sections of mouse embryos was
also useful.
2.6.1 [^Sl-labelled riboprobe preparation
Single-stranded riboprobes were prepared by in vitro transcription using
insert cDNAs cloned into vectors containing RNA polymerase initiation sites.
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L-periaxin riboprobes
The construct PrxA6, which consists of the repeat region of L-periaxin from
nt 1500-2500 cloned into the expression vector pSV SPORT (Gibco BRL), was used
to prepare 1 kb antisense and sense riboprobes for L-periaxin. PrxA6 was
prepared by PCR using primers DLS 10 and DLS 11, digestion with KpnI/Xbal,
and ligation into pSV-SPORT. Plasmid DNA was prepared by using the Promega
Wizard Maxiprep kit according to the manufacturer's directions on 500 mis of
overnight culture. 5 pg plasmid DNA was linearized by restriction digestwith Kpnl
in 50 pi total volume at 37°C overnight. For the antisense riboprobe, a Kpnl
restriction digest was used producing a 3' overhang. It has been reported that
extraneous transcripts appear when templates contain 3' overhangs. Hence it was
necessary to convert the overhang to a blunt-end by incubation with 6 U Klenow
DNA polymerase (Gibco BRL) and 20 pM dNTPs (Pharmacia) for 15 min at 30°C,
followed by incubation at 75°C for 10 min to inactivate the enzyme. The plasmid
DNA for the sense probe was linearized with Mlul. The linearized plasmid DNA
was electrophoresed on a 1% agarose gel containing ethidium bromide. The bands
were excised and the DNA was extracted using the Qiaex II gel extraction kit
according to the manufacturer's instructions. The DNA was eluted with 5 mM Tris
HC1, pH 8 in DEPC water and the concentration of the linearized template was
obtained by comparison with a DNA high mass ladder (Gibco BRL) on an agarose
gel.
S-periaxin riboprobes
Restriction digest of the 5.2 kb cDNA in pSPORT with AccI followed by
Mlul yielded a 460 nt fragment which was excised from a 1% agarose gel. 200 ng of
AccI- and Mlul-cut pIBI30 was also excised from an agarose gel and the DNA was
extracted from the gel slices using the Qiaex II gel extraction kit. The volume was
reduced to 3 pi under vacuum and a ligation was performed with 1-2 U T4 DNA
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ligase (Fermentas) for 3 h at room temperature. Competent XLl-blue cells were
transformed and plated on LB agar (Gibco BRL) containing 0.1 mg/ml ampicillin,
300 pM IPTG and 80 pg/ml Xgal for blue/white selection. Minipreps were
performed by alkaline lysis on 4 ml overnight cultures from individual white
colonies. Restriction digest followed by electrophoresis on 1% agarose gel revealed
if the insert was present. Four plasmids with the insert were sequenced (Pharmacia
sequencing kit) with T7 sequencing primer to check that it was correct. Plasmid
DNA was prepared for transcription by alkaline lysis midiprep and linearized with
Mlul for the antisense probe and BamHI for the sense probe.
P0 riboprobe
The 1 kb P0 cDNA in pSPORT cloned in at EcoRI and Xbal sites was used
for riboprobe preparation. Plasmid was prepared by alkaline lysis midi-prep and
linearized with EcoRI for an antisense probe.
In-vitro transcription
Transcription was performed for 1 hour at 37°C. The reaction contained 4
pi transcription 5X buffer (Promega), 2 pi lOOmM DTT, 20 U rRNasin ribonuclease
inhibitor (Promega), 1 pi each of 10 mM rATP, rCTP, rGTP (Promega), 5 pi
UTP (ICN), 1 pg linearized template DNA, DEPC water to 19 pi, 1 pi of either T7
(15 U, Promega), T3 (20 U, Boehringer Mannheim), or SP6 (20 U, Boehringer
Mannheim) RNA polymerase. An additional 1 pi of the appropriate RNA
polymerase was added after the first 30 min. Template DNA was removed by a 15
min incubation with 1 U RQ1 RNAse-free DNAse (Promega). The RNA was
phenol chloroform extracted and ethanol precipitated with 0.5 volume 7.5 M
ammonium acetate. In order to calculate the percent of isotope incorporation, 1 pi
was removed before centrifugation and placed in 1 ml Optiphase 'Hisafe' (Fisons
Chemicals). The pellet was taken up in 100 pi DEPC water. An aliquot of the
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supernatant and an aliquot of the pellet were also added to 1 ml of Optiphase.
Percent incorporation was calculated and the probe was resuspended at 1
ng/pl/kb in DEPC-treated water containing 10 mM DTT and stored at -40°C.
2.6.2 Tissue preparation for ISH
All glassware for the procedure was rinsed twice in 0.1% DEPC-treated
water and either autoclaved or baked at 80°C until use. Slide preparation has been
described in section 2.2.1. All solutions were made using DEPC-treated water and
then autoclaved at 121°C whenever possible.
ISH was performed on unfixed tissue except for cervical sympathetic trunks
which were fixed and then cryoprotected with 25% sucrose. Embryos and nerves
were placed in OCT in plastic molds and quickly frozen in isopentane cooled in
liquid nitrogen. The tissue was stored at -70°C until it was needed for sectioning.
Sections (13 pm) were cut at -16°C on a cryostat and collected on TESPA-coated
slides. The slides were kept at cryostat temperature during sectioning and then
transferred to a -70°C freezer.
2.6.3 Fixation and preparation for hybridization
Slides were removed from the freezer and immediately fixed in freshly
prepared 4% paraformaldehyde in PBS for 20 min at room temperature. They were
rinsed in PBS and acetylated for 10 min by transferring them to a glass dish
containing 200 ml of 100 mM triethanolamine. While stirring, 0.5 ml of acetic
anhydride was added to a final concentration of 0.25% (v/v). The slides were
washed in PBS twice for 5 min each and dehydrated by dipping for 2 min each in




The probes were diluted 1:10 in hybridization buffer containing 10 mM
DTT. Hybridization buffer consisted of 50% formamide, 10% dextran sulphate, IX
Denhardt's, 20 mM Tris HC1 (pH 8), 0.3 M NaCl, 5 mM EDTA, 10 mM NaH2P04
pH 8, and 0.5 mg/ml yeast tRNA. The diluted probes were denatured by heating
at 80°C for 2 minutes, cooled on ice briefly and placed at room temperature.
Diluted probe (25 pi) was placed on the slide over the sections and a 22 x 22 mm
clean glass coverslip was placed over it. More probe was used for larger sections.
The slides were placed horizontally in a slide box or alternatively in a plastic box.
To provide a humid chamber, 3MM paper and a tissue soaked with 20 ml 50%
formamide/5X SCC was placed in the box. The box was sealed with tape and
placed in a zip-lock plastic bag in a humidified hybridization oven overnight at
52°C.
2.6.5 Post-hybridization washes
The slides were removed and placed in a glass rack in a glass staining dish
containing the following solutions for the temperature and times indicated.
1. Solution A 5x SSC/10 mM DTT
2. Solution B 2x SSC in 50% formamide/
100 mM DTT
3. Solution C RNase buffer (0.5 M NaCl, 5 mM
EDTA, 10 mM Tris-HCl (pH 7.5)






















The sections were dehydrated by dipping the slides sequentially for 2 min in
30, 60, 80, 95% ethanol containing 300 mM ammonium acetate followed by
absolute ethanol for 2 min. The slides were air-dried and exposed to Agfa Curix
Xray film overnight in a film cassette as an indicator of exposure time for
autoradiography.
2.6.6 Autoradiography, staining and photography
Ilford K5 nuclear emulsion was diluted 1:1 with distilled water containing 2%
glycerol and was melted for 15 min at 42°C in a darkroom illuminated with a
safelight (Ilford 902S filter). After gentle mixing the slides were dipped in the
diluted emulsion and allowed to air-dry vertically. The slides were placed in light
tight boxes containing a desiccant, sealed with tape and stored at 4°C. The slides
were exposed for 2 to 4 weeks. The slides were developed in Kodak D19 for 4
minutes and fixed with 30% sodium thiosulfate. After washing in tap water the
slides were stained with Ehrlich's hematoxylin for 20 s, dehydrated through ethanol
and cleared in xylene before mounting with Cytoseal (Stevens Scientific). Darkfield
photographs was taken using an Olympus SZH10 steromicroscope with Fuji Velvia
film and scanned using a UMAX S12 scanner. Alternatively for higher
magnification, epifluorescence microscopy was performed using an Olympus BX60
microscope and photographed with Fuji Provia film.
2.7 TRANSGENESIS
2.7.1 Construct preparation
Four promoter constructs containing LacZ as a reporter gene were prepared
(Fig. 15). Different regions of the periaxin promoter were cloned into the plasmid
















Figure 15. Schematic representation of Periaxin/LacZ transgenes. The periaxin
(prx) gene is illustrated on the top with each transgene below. Prxl-nlacZ contains
5.5 kb of prx promoter, exon 1, intron 1, and most of exon 2, nlacZ, and murine
protamine-1 (mPl) gene which provides an intron and polyadenylation signal;
Prx2-nlacZ comprises 5.5 kb of prx promoter, exon 1, lacZ and mPl; Prx3-nlacZ
comprises 2 kb of prx promoter, exon 1, lacZ and mPl; Prx4-nlacZ contains the 500
bp core promoter, exon 1, lacZ and mPl. The transcription initiation site is marked
+1 and the translation start codon is marked ATG.
in frame with the lacZ coding sequence, to encode a nuclear targeted E. coli [3-
galactosidase. A segment of the mouse protamine-1 gene (mPl) (Peschon et al.,
1987) from +95 relative to the transcription start site to +625, provides an intron
and a polyadenylation site. The constructs were also cloned into the plasmid
placF, lacking the nuclear localization signal.
The periaxin promoter constructs were tested by transient transfection in
NIH 3T3 cells, and Schwann cells using either liposome-mediated transfection or
calcium phosphate precipitation. Schwann cells were grown in the presence of 50
pM forskolin before and after Lipofectamine-mediated transfection. The
transfected cells were identified by (3-galactosidase histochemistry.
pPrxl-nlacZ
pPrxl-nlacZ consisted of 5.5 kb of the periaxin promoter, exon 1, intron 1,
and 43 bp of exon 2 (5' untranslated region) linked to the lacZ reporter gene. PCR
using a 5 kb fragment of genomic clone HH1 in pIBI30 as template introduced 2
restriction sites, Xbal and Ncol, into the 3' end of exon 2. The primers used for the
PCR were T3 (forward primer) and DLS1 (reverse primer). The 3.5 kb PCR
product was purified, digested with Xbal and EcoRI and ligated into pBlueScript
KS (Stratagene), generating p3.5BS. A 7 kb fragment from the HH1 genomic clone
was inserted in dephosphorylated (using the calf intestinal alkaline phosphatase
kit, CIAP, Gibco BRL) EcoRI cut p3.5BS and the correct orientation was obtained
by restriction digest. The 10.5 kb fragment was released from the BlueScript
polylinker by digestion with Ncol and Sail and cloned into pnlacF to generate
pPrxl-nlacZ. A Promega Wizard Maxiprep was performed and the vector
sequence was removed by digestion with Hindlll and Sail.
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pPrx2-nlacZ
pPrx2-nLacZ consisted of 5.5 kb of the periaxin promoter and the reporter
gene LacZ. Prx2-nLacZ was constructed by introducing Ncol and EcoRI sites into
exon 1 by PCR. A PCR product of 2 kb of periaxin promoter including exon 1 was
obtained using a pIBI30 subcloned 7 kb fragment of the HH1 genomic clone as
template with the reverse primer DLS 21 and T3 (forward). Pfu polymerase (1 U,
Stratagene) was used in a 50 pi PCR at an annealing temperature of 55°C with a 2
min extension. The bands of the expected size were excised from a 1% agarose gel,
extracted using Qiaex II gel extraction kit (Qiagen), digested with Kpnl and EcoRI,
and ligated into Kpnl and EcoRI cut pIBI30. A Kpnl digest of HH7 released a 3.5
kb fragment which was then cloned into the 2 kb fragment in pIBI30 after Kpnl
digestion and dephosphorylation. The dephosphorylation was performed by
incubation with CIAP (Gibco BRL) in CIP buffer for 30 min at 50°C. The
orientation of the insert was determined by restriction digest. Finally the 5.5 kb
fragment was released from the vector polylinker by digestion with Ncol and Sail
and cloned into pnlacF at the Ncol and Sail sites to generate pPrx2-nlacZ. After
plasmid preparation by Qiagen midi-prep, vector sequences were removed by
digestion with Hindlll and Sail.
pPrx3-nlacZ
This construct consisted of 2 kb of the periaxin promoter linked to the lacZ
gene. pPrx3-nLacZ was constructed by introducing a Ncol site into exon 1 by PCR.
A PCR product of 2 kb of the periaxin promoter including exon 1 was obtained
using the 7 kb fragment in pIBI30 of genomic clone HH1 as template with the
reverse primer DLS 19 and T3 (forward). 1 U of pfu polymerase (Stratagene) was
used in a 50 pi PCR at an annealing temperature of 55°C with a 2 min extension.
The bands of the expected size were excised from a 1% agarose gel, extracted using
Qiaex II gel extraction kit (Qiagen), digested with Kpnl and Ncol, and ligated into
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pnlacF at the Kpnl and Ncol sites. Following plasmid preparation by Qiagen midi-
prep, vector sequences were removed by digestionwith Kpnl and Hindlll.
pPrx4-nlacZ
The construct pPrx4-nlacZ contained the 500 bp of the periaxin core
promoter linked to the lacZ gene. The restriction sites Ncol and Sail were
introduced by PCR with the forward primer DLS 25 and the reverse primer DLS 21.
A 50 pi PCR contained 1 U pfu polymerase, 0.5 pM primers, 200 pM dNTPs in pfu
polymerase buffer. An annealing temperature of 55°C and an extension of 30 s was
used for the PCR. After gel electrophoresis the 0.5 kb bands were excised and
purified as described previously, digested with Ncol and Sail and cloned into
pnlacF at the Ncol and Sail sites. The insert was checked for errors by sequencing
and plasmid was prepared by Promega Maxipep. Vector sequence was removed
by digestion with Flindlll and Sail.
2.7.2 DNA purification for injection
DNA was prepared by Qiagen midiprep or Promega Wizard Maxiprep.
Vector sequences were removed by restriction digest of 50-70 pg of plasmid. The
digested plasmids were electrophoresed on 0.8% low melting point agarose gel and
the bands corresponding to the vector-free fragments were excised and weighed.
The agarose was digested with agarase (Boehringer Mannheim) by incubation at
65°C for 15 min with 0.04 vol. 25X agarase buffer. The temperature was adjusted
to 45°C before the addition of 0.8 U agarase/100 pi followed by incubation for 1 h.
The DNA was then purified with an Elutip-D column (Schleicher & Schuell)
according to the manufacturer's instructions, followed by ethanol precipitation and
resuspension in sterile injection buffer (0.1 mM EDTA, pH 8, 10 mM Tris HC1, pH
7.5). To remove particles, the injection buffer was Millipore filtered (0.22 pm) twice
before use and all microfuge tubes were washed twice with injection buffer before
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use, vortexed each wash and then the remaining injection buffer was flicked out.
The A260 of the DNA solution was measured with a Pharmacia spectrophotometer
and the concentration of the DNA was calculated. This value was checked by
electrophoresis on a 1% agarose gel and the intensity compared to that of a high
mass ladder (Gibco BRL) by UV transillumination. Dialysis was performed on 10
gg DNA in a "waterbug" (Orr et al., 1995) against 1 liter of injection buffer for 48-72
h with 3 changes of the buffer. The concentration of the recovered DNA was
calculated again after comparison to the intensity of a high mass ladder following
electrophoresis and UV transillumination. The purified DNA was then diluted
with filtered injection buffer to obtain a concentration of 2.5 gg/ml. The DNA was
centrifuged (13,000 rpm) for 10 min to pellet any particles and the top portion was
stored in aliquots in precleaned microfuge tubes. The aliquots were stored at -70°C.
2.7.3 Production of transgenic mice
To produce transgenic mice, transgenes (Prxl-nlacZ, Prx2-nlacZ, and Prx3-
nlacZ) were introduced into the C57BL6 mouse genome by standard pronuclear
microinjection (Hogan et al., 1994). Female F1 (C57BL6 X CBA hybrid mice)
hybrids were superovulated and mated with F1 hybrid males. The oviducts from
plugged mice were removed and placed in M2 medium (Sigma). Fertilized eggs were
released from a swollen ampulla by tearing the tissue with fine forceps and
transferred to a dish containing 300 gg/ml hyaluronidase (Sigma) in M2 for a few
minutes to remove the cumulus (follicle) cells and then transferred to fresh M2.
Embryos were injected with the transgene, briefly incubated in Ml6 (Sigma) before
transfer to the oviducts of pseudo-pregnant foster mothers. The injections and
embryo transfers were performed by Professor P.J. Brophy. Mice were kept in the
Department of Veterinary Pathology Animal House, University of Edinburgh in an
isolation room. Breeding and tail biopsies were performed by Ms. Linda Ferguson
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as well as assistance with transgene screening. Tail clips were taken from possible
founders at ~postnatal-day 21 and genomic DNA was extracted.
2.7.4 Genomic DNA extraction from tail biopsies
Each tail clip was placed in a 1.5 ml screw-top vial containing 0.5 ml of
lysis buffer (100 mM EDTA, 0.125% SDS, 1 mg/ml proteinase K (Boehringer
Mannheim, 50 mM Tris HC1, pH 8) overnight at 55°C. An equal volume of
phenol/chloroform (1:1) was added and the vial was gently mixed to form an
emulsion. The vials were placed on a rotating mixer for 10 min followed by
centifugation at 5000 rpm for 5 min. The aqueous phase was removed with a
yellow tip (small point cut off to prevent shearing of genomic DNA) and
transferred to a fresh screw-top vial. The phenol/chloroform extraction step was
repeated followed by extraction with chloroform to remove any phenol. The
aqueous phase was removed and the genomic DNA was precipitated with 1/10
vol. 3 M sodium acetate pH 6 and 2 vol. ethanol. After centrifugation the DNA
was washed with 70% cold ethanol to remove salts, and resuspended in 100 pi TE.
The A260 was measured and the concentration was calculated. Genomic DNA
was stored at 4°C.
2.7.5 Transgene screening by PCR
The primers synthesized for genomic PCR were: a forward primer Lac 1 and
a reverse primer Lac 2 which produced a 500 bp product E Leconte, 1996 #7 ] . A
50 pi PCR reaction consisted of 240 ng template, 0.5 pM primers, 5 pi Dynazyme
lOx buffer, 0.2 mM dNTPs, 1U Dynazyme polymerase (Flowgen). A control
without template was included. The PCR conditions were: 94°C denaturation for 1
min, 55°C annealing for 30 s, and 72°C extension for 30 s for one cycle, followed by
28 cycles of 94°C denaturation for 30 s, 55°C annealing for 30 s, 72°C extension for
30 s. The last cycle consisted of 72°C denaturation for 30 s, 55°C annealing for 30
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s, and 72°C extension for 4 min. An aliquot of the reaction (9 gl) was run on 1%
agarose gel in TAE buffer containing 0.5 gig/ml ethidium bromide and visualized by
UV transillumination.
2.7.6 Transgene screening by Southern blotting
Genomic DNA (10 |ig) was digested overnight at 37°C with 50 U EcoRI
(Gibco BRL) containing 2.5 gg/ml BSA. The digests were resolved by 0.8% agarose
gel electrophoresis. Resolved samples were then transferred to nylon membrane
(Micron Separations Inc.) using a VacuGene XL blotting unit (Pharmacia Biotech).
The DNA was depurinated in 0.25 M HC1 for 5 min, denatured in 1.5 M NaCl, 0.5
M NaOH for 20 min and then neutralized in 1.5 M NaCl, 0.5 M Tris HC1 pH 8 for
20 min followed by 20X SSC for 1 h. The membrane was baked at 80°C for 2 h.
Probe preparation
A 2 kb probe was prepared by restriction digestion of placF DNA with SstI
followed by BamHI. The DNA was resolved by 1% agarose gel electrophoresis in
TAE buffer and the 2 kb band was excised and purified using the Qiaex II gel
extraction kit. The concentration of the probe was determined by comparison with
a low mass ladder (Gibco BRL) following gel electrophoresis in 1% agarose and UV
transillumination. The probe was labelled (50 ng) with [cc^2pj d£TP by random
priming (Gibco BRL).
Pre-hybridization
After briefly wetting the membrane with distilled water, it was placed in a 50 ml
screw-top centrifuge tube and covered with Quikhyb (5 mis, Stratagene). The
centrifuge tube was placed in a glass hybridization roller tube which was then
rotated in a hybridization oven (Techne Hybridizer HD-1B) at 65°C for 30 min.
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Hybridization
After the addition of 1 mg of sheared salmon sperm DNA (Stratagene), the labelled
probe was boiled for 8 min and immediately added to the Quikhyb in the tube and
hybridized for 2 h at 65°C.
Post-hybridization washes
The membrane was washed twice with 2x SSC containing 0.1% SDS for 10 min each
at room temperature and twice with 0.2x SSC containing 0.1% SDS for 30 min each
at 65°C. The membrane was wrapped in Saran Wrap and exposed to X-ray film
(Agfa Curix) in an X-ray cassette with an intensifying screen for 2-3 d.
Autoradiographs were developed with Kodak LX24 followed by Kodak Industrex
fixer.
2.7.7 P-galactosidase histochemistry
Mice were perfused through the left ventricle with heparinized saline
followed by freshly prepared 4% paraformaldehyde in 0.1 M phosphate buffer pH
7.3. For P-galactosidase staining tissues were quickly removed and placed in
freshly prepared 2% paraformaldehyde, 0.2% glutaraldehyde, 2 mM MgCl2, 5 mM
EGTA in 0.1 M sodium phosphate buffer pH 7.4 at 4°C for 1 h (Hogan et al., 1994).
Embryos older than E13 and adult brain were cut saggitally with a scalpel blade
before immersion in fixative. Tissues were rinsed three times, for 30 min each, with
a buffer containing 2 mM MgCl2, 0.01% sodium deoxycholate, 0.02% NP-40 in 0.1
M sodium phosphate buffer pH 7.3. The staining reaction was performed by
incubating the tissue overnight at 37°C in 1 mg/ml X-gal (Gibco BRL), 5 mM
K3Fe(CN)6 and 5 mM K4Fe(CN)6 in the rinse buffer. After washing in PBS,
postfixation was performed overnight in 10% formalin. The tissue was
photographed as whole mount preparations on an Olympus SZH10 stereo
microscope. Teased fibres were prepared of sciatic and trigeminal nerves and
mounted in 80% glycerol. Embryos and brains were cryoprotected with 25%
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sucrose and frozen in isopentane cooled in liquid nitrogen and 15 (im sections were
cut on a cryostat. Sections were briefly counterstained with 1% Orange G (w/v) in
2% tungstophosphoric acid.
2.8 STRAINS OF ANIMALS USED IN THE WORK
The rats were of the Wistar strain. All mouse tissues and embryos were from F1
hybrid mice which were produced from C57BL/6 and CBA mice. Periaxin-null
mutant mice were produced at the Centre for Genome Research, Edinburgh
University and were the result of targetted deletion of the Prx locus in ES cells
which were subsequently injected into C57BL/6 blastocysts. Heterozygous
offspring were backcrossed to the parental C57BL/6 strain before intercrossing at




3.1 IMMUNOLOCALIZATION OF L-PERIAXIN AND S-PERIAXIN
The myelin-forming Schwann cell is a polarized epithelial cell with distinct
membrane domains that contain proteins with discrete localizations (Kidd et al.,
1994; Trapp et al., 1995). PO, MBP, and PMP-22 have all been localized to
compact myelin, whereas MAG, spectrin, and F-actin are associated with the
periaxonal cytoplasmic region apposing the axon (Trapp et al., 1989b). There are
also several proteins expressed in the uncompacted regions of the Schwann cell, the
Schmidt-Lanterman incisures and paranodal loops, such as MAG, E-cadherin, and
connexin-32 (Trapp and Quarles, 1982; Fannon et al., 1995; Scherer et al., 1995).
In order to determine the localization of L-periaxin and S-periaxin and ascertain in
which regions of the Schwann cell the proteins may be functionally important
immunofluorescence and immunogold electron microscopy was performed.
3.1.1 L-periaxin localization in early postnatal peripheral nerve by immunogold
electron microscopy
Using a post-embedding immunogold technique, sections of early postnatal
rat sciatic nerve, (postnatal-day 1, 4 and 7) were immunolabelled with the affinity-
purified anti-peptide antibody, 170pepl, followed by a secondary antibody
coupled to 10 nm colloidal gold. The anti-170pepl was raised against a synthetic
peptide which comprised amino acids 713 to 728 in the repeat region of L-periaxin
only.
During early ensheathment at postnatal-day 1 in the rat, at a time when the
Schwann cell-axon unit is in a one-to-one relationship but myelin sheath formation
has not yet occurred, gold particles linked to antibodies that recognize L-periaxin
strongly decorated the Schwann cell plasma membranes. As the mesaxon spirals
around the axon forming several complete turns, L-periaxin labelling was evident on








Figure 16. Immunolocalization of L-periaxin during early ensheathment at the
electron microscopic level. At an early stage of axonal ensheathment, in rat
postnatal-day 1 sciatic nerve, L-periaxin can be detected on the uncompacted
Schwann cell membranes including the membranes of the inner and outer mesaxons
(OM). The Schwann cell in (A) has completed a half turn around the axon (Ax)
and in the cell in (B) approximately two turns. The Schwann cell plasma membrane
is also labelled. Bar, 200 nm.
Slightly later in the development of the rat sciatic nerve at postnatal-day 4,
immunogold particles were detected on the periaxonal membranes of the myelin
sheath as well as the abaxonal membranes (apposing the basal lamina) (Fig. 17A,
17B). The localization on periaxonal membranes was similar to that previously
described for MAG (Trapp et al., 1989a; Trapp et al., 1989b; Trapp et al., 1988).
When sections were labelled using antisera directed against the major myelin
protein PO and MAG and compared with sections labelled with anti-170pepl, L-
periaxin and MAG localized to the same periaxonal compartment (Fig. 18A and
18B). Like MAG, L-periaxin was excluded from compact myelin (Fig. 17A, 17B,
and 18A) which indicates that L-periaxin does not play a role in the compaction of
the myelin sheath. In contrast, PO, the major glycoprotein of peripheral myelin, was
concentrated throughout compact myelin (Fig. 18C). L-periaxin was also detected
in other regions of the Schwann cell including the Schwann cell plasma membrane
(Fig. 17A), in the cytoplasm-filled outer loops or uncompacted region of the myelin
sheath (Fig. 17B, 19A) and in Schmidt-Lanterman incisures (Fig. 19B), the
cytoplasmic channels that traverse the myelin sheath. L-periaxin colocalized with
MAG in the Schmidt-Lanterman incisures of sections that were double-labelled for
both proteins (Fig. 20).
In the regions of the sheath that flank the node of Ranvier, L-periaxin was
detected on the uncompacted cytoplasm-filled membranes of the paranodes but not
in the loops which directly appose the axolemma where the electron-densities are
known to be rich in the protein CASPR/paranodin (Fig. 21A, 21B) (Menegoz et al.,
1997; Peles et al., 1997). The electron-dense adherens-type junctional cytoplasmic
plaques that are in register across Schmidt-Lanterman incisures and paranodal
loops were strongly labelled with an antiserum directed against E-cadherin (Fig.
22B, 22C) (Fannon et al., 1995) but were not labelled by L-periaxin (Fig. 22A).
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Figure 17. Localization of L-periaxin in postnatal-day 4 sciatic nerve by
immunoelectron microscopy. (A) Immunogold particles are specifically localized
to the periaxonal and abaxonal (apposing the basal lamina) myelin membranes
(arrows) and the Schwann cell plasma membrane (arrowhead). (B) In a Schwann
cell where the outer mesaxon is visible, gold particles decorate the apposing
membranes (arrows). Ax, axon. Bar, 200 nm.
Figure 18. Comparison of L-periaxin, MAG and PO localization in postnatal-day
4 sciatic nerve by immunoelectron microscopy. (A) L-periaxin is primarily
localized to the periaxonal membranes (arrowheads). A few gold particles are also
seen on the abaxonal membranes (arrows). (B) Like L-periaxin MAG is localized to
the periaxonal membranes (arrowheads). L-periaxin and MAG are excluded from
compact myelin. (C) In contrast, PO is localized to the compact myelin sheath. Ax,
axon Bar, 200 nm.
Figure 19. L-periaxin is localized to the uncompacted channel network of
Schwann cells by immunogold electron microscopy. In postnatal-day 4 sciatic
nerve, gold particles decorate uncompacted regions of the sheath (A, arrow)
including Schmidt-Lanterman incisures (B). Ax, axon. Bar, 200 nm.
Figure 20. Colocalization of L-periaxin and MAG in Schmidt-Lanterman
incisures by double-label immunogold electron microscopy. In postnatal-day 28
trigeminal nerve, L-periaxin (10 nm gold particles) and MAG (5 nm gold particles,
arrowheads) are seen over the uncompacted channels of a Schmidt-Lanterman
incisure. Compact myelin is devoid of labelling. Ax, axon; bl, basal lamina. Bar,
200 nm.
Figure 21. L-periaxin immunogold localization at the paranode. In sections of
postnatal-day 5 sciatic nerve L-periaxin is localized to the paranodal uncompacted
membranes (A and B) but is not present in the loops which appose the axolemma
where electron densities are apparent (A, arrows). Ax, axon; bl, basal lamina. Bar,
200 nm.
Figure 22. Adherens-type junctional complexes are labelled by antibodies
against E-cadherin but not L-periaxin. In postnatal-day 8 sciatic nerve the
electron-dense cytoplasmic plaques that are in register across paranodal loops are
labelled with antibodies for E-cadherin (B and C) but not L-periaxin (A, arrow).
Ax, axon. Bar, 200 nm.
3.1.2 L-periaxin is exclusively expressed by myelin-forming Schwann cells in
peripheral nerve
There are two major types of Schwann cells in peripheral nerve, the myelin-
forming Schwann cells which express PO, MBP, and MAG, and the non-myelin-
forming which lack these proteins but express NGFR, GAP-43, LI, and N-CAM.
To determine if L-periaxin is expressed in the non-myelin-forming population of
Schwann cells, double-label immunofluorescence confocal microscopy was
performed on cryosections of postnatal-day 1 mouse sciatic nerve with antisera to
L-periaxin and GAP-43. As demonstrated in Fig 23, L-periaxin does not colocalize
with GAP-43 indicating that it is not a constituent of non-myelin-forming Schwann
cells.
To confirm this finding at the electron microscopic level immunogold stained
sections of postnatal-day 4 rat sciatic nerve were examined. L-periaxin labelling
was not detected over non-myelin-forming Schwann cells which ensheathe multiple
axons (Fig. 24). Only Schwann cells in a one-to-one relationship with an axon, i.e.
myelin-forming Schwann cells, were labelled. Consistent with these observations,
the non-myelin-forming Schwann cells of the cervical sympathetic trunk also do not
express L-periaxin (Scherer et al., 1995). The cervical sympathetic trunk is
predominantly composed of non-myelin-forming Schwann cells (Aguayo et al.,
1976).
3.1.3 L-periaxin localization in later postnatal peripheral nerve demonstrates a
shift during development
When sections of adult mouse sciatic nerve were compared with sections
from sciatic nerves of younger animals just after the most active phase of
myelination, a change in the pattern of labelling was observed. Transverse
cryosections of postnatal-day 20 (Fig. 25A and 25B) and adult (Fig. 25C and 25D)
mouse sciatic nerves immunolabelled with anti-170pepl (Fig. 25A, 25B, 25C, 25D)
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Figure 23. Immunofluorescence localization of L-periaxin and GAP-43 in mouse
sciatic nerve. Longitudinal cryosections of postnatal-day 1 sciatic nerve were
immunolabelled for L-periaxin (A, fluorescein) and GAP-43 (B, Texas red) to label
non-myelin-forming Schwann cells and examined by confocal microscopy. The
GAP-43 positive cells (B) do not colocalize with L-periaxin positive cells which is
evident in the combined image (C) demonstrating that L-periaxin is exclusively
expressed by myelin-forming Schwann cells in peripheral nerves. Bar, 10 |im.
Figure 24. L-periaxin is exclusively expressed by myelin-forming Schwann cells.
Immunogold electron microscopy of sections of postnatal-day 4 rat sciatic nerve for
L-periaxin showed that non-myelin-forming Schwann cell processes which
ensheathe multiple axons (left) are not labelled whereas the periaxonal (arrows)
and abaxonal (arrowheads) membranes of the myelin-forming cell (right), are
labelled. Ax, axon; bl, basal lamina. Bar, 200 nm.
Figure 25. Immunofluorescence localization of L-periaxin and MBP in postnatal-
day 20 and adult mouse sciatic nerve. (A, B) A transverse section of postnatal-
day 20 mouse sciatic nerve, double-labelled for L-periaxin (A, fluorescein) and MBP
(B combined image, Texas red). L-periaxin is localized to the plasma membrane
(arrowhead) as well as the abaxonal and adaxonal membranes (arrows) of
myelinating Schwann cells. MBP labeling is restricted to the myelin sheath and
shows no co-localisation. (C, D) A transverse section of adult mouse sciatic nerve
double-labelled for L-periaxin (C, fluorescein) and MBP (D combined image, Texas
red) demonstrates that L-periaxin is concentrated in the abaxonal membranes and
is absent from the adaxonal membranes as seen at postnatal-day 20. Bar, 5 gm.
and antisera directed against MBP (Fig. 25B, 25D) were examined by confocal
immunofluorescence microscopy. In large diameter fibres at postnatal-day 20, L-
periaxin immunostaining was observed in the adaxonal and abaxonal regions of the
myelin sheath (Fig. 25A, 25B) which was visualized by immunolabelling of MBP
(Fig. 25B). In small diameter fibres where the axons were thinly myelinated, the
immunolabelling appeared to colocalize with MBP but this was probably a
consequence of the resolution limitations of the microscope. In direct contrast in
adult nerve, L-periaxin was concentrated in the abaxonal Schwann cell membranes
(Fig. 25C, 25D) on the outside of the MBP+ compact myelin sheath (Fig. 25D. This
suggests that during development of peripheral nerves L-periaxin is lost from the
periaxonal collar and becomes concentrated in the abaxonal region of the sheath.
The developmental shift in localization of L-periaxin was confirmed by
immunogold electron microscopy. In postnatal-day 7 trigeminal nerve, L-periaxin
was localized to the adaxonal and abaxonal membranes (Fig. 26A) but by
postnatal-day 28 a striking redistribution in L-periaxin localization was observed
(Fig. 26B). Antibodies against L-periaxin predominantly labelled the abaxonal
membranes but not the adaxonal or periaxonal membranes, thus confirming the
localization observed by light microscopy. Immunogold particles were detected on
the Schwann cell plasma membrane and the outer membrane of the myelin sheath at
both developmental ages investigated (Fig. 26A and 26B).
Earlier work on L-periaxin had suggested that the protein was cytoskeleton-
associated due to its presence in the Triton X-100-insoluble fraction of PNS myelin.
Since I had demonstrated L-periaxin in periaxonal membranes during development
in the same region where Trapp and co-workers (Trapp et al., 1989b) have
previously localized two components of the actin cytoskeleton, F-actin and
spectrin, I wanted to investigate the localization of L-periaxin in relation to F-actin
during postnatal nerve development.
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Figure 26. Comparison of L-periaxin immunogold localization in sections of
postnatal-day 7 and postnatal-day 28 trigeminal nerve. (A) Immunogold particles
are detected on abaxonal and adaxonal myelin membranes in postnatal-day 7
sections. (B) A concentration of gold particles on the abaxonal myelin membranes
(arrows) demonstrates a redistribution of L-periaxin during nerve development.
Gold particles are also evident on the plasma membrane (arrowheads).
Bar, 200 nm.
Using immunofluorescence to localize L-periaxin and rhodamine phalloidin
binding to localize F-actin, stained cryosections from early postnatal rat sciatic
nerve were compared with cryosections from adult nerve. At early ages, F-actin
colocalizedwith L-periaxin in myelinated fibres (Fig. 27A, 27B, 27C). F-actin was
also present in other locations presumed to be non-myelin-forming Schwann cells
and the endothelial cells of blood vessels. The exact regions of co-localization
around the myelin sheath in these young nerves were difficult to resolve at the light
microscopic level but there appeared to be co-localization in the region apposing the
axon and at the plasma membrane. In contrast, in the adult nerve L-periaxin and
F-actin colocalized at the abaxonal and plasma membranes but not at the adaxonal
membrane where F-actin is readily detectable (Fig. 27D, 27E, 27F). F-actin and L-
periaxin are colocalized in the Schmidt-Lanterman incisures which are strongly
labelled for both proteins. This indicates that during the early development of
peripheral nerves L-periaxin localizes to all membrane/cytoplasmic channel regions
where there are actin-cytoskeletal components but later in development this is not
the case. Interestingly Trapp and co-workers demonstrated spectrin localization by
immuno-gold microscopy (Trapp et al., 1989b) to the abaxonal membranes,
adaxonal membranes and uncompacted cytoplasmic channels, the same regions
where L-periaxin is localized indicating that L-periaxin may be associated with
microfilaments.
Teased fibres from adult sciatic nerves were immunolabelled for L-periaxin
and MAG to examine the cytoplasmic channels of Schmidt-Lanterman incisures
and paranodal loops in the fully developed internode. L-periaxin colocalized with
MAG in Schmidt-Lanterman incisures (Fig. 28A, 28B, 28C) by immunofluorescence
confocal microscopy. There is some periaxin present at the paranodal regions but it
is not closely associated with the MAG-positive paranodal loops (Fig. 28D, 28E,
28F). L-periaxin is also evident at the node of Ranvier which is most likely plasma
membrane staining of Schwann cell microvilli (Fig. 28D).
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Figure 27. L-periaxin localization by immunofluorescence and F-actin
localization by phalloidin binding during development and in the adult sciatic
nerve. Transverse cryosections of postnatal-day 7 (A, B, C) and adult (D, E, F) rat
sciatic nerve were immunolabeled for L-periaxin (fluorescein) and phalloidin
(rhodamine) which binds to F-actin and examined by confocal microscopy. In
postnatal-day 7 sections L-periaxin (A) and F-actin (B) colocalize (C, combined)
whereas in adult sections F-actin is present in the periaxonal cytoplasm (E, arrows)
but not L-periaxin (D, arrows). In abaxonal regions L-periaxin and F-actin
colocalized (D, E, F, arrowheads).
Figure 28. Colocalization of L-periaxin and MAG in Schmidt-Lanterman
incisures and paranodes of teased fibres from adult mouse sciatic nerve. (A, B)
Teased sciatic nerve fibres were double-labelled for L-periaxin (A and D,
fluorescein) and MAG (B and E, Texas red) and examined by confocal microscopy.
L-periaxin (A) and MAG (C) are colocalized (C, combined image) in the Schmidt-
Lanterman incisures (arrows) whereas the paranodal loops which are labelled for
MAG (E, arrow) do not colocalize with L-periaxin (F). L-periaxin labels the plasma
membrane of Schwann cell microvilli at the node (arrowhead; D and F). Bar, 200
nm.
3.1.4 L-periaxin is not exposed on the Schwann cell surface
From hydrophobicity plots of the deduced amino acid sequence, L-periaxin
is not predicted to possess transmembrane domains and is therefore not believed to
be an integral membrane protein (Gillespie et al., 1994). In order to confirm that L-
periaxin is not exposed at the extracellular surface of the Schwann cell,
immunofluorescence on unpermeabilized cells and cell-surface biotinylation
experiments were performed.
Transfected 33B cells permanently expressing L-periaxin were prepared by
liposome-mediated transfection (method in section 2.4.1). Colonies were isolated
and expanded and clone 25 was selected which expressed high levels of L-periaxin
protein as detected by immunofluorescence screening. Cells from clone 25 were
metabolically labelled with [33S] methionine and immuneprecipitated with anti-
170pepl. A protein of the same Mr as L-periaxin was obtained (Fig 29A)
demonstrating that the stable transfectants were expressing full length protein.
Schwann cells from short-term cultures and cells from 33B clone 25
permanently expressing L-periaxin were immunostained without detergent
permeabilization to determine if L-periaxin was exposed on the cell surface. Four
different L-periaxin antisera were used, pl70, 170pepl, NTerm, CTerm, which
recognize different regions of the protein (see Materials and Methods, Table 1). No
staining was detected whereas labelling occurred with all four antibodies if the cells
were first permeabilized with Triton X-100 (data not shown).
The surface of cells from clone 25 was biotinylated (method in section 2.4.5)
to confirm the result by immunofluoresence. No biotinylated cell surface proteins
were immuneprecipitated with anti-170pepl after probing with streptavidin HRP
(Fig. 29B lane 1). When cells from clone 25 were first permeabilized with Triton X-
100, biotinylated periaxin was detected by immuneprecipitation with anti-170pepl
followed by probing with streptavidin FIRP (Fig. 29B lane 2). These data confirm
that L-periaxin is not exposed on the cell surface.
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Figure 29. Cell surface biotinylation of 33B cells permanently expressing L-
periaxin. 33B cells (clone 25) were examined for protein expression prior to cell
surface biotinylation studies. (A) 33B cells (clone 25) and postnatal-day 6 sciatic
nerve were metabolically labelled with [^sjmethionine, solubilized in SDS,
immunoprecipitated with anti-170pepl and analyzed by SDS-PAGE. Proteins of
the same Mr were obtained from both 33B cells and sciatic nerve. (B) Cells from
clone 25 were biotinylated before (Lane 1) and after permeabilization with Triton X-
100 (Lane 2), immuneprecipitated with anti-170pepl, separated by SDS-PAGE ,
and probed with steptavidin HRP (Lane 1 and 2) or antil70pepl (Lane 3). No
biotinylated cell surface proteins were immuneprecipitated with anti-170pepl
(Lane A). When cells were permeabilized before biotinylation then
immuneprecipitated with anti-170pepl and probed with either streptavidin HRP
(Lane 2) or anti-170pepl (Lane 3), proteins of the same Mr are apparent.
Molecular mass standards are indicated on the left.
3.1.5 The S-periaxin isoform is expressed in the Schwann cell cytoplasm in
neonatal sciatic nerve
Immunofluorescence analysis of postnatal-day 20 murine sciatic nerve had
demonstrated that S-periaxin was localized to the Schwann cell cytoplasm
(Dytrych et al., 1998). In order to determine the localization of S-periaxin in
neonatal sciatic nerve, teased fibres from postnatal-day 1 mouse sciatic nerve were
prepared and immunolabelled with a specific antibody to S-periaxin which was
raised against a synthetic peptide corresponding to the C-terminal 23 amino acids
unique to mouse S-periaxin, anti-SPeri (Dytrych et al., 1998), and with an antibody
to the 160 kDa neurofilament protein NF-M to immunolabel the axons. Teased
fibres were also immunolabelled with antibodies to L-periaxin, anti-170pepl, and
NF-M for comparison. L-periaxin was expressed in the membranes apposing the
NF-M positive axon and on the plasma membrane (Fig. 30C, 30D). In contrast, S-
periaxin was diffusely expressed in the Schwann cell cytoplasm (Fig. 30A, 30B). In
some fibres there was a concentration of S-periaxin in discrete regions of
myelinating fibres (Fig. 30E) which colocalized with MAG (Fig. 30F) suggesting that
these regions may be where the cytoplasmic channels of Schmidt-Lanterman
incisures will develop.
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Figure 30. Comparison of the localization of S-periaxin and L-periaxin in teased
fibres of postnatal-day 1 mouse sciatic nerve. Teased fibres were double-labelled
for S-periaxin (A, fluorescein) and NF-M (B, Texas red; combined image) or L-
periaxin (C, fluorescein) and NF-M (D, Texas red; combined image) and examined
by confocal microscopy. S-periaxin (A) is diffusely distributed within the Schwann
cell cytoplasm with concentrations (arrowhead) around the axon labelled by NF-M.
In contrast, L-periaxin (C) is concentrated in the membranes ensheathing the axon
and at the plasma membrane. When immunofluorescence was performed on teased
fibres double-labeled for S-periaxin (E, fluorescein) and MAG (F, Texas red)
discrete concentrations of S-periaxin colocalized with MAG (arrows). Bar, 5 gm.
3.1.6 Summary
In this chapter I have demonstrated that L-periaxin is expressed by myelin-
forming Schwann cells in discrete domains that are developmentally regulated. In
early postnatal nerve it is concentrated in the adaxonal and abaxonal membranes,
but as the myelin sheath matures, L-periaxin became predominantly localized to the
abaxonal Schwann cell membrane. L-periaxin is also localized to uncompacted
regions of the sheath. I have confirmed that L-periaxin is not exposed on the cell
surface by cell surface biotinylation but is closely associated with the cytoplasmic
face of the Schwann cell plasma membrane by its localization with immunogold. I
have also shown that both isoforms of periaxin are expressed at an early stage in
the postnatal peripheral nerve and that S-periaxin is present throughout the




Schwann cells are derived from the neural crest. The neural crest is a group
of migratory cells which emerges from the neuroepithelium as it folds to form the
dorsal neural tube. Crest cells give rise to a diverse population of cell types of
which the Schwann cell is but one (LeDouarin, 1982). In the rat hindlimb,
embryonic Schwann cell development spans about a week from approximately E14
to birth at E21. In the murine PNS the period corresponds to E12 to E18 since
Schwann cell differentiation occurs earlier in the mouse. Cells isolated from E14 rat
hind limb nerves have a distinct phenotype intermediate between neural crest cells
and Schwann cells which has been called the Schwann cell precursor (Jessen et al.,
1994). At around E16 in the rat sciatic nerve the precursor cells differentiate to
form embryonic Schwann cells (Jessen et al., 1994; Mirsky and Jessen, 1996) which
in turn become either myelin-forming or non-myelin-forming Schwann cells in the
mature PNS.
The major peripheral myelin protein PO has been shown to be expressed
very early in the Schwann cell lineage of chickens (Bhattacharyya et al., 1991) and
rats (Zhang et al., 1995) and more recently Lee and co-workers (Lee et al., 1997).
demonstrated PO mRNA and low levels of protein in a subpopulation of migrating
neural crest cells, Schwann cell precursors, and embryonic Schwann cells in the rat.
Both protein products of the periaxin gene are expressed in neonatal rodent
peripheral nerve, therefore I wanted to investigate whether the gene is expressed
during embryonic development because L-periaxin protein expression appears to
precede that of other myelin proteins both in the neonate and during remyelination
after sciatic nerve crush (Scherer et al., 1995).
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3.2.1 L-periaxin mRNA and protein is expressed in the embryonic sciatic nerve
Periaxin mRNA expression was examined by in situ hybridization on
transverse cryo-sections though the lumbro-sacral regions of E12.5 to E16.5 mouse
embryos which included the developing sciatic nerves. The probe recognized
sequences (nts 1500-2500) present in both the 4.6 and 5.2 kb mRNAs. The only
isoform-specific sequence, 0.6 kb, was unique to S-periaxin mRNA. Antisense
[33S]-labelled riboprobes generated signals after 2 weeks exposure whereas in the
same period the sense [35S]-labelled riboprobes generated no signal above
background. Serial sections probed for P0 mRNA were also examined for
comparison.
At E12.5, at a time when all of the cells in the hind limb nerves would be
Schwann cell precursors, no periaxin labelling was observed (data not shown). A
low level signal for periaxin mRNA was first detected in E13.5 sections (Fig 31A).
The positive cells were in the developing sciatic nerve. By E14.5 there were more
cells labelled with a stronger signal (Fig. 31C) indicating that periaxin mRNAs are
first expressed in embryonic Schwann cells after they differentiate from precursor
cells. In addition to peripheral nerve labelling, there was a discrete layer of labelled
cells in the body wall which was more evident at E15.5 (Fig. 31E). The sense
control had no signal (Fig. 31F). By comparison, P0 mRNA expression was strong
at E13.5 (Fig. 31B). A strong signal was seen in the dorsal root ganglia, the dorsal
and ventral roots, and the peripheral nerves including the developing sciatic nerve
(Fig. 31B, 31D).
The expression of L-periaxin protein in embryonic sciatic nerves was
examined by immunofluorescence on transverse cryosections through the trunk of
mouse embryos. Double-label immunofluorescence was performed with anti-
170pepl and NF-M as an axonal marker to identify the sciatic nerve. The vast
majority of cells in E13.5 sciatic nerve were L-periaxin negative although a few






































Figure 31. Comparison of periaxin and PO mRNA expression by in situ
hybridization during embryonic development. In situ hybridization was
performed on transverse trunk sections from mouse embryos at E13.5 (A, B), E14.5
(C, D, F), and E15.5 (E) using antisense riboprobes for periaxin (A, C, E,) and PO
(B, D) and a sense riboprobe for periaxin (F). Periaxin mRNA is first detected in
<xfew cells in E13.5 developing sciatic nerve (A, arrow) but by E14.5 more cells
expressing periaxin mRNA are apparent (C, arrow). A discrete row of cells
expressing periaxin mRNA is seen in the body wall in E15.5 sections (E, arrow). In
comparison, PO mRNA expression is strong in the sciatic nerve (arrow), dorsal
roots, dorsal root ganglia, and other nerve trunks in E13.5 (B) and E14.5 (D)
sections, sc, spinal cord; DRG, dorsal root ganglion; AS, anti-sense.
Figure 32. Immunofluorescence localization of L-periaxin in developing sciatic
nerves of mouse embryos. Transverse cryosections through the trunks of E13.5,
E14.5 and E17.5 embryos were double-labeled with anti-170pepl (A, C, E;
fluorescein) and NF-M (B, D, F; Texas red) to label axons and examined by
confocal microscopy. Very few L-periaxin labeled cells are present in the sciatic
nerve at E13.5 (A) where most of the cells are Schwann cell precursors. By E14.5
many L-periaxin labelled cells are apparent (C) in the NF-M positive sciatic nerve
(D). The L-periaxin immunoreactivity is concentrated in the nuclei but by E17.5, L-






















cells were observed at E14.5 (Fig. 32C). The most intense labelling was seen in the
nuclei although cytoplasmic staining was also detected. The same staining pattern
persisted until E17.5 where there was an up-regulation of membrane associated L-
periaxin and no nuclear immunolabelling (Fig. 32E). Therefore, protein expression
correlates well with mRNA expression demonstrating that L-periaxin is first
expressed in the early embryonic Schwann cell immediately after differentiation
from its precursor cell.
3.2.2 S-periaxin mRNA is first expressed at postnatal-day 1
The riboprobe used for the previously described in situ hybridization studies
recognized both mRNA species, the 4.6 kb which encodes L-periaxin and the 5.2 kb
mRNA which encodes S-periaxin. Specific S-periaxin mRNA expression was
examined by in situ hybridization on transverse cryosections though the lumbo¬
sacral region of E16.5 mouse embryos which included the sciatic nerve, E17.5 and
postnatal-day 1 sciatic nerves, and postnatal-day 2 hindlimb. The [35S]-labelled
riboprobe used recognized a sequence present in a 0.6 kb region of the 5.2 kb mRNA
unique to S-periaxin. Antisense [35S]-labelled riboprobes generated signals after 2
weeks exposure whereas the sense [33S]-labelled riboprobes generated no signal
above background.
There was no signal above background with longer exposure of 3 weeks in
E16.5 embryo sections (Fig. 33A). The first positive cells were observed in
postnatal-day 1 mouse sciatic nerve (Fig. 33B) sections demonstrating that S-
periaxin expression occurs later than the L-periaxin isoform. These data also
demonstrate that the early embryonic mRNA which was observed with a [3^S]-
labelled riboprobe which recognizes both mRNAs was detecting the 4.6 kb mRNA
exclusively in those early embryonic Schwann cells and body wall cells.
Ultrastructural examination of embryonic Schwann cells in E16.5 mouse














Figure 33. S-periaxin mRNA expression in murine sciatic nerve by in situ
hybridization. In situ hybridization was performed on transverse cryosections
through the trunk of E16.5 embryos (A), postnatal-day 1 (PI) sciatic nerve
cryosections (B) and postnatal-day 2 transverse hindlimb cryosections (C, D) using
an antisense riboprobe unique to S-periaxin (A, B, C) and a sense control (D). In
cryosections through E16.5 sciatic nerve there was no signal for S-periaxin mRNA
(A). S-periaxin mRNA is first detected in PI sciatic nerve (B). In P2 hindlimb
sections, the sense riboprobe (D) generated no signal above background when
compared to a serial section using the antisense riboprobe (C). AS, anti-sense; S,
sense. Bar, 200 pm.
Figure 34. Electron micrographs of transverse sections from E16.5 and postnatal-
day 1 sciatic nerve. (A) Embryonic Schwann cells in E16.5 sciatic nerves ensheathe
multiple small axons. (B) Schwann cells in postnatal-day 1 sciatic nerve are mainly
in al:l relationship with axons. Bar, 1 |im.
Schwann cells ensheathe multiple small axons whereas at postnatal-day 1 when S-
periaxin is expressed, many Schwann cells are observed in 1:1 relationships with
axons (Fig 34B).
3.2.3 L-periaxin expression in embryonic Schwann cells in a predominantly
non-myelinating nerve
PO, the major PNS myelin protein, was shown to be expressed very early in
development, in a population of neural crest cells, Schwann cell precursor cells and
embryonic Schwann cells (Lee et al., 1997). PO mRNA was also present in most of
the embryonic Schwann cells of the rat cervical sympathetic trunk and was then
down-regulated during development (Lee et al., 1997). The cervical sympathetic
trunk in the adult is composed of around 95% non-myelin-forming Schwann cells
(Lee et al., 1997). PO was also expressed in satellite cells in the dorsal root ganglia.
Therefore, PO is expressed in all embryonic Schwann cells regardless of their fate.
Since L-periaxin is only expressed in myelin-forming Schwann cells in the
neonate and is expressed in embryonic Schwann cells long before they form a 1:1
relationship with an axon, I wanted to determine if L-periaxin was a very early
marker of the myelin-forming Schwann cell or like PO was expressed in all
embryonic Schwann cells.
In order to determine whether all embryonic Schwann cells express L-
periaxin, dissociated cell cultures isolated from embryonic mouse sciatic nerves
were prepared and immunolabelled with an embryonic Schwann cell marker, to
label all Schwann cells, and L-periaxin. Embryonic Schwann cells express the
proteins S100 (Jessen et al., 1994) and 04 (Mirsky et al., 1990). Since several
monoclonal antibodies to S100 protein did not immunostain mouse Schwann cells
reliably, the monoclonal antibody 04, which recognizes among other things, the
lipid antigen sulfatide on embryonic, neonatal, and adult myelin-forming and non-
myelin-forming Schwann cells in the rat (Mirsky et al., 1990), was chosen for these
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studies. Short-term cultures were used because L-periaxin is down-regulated with
other myelin proteins after longer times in culture in the absence of growth factors or
agents that elevate intracellular cAMP (Morgan et al., 1991; Shuman et al., 1988).
Sciatic nerves were removed from E16.5 mouse embryos, dissociated, and plated on
coverslips. After the cells had adhered to the coverslip and spread, they were
labelled with 04 antibody. The coverslips were fixed and immunolabelled with
anti-170pepl followed by secondary antibodies (Fig. 35A, 35B, 35C, 35D).
Positive cells were counted from 3 experiments which showed that 88.6 ± 3.7% of
the 04 positive cells expressed L-periaxin. Therefore 11.4% of the Schwann cells
did not express L-periaxin. Two possible explanations exist. One possibility is
that L-periaxin is expressed only in Schwann cells destined to be myelin-forming
and the 11.4% L-periaxin" 04+ cells may represent a population of cells destined
to remain non-myelin-forming. Another possibility is that L-periaxin is expressed
in all embryonic Schwann cells at some time point during development whether they
are destined to myelinate later or not and in the window of time in which the counts
were done there were cells which had not yet begun to express the protein.
To distinguish between these two possibilities, L-periaxin expression was
examined in the cervical sympathetic trunk where most of the Schwann cells in the
adult are non-myelin-forming. In transverse sections through E16.5 mouse embryos
very few L-periaxin positive cells were observed (Fig. 36A and 36C) when
compared with serial sections labelled with a polyclonal antibody directed against
S100 (Fig. 36D and 36F). In contrast, in the vagus nerve, which is myelinated in the
mature animal, many L-periaxin positive Schwann cells were observed (Fig. 36A
and 36C). When E16.5 cervical sympathetic trunks were removed and
longitudinally cryosectioned, and immunolabelled for L-periaxin in combination
with propidium iodide, which binds to DNA and thus labels all nuclei, more L-
periaxin positive cells were observed (Fig. 37A, 37C). The labelled cells were not
distributed evenly in the trunk (Fig. 37D, 37F) and areas with no positive labelling
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Figure 35. Immunofluorescence localization of L-periaxin and 04 in dissociated
E16.5 sciatic nerve cultures. Sciatic nerves were dissociated, placed in short-term
culture and immunolabeled with 04 (B, D; Texas red) as a marker for embryonic
Schwann cells and L-periaxin (A, C; fluorescein). Most of the 04 positive cells are
L-periaxin positive. L-periaxin labeling is predominantly nuclear but some
cytoplasmic labeling is apparent (C). Bar, 20 |im.
Figure 36. Comparison of the immunofluorescence localization of L-periaxin and
S100 in Schwann cells in the embryonic cervical sympathetic trunk (est) and
vagus nerve (v). Serial transverse sections through the cervical region of E16.5
mouse embryos were immunolabeled for L-periaxin (A; fluorescein) and NF-M
(Texas red; B C, combined) or S100 (D; fluorescein) and NF-M (Texas red; E, F,
combined) and examined by confocal microscopy. A few L-periaxin+ cells are
present in the est, whereas many such cells are present in the vagus nerve (A), in
contrast an antibody against S100 labelled all the Schwann cells in both the est and
vagus nerves (D). CA, carotid artery. Bar, 20 pm.
Figure 37. Localization of L-periaxin in E16.5 cervical sympathetic trunk by
immunofluorescence confocal microscopy. Longitudinal cryosections of E16.5
mouse cervical sympathetic trunks were immunolabeled for L-periaxin (A, D;
fluorescein) and nuclei were labeled with propidium iodide (B, E; red). The
majority of the cells were not labelled but there were L-periaxin labelled Schwann
cells with some sections containing more L-periaxin positive cells (A) than other
sections (B). The immunoreactivity was concentrated in nuclei (D, E, F; arrow).
Bar, 20 gm.
were evident. About 20% of the Schwann cells in the trunk were L-periaxin positive
at this stage of development. These results indicate that L-periaxin protein is not
expressed in the majority of the embryonic Schwann cells destined to be non-
myelin-forming.
In situ hybridization studies were performed on transverse sections through
the cervical sympathetic trunk of E16.5 and postnatal-day 1 mice to determine if L-
periaxin mRNA was present in the Schwann cells of a predominantly non¬
myelinated nerve. In most sections from E16.5 embryos no positive cells were
detected but in one section there were a few weakly positive cells when compared
with the more strongly labelled vagus nerve which is destined to be myelinated (Fig.
38C, 38D). By postnatal-day 1 positive cells were not observed in the sympathetic
trunk (Fig. 38G, 38H). However, because of the relatively small numbers of
embryonic Schwann cells in cervical sympathetic trunk transverse sections,
longitudinal sections were examined and compared with sections of vagus nerve.
There appeared to be a weak signal in some cells at E16.5 (Fig. 38A, 38B) and PI
(38E, 38F) which correlated with the proportion of cells in which L-periaxin protein
was observed. Therefore L-periaxin mRNA expression in cells of the sympathetic
trunk is not down-regulated by postnatal-day 1. This weak labelling (Fig 381) is in
marked contrast to that observed in the vagus nerve at E16.5 (Fig. 38J). The vagus
nerve has a much higher cell density than the sympathetic trunk which could
account for some of the difference in the intensity of labelling, nevertheless
individual cells were much more intensely labelled in the vagus. In addition, upon
examination of E16.5 transverse sections a few cells were observed which
expressed L-periaxin mRNA in the wall of the developing esophagus which are
probably enteric Schwann cells (Fig. 38K, 38L). These results suggest that L-
periaxin is expressed at very low levels in a subset of embryonic Schwann cells



























Figure 38. Localization of L-periaxin mRNA in the cervical sympathetic trunk
(est). In situ hybridization was performed on longitudinal cryosections of the est
(A, B, I) and vagus nerve (v; J) at E16.5 and postnatal-day 1 (E, F) and transverse
sections at E16.5 (C, D,) and postnatal-day 1 (G, H) and examined by
epifluorescence microscopy. At E16.5 very sparse labeling is evident in the est in
longitudinal sections (A, B) and transverse sections (C, D; arrow, nerve trunk)
compared with the strongly labeled vagus nerve (C, D, J). Labeling was observed in
the longitudinal sections of est at postnatal-day 1 (E, F) but not in transverse
sections (G, H). Labeling is also observed in the muscularis externa of the
esophagus (arrows; K, L) which are probably glial cells in the myenteric plexus, ca,
carotid artery. Bar, 50 pm.
protein were not even detectable in the satellite cells of the dorsal root ganglia
which constitute another population of Schwann cells that do not myelinate.
3.2.4 The L-periaxin protein expressed in embryonic sciatic nerve is the full
length protein
Since antibodies raised against N-terminal and C-terminal peptides of L-
periaxin did not immunolabel early embryonic Schwann cells, I wanted to confirm
that the protein recognized by anti-170pepl was the same size as the protein
originally identified in mature peripheral nerves. Sciatic nerves were removed from
E15.5 mouse embryos (23 nerves/lane) and postnatal-day 3 (P3) mice and
subjected to SDS-PAGE electrophoresis. After transfer to PVDF membrane and
blotting with anti-170pepl, the bands were visualized by enhanced
chemiluminescence. The band observed in the blot of E15.5 nerves (Fig. 39) had the
same mobility as the P3 control demonstrating that the protein in embryonic nerves
was indistinguishable in size from L-periaxin. The reason why the N and C
terminal peptide antibodies did not immunolabel embryonic nerves might be related
to the sensitivity of the antisera or the conformation of the protein at this stage of
development.
3.2.5 L-periaxin is transiently expressed in skeletal muscle
A striking finding from the in situ hybridization studies on developing mouse
embryos was the discrete layer of cells in the body wall that were labelled using the
periaxin riboprobe (Fig. 31E, 40A, 40B ) which first appeared labelled at E14.5 (Fig.
31C). These cells were not present in the sections labelled with the PO riboprobe.
Silver grains were also observed over elongated cells (Fig. 40A, 40B) that were not
associated with peripheral nerves and L-periaxin immunolabelling on embryo
sections revealed labelled cells that were not associated with NF-M positive axons.










Figure 39. Western blot analysis of L-periaxin from embryonic sciatic nerves.
Sciatic nerves from E15.5 and postnatal-day 3 (P3) mouse sciatic nerves were
analyzed by SDS PAGE. Following transfer to PVDF membrane and blotting with
anti-170pepl, the bands were visualized with enhanced chemiluminescence. The
Mr of E15.5 nerves and P3 nerves were the same demonstrating that the embryonic
L-periaxin is the full length protein. Molecular mass standards are indicated on the
left.
Figure 40. Localization of L-periaxin mRNA and protein in a population of cells
not associated with peripheral nerves. In situ hybridization was performed on
transverse cryosections of E16.5 embryos using a riboprobe for periaxin (A, B).
Elongated cells were labeled as well as cells in the body wall (arrows). Transverse
cryosections of E15.5 mouse embryos were immunolabeled for L-periaxin
(fluorescein) and nuclei were labeled with propidium iodide (red). A layer of L-
periaxin labeled cells were present in the body wall (arrows; C, D) and in the
developing hindlimb (arrows; E, F) which were not associated with peripheral
nerves (n). Occasionally elongated multinucleated cells were labeled (G, H) which
had the appearance of myotubes. L-periaxin was also evident in the nuclei of these
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170pepl and labelled with propidium iodide. L-periaxin labelling was observed on
the plasma membrane of a layer of cells in the body wall (Fig. 40C and 40D). Other
labelled cells were observed that had nuclear labelling as well as plasma membrane
labelling (Fig. 40E and 40F). Occasionally large multinucleated cells were labelled
which had the appearance of myotubes (Fig. 40G and 40H).
To positively identify the labelled cells, double-label immunofluorescence
microscopy was performed using anti-170pepl and a monoclonal antibody that
recognized myosin heavy chain (MHC) which is present in skeletal muscle cells.
The L-periaxin positive cells in the body wall (Fig. 41A) were also labelled by MHC
(Fig. 41B). Only a subset of muscle cells in the body wall expressed L-periaxin.
Previous work showed that L-periaxin was not present in adult rat skeletal
muscle by Western blotting (Gillespie et al., 1994). Since L-periaxin was expressed
in embryonic muscle, the expression during postnatal development was examined
by immunofluorescence on muscles of the mouse hind limb. L-periaxin staining was
observed in cells which colocalized with MHC in postnatal-day 4 limb muscle (Fig.
41C and 41E). At postnatal-day 8, few L-periaxin labelled cells were observed
and no labelled cells were observed at postnatal-day 10 (data not shown),
demonstrating that L-periaxin is transiently expressed in a subset of skeletal muscle
cells during embryonic development and early postnatal life.
3.2.6 Analysis of embryonic muscle in periaxin-null mice
Embryos from mice with a targeted disruption of the periaxin gene by
homologous recombination were examined to confirm that the antibody to L-
periaxin and the [^S] periaxin riboprobe used for in situ hybridization studies were
recognizing products of the periaxin gene in embryonic muscle. Cryosections from
E15.5 periaxin-mi\\ embryos and wild type embryos were immunolabelled with anti-
170pepl and anti-NF-M. There were no L-periaxin labelled cells in the NF-M
positive sciatic nerve (Fig. 42A and 42B). When the muscle cells in the body wall
140
Figure 41. Localization of L-periaxin and myosin heavy chain (MHC) in skeletal
muscle by immunofluorescence microscopy. Transverse cryosections through the
body wall of E16.5 mouse embryos and postnatal-day 4 hindlimbs were double-
labeled for L-periaxin (A, C, E; fluorescein) and MHC (B, D, F; Texas red) and
examined by confocal microscopy. The L-periaxin labelled cells in the body wall
(B) and limb muscle (D, low magnification; F, high magnification) colocalized with
MHC. Bar, 20 pm.
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Figure 42. Schwann cell and skeletal muscle cell L-periaxin expression are
products of the same gene. Double-label immunofluorescence localization of L-
periaxin and NF-M in transverse cryosections through the trunk of E15.5 periaxin
null embryos were examined by confocal microscopy. There were no positive L-
periaxin immunolabeled cells in the body wall (C; fluorescein), or sciatic nerve (sn;
A, fluorescein) which was identified by NF-M+ axons (Texas red), arrows, NF-M
positive axons. Bar, 20 gm.
(Fig 42C) and skeletal muscle cells were examined, no L-periaxin positive cells were
detected. These data conclusively demonstrate that the periaxin mRNA and
protein observed in embryonic Schwann cells and muscle cells are the products of
the same gene.
3.2.7 Summary
L-periaxin mRNA and protein were found to be first expressed in embryonic
Schwann cells coinciding with the developmental switch from precursor cell to
embryonic Schwann cell which occurs at E14 in the mouse. That these cells were
indeed Schwann cells was confirmed by double-label immunocytochemistry on
dissociated embryonic sciatic nerve cultures using 04 as a Schwann cell marker.
Interestingly, the protein was predominantly expressed in Schwann cell nuclei until
E17.5 when it assumed a predominantly plasma membrane localization.
It seems very likely that L-periaxin is largely expressed by embryonic
Schwann cells that are destined to be myelin-forming in the mature nerve since most
of the Schwann cells in the embryonic sciatic nerve, as detected by 04
immunostaining, express L-periaxin. However, there was a small population of
cells which was 04+, L-periaxin" suggesting that these cells may be destined to
become non-myelin-forming Schwann cells. In the cervical sympathetic trunk, where
most of the Schwann cells are non-myelin-forming in the adult, about 20% of the
cells were L-periaxin+ at E16.5. This is a higher percentage than would be
predicted by comparison with the adult nerve if L-periaxin were a marker for
myelin-forming embryonic Schwann cells. Nevertheless, cells in the cervical
sympathetic trunk are still proliferating at this stage of development and they
continue to divide until around postnatal-day 15, whereas the rate of proliferation
in myelin-forming cells drops off at birth (Stewart et al., 1993). Thus the cells
which are L-periaxin positive in the E16.5 cervical sympathetic trunk may represent
those cells destined to be myelin-forming whereas the L-periaxin negative cells may
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have a non-myelin-forming fate and may continue to proliferate until postnatal-day
15. An alternative scenario is that L-periaxin may be expressed at basal levels in
embryonic Schwann cells destined to be non-myelin-forming and then down-
regulated in the adult, as occurs for PO. PO mRNA is expressed at basal levels in
most of the embryonic Schwann cells in the cervical sympathetic trunk whereas L-
periaxin mRNA and protein are expressed at low levels in a subset of the
embryonic Schwann cells. PO is also expressed in satellite cells in the dorsal root
ganglia whereas periaxin is not. Because L-periaxin mRNA was observed in cells
which appear to be enteric glia it seems likely that there is a basal level of L-
periaxin mRNA expression in some Schwann cells which do not form myelin.
I have shown that S-periaxin mRNA and protein are not expressed during
embryonic development and are first expressed at postnatal-day 1 in the mouse.
The relative abundance of the two mRNAs is difficult to evaluate by in situ
hybridization since the probe used for the smaller mRNA recognizes both species.
Northern analysis in postnatal-day 5 rats (Gillespie et al., 1994) and postnatal-day
3 mice (L. Dytrych, PhD thesis) demonstrate that the two distinct mRNAs are of
equal abundance.
L-periaxin was previously thought to be exclusively expressed by myelin-
forming Schwann cells (Scherer et al., 1995). I have now shown that L-periaxin is
expressed transiently in skeletal muscle, first appearing at E14.5 in the mouse. The
lack of L-periaxin immunoreactivity in the periaxin null mutant embryo confirmed
the mRNA and protein detected in Schwann cells and skeletal muscle were both
products of the periaxin gene.
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3.3 NUCLEAR EXPRESSION OF L-PERIAXIN
During embryogenesis it was surprising to find that L-periaxin was
expressed in the nuclei of embryonic Schwann cells. Strikingly this expression was
very sharply developmentally regulated. A similar expression pattern has been
observed for myelin basic proteins (MBPs) (Allinquant et al., 1991; Hardy et al.,
1996; Pedraza, 1997; Pedraza et al., 1997) in oligodendrocytes. In immature
oligodendrocytes exon II-containing MBPs are partially localized to the nucleus and
as oligodendrocytes mature the MBP isoforms are translocated from the nucleus.
The authors suggest that nuclear entry of these MBP isoforms may be the initiating
mechanism for myelination. Since L-periaxin is expressed before MBP in embryonic
Schwann cells, it was of great interest to study the nuclear localization of the
protein further.
3.3.1 The localization of L-periaxin is predominantly nuclear in embryonic
Schwann cells
The localization of L-periaxin and propidium iodide to detect cell nuclei
was examined by confocal immunofluorescence on cryosections from mouse
embryonic E15.5 nerve trunks and on teased mouse sciatic nerves at E15.5. Many
L-periaxin positive nuclei (Fig. 43A) were observed which colocalized with
propidium iodide positive nuclei (Fig. 43B and 43C). L-periaxin labelling of the
plasma membranes was demonstrated more clearly in teased sciatic nerve (Fig. 43D
and 43F). It is also evident in Fig. 43A and 43D that there was a greater abundance
of the protein in nuclei than in other cellular regions.
3.3.2 L-periaxin protein expression is developmentally regulated
Short-term dissociated cultures of mouse embryonic Schwann cells and

















Figure 43. Immunolocalization of L-periaxin in embryonic Schwann cell nuclei.
Transverse cryosections through the trunk and teased sciatic nerve fibres were
immunolabeled with anti-170pepl and stained with propidium iodide to label
nuclei and were examined by confocal microscopy. L-periaxin (A, C; fluorescein)
colocalizes with propidium iodide (B, E; red) stained nuclei in peripheral nerve
trunks (A, B; C, combined) and teased fibres (D, E; F, combined). In the teased
fibre preparation L-periaxin is also seen in Schwann cell processes (D). Bar, 20 gm.
L-periaxin by immunofluorescence confocal microscopy. At E16.5 strong nuclear
labelling was observed (Fig. 44A) with the nucleolus devoid of immunostaining.
However by postnatal-day 1 the protein redistributed to the cytoplasm and plasma
membrane (Fig. 44B). These data demonstrate that L-periaxin is targeted to
different cellular compartments during Schwann cell development.
3.3.3 Nuclear L-periaxin is not the consequence of programmed cell death.
To examine whether L-periaxin expression in the nucleus of embryonic
Schwann cells reflected the fact that these cells were undergoing programmed cell
death, terminal deoxynucleotide transferase mediated UTP nick end-labelling
(TUNEL) was performed on E15.5 cryosections of mouse sciatic nerve in
combination with L-periaxin immunofluorescence. The L-periaxin positively
labelled nuclei were not TUNEL labelled (Fig. 45A, 45B, 45C ). Hence nuclear L-
periaxin does not reflect fragmented DNA indicative of dying cells.
3.3.4 Nuclear targeting of L-periaxin is affected by cell contact
When the L-periaxin cDNA was transiently transfected into heterologous
cells or used to make stable transfectants, the majority of the protein produced was
localized to the nucleus. To examine whether cell density affects the nuclear
targeting of L-periaxin, low density and high density cultures of 33B cells
permanently expressing L-periaxin were prepared and immunolabelled. Cells in
low density cultures displayed strong nuclear labelling (Fig. 46A) and like the
embryonic cultured Schwann cells, the nucleoli were devoid of labelling. In contrast,
nuclear labelling was not observed when cells were grown at high density where the
labelling was cytoplasmic (Fig. 46B).
To test whether this process was reversible and the cytoplasmic L-periaxin
would be retargeted to nuclei, a high density monolayer was damaged by scraping
with a blue pipette tip. This process allowed cells to migrate into the cell-free
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Figure 44. Nuclear expression of L-periaxin in embryonic and neonatal cultured
Schwann cells by immunofluorescence microscopy. Cultured Schwann cells from
E16.5 and postnatal-day 1 (PI) sciatic nerves were immunolabeled with anti-
170pepl and examined by confocal microscopy. At E16.5 L-periaxin is
predominantly nuclear (A) whereas at PI the cytoplasm and plasma membrane are
labeled (B). Bar, 10 pm.
Figure 45. Nuclear L-periaxin expression is not the result of apoptosis.
Cryosections of E15.5 sciatic nerves were labeled for L-periaxin (fluorescein) and
TUNEL (Texas red) and examined by confocal microscopy. L-periaxin labeled cells
(A) do not colocalize with TUNEL labeled nuclei (B; C, combined). Bar, 10 pm.
Figure 46. The nuclear localization of L-periaxin is affected by cell-cell contact.
Low density and high density cultures of permanently-expressing 33B cells were
immunolabeled with anti-170pepl and examined by confocal microscopy. Cells
grown at low density (A) displayed mainly nuclear L-periaxin whereas cells in high
density cultures (B) had mainly cytoplasmic L-periaxin. Two hours after a high
density culture was wounded (C), cells with nuclear L-periaxin were seen in the cell-
free space (arrows). Bar, A, B, 20 gm; C, 50 |xm.
space. Cells which displayed nuclear labelling were observed migrating into the
cell-free space 2 h after scraping the monolayer (Fig. 46C).
These results demonstrate that cell-cell contact prevents nuclear targeting of
L-periaxin and that translocation from the nucleus is reversible.
3.3.5 L-periaxin has a PDZ modular protein-binding domain at its extreme N-
terminus
The domain structure of L-periaxin was described by Gillespie et al., 1994
and previous database searches had not revealed any sequence similarities to any
known proteins. In the process of searching for a possible nuclear localization
signal, a database search using the deduced amino acid sequence of L-periaxin
revealed a region of 52 amino acids in the extreme N-terminus of L-periaxin with a
49% identity with the tight junction protein ZO-1 (Itoh et al., 1993; Willott et al.,
1993). This identity with ZO-1 was extremely interesting because like L-periaxin,
ZO-1 was targeted to the nucleus. However, of more functional significance ZO-1 is
a member of a family of proteins with a modular protein-binding domain called the
PDZ domain which is implicated in mediating signal transduction. And most
importantly the region of identity with L-periaxin was within the PDZ domain.
When a comparison of the N-terminus of L-periaxin with other PDZ domains from
various proteins was conducted (Fig. 47), it was clear that L-periaxin possessed a
PDZ domain from amino acids 14 to 98.
PDZ domains were originally identified based on sequence similarity in
PSD-95, the post-synaptic density protein, the Drosophila septate junction protein
Discs-Large (dig), and ZO-1 (Cho et al., 1992; Woods and Bryant, 1991; Willott et
al., 1993). Proteins with PDZ domains interact with the cytoplasmic tail of integral
membrane proteins (Saras and Heldin, 1996) and the cytoskeleton (Sheng, 1996)
and particularly relevant for this work, most of these proteins have been localized
to the plasma membrane (Sheng, 1996).
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Figure 47. Identification of a PDZ domain at the N-terminus of L- and S-
periaxin. The sequence of mouse L- and S-periaxin between amino acids 14 and 98
was compared with PDZ domains in the nNOS (residues 14-100) (Bredt et al.,
1991), PSD-95 (residues 309-393) (Cho et al., 1992), discs-large (dig) (residues
482-566), (Woods et al., 1991), SAP97 (residues 461-545) (Miiller et al., 1995),
ZO-1 (residues 408-491) (Willott et al., 1993), ZO-2 (residues 93-176) (Jesaitis et
al., 1994), and InaD (residues 361-447) (Shieh et al., 1996). The eight segments
within the domain comprising six (3 strands and two a-helices (Doyle et al., 1996).
Black blocks show amino acid identity and grey shading indicates conservative
substitutions.
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3.3.6 The basic domain of L-periaxin is responsible for nuclear targeting
In an effort to identify a region of L-periaxin that was responsible for
nuclear targeting, cDNA constructs were prepared with deleted regions and cloned
into an expression vector for transient transfection studies. Three constructs were
prepared with deletions in the entire N-terminus (PrxA3) including the PDZ










Domain structure of L-periaxin and deletion mutants
After transient transfection in 33B cells it was clear that nuclear targeting
was only abolished in the construct in which the N-terminus was deleted (data not
shown). The deleted region in the N-terminus comprised two domains, the PDZ
and the basic domains. Constructs were prepared which deleted the PDZ domain
(PrxAlO) and the basic domain (PrxA12). Liposome-mediated transient
transfections were performed on Hela cells, 33B cells and Schwann cells prepared
from primary cultures. Immunofluorescence was performed using anti-170pepl for
cells transfected with the full length L-periaxin and PrxA12, and anti-NTerm for
cells transfected with PrxAl. As shown in Fig. 48 using the full length L-periaxin
(Fig. 48A, 48D, 48G) and the repeat region deletion PrxAl (Fig. 48C, 48F, 481) as
controls, only the basic domain deletion PrxA12 dramatically abolished nuclear
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Figure 48. The basic domain of L-periaxin is responsible for nuclear targeting.
Hela cells (A, B, C), 33B cells (D, E, F) and Schwann cells (G, H, I) were transfected
with the full length L-periaxin cDNA (A, D, G), PrxA12 (lacking the encoded basic
domain) (B, E, H) and PrxAl (lacking the encoded repeat region) (C, F, I). A
schematic of the constructs are shown on the top panel. Immunofluorescence was
performed with anti-170pepl for the full length protein and PrxA12, and anti-
NTerm for PrxAl and examined by confocal microscopy. Nuclear staining was
observed in all cell types examined with the full length L-periaxin (A, D, G) and
PrxAl (C, F, I). Only cytoplasmic staining was observed in all cell types transfected
with PrxA12 (B, E, H). Bar, 20 pm.
staining in Hela cells (Fig. 48B), 33B cells (Fig. 48E), and Schwann cells (Fig. 48H).
Therefore the basic domain of L-periaxin appears to be responsible for nuclear
targeting.
3.3.7 The basic domain of L-periaxin targets green fluorescent protein (GFP) to
the nucleus
GFP from the jellyfish Aequorea victoria has been used as a tag to trace the
translocation of proteins in living cells (Ogawa et al., 1995). In order to confirm
that the basic domain was responsible for nuclear targeting of L-periaxin the 234 bp
basic domain was fused to GFP under the control of the CMV promoter (BD-GFP)
in order to monitor the location of the basic domain-GFP fusion protein in living
cells. After transient transfection of GFP alone in Hela cells (Fig. 49A), 33B cells
(Fig. 49C ), and Schwann cells (Fig. 49E) a strong green fluorescence was observed
uniformly distributed throughout the cytoplasm and nucleus. In contrast, BD-GFP
accumulated only in the nucleus (Fig. 49B, 49D, 49F) demonstrating that the basic
domain of L-periaxin was sufficient to target GFP to the nucleus. It is interesting to
note that BD-GFP also accumulates in the nucleolus which may be due to the high
affinity that basic peptides have for B23, the major acidic nucleolar protein
(Breeuwer and Goldfarb, 1990; Goldfarb, 1988).
3.3.8 The basic domain of L-periaxin contains a putative nuclear localization
signal (NLS)
The deduced amino acid sequence of the basic domain of L-periaxin
contains a lysine-rich stretch (underlined), nts 136-139, which may be a part of a
NLS. It also has an arginine-rich stretch (underlined) closer to the end of the






















Figure 49. The basic domain of L-periaxin targets GFP to the nucleus. Hela cells
(A, B), 33B cells (C, D,) and Schwann cells (E, F) were transfected with either GFP
(A, C, E) or BD-GFP (B, D, F) and examined by confocal microscopy. GFP was
distributed throughout the nuclei and cytoplasm of all cell types examined (A, C, E)
whereas BD-GFP was confined to nuclei (B, D, F). Bar, 10 pm.
The amino acid sequence of the basic domain was compared to the
sequences of classic NLSs both single, as in the SV40 large T antigen (Kalderon et
al., 1984), and the bipartite forms (Lodish et al., 1995). The 4 lysines at nts 136-
139 could be a NLS. To test whether the stretch of lysines were responsible for
nuclear localization, two of the lysines were mutated to threonines in the full length
cDNA and transfected into several cell lines to observe the localization of the
mutated protein. The mutated protein was still located in the nucleus (data not
shown) demonstrating that mutating two amino acids of a highly basic region did
not prevent nuclear import.
Single L-periaxin PVKKKKMV
It is important to note that NLSs have been described which do not fall into
the classic NLS, both single or bipartite, category. It is possible that the stretch of
lysines and the stretch of arginines can both act together as a NLS.
3.3.9 The energy requirements of nuclear translocation
The energy released by ATP hydrolysis is essential for import of a protein
with a NLS across a nuclear pore into the nucleus (Lodish et al., 1995). Pedraza
and co-workers found in their work on the nuclear translocation of MBP that it was
an active process requiring energy (Pedraza et al., 1997). Schwann cells and Hela
cells transiently expressing BD-GFP were used to observe if nuclear transport was
affected by energy depletion. Cells were incubated at 37°C in glucose-free medium
containing 2-deoxyglucose (an inhibitor of glycolysis) and sodium azide (an
inhibitor of mitochondrial electron transport) for 1 and 2 h. After 2 h incubation










some cells were allowed to recover for 2 h in the presence of glucose. After
Schwann cells were depleted of energy for 1 (Fig. 50B) and 2 h (Fig. 50C ) there was
transport arrest of BD-GFP because cytoplasmic protein was visible but a strong
nuclear localization was still observed indicating that the arrest may be partial or
that some of the BD-GFP protein was bound in the nucleus and remained there
after energy depletion. Upon recovery after energy depletion, all of the protein
translocated back to the nucleus (Fig. 50D). These results demonstrate that energy
depletion has an effect on nuclear translocation since significant labelling was seen
in the cytoplasm of depleted cells. Small proteins lacking NLSs diffuse into the
nucleus independent of the energy charge of the cell (Breeuwer and Goldfarb, 1990).
However this seems unlikely for BD-GFP since GFP alone remained partially in the
cytoplasm. It seems more likely that the basic domain targets GFP to the nucleus
where the protein binds to a nuclear component.
3.3.10 Nuclear L-periaxin is insoluble in non-ionic detergent
Because L-periaxin was shown to be in the Triton X-insoluble fraction of
PNS myelin (Gillespie et al., 1994) and present in Schwann cell cytoskeletons
prepared from cultured postnatal sciatic nerve (B. Kelly, personal communication)
it was presumed to be associated with a component of the cellular cytoskeleton.
Since some of the BD-GFP remained in the nucleus during energy depletion
experiments I wanted to determine whether L-periaxin was bound to a component
of the nuclear cytoskeleton.
To examine if nuclear L-periaxin was soluble in non-ionic detergent, cell
cultures of permanently expressing 33B cells (clone 25) were extracted with 0.5%
Triton X-100 in a cytoskeleton stabilization buffer. After fixation and
immunolabelling, immunofluorescence confocal microscopy was performed. As
evident in Fig. 51A and 51B nuclear L-periaxin remains associated with the Triton
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Figure 50. The nuclear targeting of BD-GFP fusion protein is affected by energy
depletion. Cultured Schwann cells transiently transfected with BD-GFP were
incubated in medium (A) or glucose-free medium containing 2-deoxyglucose for 1 h
(B) or 2 h (C). Cells were also incubated for 2 h with 2-deoxyglucose followed by 2
h in medium containing glucose (D). After fixation cultures were examined by
confocal microscopy. After incubation with 2-deoxyglucose for 1 or 2 h, BD-GFP
fusion protein was observed in the cytoplasm and nucleus (B, C) whereas control
(A) or cells after recovery in glucose (D) displayed only nuclear fluorescence. Bar,
10 pm.
B
Figure 51. Nuclear L-periaxin is insoluble in non-ionic detergent. Permanently
L-periaxin expressing 33B cells were immunolabeled for L-periaxin after Triton X-
100 extraction and examined by confocal microscopy. (A) L-periaxin (fluorescein)
remains associated with the nucleus. At higher magnification, L-periaxin is also seen
associated with the cytoskeleton and plasma membrane (B; arrow). Bar, 10 |im.
The structure does not appear to be the nuclear lamina as the protein was detected
throughout the nucleus.
Another membrane-associated protein with PDZ domains, the tight junction
protein ZO-1, redistributes to the nucleus in vitro in cells plated at low density and
is found in nuclei in vivo in distinct regions of the intestinal villus (Gottardi et al.,
1996). In contrast to L-periaxin, nuclear ZO-1 is soluble in Triton X-100 whereas
the protein is insoluble when targeted to tight junctions (Gottardi et al., 1996).
3.3.11 Summary
L-periaxin is expressed predominantly in the nucleus of embryonic Schwann
cells in vivo and in vitro in short-term cultures. This nuclear localization is
developmentally regulated and by E17.5, it was no longer observed. Embryonic
Schwann cells displaying L-periaxin in their nuclei were not undergoing
programmed cell death.
When L-periaxin was transfected into heterologous cells, the protein was
transported to the nucleus. Cell-cell contact inhibited nuclear translocation and the
process was reversible. The basic domain in L-periaxin was shown to be
responsible for nuclear targeting because the mutant protein with the basic domain
deleted did not localize to the nucleus. The role of the basic domain in nuclear
targeting was confirmed by the use of a GFP fusion protein containing the basic
domain which translocated to the nucleus. The nuclear import of BD-GFP was
shown to require energy because cytoplasmic staining was observed after energy
depletion even though all of the nuclear BD-GFP did not redistribute to the
cytoplasm. Nuclear L-periaxin binds to a nuclear component and is insoluble in
non-ionic detergent. Examination of the basic domain sequence revealed two
possible NLSs.
A modular protein-protein binding PDZ domain was identified at the
extreme N-terminus of the protein. Like other PDZ containing proteins, L-periaxin
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is localized to the cytoplasmic side of the plasma membrane and probably, like
other PDZ containing proteins, the PDZ domain binds to the cytoplasmic tail of an
integral membrane protein in the Schwann cell plasma membrane. The PDZ domain
is also present in the smaller isoform, S-periaxin, which has a cytoplasmic
distribution suggesting that other factors influence PDZ-protein binding.
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3.4 TRANSGENESIS
While this work was in progress, the structure of the murine periaxin gene
was determined (Dytrych et al., 1998). It was shown by Dytrych et al., 1998 that
the mouse promoter is TATA-less, contains a single transcription initiation site, a
CAAT box consensus sequence (-86 to -76), and an octomer motif (-236 to -243)
which may be a binding site for the POU family of transcription factors two of
which are present in Schwann cells, Oct-1 and Oct-6 (Blanchard et al., 1996). They
also identified a sequence (-317 to -306) with homology to the GCRE element
present in the promoters of other myelin genes.
Transcriptional regulation is important for understanding the stage and cell
specific expression of genes. Since I had shown that the periaxin gene was
exclusively expressed in myelin-forming Schwann cells in the adult, embryonic
Schwann cells and a subset of skeletal muscle cells in the embryo up to postnatal-
day 8, I sought to identify by transgenesis the regulatory elements in the periaxin
gene responsible for cell specific expression.
3.4.1 Preparation of LacZ constructs
The E. coli LacZ gene was used as a reporter gene so that the localization of
the transgene could be identified at the cellular level by P-galactosidase
histochemistry. The SV40 large T-antigen NLS (Lanford et al., 1988) was used to
target P-galactosidase to the nucleus. Each transgene was inserted into pLacF and
pnLacF (with NLS) plasmids (see Materials and Methods, 2.7.1). In these
plasmids a segment of the mouse protamine-1 gene (mPl) provides an intron and a
polyadenylation site (Peschon et al., 1987). The following constructs were
prepared from the periaxin genomic clone HH1: Prxl-nlacZ which contained 5.5 kb
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Structure of the periaxin gene and transgenes
upstream of the transcription initiation site, exon 1, intron 1 and exon 2; Prx2-nlacZ
which was the same as Prxl-nLacZ except it lacked intron 1 and exon 2; Prx3-
nlacZ which contained 2 kb upstream of the transcription initiation site and exon 1;
and Prx4-nlacZ contained exon 1 and 500 bp upstream.
3.4.2 Prxl-4 lacZ constructs drive transcription in cultured cells upon transient
transfection
Transient transfections were performed on primary cultures of rat Schwann
cells and NIH 3T3 cultured cells. Gene expression was analysed by (3-
galactosidase histochemistry. All 4 of the constructs were able to drive
transcription in Schwann cells and NIH 3T3 cells. Prx3-nlacZ and Prx4-nlacZ
transgenes were expressed in many Schwann cell nuclei (Fig. 52E and 52G) and NIH
3T3 cell nuclei (Fig. 52F and 52H). Prx2-nlacZ was expressed in a larger number of
NIH 3T3 cells (Fig. 52D) than was Prx2-lacZ in Schwann cells (Fig. 52C). In
contrast, very few (1 or 2 per coverslip) Prxl-nlacZ expressing cells were found in
both NIH 3T3 cells (Fig. 52B) and Schwann cells (Fig. 52A).
The Schwann cell cultures used for these transfections were de¬
differentiated cells that had been induced with forskolin to up-regulate L-periaxin










Figure 52. Expression of Prx-lacZ constructs by transfection in Schwann cells
and NIH3T3 cells. (3-galactosidase histochemistry was performed on transiently
transfected Schwann cells (A, C, E, G) and NIH3T3 cells (B, D, F, H) using periaxin
promoter/LacZ constructs Prxl-nlacZ (A, B), Prx2-lacZ on Schwann cells (C) and
Prx2-nlacZ on NIH3T3 cells (D), Prx3-nlacZ (E, F), and Prx4-nlacZ (G, Id). Arrows
mark lightly stained cells. Bar, 50 pm.
to the culture medium both before and after transfection to induce myelin gene
expression (Kelly et al., 1992; Morgan et al., 1991; Shuman et al., 1988). In spite of
this only 40-50% of the Schwann cells expressed L-periaxin by immunofluorescence.
Therefore over half of the cells in the cultures do not reflect the in vivo myelin-
forming Schwann cell phenotype. Nevertheless, these data do show that these
constructs are able to drive transcription.
3.4.3 Prx2-nlacZ transgene is expressed in myelin-forming Schwann cells in
peripheral nerves in transgenic mice
Vector sequences were removed from the transgenes in pnLacF before
purification for microinjection into the pronucleus of murine fertilized eggs by
standard techniques (Hogan et al., 1994). The fertilized eggs were produced from
an F1 hybrid (C57BL6 X CBA) cross. Genomic DNA was prepared from tail
biopsies and screened by PCR and Southern blot analysis for the presence of the
transgene. PCR primers gave a 500 bp product from the LacZ gene and a 2 kb probe
from the LacZ gene was used for Southern blotting. An example of each screen is
shown in Fig. 53.
Seven founder mice were identified by PCR followed by Southern screening
after which sciatic and trigeminal nerves from all lines were examined after (3-
galactosidase histochemistry. Two of the founders did not pass the transgene to
the next generation suggesting that they were mosaic in germline tissues. Two of the
five remaining lines had positive (3-galactosidase staining in some cells in the sciatic
(Fig. 54A) and trigeminal nerves. Teased nerve preparations from sciatic nerve
demonstrated (3-galactosidase stained nuclei in myelin-forming Schwann cells (Fig.
54B and 54C). Not all myelin-forming Schwann cells expressed the transgene and
in one line there were very few cells with positively stained nuclei indicating that the













Figure 53. PCR and Southern blot analysis used for transgene screening. (A)
PCR was performed on 240 ng of genomic DNA from mouse tail biopsies using
Lacl and Lac2 primers followed by 1% agarose gel electrophoresis. One kb ladder
is on the left. NT, PCR with no DNA. (B) Southern analysis of 10 |i.g of EcoRI
digested genomic DNA from mouse tail biopsies probed with a 2 kb fragment of
LacZ. One kb ladder is on the left.
B
Figure 54. Prx2-nlacZ expression in sciatic nerve. (A) P-galactosidase staining of
sciatic nerves from transgenic line TF11 (top) and wild type mice (bottom). (B and
C) Teased fibres from a (3-galactosidase stained sciatic nerve from a TF11 line
mouse showing nuclear staining. Bar, 20 pm.
nlacZ transgene did not include all of the essential regulatory elements needed for
Schwann cell expression.
3.4.4 Prx2-nlacZ transgene is expressed in the central nervous system
To assess if the transgene was expressed in other tissues, E17.5 embryos
and tissues from adult mice were subjected to (3-galactosidase histochemistry.
Interestingly the brains from 4 lines displayed (3-galactosidase staining including the
ones where the transgene was expressed in peripheral nerve.






The regions of the brain with (3-galactosidase stained nuclei were different in
all of the lines (Fig. 55). No other tissues had specific nuclear (3-galactosidase
staining. These data suggest that the periaxin gene has a silencing element which is
not located in the 5.5 kb promoter. Negative regulatory elements that repress
neuronal genes in non-neuronal cells and neuronal cells have been demonstrated for
several genes (reviewed in Schoenherr and Anderson, 1995).
3.4.5 Prx3-nlacZ transgene is also expressed in the CNS but not in the PNS
Five Prx3-nlacZ founder mice were identified by PCR and Southern blot
analysis and peripheral nerve, brain, and other tissues were examined for (3-
galactosidase positively stained nuclei. The Prx3-nlacZ transgene was not
















Figure 55. Prx2-nlacZ expression in brain. Brains from 4 lines, TF11, TM3, T033,
and TOll, of Prx2-nlacZ transgenic mice were sagittally sliced and stained as
whole mount preparations for [3-galactosidase histochemistry. Rostral is to the left
(A to E). (F) cerebellum. (G) anterior surface of the cortex, ac, anterior
commissure; c, cortex; cb, cerebellum; dm, dorsal medial hypothalamic nucleus; H,
hypothalamus; h, hippocampus; ic, inferior colliculus; Is, lateral septal nucleus; Pn,
pontine nucleus; sc, superior colliculus; th, thalamus, wm, white matter.






As in Prx2-nlacZ transgenics, expression in the brain was exhibited by two
of the five lines (Fig. 56A, 56B, 56C, 56D) and cell nuclei were stained by (3-
galactosidase histochemistry (Fig. 56D inset). CNS expression was not unexpected
after the results obtained with Prx2-lacZ transgenic mice, thereby confirming that
there is very likely a neural silencer in the periaxin gene. These transgenic data show
that the 2 kb periaxin promoter may not contain the regulatory elements needed to
drive Schwann cell expression in vivo. Since only two of the lines showed any
transgene expression analysis of additional lines will be necessary to see if the
transgene is expressed in the PNS.
3.4.6 Prxl-nlacZ transgene is expressed in both the PNS and CNS
Five Prxl-nlacZ founder mice were identified by PCR and Southern blotting
and PNS and CNS tissues from three of the lines were subjected to (3-galactosidase
histochemistry. All three lines expressed the transgene in the CNS and one line,
TV1, expressed the transgene in Schwann cells in the PNS.





Figure 56. Prx3-nlacZ expression in brain. Brains from 2 lines, TR3 (A, B) and
TP41 (C, D), of Prx3-nlacZ transgenic mice were sagittally sliced and stained as
whole mount preparations for [3-galactosidase histochemistry, c, cortex; cb,
cerebellum; H, hypothalamus; OB, olfactory bulb. Inset in (D) shows nuclear (3-
galactosidase staining in cells in the cortex. Bar, 50 (im.
Almost all Schwann cells in the sciatic nerves displayed LacZ expression
(Fig. 57C). Teased fibres of sciatic nerve showed that all myelinated internodes
observed had Schwann cells with positively stained nuclei (Fig. 57D). Expression
was also observed in the dorsal and ventral roots but not in the dorsal root ganglia
(Fig. 57B). The brain of Prxl-nlacZ transgenic mice showed strong expression of the
transgene in the choroid plexus (Fig. 57A) and weaker staining in the cerebellum,
inferior colliculus, and thalamus. These results indicate that the neural silencer is
not in the first intron of the periaxin gene.
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Figure 57. Prxl-nlacZ expression in the CNS and PNS. Tissues from line TV1
Prxl-nlacZ transgenic mice were stained as whole mount preparations for p-
galactosidase. In the brain (A) strong labeling is evident in the choroid plexus
(arrow), with weaker labeling in the thalamus, cerebellum and inferior colliculus. In
the PNS, the ventral roots are stained (B) but not the spinal cord (sc) or the dorsal
root ganglia (arrow). A P-galactosidase-positive sciatic nerve from TV1 (C; top
nerve) is compared with a control sciatic nerve (C; lower nerve). Teased sciatic
nerve fibres have positively stained nuclei (D; low magnification, E; high
magnification, arrow- myelin sheath; arrowhead- Schmidt-Lanterman incisure).
3.5.7 Summary
Experiments to analyse the regulation of the periaxin gene were undertaken
by generating transgenic mice. Four constructs were prepared from the periaxin gene
using LacZ as a reporter gene. The constructs were initially used in transient
transfection experiments to evaluate expression in Schwann cells and a fibroblast
cell line. The results from the transfections were inconclusive because I was not able
to reproduce the phenotype of a myelin-forming Schwann cell in culture in order to
best compare the expression of the transgenes with that of fibroblasts. But the
transfection experiments did show that the promoter constructs could drive the
expression of the LacZ gene. Also it is known that the requirements for tissue-
specific expression in cultured cells do not necessarily reflect the requirements in
transgenic mice (Hoyle et al., 1994).
Transgenic mice were generated from three of the periaxin gene constructs.
Analysis of five lines of mice with the Prx2-nlacZ transgene where LacZ was driven
by 5.5 kb of the periaxin promoter showed that regulatory elements were missing for
correct PNS expression even though there was some expression in myelin-forming
Schwann cells. Analysis of other tissues for (3-galactosidase expression also
demonstrated that a neural silencer was very likely present in some part of the
periaxin gene because the transgene was expressed in the CNS. The pattern of CNS
expression was different in each line examined. Variation in expression within lines
is frequently observed due to the influence of surrounding sequences in different
chromosomal sites in which the transgene is inserted (Bonnerot et al., 1990).
Analysis of mice expressing the Prxl-nlacZ transgene which contained the first
intron of the periaxin gene showed similar results to the Prx2-lacZ transgenics with
respect to CNS expression indicating that a neural silencer was not present in the
first intron. One line of Prxl-nLacZ transgenic mice showed correct PNS expression
in myelin-forming Schwann cells. Mice expressing the transgene driven by 2 kb of
the periaxin promoter also expressed the transgene in the CNS but in contrast to
176
Prx2-nlacZ transgenics these mice did not show any PNS expression suggesting that





In this thesis the stage at which L-periaxin and S-periaxin mRNA and
protein are expressed in developing peripheral nerve was established. L-periaxin is
developmentally regulated and relocates during development to the abaxonal
surface of the Schwann cell-axon unit. The protein has a cortical localization in
mature Schwann cells but in embryonic Schwann cells it is targeted to the nucleus.
The basic domain of L-periaxin was shown to be responsible for nuclear targeting.
A PDZ domain was identified in the extreme N-terminus of both S- and L-periaxin
which is likely to be at least partly responsible for the association of L-periaxin
with the plasma membrane of the Schwann cell. The regulation of the periaxin gene
was studied by transgenesis by which it was shown that a region 5.5 kb upstream
from the transcription initiation site could direct expression to myelinating Schwann
cells. The expression of the reporter gene in cells of the central nervous system
indicates the presence of a neural silencer in the periaxin gene.
4.1 Periaxin, PDZ proteins and signalling
Immunogold localization of L-periaxin demonstrated that during early
myelination the protein is concentrated in the abaxonal and adaxonal membranes
of the Schwann cell but as myelin sheaths mature it becomes concentrated in the
abaxonal plasma membrane. Therefore, after the active phase of myelination L-
periaxin is lost from the periaxonal membranes. This shift may reflect some
functional or structural change in the periaxonal collar during sheath maturation
and suggests that L-periaxin may be involved in membrane-protein interactions that
serve to stabilize the myelin sheath. Nevertheless, at all stages of myelination L-
periaxin was present at the Schwann cell plasma membrane apposing the basal
lamina. This cortical localization of L-periaxin along with the presence of a PDZ
domain in the N-terminus suggests that the protein may be involved in signalling
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mechanisms at the plasma membrane which in early developmental stages might
reflect axon-glial signalling.
Proteins involved in signalling cascades often contain protein-protein
interaction domains that promote the assembly of macromolecular complexes.
These specialized regions include Src homology (SH2 and SH3) domains,
pleckstrin-homology (PH) domains, phosphotyrosine-binding (PTB) domains, and
PDZ domains. Many proteins with PDZ domains, or that interact with PDZ
proteins, localize to the plasma membrane and interact with the cytoplasmic tails
of membrane proteins. Biochemical evidence suggests that the PDZ domain
functions as a protein-binding module that mediates interactions between
intracellular complexes and plasma membrane receptors (Sheng, 1996). Therefore
PDZ domain proteins may provide a structural framework for recruiting proteins
into membrane-bound complexes as has been shown for PSD-95, which mediates
K+ channel (Kim et al., 1995) and NMDA receptor clustering (Kornau et al., 1995).
Thus far, it has been suggested that PDZ domains have two major functions,
primarily on the basis of their interactions with plasma membrane proteins and
their presence in known signalling molecules such as dig tumour suppressor protein
(Fanning and Anderson, 1996), neuronal nitric oxide synthase (Brenman et al.,
1996) and the FAP-1 protein tyrosine phosphatase (Sato et al., 1995). First, PDZ
proteins may act as organizers of cortical transduction complexes in which the
domain serves as a scaffold on which the macromolecular signalling complex is
assembled. These complexes have been termed transducisomes (Tsunoda et al.,
1997). Secondly, they may function as linker proteins that structurally and
functionally connect transmembrane proteins with the actin cytoskeleton via actin-
binding proteins such as protein 4.1 (Lue et al., 1994). The cytoskeleton association
of L-periaxin based on its insolubility in non-ionic detergent was important in the
initial identification of this protein (Gillespie et al., 1994).
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PDZ domains are believed to share a common three-dimensional structure
which has recently been determined for the third PDZ domain of PSD-95 and which
has been shown to interact with a sequence found at the carboxy-terminus of
certain plasma membrane proteins (Doyle et al., 1996). Binding occurs through a (3-
sheet-antiparallel interaction whereby the carboxy-terminal amino acid of the
transmembrane protein fits into a hydrophobic pocket in the folded PDZ module at
the carboxylate binding loop which is formed by the (3B strand and the aB helix.
Although the complementary binding site for some PDZ domains is the consensus
peptide sequence (S/T)XV, others recognize somewhat different sequences and can
even form homophilic clusters with the PDZ domains of other proteins (Songyang et
al., 1997). The divergence of the periaxin PDZ domain in the C-terminal
carboxylate binding loop, particularly within the GLGF sequence that lines the
peptide-binding groove suggests that periaxin may represent a new type of PDZ
protein with a distinct binding specificity.
PDZ domains have been organized into two groups based on the identity of
the first residue in the aB helix (aBl) (Songyang et al., 1997). This residue confers
binding specificity at the -2 position of the binding peptide. Group I PDZ domains
have a basic residue at the aBl position and the subgroup IA are those domains
with a histidine in this position. Group II PDZ domains lack a basic residue at aBl.
Periaxin falls into Group II with a tyrosine residue at position 77 in the aB region
(aBl) (Fig. 58, depicted as yellow boxes). The PDZ domain of neuronal nitric oxide
synthase (nNOS) also has a tyrosine residue at position 77 in the sequence (aBl)
and has been shown to bind tightly to peptides ending in D-X-V (Strieker et al.,
1997). Preference for aspartic acid at the -2 peptide position was mediated by Y77
and when the sequence Y77D78 was changed to H77E78 the binding specificity of
peptide was altered from D-X-V to T-X-V (Strieker et al., 1997). Because periaxin
has the identical residue at position aBl as nNOS it seems highly likely that the
protein with which periaxin interacts has a C-terminal D-X-V/X motif. Although
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Figure 58. Position of the amino acids in the PDZ domains of different proteins
that are likely to bind to the C-terminal sequence of their binding partners.
Basic residues-blue, acidic residues- red, hydrophilic residues- green, hydrophobic
residues-white. Modified from Songyang et al., 1997.
the PDZ domain of periaxin differs in the carboxylate binding loop from other PDZ
proteins it appears that most of the residues which comprise the pocket at position
0 (which select valine) are highly conserved except for the residue at position AB6
(serine) which may account for a different binding specificity at position 0 (V/X)
when compared to other PDZ domains.
The identification of a PDZ domain in the periaxin proteins is a significant
step forward in progress to determining the function not only of periaxin but also of
other PDZ domain-containing proteins. This PDZ domain may either participate in
the membrane-protein interactions that are required to promote spiralization or it
may function in recruiting proteins to a cortical scaffold important in
transmembrane signalling. S-periaxin is not concentrated at the plasma membrane
but is distributed throughout the cytoplasm of the Schwann cell suggesting that its
PDZ domain may not be sufficient to ensure cortical targeting. Indeed this may
reflect an entirely distinct function for this smaller isoform. The unique C-terminus
of S-periaxin may target the protein away from the plasma membrane. Another
possibility is that the functional periaxin PDZ domain is larger than the consensus
domain. The consensus PDZ domain contains approximately 80 amino acids. The
third PDZ domain of PSD-95 is functionally active as a 101 amino acid
polypeptide but the functional nNOS PDZ domain requires an additional 30 amino
acids (Strieker et al., 1997). The PDZ domain of periaxin encompasses amino acids
14 to 98 and the S-periaxin isoform is 148 amino acids in length. Thus it is possible
that the periaxin PDZ domain requires a longer sequence than the minimum PDZ
domain to promote binding specificity.
Although most PDZ proteins are localized to the cell cortex, there is an
increasing recognition that they do not always function at the plasma membrane. A
possible role in in nuclear signalling has been suggested by the fact that the tight
junction-associated protein Z0-1 localizes to the nucleus before it is recruited to
sites of cell-cell contact (Gottardi et al., 1996). Another example is SIP-1, a nuclear
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binding partner for the transcriptional factor SRY, which is a PDZ protein that is
thought to participate in a macromolecular transcription complex (Poulat et al.,
1997).
4.2 Nuclear targeting of L-periaxin
The classical nuclear import pathway involves two steps: NLS-dependent
binding to the nuclear pore complex followed by energy-dependent translocation
through the pore (Newmeyer and Forbes, 1988; Richardson et al., 1988). NLS-
dependent binding occurs in the cytoplasm through a NLS receptor which is
comprised of a heterodimer composing importin-a (or a-karyopherin) and
importin-(3 (or (3-karyopherin) (reviewed in Gorlich and Mattaj, 1996; Nigg, 1997).
First the NLS binds to the importin-a subunit then the entire complex docks at the
nuclear pore whereby the importin-(3 subunit binds to nucleoporins. The
translocation of the complex through the nuclear pore occurs by an energy-
dependent process which involves the GTPase Ran/TC4 (Moore and Blobel, 1993).
In addition NLS-independent and importin-independent pathways have also been
described but their mechanisms are still unclear (Fagotto et al., 1998).
L-periaxin is mainly localized to the nucleus in embryonic Schwann cells.
Transient expression of L-periaxin in several cell lines including primary Schwann
cells also revealed nuclear localization of the protein. The basic domain of L-
periaxin was shown to be responsible for nuclear targeting and was sufficient to
target GFP to the nucleus. Nuclear translocation was shown to require energy
indicating that it is an active process. Indeed, it is unlikely that nuclear
translocation is the result of diffusion for a protein of a molecular mass of 147 kDa
such as L-periaxin. Small proteins can diffuse through the nuclear pore complex
but proteins above 40 to 60 kDa are prevented and can only enter the nucleus in an
active manner (Gorlich and Mattaj, 1996). Therefore an active transport process
through the nuclear pore complex usually requires a NLS although a "piggyback"
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mechanism can occur in which a protein enters the nucleus by interacting with a
NLS-containing protein (Dingwall et al., 1982). Examination of the deduced amino
acid sequence of the basic domain of L-periaxin revealed two putative NLSs, one in
a lysine-rich region, the other enriched in arginine residues. There is also another
region of 10 amino acids that has 50% lysine and arginine residues content and lies
between the two former regions. Mutation of two of the lysine residues in one
putative NLS did not abolish nuclear import. It is possible that the two remaining
lysines along with the stretch of arginines or the third arginine/lysine-rich region can
still act as a bipartite NLS. Therefore it will be interesting to mutate all four lysines
and then examine nuclear import as well as mutating the arginines. It remains to be
determined whether any of these putative NLSs can direct nuclear entry on their
own.
4.3 Cell-cell contact, nuclear localization and signalling
Nuclear localization in heterologous cells was shown to be regulated by cell-
cell contact. L-periaxin was targeted to the nucleus when cells were grown at low
density but not at high density. Therefore cell contact inhibited nuclear
translocation and one signal for nuclear translocation may be the loss of cell-cell
contact. This was shown to be the case in vitro because wounding the monolayer
generated cell-free areas in which adjacent cells were observed with nuclear
accumulation of L-periaxin. This result raises the possibility that cell density in
embryonic nerve versus postnatal nerve may regulate nucleocytoplasmic
distribution of the protein.
The nuclear accumulation of L-periaxin in embryonic Schwann cells is
sharply developmentally regulated and by E17.5 nuclear L-periaxin is no longer
observed. In embryonic nerve Schwann cells envelop many axons but at around
postnatal-day 1 they form a 1:1 relationship with axons. A transitional stage in this
process may occur at E17.5 just prior to the Schwann cell singling out an axon to
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ensheathe. Axonal signals may regulate this event and L-periaxin may be involved
in this signalling. The Schwann cell is always in close contact with axons.
Therefore, the only other cell-cell contact that this cell has is with itself when it
surrounds an axon and with other Schwann cells at the node of Ranvier where their
microvilli interdigitate. It is possible that this "autotypic" contact inhibits nuclear
accumulation of L-periaxin.
Because cells in low density cultures are dividing more frequently than cells
in high density cultures it is possible that cell proliferation may be responsible for
nuclear accumulation. This appears unlikely because the peak of DNA synthesis in
Schwann cells in vivo occurs between E19 and E20 in the rat (Stewart et al., 1993)
which is just after the time when nuclear L-periaxin is lost. Therefore nuclear
expression of L-periaxin does not correlate with cell proliferation.
Perhaps the most attractive hypothesis to explain the nuclear localization of
L-periaxin in embryonic Schwann cells may be in the context of its binding to a
plasma membrane protein via the PDZ domain. It is possible that this "binding
partner" is not expressed before E17.5 in which case L-periaxin is translocated to
the nucleus by default. In the presence of this "binding partner", L-periaxin is
prevented from nuclear translocation and is tethered to the plasma membrane.
Therefore when L-periaxin is transfected into heterologous cells, in the absence of
its "binding partner", it is transported to the nucleus. It will of course be very
interesting to identify the protein which binds to the PDZ domain of periaxin and
determine if its expression pattern correlates with this hypothesis. Other PDZ
proteins are found in cell nuclei. ZO-1 translocates to the nucleus in response to
inhibition of cell-cell contact (Gottardi et al., 1996), hDlg (human discs large)
localizes to cell nuclei as well as sites along membranes and p55 localizes to the
nucleus of epithelial cells (Lutchman et al., 1997). Several membrane-associated
proteins such as the focal adhesion localizing protein zyxin and the adherens
junction-associated protein (3-catenin have been shown to exhibit transient nuclear
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localization (Fagotto et al., 1998). The functional significance of the nuclear
translocation of these proteins is as yet unknown but they may modulate signalling
pathways from the plasma membrane to the nucleus.
4.4 The phenotype of embryonic Schwann cells
The phenotypes of myelin-forming and non-myelin-forming Schwann cells
are quite distinct in the adult. However the nature of the precise signals that
determine this divergence of fate are still not clear. I was interested to determine if
there were phenotypic differences in embryonic Schwann cells which might indicate
if their fate were predetermined. Because L-periaxin is a gene expressed exclusively
by myelin-forming Schwann cells in the adult PNS and is expressed in embryonic
Schwann cells well before myelination and the expression of myelin specific genes, it
was a candidate as a marker for embryonic cells destined for a myelin-forming fate.
On the other hand, PO is expressed widely in embryonic Schwann cells regardless of
their fate and is even expressed in satellite cells of the DRG. It has been suggested
that there may be a PO inhibitory signal which regulates PO gene expression in non-
myelin-forming cells later in development (Lee et al., 1997). The PO gene is
expressed at much higher levels in the embryo than L-periaxin therefore Lee and co¬
workers were able to detect two distinct populations of cells expressing PO mRNA:
these were cells with basal levels in the embryo and cells with much higher levels
during myelination. When the amounts of L-periaxin mRNA in cells of the
predominantly non-myelin-forming sympathetic trunk were compared with cells in
a nerve trunk that becomes myelinated, a significant difference in expression levels
was detected indicating that L-periaxin like PO may be expressed at basal levels in
embryonic Schwann cells destined not to myelinate. L-periaxin was also expressed
in cells in the embryonic gut wall which are probably enteric glia, but, in contrast to
PO, L-periaxin is not expressed in DRG satellite cells. Therefore the satellite cells of
the DRG appear to have a distinct phenotype when compared to other types of
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Schwann cells. Interestingly, in the ErbB3 null mutant, all Schwann cells in
peripheral nerves and enteric glia were absent but DRG satellite cells differentiated
normally, indicating that the ErbB3 receptor is not responsible for the regulation of
satellite cell development and that these cells may comprise a distinct Schwann cell
lineage.
The transcription factor Krox-20 is expressed only in Schwann cells that are
myelin-forming in the adult and is expressed in the embryonic Schwann cells that
are destined to be myelin-forming. Krox-20 is first expressed at around E15.5 in
sciatic nerve (Topilko et al., 1994) which is later than L-periaxin. Interestingly as
was found for L-periaxin, the satellite cells of the DRG do not express Krox20 in
vivo but when these cells are put into culture Krox-20 expression is induced which
suggests that negative regulation restricts Krox20 expression in satellite cells in vivo
(Topilko et al., 1996). Therefore embryonic DRG satellite cells have a distinct
phenotype from Schwann cells, they are L-periaxin", Krox-20"' P0+, S100+ and are
unlike non-myelin-forming Schwann cells as demonstrated by the phenotype of the
ErbB3 mutant mouse (Riethmacher et al., 1997).
4.5 L-periaxin expression in skeletal muscle
L-periaxin mRNA and protein are detected in embryonic skeletal muscle
cells at the same time that the mRNA and protein are detected in peripheral nerves.
The expression was shown to be specific because of the absence of skeletal muscle
expression in the periaxin null mutant embryo. The protein is developmentally
regulated in muscle cells and its localization closely resembles that in Schwann cells
in that it is detected in the cortical region of the cell and in the nucleus in the embryo
but postnatally it is only localized at the cell cortex. Unlike the pattern of Schwann
cell expression, L-periaxin was not expressed in all skeletal muscle cells at any time
point examined and its appearance was transient. This raised the possibility that
L-periaxin is expressed in a skeletal muscle stem cell or satellite cell and it will be
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particularly interesting to determine if L-periaxin is re-expressed in muscle during
regeneration after injury.
4.6 Gene regulation and silencing
To elucidate the molecular mechanisms that are involved in PNS myelination
it is important to analyze the transcriptional regulatory components of Schwann
cell-specific genes. The generation of transgenic mice constitutes a powerful means
of examining the molecular mechanisms of gene regulation in vivo. I sought to
identify DNA sequences in the periaxin gene that are sufficient to direct Schwann
cell-specific expression. Transfection experiments demonstrated that all of the
constructs were expressed in both Schwann cells and heterologous cells. We
proceeded with the generation of transgenic mice in spite of these results because
the requirements in cultured cells and transgenic mice are in some cases different. In
retrospect, these transfection results demonstrate that the regulatory elements
necessary to restrict expression to Schwann cells were not present in any of the
periaxin-LacZ constructs tested which is what was later observed by transgenesis.
On the other hand, 2 kb of the periaxin promoter was sufficient for Schwann cell
expression in cultured Schwann cells but Schwann cells expression was not
observed by transgenesis indicating that the Schwann cell transfection paradigm
used in these studies does not adequately reflect the in vivo situation.
Transgenic mice were produced using different periaxin-LacZ constructs. I
was able to show that correct PNS expression may require more than 2 kb of the
periaxin promoter indicating the presence of a transcriptional regulatory element
between -2 kb and -5.5 kb that is required for Schwann cell expression. However
additional transgenic lines will have to be analyzed to be certain that the 2 kb
promoter is not sufficient for PNS expression. Using 5.5 kb of the periaxin promoter
only partial PNS expression was observed suggesting that regulatory elements
which enhance periaxin expression were missing. When the first intron of the
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periaxin gene was included in the construct with the 5.5 kb promoter one transgenic
line showed correct PNS expression. It is known that introns can play a role in
facilitating transcription by 10 to 100-fold in transgenic mice (Brinster et al., 1988).
The first intron of the periaxin gene very likely contains an enhancer element which
increases Schwann cell-specific expression.
Introns also are known to contain gene silencing elements and negative
regulation of neuronal gene transcription has been described for an increasing
number of neuronal genes (Hoyle et al., 1994; Kallunki et al., 1995; Wuenschell et
ah, 1990). Many studies have shown that the deletion of certain regulatory regions
from constructs in which neuronal-specific expression was expected resulted in
expression in non-neuronal cells. This has been shown for the superior cervical
ganglion 10 (SCG-10) gene (Wuenschell et alv 1990), the type II sodium channel gene
(Chong et al., 1995), and the nicotinic acetylcholine receptor P2 subunit gene (Bessis
et al., 1997) among others. A consensus neural restrictive silencer element (NRSE)
was identified and a zinc finger protein known as neural restrictive silencer factor
(NRSF) or RE-l-silencing transcription factor (REST) was shown to bind to NRSE
and silence NRSE-containing genes in non-neuronal cells (Chong et al., 1995;
Schoenherr and Anderson, 1995). REST is expressed in most non-neuronal cells
and in neuronal precursors but is down-regulated in neurons during development.
Recent studies have revealed REST in specific regions of the adult rat brain
suggesting that it acts as a negative regulator and counteracts positive regulators to
modulate gene expression in neurons as well as non-neuronal cells (Palm et al.,
1998). The LI gene which is expressed by both neurons and Schwann cells has
recently been shown to contain a NRSE which is located in the second intron
(Kallunki et al., 1997). For optimal silencing in non-neural cells it was found that
sequences in the first intron were required along with the promoter and the NRSE in
the second intron. Other transcriptional repressive elements have been identified
and recently a novel repressive element in the GAP-43 gene, the nNOS gene, and a
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25 kDA synaptosomal-associated protein gene has been described which is located
downstream of the TATA box (Weber and Skene, 1997). Repressive elements may
also regulate transcription of the myelin PLP gene. Transfection studies
demonstrated that the first intron is required for oligodendrocyte specificity (Wight
and Dobretsova, 1997). In an even more complex example, transgenic mice
generated with different 5' regions of the dopamine p-hydroxylase gene
demonstrated that tissue-specific expression is mediated by positive regulatory
elements while negative elements refine the cell-specific expression to the
appropriate neurons (Hoyle et al., 1994).
Transgenic mice generated using all three periaxin-lacZ constructs showed
CNS expression of the transgene. This indicates that negative regulation may also
play a role in modulating periaxin gene expression. Transgenic mice generated with
the Prxl-nlacZ construct which included sequences from the entire first intron also
displayed CNS expression indicating that the sequences which silence expression in
the CNS are not located in the 4.9 kb first intron or in the 5.5 kb proximal promoter.
The second intron (88 nt) and the third intron (116 nts) are relatively small but the
fourth (2.9 kb) and the fifth (7.5 kb) introns are considerably larger. These two
large introns are the obvious places in which to look for a NRSE in future work. The
data from these transgenic mice experiments indicate that periaxin gene regulation
is complex and involves regulatory elements located upstream, within the first
intron and in as yet unidentified regions.
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FUTURE WORK
The identification of a PDZ domain in periaxin opens up an exciting area of
future work. Since PDZ proteins are believed to act as organizers of transduction
complexes and function as scaffolds on which macromolecular signalling complexes
are assembled, it is important to identify the other components of the periaxin
signalling complex or transducisome. The first step in unraveling this complex
would be to identify the polypeptide(s) which bind(s) to the periaxin PDZ domain.
Other binding partners for PDZ proteins have been identified using the yeast two-
hybrid system with the PDZ domain as bait (Nishimune et al., 1996). It will also be
interesting to see if the periaxin PDZ domain has unique structural features which
might explain the cytoplasmic localization of the smaller isoform. Therefore once
the binding partner is found it will be possible to see if the functional periaxin PDZ
domain requires amino acids in addition to the identified consensus sequence.
The sequence responsible for nuclear targeting of L-periaxin can be identified
by further deletion and mutation experiments. Because the detergent-insolubility of
nuclear L-periaxin suggests that it is binding to some nuclear component it will be
particularly interesting to see if it binds to DNA. This could be determined by
DNA footprinting experiments. It will also be interesting to explore the significance
of the nuclear localization of L-periaxin in the embryo.
It will be important to perform transection experiments on adult mice in
which the cervical sympathetic trunk is transected and examined at a later time
point to detect if loss of axonal contact in non-myelin-forming cells results in the
expression of L-periaxin mRNA at a basal level as has been shown to occur for PO.
This type of experiment may be able to definitively answer the question whether L-
periaxin is a marker for embryonic Schwann cells in peripheral nerves destined to
myelinate.
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The periaxin gene is essential for normal peripheral nerve function (Gillespie
et al., paper in preparation). The transcriptional elements responsible for Schwann
cell-specific expression of periaxin are important to identify and further fine
mapping of the 5' positive regulatory elements necessary for Schwann cell
expression which are probably located in the -2 kb to -5.5 kb region will be
essential. The negative regulatory elements which suppress CNS expression will
also be important to identify in the context of this myelin gene as well as for our
understanding of gene regulation in the PNS in general. This work provides a basis
for these future studies which will help to characterize the requirements for the
regulation of periaxin which is now known to be an essential gene for the assembly
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We report the cloning and subcellular localization of a
novel Schwann cell-specific protein of 147 kd that we
have named periaxin. Periaxin has a remarkable domain
of repetitive pentameric units in the primary sequence.
It is expressed in the first uncompacted whorls of mem¬
brane that ensheathe the axon, and further synthesis of
the protein in the rat sciatic nerve parallels the deposi¬
tion of myelin. In mature myelin, periaxin colocalizes
with the myelin-associated glycoprotein in the cyto¬
plasm-filled periaxonal regions of the sheath but is ex¬
cluded from compact myelin. We propose that periaxin
has a role in axon-glial interactions, possibly by inter¬
acting with the cytoplasmic domains of integral mem¬
brane proteins such as myelin-associated glycoprotein
in the periaxonal regions of the Schwann cell plasma
membrane.
Introduction
Schwann cells undergo major morphological changes
during the development of the peripheral nervous
system (PNS) (Jessen and Mirsky, 1991). During their
proliferative phase, they must insinuate themselves
within axon bundles to establish a 1:1 relationship
with individual axons, whereupon they extend longi¬
tudinally to form the future internode (Martin and
Webster, 1973; Peters and Muir, 1959; Webster et al.,
1973). Axonal signals play a vital role in the morpholog¬
ical and functional differentiation of Schwann cells.
Axonal contact stimulates Schwann cell proliferation
(Salzer and Bunge, 1980; Sobue and Pleasure, 1985)
and basement membrane formation (Bunge et al.,
1986) and is also critical for myelin synthesis (Brunden
et al., 1990; Bunge et al., 1986; Lemke and Chao, 1988).
The molecular basis of axon-Schwann cell interaction
has yet to be elucidated but it is widely believed that
the plasma membrane proteins L1, the myelin-asso¬
ciated glycoprotein (MAG), and P0, all members of
the immunoglobulin superfamily, have a role in the
initiation of axonal ensheathment by Schwann cells
(Doyle and Colman, 1993).
A myelinating Schwann cell envelops an adjacent
axon with a layer of cytoplasm that is bounded by
an extension of the Schwann cell plasma membrane.
After several rounds of spiralization, cytoplasm is ex¬
truded by the apposition of the cytoplasmic surfaces
of the membrane to allow compaction of the mature
multilamellar sheath. However, even in mature com¬
pact myelin, Schwann cell cytoplasm does persist in
channels called Schmidt-Lanterman incisures and in
the adaxonal or periaxonal rim of the mature sheath
(Bunge et al., 1989). The purpose of these cytoplasm-
filled channels is unclear. They may serve as supply
lines for the delivery of nutrients or membrane to the
distal regions of the sheath. Alternatively, they may
provide the submembranous scaffolding required for
appropriately orienting or locating proteins within
discrete regions of the periaxonal myelin membrane.
Indeed, it has been proposed that MAG interacts with
microfilaments via spectrin, which might account for
the restricted localization of MAG in the myelin
sheath (Trapp et al., 1989a).
The intracellular events that trigger the morphologi¬
cal differentiation of the Schwann cell following
axon-glial interaction are largely unknown. The sec¬
ond messenger cyclic AMP may function in the signal¬
ing process because elevated levels of intracellular
cyclic AMP can mimic some of the effects of axonal
contact in cultured Schwann cells (Kelly et al., 1992;
Morgan et al., 1991; Porter et al., 1986; Sobue and
Pleasure, 1984; Sobue et al., 1986). Notwithstanding
theevidence for cyclic AMP involvement, the intracel¬
lular targets for such signals, which presumably in¬
clude the cytoskeleton, remain unknown.
We are interested in elucidating the intracellular
events that drive axonal ensheathment following the
interaction between the Schwann cell and the axon.
In this paper, we report the molecular cloning of a
PNS myelin protein with a size of 147 kd deduced
from the sequence of a full-length cDNA clone. Be¬
cause this protein is primarily localized in the periaxo¬
nal membranes of myelinating Schwann cells, we call
it periaxin. Periaxin is relatively abundant but, unlike
the major protein of PNS myelin P0, it is not an integral
membrane protein. Periaxin is implicated in the earli¬
est stages of myelin deposition because it is detect¬
able in the first layers of Schwann cell cytoplasm that
ensheathe the axon. Since the physical properties of
periaxin are those expected of a cytoskeleton-associ-
ated protein, we propose that periaxin might link the
cytoskeleton with the cytoplasmic domains of integral
membrane proteins (such as MAG) in the periaxonal
regions of the Schwann cell plasma membrane.
Results
A Protein of M, 170 kd Is an Abundant and
Specific Component of Rat PNS Myelin
In a search for cytoskeletal and cytoskeleton-asso-
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Figure 1. Identification of Periaxin as a Peripheral Nerve-Spe¬
cific Protein with the Anti-p170 Antibody
(A) Rat sciatic nerve myelin was analyzed on 5%-17% gradient
SDS-PAGE gels. One lane (CB) was stained with Coomassie blue
(65 pig protein), and the other lane (WB) (1 gg protein) was trans¬
ferred to nitrocellulose and immunostained with rabbit anti-
p170 antibody. The immunoblot demonstrates that the anti-p170
antibody specifically recognizes a protein of Mr 170 kd.
(B) Homogenates of brain (B), lung (L), heart (H), liver (Li), kidney
(K), muscle (M), spleen (Sp), and sciatic nerve (S) were homoge¬
nized in phosphate-buffered saline containing 0.1% Triton X-100.
Aliquots of the homogenates (1 gg of protein for sciatic nerve;
15 gg of protein for all other tissues) were electophoresed by
SDS-PACE on 5%-17% gradient gels, transferred to nitrocellu¬
lose, and immunostained using rabbit anti-p170 antibody at
1:1000 dilution. Periaxin is clearly shown to be present only in
peripheral nerve tissue.
body in rabbits against a high molecular weight, Tri¬
ton X-100-insoluble protein of rat PNS myelin, which
recognizes a protein with an estimated size of 170
kd (p170) by SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) (Figure 1A). When PNS myelin proteins
are resolved by SDS-PAGE and stained with Coomas¬
sie blue, p170 appears to be a prominent constituent
of PNS myelin in comparison with other well-charac¬
terized proteins such as MAG, 2',3'-cyclic nucleotide
3'-phosphohydrolase, and the myelin basic proteins,
although it is not as abundant as P0, the major integral
membrane of PNS myelin (Figure 1). The recovery of
p170 in the myelin fraction is drastically reduced in the
absence of proteinase inhibitors, and Western blot
analysis shows that this is a consequence of extensive
degradation (data not shown). In light of the fact that
we subsequently localized p170 to the periaxonal
membranes of PNS myelin, we have named it periaxin.
In the rat, periaxin is exclusively found in the PNS
(Figure 1B), and this pattern of expression is common
to a variety of vertebrates, including human, pig, pi¬
geon, cow, and Torpedo (data not shown).
Molecular Cloning and Sequence of Periaxin
To establish the primary structure of periaxin, several
overlapping clones were isolated, and the sequence
of a 4,657 bp cDNA clone pA1BG was established (Fig¬
ure 2).ThiscDNA has a single long open reading frame
and an initiation ATG within a strong Kozak concen¬
sus sequence (RNNATGG) (Kozak, 1991). The deduced
sequence of 1389 amino acids would encode a protein
of 147,063 daltons, which is at variance with the appar¬
ent size of the protein from SDS-PAGE. Therefore,
we were concerned to ensure that another initiation
methionine codon did not exist 5' to the known se¬
quence. This was particularly important to establish
since there are no in-frame stop codons in the 5' un¬
translated region of pA1BG. Repeated attempts by a
variety of methods to isolate other cDNA clones, in¬
cluding rapid amplification of cDNA ends, did not
extend the sequence further at the 5' end. Although
several clones were characterized, all terminated at
their 5'ends within a few nucleotides of the sequence
shown in Figure 2. Further evidence that we had iso¬
lated a clone which encoded the full length of the
protein came from in vitro transcription-translation
experiments. These showed that the protein encoded
by pA1BG has an identical Mr to the protein immuno-
precipitated from a translation programmed with
sciatic nerve mRNA (Figure 3A, lanes 1 and 2). Fur¬
thermore, the protein encoded by pA1BG is immuno-
precipitated by anti-p170 antibody (Figure 3A, lane 3),
which demonstrates that pA1BG does indeed encode
periaxin. Since we had earlier found that the N-ter-
minus of periaxin is blocked and not amenable to
direct amino acid sequencing, we raised and affinity
pu rified an antibody against a synthetic peptide corre¬
sponding to amino acids 713-728 (Figure 2) to confirm
the correct reading frame of pA1BG independently.
This antibody (anti-170pep1) recognizes periaxin in
Western blot analysis, thus establishing the correct
reading frame (Figure 3B).
Two distinct mRNAs are detected by Northern blot
analysis (see Figure 7A). However, both mRNAs seem
to be the product of a single gene, since only one
major fragment is detected when genomic DNA is
blotted after digestion with several restriction en¬
zymes (Figure 4).
The Deduced Primary Structure
Neither the nucleotide nor the deduced amino acid
sequence of periaxin is significantly similar to any
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1 AACTCTGGAGGTGTCTGGAGGCCCACTGAGCCCCAGACCCAGGAGGCCCAAGTAGCTGGAACTGACCCTCAGGCAGCAAGACCTCAAAGGAAGAGTGAAATTCCGGCTTAC 111
112 AGCTGTACATCACCCCGAGTGGGGCTCCTGTCAGGAGAAAAGACCATCACCCAGGAAGCGGCTCAGCGGCAGCTGCTCCATCAGGAGCTGAAGCTGGTCCT ACAGCAGAAG 222
223 GAGGAGAGGAAACAGGAGCCTGAGCCCCAGGTGACTCTCTGCAGAGCTATGGAGGCCAGGAGCCGCAGCGCTGAGGAGCTGAGACGAGCGGAGTTGGTGGAGATTATCGTG 333
MEARSRSAEELRRAELVEI IV 21
334 GAGACAGAGGCGCAGACCGGGGTCAGCGGCTTCAATGTAGCAGGCGGCGGCAAAGAAGGAATCTTTGTCCGCGAGCTGCGAGAGGACTCACCGGCCGCCAAGAGCCTCAGT 4 4 4
22ETEAQTGVSGFNVAGGGKEGIFVRELREDSPAAKSLS 58














1222 GCTGCAGTGGTCAAAGTCCCCACCCTGGATGTGGCAGCTCCGTCTGTGGAGGTGGACCTGGCTTTGCCAGGTGCAGAGGTGGAGGCCCAGGGAGAGGTACCTGAAGTGGCT 13 32
318 AAVVKVPTLDVAAPSVEVDLALPGAEVEAQGEVPEVA 354
1333 CTCAAGATGCCCCGTCTCAGTTTCCCCCGTTTTGGGGTTCGAGGGAAGGAAGCTACTGAAGCCAAGGTAGTCAAGGGCAGCCCTGAGGCCAAAGCAAAGGGTCCCAGACTT 14 4 3
355 LKMPRLSFPRFGVRGKEATEAKVVKGSPEAKAKGPRL 391
144 4 CGAATGCCXACCTTTGGGCTTTCTCTCCTGGAATCCCGGCCCTCTGGCCCTGAAGTTGCTGCTGAGAGCAAGCTGAAGCTACCCACCCTCAAGATGCCCTCTTTCGGCATC 1554
392 RMPTFGLSLLESRPSGPEVAAESKLKLPTLKMPSFGI 428
1555 AGCGTAGCTGGGCCTGAGGTCAAGGCACCCAAAGGGCCTGAAGTGAAGCTCCCCAAAGTTCCTGAGATCAAACTCCCGAAAGCGCCAGAGGCAGCCATTCCAGATGTGCAA 1665













2332 GCCGTGCCTGATGTCCCCCTTCCAGAACTACAGCTGCCCAAAGTGCCACAGGTCCCAGACGTGCATCTTCCCAAAGTGCCAGAGATGAAGTTGCCCAAGGTTCCTGAGGCA 2 4 4 2
688 AVPDVPLPELQLPKVPQVPDVHLPK VPEMKLPKVPEA 724
244 3 CAGAGGAAATCTGCAGGGGCGGAGCAGGCAGAAAAGACCGAATTTAGCTTCAAGTTGCCCAAGATGACTGTGCCCAAGTTGGGGAAAGTGACCAAGCCTGGGGAGGCAGGT 2553
725 O R K S AGAEQAEKTEFSFKLPKMTVPKLGKVTKPGEAG 761
2554 ATTGAGGTTCCAGACAAACTCCTGATACTTCCCTGTCTGCAGCCAGAGGTGGGCACTGAGGTGGCCCGTGTTGGTGTCCCTTCCCTCTCTCTCCCTTCTGTGGAGCTTGAC 2664
762 IEVPDKLLILPCLQPEVGTEVARVGVPSLSLPSVELD 798











984 EG KGWGWDG KVKMPKLKM PSFGLSRG KEAEIQDGRVS 1020
3331 CCAGGAGAAAAGCTGGAAGCCATAGCTGGGCAGCTTAAGATCCCTGAGGTGGAACTGGTCACACCAGGAGCTCAGGAGACAGAGAAGGTCACCAGTGGAGTGAAGCCATCA 34 41
1021 PGEKLEAIAGQLKIPEVELVTPGAQETEKVTSGVKPS 1057
344 2 GGCCTCCAGGTGTCCACCACTAGGCAGGTGGTTGCAGAGGGCCAGGAGGGGGCGCAGAGGGTGTCCTCATTAGGTATCTCTTTGCCCCAGGTGGAACTGGCCAGCTTTGGG 3 552
1058 GLQVSTTRQVVAEGQEGAQRVSSLGISLPQVELASFG 1094
3553 GAGGCAGGCCCTGAGATCGCAGCCCCATCTGCAGAGGGCACAGTAGGCTCTAGGATCCAGGTGCCACAGGTGATGCTGGAGTTGCCGGGAACCCAGGTGGCAGGGGGTGAT 3663
1095 EAG PE IAAPSAEGTVGSRIQVPQVMLELPGTQVAGGD 1131
3664 CTGTTAGTGGGTGAGGGCATCTTCAAGATGCCCACAGTGACAGTGCCCCAGTTAGAGCTGGATGTGGGGTTGGGCCATGAAGCCCAGGCTGGTGAAACAGCCAAGAGTGAG 377 4
1132 LLVGEGIFKMPTVTVPQLELDVGLGHEAQAGETAKSE 1168






4108 GAGGAGGAAGAAGGCAGTGGGGAAGGGGCTTCCGGTCGCCGTGGTCGGGTCAGGGTCCGCTTGCCTCGTGTAGGCTTGGCTTCCCCTTCT AAAGGCTCTAAGGGACAGGAG 4 218
1280 EEEEGSGEGASGRRGRVRVRLPRVGLASPSKGSKGQE 1316
4 219 GGTGATGCGGCCTCCAAGTCCCCAGTTGGGGAGAAGTCCCCCAAGTTCCGCTTTCCTAGGGTGTCCTTAAGCCCCAAGGCCCGGAGTGGGAGTAAGGACCGGGAAGAAGGT 4 329
1317 GDAASKSPVGEKSPKFRFPRVSLSPKARSGSKDREEG 1353
4 330 GGATTCAGGGTCCGACTGCCCAGTGTGGGTCCGACTGCCCAGTGTGGGATTTTCAGAAACAGCAGCTCCAGCTCCGCCAGGATTGAGGGGACCCAGGCTGCTGCCATCTGA 4 4 4 0
1354 G FRVRLPSVGPTAQCGI FRNSSSSSAR I EGTQAAA I 1390
4 4 41 AGCCCTGGGACAGCTGTGGATTCCCCCTCTTGTCTTCCCATCCCCATCCCTGCTCCCCATTTTATGTGTGACATTACTAGCACTAATCCTCAGAGGGCTTGAAGGTGGGCA 4 551
4 552 GCTGACTCAGGCAGGAGCGGTCTGTGCCACCTCATTGGCTGACGTGCCTGTATATCATGCCAAGCTCTGTGAATAAAATAATTCAAAAGTTAAAAAAAAAAAAAAA 4 657
Figure 2. The Complete Nucleotide and Deduced Amino Acid Sequence of Rat Periaxin Clone pA1BG
The amino acid sequence was deduced from the first in-frame methionine, which also has a strong Kozak initiation consensus sequence
RNNATGC. The underlined amino acid sequence denotes the 170pep1 peptide, and the sequence in bold type (AATAAA) indicates
a polyadenylation signal. Periaxin contains 1389 amino acids (including the initiation methionine) and has a calculated molecular
weight of 147,063.
other sequence in the GenBank or EMBL databases.
The closest match at 18% similarity is shown by colla¬
gen type IV over a 600 amino acid region from amino
acid 780 to the C-terminus of periaxin. It seems likely
that this merely reflects the abundance of proline,
serine, and glycine residues in that region of the pro¬
tein. Overall, periaxin is slightly basic (pi, 8.6), but
this obscures the presence of a highly basic domain
near the N-terminus between amino acids 118 and 196
and an acidic region encompassed by residues 1036-
1163 toward the C-terminus.
Periaxin does not appear to be an integral mem¬
brane protein. Hydrophobicity plots reveal no evi¬
dence for transmembrane hydrophobic domains in
the sequence, and, although it does possess a single
consensus N-glycosylation site at amino acid 1373, this
site is not used since treatment with N-glycosidase F
does not cause a shift in the mobility of the protein
in SDS-PAGE (Figure 5). Under the same conditions,
the major form of the glycoprotein MAG found in the
PNS, S-MAG, is deglycosylated and shows a shift in
Mr from 100,000 before deglycosylation to 67,000 after
deglycosylation, which is close to the known size of
the polypeptide (Frail et al., 1985) (Figure 5). There is
a large number of potential phosphorylation sites in
the protein: 11 for cyclic AMP kinase, 29 for glycogen
synthase kinase 3, 2 for protein kinase C, and 11 for











= 5 _ 1
c o = E
■- U O) B














Figure 3. Confirmation That Periaxin Clone pA1BG Contains the
Complete Coding Region and the Correct Open Reading Frame
(A) Comparison of the Mr of the protein made in translations
programmed with sciatic nerve mRNA and mRNA transcribed
from the pA1BG cDNA cloned into pSPORT 1 vector. The mRNAs
were translated in a rabbit reticulocyte lysate, and the samples
were as follows: lane 1, rat sciatic nerve translation products
immunoprecipitated with anti-p170 antibody; lane2, translation
of pA1BG mRNA; lane 3, as for lane 2 but immunoprecipitated
with anti-p170 antibody. A single major protein migrated with
an M, of 170 kd in all three lanes. This indicates that the entire
coding region for periaxin is present in the pA1BG clone.
(B) Rat sciatic nerve myelin was electrophoresed on 5%-17%
gradient gels and stained with Coomassie blue (lane 1; 40 pg of
protein) or transferred to nitrocellulose (lanes 2 and 3). The blots
(each containing 1 pg of protein) were immunostained using
rabbit anti-p170 antibody (lane 2) and the rabbit anti-170pep1
antibody raised against the peptide sequence VPEMKLPKV-
PEAQRKS (amino acids 713-728 of the deduced periaxin se¬
quence). The anti-170pep1 antibody recognizes periaxin and
confirms the correct reading frame of the deduced amino acid
sequence.
Figure 4. Southern Blot Analysis of the Periaxin Gene
Rat genomic DNA was digested with FHindlII, EcoRI, Bglll, and
BamHI as indicated above each lane and electrophoresed on a
0.8% agarose gel. After transfer to Hybond-N membrane, the
blot was hybridized with a pA1BG cDNA PCR fragment (nucleo¬
tides 1-265) that had been 32P labeled by random priming. Molec¬
ular weight markers (kb) are indicated at the left margin. The
presence of only one hybridizing band in each lane indicates a
single copy periaxin gene.
ture predictions using the algorithms of Chou-Fass-
man and Robson-Carnier does not expose any consis¬
tent regions of a-helical structure.
The most remarkable feature of the primary struc¬
ture of periaxin is the presence of a series of repeats
throughout a rather long region comprising amino
acids 430-730. The core repeat is a pentamer in which
the variable amino acid is always either alanine or
N-Glycosidase F








Figure 5. Periaxin Is Not N-Glycosylated
Rat sciatic nerve myelin was incubated at 37°Cwith (+) orwithout
(-) N-glycosidase F as described in Experimental Procedures.
The digests were electrophoresed on 5%-17% gradient gels and
transferred to nitrocellulose. The blots were immunostained us¬
ing rabbit anti-p170 or rabbit anti-MAG antibody as control.
Incubation in the presence of N-glycosidase F did not alter the
mobility of periaxin, indicating that there are no N-linked oligo¬
saccharide chains present on the molecule. In contrast, cleavage
of the N-linked oligosaccharides of MAG resulted in a large in¬
crease in the mobility of the protein.
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432 GPEVK APK 531 VPEMK 627 IPDMA
440 GPEVK LPK 536 LPDMK LPK 632 VPDVR
448 VPEIK LPK 544 VPEMA 637 LPEVQ LPK
456 APEAA 549 VPDVH 645 VSELK LPK
461 IPDVQ 554 LPDIQ LPK 653 VPEMT
466 LPEVQ LPK 562 VPEMK 658 MPDIR
474 MSDMK LPK 567 LPDMK LPK 663 LPEVQ LPK
482 IPEMA 575 VPEMA 671 VPDIK
487 VPDVH 580 VPDVR 676 LPEIK LPK
492 LPEVK LPK 585 IPEVQ LPK 684 VPEMA
500 VPEMK 593 VSEVK LPK 689 VPDVP
505 VPEMK LPK 601 IPDMA 694 LPELQ LPK
513 IPEMA 606 VPDVR 702 VPQ
518 VPDVH 611 LPELQ LPK 705 VPDVH LPK
523 LPDIQ LPK 619 MSEVK LPK 713 VPEMK LPK
721 VPEAQ




































Figure 6. The Repeat Motif of Periaxin
(A) The smallest units in the repeat region are a pentapeptide and
a tripeptide spacer. The pentapeptide comprised the following
amino acids: aliphatic nonpolar:pro:glu or asp:aliphatic nonpo-
lar:variable. The underlined sequences substitute serine for pro¬
line. The numbers refer to the position of the amino acids in
the sequence shown in Figure 2.
(B) Dot matrix plot analysis showing the region between residues
430 and 730 that is rich in repeats. The periaxin amino acid se¬
quence was compared with itself using the MacVector software
package with a window size of 30 and a minimum score of 80%,
and the results were plotted as a dot matrix. The repeat region
is shown in expanded view to demonstrate the multiple repeated
units. This was the only region in the protein to have a significant
content of repeated sequences.
(C) The domain structure of periaxin. The repeat-rich region sep¬
arates a strongly basic N-terminal segment from the acidic
C-terminus.
glutamine or one of the basic amino acids (Figure 6A),
as follows:
aliphatic nonpolar:pro:glu or asp:a!iphatic
nonpolanvariable
Higher order repeats are also apparent, and these
are most dramatically revealed by a dot matrix plot
comparison of the periaxin amino acid sequencewith
itself (Figure 6B). This region appears to be less flexible
than the rest of the polypeptide, as shown by analysis
1 3 6 8 10 12 16 20 30 150
Figure 7. Periaxin Expression Parallels Myelination in Rat Sciatic
Nerve
(A) Developmental expression of periaxin mRNA. Sciatic nerve
total RNA from rats of various ages was electrophoresed (10 pg
per lane) on a 1% formaldehyde agarose gel, transferred to Hy-
bond-N membrane, and probed with a PCR fragment of the
pA1BG cDNA (bases 1-265) that had been 32P labeled by random
priming. Postnatal ages (in days) are indicated at the top of the
figure, and the ethidium bromide-stained 18S RNA in each lane
is shown in the bottom panel to demonstrate that the RNA load¬
ings are similar. Molecular weight markers are indicated at the
left margin in kilobases. The levels of periaxin mRNA increase
sharply at day 5 and peak at around day 15, following which
periaxin mRNA becomes barely detectable by day 21.
(B) Immunoblot analysis of the developmental expression of per¬
iaxin. Sciatic nerves from rats of different ages were homoge¬
nized in phosphate-buffered saline containing 0.1% Triton X-100
and electrophoresed on 5%-17% gradient gels (5 gg of protein
per lane), transferred to nitrocellulose, and immunostained with
anti-p170 antibody. The postnatal ages (in days) are indicated
at the top of each lane and show that periaxin protein expression
increased steadily from birth and peaks between day 8 and day
20. The amounts of periaxin in sciatic nerve homogenates de¬
clined dramatically in the adult.
with the GCG and MacVector packages. Therefore, it
may be that the repeat region serves to extend the
protein, thus keeping the basic and acidic domains
well separated (Figure 6C).
Developmental Expression of Periaxin
in Sciatic Nerve
Both periaxin and its message are first detectable in
sciatic nerve homogenates soon after birth (Figures
7A and 7B). Two distinct mRNAs of approximately 4.7
and 5.2 kb are detected by Northern blot analysis (Fig¬
ure 7A). However, the relative amounts of these two
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Figure 8. Comparison of Periaxin, MAC, and P0 Localization in the Sciatic Nerves of 3-to4-Day-Old Rats by Immunoelectron Microscopy
In longitudinal section, 10 nm gold particles are primarily localized to periaxonal myelin membranes in sciatic nerve (A, arrows). In
transverse section, periaxin (B) colocalizes with MAC (C) in periaxonal membranes, whereas P0 (D) is distributed throughout compact
myelin. The axon (A) is indicated in each panel. Bar, 200 nm.
forms do not change during development, and it
seems likely that they represent mRNAswith the same
coding region but different-sized 3' untranslated se¬
quences. It is presumed that the larger mRNA corre¬
sponds to a message with a longer untranslated re¬
gion, and we have some preliminary evidence from
the sequencing of another group of clones that this
is the case.
Figure 7shows that message and protein levels peak
in the sciatic nerve between postnatal days 8 and 20;
thereafter, they decline precipitously, which suggests
that periaxin is primarily involved in the early phases
of myelin deposition. The relative amounts of periaxin
mRNA during the most active period of myelin deposi¬
tion in the sciatic nerve parallel those of the major
myelin protein P0 (Lemke and Axel, 1985), although















Figure 9. Immunoelectron Microscopic Detection of Periaxin in Uncompacted Myelin
A Schwann cell with a prominent nucleus (N) is shown at an early stage of axonal ensheathment in (A). Periaxin is present in the
cytoplasm-filled tongues of myelin that surround the axon, but in regions where the membranes have compacted, it is restricted to
the periaxonal membranes. Periaxin persists in abaxonal uncompacted layers of myelin (B, arrow) and in Schmidt-Lanterman incisures
(C and D, arrow). Close to the nodal regions (No), periaxin is predominantly found in the periaxonal membranes of compact myelin
(E, large arrows) and not in the paranodal loops (E, small arrows). The axon (A) is indicated in each panel. Bar, 200 nm.
the decline in periaxin mRNA in the adult nerve is
more marked.
Subcellular Immunolocalization
To gain some insight into the function of periaxin, we
investigated its localization in the myelin membrane
at different stages of axonal ensheathment in the in¬
tact sciatic nerve by immunoelectron microscopy. In
longitudinal sections of sciatic nerves stained with the
affinity purified anti-peptide antibody, gold particles
are localized to the periaxonal membranes of myelin
(Figure 8A). Negligible labeling of compact myelin is
observed. This localization is remarkably similar to
that of MAG (compare Figures 8B and 8C), which has
previously been documented by Trapp and cowork¬
ers (Trapp, 1988; Trapp et al., 1989a, 1989b; Trapp and
Neuron
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Quarles, 1984). By comparison, P0, the major mem¬
brane glycoprotein of PNS myelin, is distributed
throughout compact myelin (Figure 8D). The colocali-
zation of periaxin and MAG suggests that they may
interact in the periaxonal space.
Gold particles are distributed throughout the first
three or four spirals of Schwann cell cytoplasm in
nerves immunolabeled for periaxin at an early stage
of axonal ensheathment (Figure 9A). However, Figure
9A also shows that in those regions of the sheath
where the membranes are apposing, the gold parti¬
cles appear to be localizing to the periaxonal mem¬
branes. In mature myelinated fibers, periaxin persists
in the abaxonal noncompacted layers that are filled
with Schwann cell cytoplasm (Figure 9B). A character¬
istic feature of the localization of MAG in the PNS is
its enrichment in Schmidt-Lanterman incisures and
paranodal loops in addition to the periaxonal region
(Trapp, 1988; Trapp et al., 1989a, 1989b; Trapp and
Quarles, 1984). In contrast, periaxin does not show
the same type of distribution. Some periaxin is found
in Schmidt-Lanterman incisures (Figures 9C and 9D),
but it appears to be excluded from paranodal loops
(Figure 9E).
Discussion
Neurons have a profound effect on the cell biology
of the Schwann cell. However, the chain of events
that determines the fate of the myelin-forming
Schwann cell is still unclear. A prerequisite for unrav¬
eling the order of events will be the identification of
the key genes that are expressed by the Schwann cell
at the earliest stages of commitment to the myelin-
forming path. In this paper, we demonstrate that a
novel protein, periaxin, is detectable in the first layers
of Schwann cell cytoplasm which encircle an axon
during myelination. The extent of periaxin expres¬
sion, both in terms of protein and mRNA, reflects the
activity of PNS myelin deposition, and once the ma¬
ture myelin sheath is established, the amount of the
protein declines to barely detectable levels in the sci¬
atic nerve. This suggests that periaxin has a role in
ensheathment and spiralization but is perhaps less
involved in the maintenance of the multilamellar
structure in mature nerves.
The structure of periaxin provides some clues as to
its function. It has a striking series of repetitive motifs
in its deduced amino acid sequence, which are lo¬
cated to the C-terminal side of an N-terminal highly
basic domain (Figure 6C). The only other region of
the protein where there is a preponderance of acidic
or basic amino acids is an acidic domain close to the
C-terminus. The structural significance of the repeats
has yet to be determined, but it is significant that
repeated sequence units over quite long stretches
of polypeptide sequence are particularly common
amongst proteins which interact with the cytoskele-
ton (Matsudaira, 1991). This region is predicted to be
rather rigid and relatively inflexible, and the repetitive
sequence may serve as a spacer that would act to
separate two functional domains, such as the acidic
and basic regionsof the protein, as has been proposed
for the KDM repeats of the microtubule-associated
protein MAP4(West et al., 1991). By keeping the acidic
and basic domains apart, they would be available for
interaction with other polypeptide chains, including
periaxin itself. Structure prediction programs indicate
that periaxin has little secondary structure and a
rather open linear conformation. Therefore, periaxin
is an excellent prospective linker protein for coupling
periaxonal proteins to elements of the Schwann cell
cytoskeleton, particularly so since it has the solubility
properties of a cytoskeleton-associated protein. En¬
sheathment and spiralization around the axon require
drastic changes in cell shape, and the cytoskeleton is
strongly implicated in the morphological differentia¬
tion of myelin-forming cells (Kelly et al., 1992; Vouyi-
ouklis and Brophy, 1993; Wilson and Brophy, 1989).
There is considerable evidence that the integral
membrane glycoprotein MAG is an adhesion mole¬
cule with a role in axonal-glial interaction (Owens and
Bunge, 1991; Poltorak et al., 1987; Salzer and Colman,
1989; Salzer et al., 1987), particularly at early stages of
myelination (Martini and Schachner, 1988; Owens and
Bunge, 1989). In contrast with MAG, P0 appears to be
primarily concerned with myelin compaction (D'Urso
et al., 1990; Filbin et al., 1990; Giese et al., 1992). It has
been proposed that the C-terminal tail of MAG and
the actin cytoskeleton are linked, possibly by means
of the actin-binding protein spectrin (Trapp et al.,
1989b). These interactions might have several func¬
tional implications. First, a strong association between
the cytoplasmic surface of the periaxonal membrane
and the cytoskeleton could provide the anchor points
for microfilament attachment. These sites could then
serve as the foci through which the force generated
by the microfilament system might be transduced to
drive the spiralization of myelin (Trapp et al., 1989b).
Second, the necessity for the presence of Schwann
cell cytoplasm between the periaxonal membranes
might require a structure that could act as a physical
spacer, thus preventing apposition and membrane
compaction, as first suggested by Trapp and Quarles
(1982). Third, the assembly of integral membrane pro¬
teins into domains is believed to be determined by
their connections to the cortical cytoskeleton (Luna
and Hitt, 1992). In thesedomains, such proteins could,
for example, function optimally as intercellular adhe¬
sion molecules. The localization of periaxin to the first
uncompacted spirals which surround the Schwann
cell, together with its exclusion from compact myelin,
suggests that it may have a role in one or more of these
possible functions, perhaps by means of interactions
with integral membrane proteins such as MAG. Peri¬
axin itself does notappearto bean integral membrane
protein with a transmembrane domain. Therefore, it
probably copurifies with the myelin membrane owing
to its association with other proteins. Although peri¬
axin colocalizes with MAG in the periaxonal mem-
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branes, it is significant that it does not show the
enrichment in the paranodal regions or Schmidt-
Lanterman incisures which is found for MAG in the
PNS (Trapp, 1988; Trappet al., 1989a, 1989b; Trapp and
Quarles, 1982, 1984). From the relative intensities of
Coomassie blue staining after SDS-PAGE, it can be
concluded that there is much more periaxin than
MAG in PNS myelin. Therefore, the fact that periaxin is
not enriched in the paranodal loops and the Schmidt-
Lanterman incisures does not preclude the possibility
that there is sufficient periaxin to interact with MAG
in these locations.
A particularly intriguing finding from this work is
that periaxin is exclusively found in the PNS in all
species examined. These observations raise the im¬
portant question of how myelination in the PNS and
CNS differs and what features of the cell biology of
the Schwann cell might account for the requirement
for periaxin expression at an early stage of axonal en¬
sheathment. Myelin compaction occurs almost imme¬
diately after membrane ensheathment in the CNS,
whereas in the PNS the cytoplasm is extruded more
gradually, presumably to prevent apposition of the
cytoplasmic surfaces of the growing myelin mem¬
brane (Field et al., 1968). Therefore, the presence of
periaxin in the Schwann cell may promote en¬
sheathment by preventing premature compaction.
Periaxin is a quantitatively significant component
of PNS myelin. Therefore, it is perhaps surprising that
this protein has not been described previously, since
the protein composition of myelin, both in the CNS
and the PNS, has been the subject of intense study.
The extreme susceptibility of periaxin to proteolysis
during the isolation of myelin may account for this
dearth of knowledge. A protein with a similar Mr to
periaxin has been described in Schwann cells induced
by axonal contact, which was identified as a glycopro¬
tein from lectin binding studies (Shuman et al., 1986,
1988). A second protein called Schwann cell-associ¬
ated glycoprotein with an M, of 170 kd from SDS-
PAGE has been described by Western blot analysis
and by immunocytochemistry at the light level in a
separate report (Dieperink et al., 1992). Although it is
possible that Schwann cell-associated glycoprotein
and periaxin are related, the fact that the former is
believed to be a transmembrane glycoprotein, whereas
periaxin is not, makes this possibility less likely (Diep¬
erink et al., 1992). As is apparent from Figure 1, there
are several proteins in the vicinity of the 170 kd marker
in SDS-PAGE separations of rat PNS myelin, and it
seems likely that Schwann cell-associated glycopro¬
tein is one of the other proteins in that region of
the gel.
In summary, we have identified a novel protein with
a pattern of developmental expression and subcellu¬
lar localization consistentwith its having an important
role in the ensheathment of axons by Schwann cells.
Furthercharacterization of thefunction of this protein
should help to elucidate the molecular mechanisms
that underlie the engagement and ensheathment of
nerve fibers by Schwann cells in the PNS. The avail¬
ability of the cDNA that encodes periaxin and a knowl¬
edge of its amino acid sequence will now permit a
more detailed analysis of its function in myelination.
Experimental Procedures
Isolation of Myelin
Myelin was prepared from CNS tissues of several species as pre¬
viously described (Gillespie et al., 1989). PNS tissues were frozen
in liquid nitrogen, pulverized, and homogenized in a 10 mM
HEPES (pH 7.4) buffer containing 0.85 M sucrose and 3 mM dithio-
threitol to which was added a proteinase inhibitor cocktail com¬
prising of phenylmethylsulfonyl fluoride (2 mg/ml), leupeptin
(10 gg/ml), chymostatin (0.7 mg/ml), antipain (10 gg/ml), pepstatin
(15 nM), Na-p-tosyl-L-lysine chloromethyl ketone (0.5 mM), ben-
zamidine(10 gg/ml), EDTA(1 mM), and EGTA(1 mM). The homog-
enate was centrifuged at 4000 x g for 10 min at 4°C. Sucrose
(0.25 M) in the same buffer used for homogenization was layered
over the supernatant, and this was centrifuged at 80,000 x g for
90 min at 4°C. Myelin was collected at the interface between
the two sucrose layers and osmotically shocked by resuspension
in 20 vol of ice-cold water with the proteinase inhibitor cocktail.
The myelin suspension was centrifuged at 10,000 x g for 30 min,
and the pellet was shocked twice more.
Antibodies
The anti-p170 antibody was raised in rabbits against p170 puri¬
fied by electroelution from polyacrylamide gels after SDS-PAGE
of PNS myelin (Hunkapiller et al., 1984) and was used at a dilution
of 1:1000 forWestern blot analysis. A mouse polyclonal antibody
was also generated against the same antigen. A rabbit antibody
(170pep1) was raised against a synthetic peptide VPEMKLPKV-
PEAQRKS, a generous gift from Prof. N. Groome, Department
of Biology, Oxford Brookes University, which comprised amino
acids 713-728 of the complete periaxin sequence. To enhance
its antigenicity, the peptide was coupled to Keyhole Limpet he-
mocyanin by standard techniques. Anti-170pep1 antibody was
affinity purified by chromatography on a column of peptide cou¬
pled to CNBr-activated Sepharose (Sigma Chemical Company,
Poole, England) and was used at 1:50for immunoblotting. Affinity
purified rabbit anti-MAG and anti-P0 antibodies were a gener¬
ous gift from Prof. D. R. Colman, Brookdale Centre for Molecular
Biology, Mount Sinai Medical Center, NY.
Western Blot Analysis
Proteins were analyzed by SDS-PAGE on 5%-17% gradient poly¬
acrylamide gels using the buffer system of Laemmli (1970). The
separated proteins were then electrotransferred to nitrocellu¬
lose accordingto the method of Towbin etal. (1979).The nitrocel¬
lulose was blocked by incubation for 3 hr with 0.2% (w/v) gelatin
in phosphate-buffered saline containing 0.1% (v/v) Triton X-100.
Proteins were detected by incubation with appropriately diluted
primary antibodies in blocking buffer followed by goat anti-
rabbit IgG-horseradish peroxidase conjugate (Scottish Antibody
Production Unit, Carluke, Scotland). After washing 3 times with
blocking buffer and oncewith phosphate-buffered saline, immu-
noreactive proteins were detected using 3,3'-diaminobenzidine
HCI and PhO;, (Sigma) as substrates in 50 mM Tris-HCI (pH 7.4).
The peroxidase reaction was terminated with 2% SDS.
Deglycosylation of Myelin Proteins
Rat sciatic nerve myelin (20 gg of protein for MAG; 4 gg for
periaxin) was solubilized in 1% SDS, 1% b-mercaptoethanol by
boiling for 2.5 min. After cooling, the samples were divided into
two equal aliquots, and each was diluted to 98 gl in 20 mM
EDTA, 1% Nonidet P-40, and 0.1 M phosphate buffer (pH 6.3).
N-Glycosidase F (2 gl; 0.4 U; Boehringer Mannheim, Lewes, En¬
gland) was added to one set of samples, water was added to the
other set, and all were incubated overnight at 37°C. Each sample
was electrophoresed on 5%-17% gradient gels (Laemmli, 1970),
and after transfer to nitrocellulose, the blots were immuno-
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stained with either rabbit anti-MAG (1:500 dilution) or rabbit
anti-p170 (1:1000) antibody.
Isolation and Characterization of cDNA Clones from Rat
Sciatic Nerve Libraries
Total RNA was isolated from the sciatic nerves of 10-day-old rats
using RNazol B following the manufacturer's instructions (Bio¬
genesis, Bournemouth, England). Poly(A)+ RNA was purified
(Aviv and Leder, 1972) and used to construct a Xgtl 1 cDNA library
(Kelly et al., 1992), in which 3 x 105 recombinants were screened
with the anti-p170 antibody (Young and Davis, 1983). Six positive
clones were identified with a goat anti-rabbit antibody conju¬
gated to horseradish peroxidase (North East Laboratories, Ux-
bridge, England). After plaque purification, one of the clones,
pC2, was subcloned into M13 mp18 and mp19 vectors (Phar¬
macia, Milton Keynes, England) and sequenced by the chain
termination technique (Sanger et al., 1977) using Sequenase
(Cambridge Bioscience, Cambridge, England). An additional
3 x 105 recombinants were then screened by hybridization using
a digoxigenin-labeled Hindi 11—Apal fragment (nucleotides 1796-
2677 of the pA1BG cDNA) according to the manufacturer's in¬
structions (Boehringer Mannheim). One clone (pD5) was se¬
quenced and found to have a 5' end at nucleotide 1128 of the
pA1BG sequence, but it lacked the poly(A) tail. A Pstl fragment
of this clone (nucleotides 1228-2457) was labeled with digoxi-
genin and used to screen 2.5 x 105 recombinants from a unidirec¬
tional postnatal day 5 rat sciatic nerve cDNA library constructed
in Sall-Notl double-digested Xgt22A (GIBCO BRL, Paisley, Scot¬
land) following the manufacturer's instructions. Of the 12 clones
isolated and plaque purified, the largest (pBG), which comprised
almost all of the full-length pA1BG cDNA (from base 41 up to
and including the polyjA] tail), was subcloned into the pSPORT
1 plasmid (GIBCO BRL) for restriction site analysis. Large restric¬
tion fragments encompassing the entire pBG clone were direc-
tionally subcloned into M13 phagescript (Stratagene, Cam¬
bridge, England) mp18 and mp19 vectors, and both strands were
sequenced using a combination of unidirectional deletions
(Henikoff, 1984) and specific oligonucleotide primers comple¬
mentary to the derived DNA sequence.
To obtain more sequence 5' to pBG, a random primed postna¬
tal day 15 rat sciatic nerve library was constructed using 150 ng
of random hexamers (GIBCO BRL) to prime first strand synthesis.
Following second strand synthesis and the addition of EcoRI-
Notl adaptors, the cDNA was ligated into EcoRI-digested Xgt11
(Promega, Southampton, England) and packaged using Giga-
pack Gold packaging extracts (Stratagene). A portion of the li¬
brary (3 x 105 recombinants) was screened using a digoxigenin-
labeled cDNA probe derived from the extreme 5' end of pBG
(nucleotides 41-598 of the pA1BG sequence), and 10 positive
clones were identified. On sequencing both strands of one of
the clones, pA1, an extension of 40 bases at the 5' end of pBG
was obtained. The full-length clone pA1BG was obtained by ligat-
ing the Sail—Sstll fragment (5' end) from pA1 to the Sstll-Notl
(3' end) fragment of pBG, and the resulting construct was sub¬
cloned into pSPORT 1 for further analysis. To determine whether
a full-length clone might possess additional nucleotides 5' to
pA1BG, the remainder of the random primed Xgt11 cDNA library
was amplified (Sambrook et al., 1989), and aliquots equivalent
to 1 x 105 pfu were subjected to polymerase chain reaction (PCR)
using a combination of Xgt11 forward and reverse primers (New
England Biolabs, CP Laboratories, Hertfordshire, England), a
pA1BG-specific primer (5'-TAGCTCTGCAGAGAGTCACC-3'), and
a pA1BG-specif ic nested primer (5'-TGATGTACAGCTGTAAGC-
CGG-3'). In addition, the 5' rapid amplification of cDNA ends
protocol (Frohman et al., 1988) was performed with dCTP as the
terminal transferase substrate, 5-GGCCACGCGTCGACTAG-
TAC(G)i6-3' as the PCR anchor primer, and the pA1BG-specif ic
primers described above. Each PCR was subjected to 30 cycles
of amplification with 2.5 U of Taq polymerase (GIBCO BRL) in
a total volume of 100 pi of a buffer supplied by the manufacturer.
The MacVector (IBI, Cambridge, England) and University of
Wisconsin GCG software packages (Devereaux et al., 1984) were
used for sequence analysis.
Northern and Southern Blot Analyses
Poly(A)+ RNA was electrophoresed on 1 % formaldehyde agarose
gels (Kroczek and Siebert, 1990) and transferred to Hybond-N
membrane (Amersham, Aylesbury, England) by vacuum blotting
in 20x SSC. The filters were probed for 1.5 hr in QuikHyb solu¬
tion (Stratagene) with a PCR fragment spanning bases 1-265 of
the pA1BG clone that had been 32P labeled by random priming
(Feinberg and Vogelstein, 1983). The blots were washed to a final
stringency of 0.1 x SSC at 65°C.
Genomic DNA for Southern blots was isolated from rat liver
(Ausubel et al., 1989) and digested with restriction enzymes for
3 hr at 37°C. The digested DNA was electrophoresed on 0.8%
agarose gels, denatured in 0.5 M NaOH, and vacuum transferred
to Hybond-N in 20x SSC. Hybridization with the same 32P-
labeled PCR fragment was as described for the Northern blots.
Blots were exposed to Fuji RX film (Genetic Research Instrumen¬
tation, Dunmow, Essex, England) and developed using Kodak
LX24 developer and FX40 fixer.
In Vitro Transcription and Translation
Clone pA1BG was ligated into the pSPORT 1 vector and purified
using Qiagen tips (Hybaid, Teddington, England) following the
manufacturer's instructions and digested with Xbal. T7 RNA
polymerase was used to transcribe 2.5 gg of purified plasmid
in a 25 pi reaction mixture using the Riboprobe Gemini II sys¬
tem (Promega). Capped mRNA was obtained by including
m7(G)(5')ppp(5')G (Boehringer Mannheim) in the transcription
mixture.
Aliquots of the mRNA transcribed in vitro and total RNA from
day 15 rat sciatic nerve were used to program a reticulocyte lysate
translation system (Promega). A fraction of the total translation
products was solubilized by boiling in 2% SDS containing 10 gg/
ml leupeptin and 10 pg/ml antipain and was diluted with 4 vol
of solution A (50 mM Tris-HCI [pH 7.4], 2.5% (v/v) Triton X-100,
150 mM NaCI, 4 mM EDTA) containing 10 pg/ml leupeptin and
10 pg/ml antipain. Anti-p170 antibody (15 pi) was added, and
the immunocomplexes were incubated for 60 min at room tem¬
perature, following which protein A agarose (Sigma) was added
for an additional 60 min. Immunocomplexes were centrifuged
at 13,000 x g for 5 min and washed 6 times with solution A
containing 0.1 % SDS and finally with solution A without deter¬
gents. The samples were solubilized and electrophoresed on
5%-17% gradient polyacrylamidegels(Laemmli, 1970). Gelswere
stained with 0.2% Coomassie blue (PAGE Blue83, BDH, Glasgow,
Scotland), destained, incubated for 30 min in Amplify (Amer¬
sham), and dried. The dried gel was exposed to X-ray film (Fuji
RX) at —70°C.
Electron Microscopy
Sciatic nerves from 3- to 4-day-old rats were fixed by immersion
in 4% formaldehyde (freshly prepared from paraformaldehyde)
in a 0.01 M periodate, 0.075 M lysine, 0.1 M phosphate buffer
containing 3% sucrose at pH 7.4 (McLean and Nakane, 1974) for
2 hr at room temperature. The tissue was washed several times
with phosphate buffer containing 3.5% sucrose and stained with
0.25% tannic acid in the same buffer for 1 hr at 4°C (subsequent
steps were performed at 4°C). After several washes in phosphate
sucrose buffer, aldehydes were quenched in 50 mM NH4CI in
the same buffer. The tissue was then washed 4 times in 0.1 M
maleate buffer (pH 6.2) containing 4% sucrose, followed by 2%
uranyl acetate in maleate sucrose buffer for 1 hr. The tissue was
dehydrated to 90% ethanol (from 70% ethanol onward, all steps
were at -20°C), infiltrated with a 1:1 ratio of LR Gold (Agar Scien¬
tific Ltd., Stanstead, Essex) and ethanol, followed by a 7:3 ratio
of LR Gold and ethanol and two changes of LR Gold for 2-3 hr
each. The tissue was infiltrated overnight in LR Gold containing
0.5% benzoin methyl ether and embedded in gelatin capsules.
Polymerization was by ultaviolet irradiation at a wavelength of
365 nm for 24 hr at -20°C.
Sections on formvar carbon-coated nickel grids were blocked
with 1% bovine serum albumin, 0.5% fish skin gelatin, 0.05%
Triton X-100, 0.05% Tween 20 in Tris buffer (10 mM Tris, 500 mM
NaCI [pH 7.4]) for 30 min at room temperature and incubated
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with anti-Po, anti-MAG, or anti-170pep1 antibody in the same
buffer overnight at 4°C. Grids were washed 4 times with the
above buffer and incubated for 1 hr with goat anti-rabbit IgG
conjugated to 10 nm gold (1:20; Amersham). The grids were then
washed on drops of distilled water, fixed with 2.5% aqueous
glutaraldehyde, and rinsed in a stream of distilled water. After
postfixing for 15 min with 2% aqueous 0s04, the grids were
stained with lead citrate and examined at 80 kV in a JEOL 100CX
electron microscope.
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The structural integrity of Schwann cells, particularly the
paranodal loops, has been shown to be sensitive to calcium
(Blank et al., 1974). When cultured sensory ganglia were in¬
cubated in low calcium medium, lengthening of the node of
Ranvier, swelling of the extracellular space between the
paranodal loops, and separation and shrinkage of the axon
away from the myelin sheath were observed. Over time, dis¬
sociation of the junction between the paranodal loops and
the axolemma was noted. These changes were reversible
upon return to normal calcium concentrations. These data
prompted us to examine whether cadherins might be in¬
volved in the formation and maintenance of the nodal ar¬
chitecture.
The cadherins are a superfamily of calcium dependent
adhesion proteins that function in cell recognition and segre¬
gation, morphogenetic regulation, and tumor suppression
(for reviews see Magee and Buxton, 1991; Takeichi, 1991;
Geiger and Ayalon, 1992; Grunwald, 1993). The classical
cadherins are the most well studied and include N-cadherin
(neural radherin, ACAM), F.-cadherin (epithelial cadherin,
uvomorulin, arc LCAM), and P-cadherin (placental cadhe¬
rin). They have a common primary structure that consists of
an NH2-terminal extracellular domain, a short transmem¬
brane domain and a highly conserved COOH-terminal cyto¬
plasmic domain which is responsible for interaction with
cytoplasmic proteins (Nagafuchi and Takeichi, 1988) and
subsequent stabilization of junctional complexes (Nathke et
al., 1994). The extracellular domain can be divided into five
regions referred to as extracellular regions 1 (EC1) to EC5
(Grunwald, 1993). EC1 through EC4 are highly homologous
to each other and contain putative calcium binding se¬
quences. EC5 is the least homologous region and had been
distinguished from the other EC regions as a premembrane
domain (BerndorfiF et al., 1994) or the extracellular anchor
domain (Magee and Buxton, 1991).
Using highly specific antibodies that we raised against
EC5 of E-cadherin, we now demonstrate by confocal laser
and electron inununomicroscopy that E-cadherin is a major
adhesive glycoprotein restricted to noncompacted plasma
membranes within myelin internodes in peripheral nerve.
E-Cadherin is excluded from myelin and therefore does not
take an active role in the compaction or adhesion of these
membranes Most importantly, E-cadherin is not detected in
the axonal membrane, and thus in the PNS, E-cadherin
uniquely mediates adhesion between plasma membranes
elaborated by a single cell. E-cadherin is concentrated at the
inner and outer loops, and in Schmidt-Lanterman incisures,
but is most intensely distributed in plasma membranes as¬
sociated with electron-dense cytoplasmic plaques that are in
register across paranodal loops. We identify these complexes
as helically arranged adherens-type junctions that are auto-
typic; that is, they link plasma membrane wraps of the same
Schwann cell. Our findings reveal that cytoplasmic regions
in the Schwann cell are actively self-adherent and structur¬




For neurofilament immunolabeling, a mixture of two mouse monoclonal an¬
tibodies, SMI 32 and RMO108. was used. SMI32 (Sternberger Mono-
clonals Inc., Baltimore, MD) recognizes a nonphosphorylated epitope in
high neurofilament protein, and RMO108 (Lee et al., 1987) recognizes a
phosphorylated epitope in rat middle neurofilament protein. MAG antibod¬
ies (Mouse anti-MAG clone 513; Boehringer-Mannheim Biochemicals, In¬
dianapolis, IN) were used for double-labeling experiments. 0-Catenin anti¬
bodies (mouse anti-/3-catenin), used for immunocytochemistry, were a gift
of Karen Knudsen (Lankenau Medical Research Center, Wynnewood, PA).
Phalloidin-rhodamine (0.33 pM; Molecular Probes, Eugene, OR) was used
to localize F-actin, and diD (l-l'-dioctadecyl-3,3,3'3,3'-tetramethylindodi-
carbocyanine, Molecular Probes) was used at 25 pm/ml to label mem¬
branes. Commercially available E-cadherin antibodies, DECMA-1 (rat
anti-uvomorulin) and ECCD-2 (rat anti-E-cadherin) were purchased from
Sigma Chem. Co., St. Louis, MO and Zymed Labs Inc. (S. San Francisco,
CA), respectively. N-cadherin antibodies (mouse anti-ACAM, clone GC-4)
and mouse anti-vinculin (clone hVIN-1) were purchased from Sigma Chem.
Co. Rabbit anti-ct- and (3-catenin, were a gift ofBarry Gumbiner (Memorial
Sloan-Kettering Cancer Center, New York, NY).
Preparation ofEcadEC5 Antibodies
To produce an E-cadherin specific antibody, E-cadherin cDNA was RT-PCR
amplified from total RNA which had been purified from adult mouse brain
(strain B6D2 F|) using RNAzol B (Cinna/Biotecx, Houston, TX). A 300-
bp Bam III fiagiueiit (nucleotides 1920-2212, Nagafuchi ct al., 1987),
which contained most of the fifth extracellular region and a small portion
of the transmembrane domain of mouse E cadherin (see Fig. 1 A), was
purified and subcloned into the glutathione-S-transferase (GST) fusion pro¬
tein bacterial expression vector, pGEX 3X (Pharmacia, Piscataway, NJ).
The fusion protein, GST-EcadEC5, was purified from bacterial lysates by
affinity chromatography using glutathione-agarose (Sigma Chem. Co.).
GST-EcadEC5 was digested with Factor Xa (Boehringer-Mannheim Bio¬
chemicals) to generate an EcadECS fragment which was then purified using
Pharmacia Mono Q FPLC anion exchange chromatography. Rabbits were
immunized with EcadEC5 at Pocono Rabbit Farms (Canadensis, PA).
To generate EcadEC5 antibodies, a primary injection (50 /rl) of purified
EcadEC5 (100 pg) emulsified in Freund's complete adjuvant was injected
into the popliteal lymph nodes of rabbits. Boosts, consisting of EcadEC5
(50 pg) emulsified in Freund's incomplete adjuvant were administered by
subcutaneous injection on days 7, 14, and 28, and every fourth week there¬
after. Serum was collected weekly. High titer antiserum (>1:5,000 dilution
on Western blots of fusion protein) was obtained after the third boost.
Anti-EcadEC5 was affinity purified (Harlow and Lane, 1988) using GST-
EcadEC5-conjugated Sepharose columns.
SDS-PAGE and Western Blotting
Freshly dissected adult mouse (strain B6D2 Fi) or rat (Sprague Dawley)
sciatic nerves were homogenized in 5% SDS, 200 mM DTT, aprotinin (1
pg/ml), leupeptin (10 pg/ml), 1 mM pefabloc SC. and pepstatin (10 pg/ml)
(Boehringer-Mannheim Biochemicals). The homogenates were briefly cen-
trifuged for 1 min at 14,000 rpm to remove insoluble material, diluted 1:1
with SDS PAGE sample buffer and boiled for 5 min. Sciatic ncrvo homog
enates were separated by SDS-PAGE using 7.5% polyacrylamide gels and
transferred to nitrocellulose. An osmotically shocked membrane fraction
was prepared from two week old Wistar rat trigeminal or sciatic nerves as
previously described (Gillespie et al., 1994), separated by SDS-PAGE on
5-17 % gradient polyacrylamide gels and transferred to nitrocellulose. For
immunodetection, the nitrocellulose was blocked with 5% nonfat milk and
incubated with primary antibodies. Anti-EcadEC5 was used at 1:1,000 dilu¬
tion (serum) or at 2.5 pg/ml (affinity purified). Commercial primary anti¬
bodies were diluted according to the manufacturers' recommendations. For
detection, the blots were incubated with alkaline phosphatase (Sigma
Clicui. Co.) ui pcioxidase (Jackson IuuiiuuuRcsearch Laboratories, Inc.,
West Grove. PA) conjugated secondary antibodies and developed with nitro
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blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate (Sigma Chem.
Co.) or chemiluminescence (Amersham Corp.). Relative molecular weights
for E-cadherin and the catenins were calculated using broad range molecu¬
lar weight standards (Bio-Rad Laboratories, Cambridge, MA).
Immunoprecipitations
Freshly dissected kidney and sciatic nerve from adult mice (Strain B6D2
Fi), and human brain tissue were homogenized in ice cold 2% SDS, TBS
(20 mM Tris, pH 7.5, 150 mM NaCl), aprotinin (1 pg/ml), leupeptin (10
Mg/ml), 1 mM pefabloc SC, and pepstatin (10 pg/tnl), and boiled for 5 min.
Homogenates (200 jil) were mixed with 800 pi ice cold immunoprecipita-
tion buffer (1% NP-40, 1% Triton X-100, 1 mM CaCh in TBS) and
precleared with protein A-Sepharose (20 pi; Sigma Chem. Co.) or goat
anti-rat IgG agarose (50 pi; Sigma Chem. Co.). The homogenates were in¬
cubated with rabbit anti-EcadEC5 (2.5 pi), DECMA-1 (1 pi), or ECCD-2
(2.5 pi) for 60 min, followed by protein A-Sepharose (20 pi), or goat
anti-rat IgG agarose (50 pi) for an additional 30 min. The resin was col¬
lected by centrifugation, washed extensively with immunoprecipitation
buffer, resuspended in SDS-PAGE sample buffer, and analyzed by SDS-
PAGE and immunoblotting.
Immunohistochemistry
Sciatic nerves, obtained from 4% paraformaldehyde perfused mice and rats
were cyroprotected with 20% sucrose and quick frozen in Tissue-Tek OCT
compound (Miles Inc., Kankakee, IL) in liquid nitrogen. Cryosections (15
pm) were placed on TESPA (3-aminopropyltriethoxysilane; Sigma Chem.
Co.) treated glass slides, stored at -80°C, and immunostained following
standard procedures. To TESPA treat slides, slides were dipped in 2%
TESPA (diluted in acetone) and then rinsed two times in acetone and one
time in water. The slides were dried in a 50°C oven and stored at room tem¬
perature. For immunolabeling, sections were placed in 4% paraformalde¬
hyde for 5 min, washed twice (10 min each) with TBS, and treated with
blocking solution (5% normal goat serum, 0.1% Triton X-100 in TBS) for
15 min. The sections were then incubated with primary antibodies for 18 h
at room temperature. For E-cadherin immunolabeling, affinity purified
anti-EcadEC5 (25 pg/ml) was used; commericial antibodies were used ac¬
cording to the manufacturers' recommendations. After washing and block¬
ing as described above, the sections were incubated with species specific
fluorochrome-conjugated secondary antibodies (Jackson ImmunoResearch
Laboratories, Inc.) for 30 min at room temperature and washed with TBS.
Mounting medium (50 mM Tris, pH 8.6, 2.5% DABCO [1,4-diazabicy-
clo{2.2.2}octane; Sigma Chem. Co.], 90% glycerol) and cover slips were
applied.
Because the mouse /3-catenin antibodies were sensitive to paraformalde¬
hyde fixation, methanol-fixed teased sciatic nerve fibers were used for dou¬
ble immunolabeling with mouse /3-catenin and rabbit EcadEC5 antibodies.
To obtain teased nerve fibers sciatic nerves were dissected from adult mice
and placed in ice cold tissue culture medium (DME, 7.5% fetal bovine se¬
rum; GIBCO BRL, Gaithersburg, MD). After the epineurium was re¬
moved, the nerves were gently teased with a stainless steel probe to free
individual fibers, fixed in —20°C methanol for 20 min and immunostained
as described above.
After immunolabeling, sections and teased libers were examined with a
Leica TCS 4D confocal scanning microscope.
Confocal Microscopy Image Analysis
For each image, a data set from a series of incremental scans through the
z axis of a tissue section was collected. Each scan produced a thin optical
image of the x, y plane of the tissue section. Thus a complete data set could
be used to generate three-dimensional reconstructions of labeled tissue, or
a single scan could be used to show low-magnification images with excep¬
tional clarity (see Fig. 4) and details of highly magnified morphological fea¬
tures (see Fig. 5 B, insets). However the z axis of single scans were often
too thin to view structures in their entirety. Therefore geometric plane
projections, which are "compressions" of three-dimensional data sets (i.e.,
a series of scans) into single flat images, were used to obtain images of nerve
structure (see Figs. 5, A and B, and 7 D).
To generate views of labeled images from many different angles, the data
from a series of scans was computationally rotated (see Fig. 5 C) and
presented as geometric plan projections. Stereo images (see Fig. 6) were
obtained by rotating geometric plane projections by 5°. Finally, video ani¬
mation and three dimensional reconstructions, were used to aid in the in¬
terpretation of immunofluorescence patterns. All image processing was
done using the Scanware software on the Leica TCS 4D confocal scanning
microscope and Adobe Photoshop software.
Confocal images resulting from the analysis of tissue sections labeled
with only one primary antibody are shown in glow color scale. This color
scale shows the most intense labeling in white and the middle range intensi¬
ties in yellow/orange. The use of the glow color scale seemed to yield supe¬
rior visibility of the signal in the middle and low intensity ranges as com¬
pared to the gray color scale.
For double immunostained sections, data from two channels were col¬
lected simultaneously thus providing a precise colocalization, and individu¬
ally analyzed to show the localization of each antigen. The data from one
channel is indicated in green and data from the other channel is indicated
in red. To examine the distribution of two antigens, data from both channels
were overlayed to produce a single image in which regions of colocalization
are indicated in yellow.
To compensate for the many scans required for three dimensional analy¬
ses low averaging values were used. This decreased the time required for
each scan, and therefore allowed more scans to be performed before the sig¬
nal quenched. However, one consequence of low averaging values was some
statistical noise which produced a certain degree of graininess in the images
(see Fig. 7, C and D).
Immunoelectron Microscopy
Sciatic nerves (8-d old) and intestine (18-d old) from Wistar rats were fixed
by immersion in 4% paraforamldehyde, 0.1% glutaraldehyde, 0.5 mM
CaCL, in 0.1 M sodium cacodylate buffer containing 3% sucrose, pH 7.4,
for 2 h at room temperature. The tissue was rinsed in cacodylate buffer con¬
taining 3 % sucrose, washed several times with phosphate buffer containing
3% sucrose, and stained with 0.25% tannic acid in the same buffer for 1 h
at 4°C (subsequent steps were performed at 4°C). After several washes in
phosphate sucrose buffer, aldehydes were quenched in 50 mM NH4CI in
the same buffer. The tissue was then washed four times in 0.1 M maleate
buffer, pH 6.2, containing 4% sucrose, followed by 2% uranyl acetate in
maleate sucrose buffer for 1 h. The tissue was dehydrated to 90% ethanol
(from 70% ethanol onward all steps were at -20°C), infiltrated with a 1:1
ratio of LR Gold (Electron Microscopy Sciences, Fort Washington, PA) and
ethanol, followed by a 7:3 ratio of LR Gold and ethanol, and two changes
of LR Gold for 2-3 h each. The tissue was infiltrated overnight in LR gold
containing 0.5% benzoin methyl ether and embedded in gelatin capsules.
Polymerization was by UV irradiation at a wavelength of 365 nm for 24 h
at -20°C.
Sections on formvar-coated nickel grids were blocked with 1% BSA,
0.5% fish skin gelatin, 0.05% Triton X-100, 0.05% Tween 20 in Tris buffer
(10 mM Tris, 500 mM NaCl, pH 7.4) for 30 min at room temperature, and
incubated with affinity purified anti-EcadEC5(25 /rg/ml) in the same buffer
for 3 h at room temperature. Grids were washed four times with the above
buffer and incubated for 1 h with goat anti-rabbit IgG conjugated to 10 nm
gold (1:20; Amersham Corp., Arlington Heights, IL). The grids were then
washed on drops of distilled water, fixed with 2.5% aqueous glutaraldehyde
and rinsed in a stream of distilled water. After postfixing for 15 min with
2% aqueous OsC>4 the grids were stained with lead citrate and examined
at 80 kV in a JEOL100CX electron microscope.
Results
E-Cadherin and Its Associated Proteins, a- and
I3-Catenin Are Expressed in Adult Peripheral Nerve
To generate specific polyclonal antibodies against E-cadhe¬
rin, most of the EC5 domain (Fig. 1 A) ofmouse E-cadherin
(EcadEC5) was bacterially expressed as a GST fusion pro¬
tein. The fifth extracellular domain was chosen because it is
the least homologous region among the cadherins. For exam¬
ple, mouse N-cadherin, a likely candidate for expression in
peripheral nerve, has only 34% identity in a 102-amino acid
stretch with the EcadEC5 sequence and among the mam¬
malian cadherin sequences in the Genbank database, bovine
P-cadherin has the highest degree of identity (43% in a
stretch of 85 amino acids). In both sequences the maximum
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Figure 1. Characterization of EcadEC5 antibodies. (A) E-cadherin has a large extracellular domain (white) which can be divided into five
homologous regions termed extracellular regions 1 through 5 (EC1-EC5), a short transmembrane domain (black) and a cytoplasmic domain
(gray). EC5 is the least homologous region and was used to generate specific polyclonal antibodies. The antigenic epitope for EcadEC5
consists of 82 amino acids from EC5 and 19 amino acids from the transmembrane domain. (B) Kidney (K) and brain homogenates (Br)
were separated by SDS-PAGE and transferred to nitrocellulose. E-Cadherin was detected in kidney homogenates with anti-EcadEC5 (lane
1) and N-cadherin was detected in brain homogenates with CG-4 (anti-ACAM, lane 2). Molecular weight standards (200, 116, and 97
kD) are indicated to the right of the blot. (C) E-cadherin was immunoprecipitated from mouse kidney (K, lanes 1, 3, 5, and 7) and sciatic
nerve (SN, lanes 2, 4, 6, and 8) homogenates using ECCD-2 (lanes 1 and 2), DECMA-1 (lanes 3 and 4) or anti-EcadEC5 (lanes 5-8),
separated by SDS-PAGE, and transferred to nitrocellulose. Immunoprecipitated protein was detected using anti-EcadEC5 (lanes 1-4),
ECCD-2 (lanes 5 and 6) or DECMA-1 (lanes 7 and 8). (IP Ab) Immunoprecipitation antibody; (Det Ab) detection antibody. Molecular
weight standards (200, 116, and 97 kD) are indicated to the right of the blot.
number of contiguous identical amino acids is four. Thus, we
considered it unlikely that antibodies directed against the
EcadEC5 epitope would recognize either P- or N-cadherin.
On immunoblots of kidney homogenates, a well-charac¬
terized source of E-cadherin (Gumbiner and Simons, 1987;
Behrens et al., 1989), anti-EcadEC5 detected a single band
of 130 kD (Fig. 1 B, lane 1). This relative molecular mass
was slightly larger than that reported for E-cadherin in other
cells (120 kD, Nagafuchi et al., 1987), and was similar to
the reported relative molecular mass of N-cadherin (130
kD). To confirm that anti-EcadEC5 detected E-cadherin and
not N-cadherin, anti-ACAM (clone GC-4), a commercially
available N-cadherin antibody, was used to detect N-cad¬
herin in brain homogenates. Anti-ACAM detected a single
band of 140 kD in brain homogenates (Fig. 1 B, lane 2),
which migrated more slowly than E-cadherin (Fig. 1 B, lane
1), strongly indicating that anti-EcadEC5 does not recog¬
nize N-cadherin.
To verify the specificity of anti-EcadEC5, E-cadherin was
immunoprecipitated from adult kidney and sciatic nerve
homogenates with ECCD-2 or DECMA-1 and detected by
immunoblotting with anti-EcadEC5 (Fig. 1 C, lanes 1-4).
The reverse experiment, in which E-cadherin was immuno¬
precipitated with anti-EcadEC5 and detected with ECCD-2
or DECMA-1, was also performed (Fig. 1 C, lanes 5-8).
DECMA-1 is a monoclonal antibody which blocks E-cadhe¬
rin function and recognizes an epitope in the EC5 region of
E-cadherin (Ozawa et al., 1989). ECCD-2 is a monoclonal
antibody which recognizes E-cadherin but does not inhibit
its function (Shirayosi et al., 1986). In all immunoprecipita¬
tion experiments, single bands, having identical molecular
masses of 130 kD, were detected in the kidney (Fig. 1 C,
lanes 1, 3, 5, and 7) and sciatic nerve (Fig. 1 C, lanes 2, 4,
6 and 8) homogenates. Note that when anti-EcadEC5 was
used to immunoprecipitate E-cadherin from kidney homog¬
enates, a very intense broad signal was obtained upon de¬
tection with ECCD-2 (Fig. 1 C, lane 5). This was likely
due to the efficiency of EcadEC5, a polyclonal antibody, as
an immunoprecipitating agent, and the high reactivity of
ECCD-2 with E-cadherin. The results of the immunoprecip¬
itation experiments demonstrate that anti-EcadEC5 spe¬
cifically recognizes the same protein as ECCD-2 and
DECMA-1, i.e., E-cadherin.
In sciatic nerve homogenates, ECCD-2 (Fig. 2 A, lane 1)
and anti-EcadEC5 (Fig. 2 A, lane 2) both detect bands of
M30 kD. This band was not detectable in competition ex¬
periments in which anti-EcadEC5 and the fusion protein
GST-EcadEC5 were preincubated (Fig. 2 A, lane 3). In epi¬
thelial cells, E-cadherin associates with a-, (3-, and 7-cate-
nin, a family of cytoplasmic proteins whose interactions
with cadherins appear to be required for adhesion (Hirano
et al., 1992; Kintner, 1992). Therefore we probed identical
immunoblots with a- and /3-catenin antibodies and found
that bands having molecular masses of ~108 and ~95 kD,
which corresponded to the relative molecular masses of
a- and /3-catenins, respectively (Ozawa et al., 1989; Hinck
et al., 1994) were detected in sciatic nerve homogenates
(Fig. 2 A, lanes 4 and 5). E-cadherin and a- and /3-catenin
were also found in osmotically shocked membrane fractions
of sciatic and trigeminal nerves (Fig. 2 B). Because this
membrane fraction is known to consist almost entirely of
Schwann cell plasma membranes and myelin, E-cadherin in
this fraction was likely to be derived from Schwann cells.
The presence of a- and /3-catenins in these membranes sug¬
gested that they were associated with E-cadherin, and/or
perhaps other as yet unidentified cadherins.
EcadEC5 Antibodies Specifically Recognize
Adherens Junctions
Previous immuno-electron microscopy studies have estab¬
lished that E-cadherin is a marker of adherens junctions in
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Figure 2. E-cadherin and a- and /3-catenins are expressed in periph¬
eral nerve. Adult mouse sciatic nerve homogenates (A) and an os-
motically shocked membrane fraction from trigeminal nerves (B)
were separated by SDS-PAGE, transferred to nitrocellulose and im-
munostained using ECCD-2 (A, lane 1), affinity purified anti-
EcadEC5 (A, lanes 2 and 3, B, lane 1), anti-a-catenin (A, lane 4,
B lane 2) or anti-|3-catenin (A, lane 5, B, lane 3). Ag, GST-
EcadEC5. Molecular weight standards (200, 116 and 97 kD) are
indicated to the right of the blot in A.
rat intestine (Boiler et al., 1985). To verily the specificity of
EcadEC5 antibodies that we raised for the localization
studies, anti-EcadEC5 was tested on thin sections of rat in¬
testinal tissue (Fig. 3). At the lateral boundaries of longitudi¬
nally (Fig. 3 A) and obliquely (Fig. 3 B) sectioned rat intes¬
tine, adherens junctions (arrows) and desmosomes (A,
arrowheads and B, asterisk) are evident. EcadEC5 antibod¬
ies strongly and specifically labeled adherens junctions (Fig.
3, arrows) but did not label desmosomes (arrowheads) or any
other structures.
E-Cadherin Has a RestrictedDistribution within
the Cytoplasmic Compartments ofPeripheral Nerve
Schwann Cells, and is Highly Concentrated in
Schmidt-Lanterman Incisures and Paranodes
In tissue sections anti-EcadEC5 intensely labeled trigeminal
and sciatic nerves from mice and rats. Confocal microscopy
was routinely used to localize E-cadherin distribution in
these tissues. In cross sections of E-cadherin immunolabeled
peripheral nerve, individual fibers were easily identified by
circumferential fluorescence (Fig. 4 A), indicating that
E-cadherin was present in the outer cytoplasmic loops of
Schwann cells. At the outer loop, at least one intense fluores¬
cent spot could be detected (Fig. 4 A, small arrows), indicat-
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Figure 3. EcadEC5 antibodies
specifically recognize adhe¬
rens junctions. Longitudinally
(A) and obliquely (B) sec¬
tioned rat intestinal tissue was
labeled with EcadEC5 an¬
tibodies. The apically lo¬
cated microvilli are at the top
of the figure. At the lateral
surface, adherens junctions
are strongly labeled with
EcadEC5 antibodies (ar¬
rows). Desmosomes (A, ar¬
rowheads), including those
with an extensive filamentous
network (B, asterisk), are de¬
void of label. Bars, 0.1 fim.
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Figure 4. E-cadherin localizes to the cytoplasmic compartments of Schwann cells. Cryosections of adult mouse sciatic nerve were im-
munolabeled with anti-EcadEC5 and viewed by confocal microscopy. (A) In cross section, anti-EcadEC5 localized to numerous puncta
in the outer loops (small arrows) and a single dot in the inner loops (open arrow). Labeling of the Schwann cell cytoplasm (arrowhead)
was faint. The inset in A shows two nerve fibers labeled with EcadEC5 (red) and diD (green), a lipophilic dye that intensely labels myelin.
A cross section of a Schmidt-Lanterman incisure, labeled by anti-EcadEC5, is apparent in this field (A, inset, arrow). (B) In longitudinal
section, anti-EcadEC5 labeling revealed the classic morphology of Schmidt-Lanterman incisures (large arrow, and see inset).
Anti-EcadEC5 also labeled the outer loop of nerve fibers (small arrow) and the paranodes (arrowhead). (See Fig. 5 A for the intensity
scale.) Bars: (A and B) 10 /im; (insets) 2 pm.
ing that E-cadherin was concentrated in discrete subdo-
mains. Punctate labeling at the inner loop was occasionally
noted (Fig. 4 A, open arrow), but, in contrast to the outer
loop, only one E-cadherin site per inner loop was detected.
The Schwann cell cytoplasm was also faintly labeled (Fig.
4 A, arrowhead), consistent with synthesis of this transmem¬
brane protein on rough endoplasmic reticulum and post-
translational processing in the Golgi apparatus. Signifi¬
cantly, compact myelin and axons were devoid of E-cadherin
immunofluoresence. Fig. 4 A (inset) shows two myelinated
axons labeled with E-cadherin (red) and diD (green), a
lipophilic dye which intensely labels myelin. Note the ab¬
sence of E-cadherin in the myelin and axons, and the punc¬
tate E-cadherin labeling surrounding the myelin, which cor¬
responds to the outer loop. The arrow (Fig. 4 A, inset)
indicates a cross section of a Schmidt-Lanterman incisure,
which was also intensely labeled by anti-EcadEC5. In lon¬
gitudinal section, the outer loops were labeled in discontinu¬
ous tracts resembling "beads on a string" that were parallel
to the axes of the fibers (Fig. 4 B, small arrow). It is interest¬
ing to note that, in contrast to the outer loop, clearly
delineated E-cadherin tracts were not found at the in¬
ner loops in longitudinal sections. Longitudinal sectioning
also revealed that E-cadherin was highly concentrated in
Schmidt-Lanterman incisures (Fig. 4 B, large arrow and in¬
set) and paranodes (Fig. 4 B, arrowhead). Thus in Schwann
cells, E-cadherin is found exclusively in the outer and inner
loops, paranodes, Schmidt-Lanterman incisures, i.e. in the
regions which comprise the continuous cytoplasmic channel
network that forms the boundary domain of compact myelin.
At high resolution, E-cadherin immunofluorescence
clearly yielded the classical funnel-shaped image of
Schmidt-Lanterman incisures (Hall and Williams, 1970;
Ghabriel and Allt, 1981) in both trigeminal and sciatic
nerves (Fig. 5 A, arrows). These thin spiral channels inter¬
rupt compact myelin within the internode and have been im¬
plicated in the metabolic maintenance of the myelin sheath
(Ghabriel and Allt, 1981). At both ends of an incisure ring¬
like structures which completely encircled the axon were
detected (Fig. 5 A), with slightly more intense labeling at
the periphery (see also Fig. 4 B, inset). Often Schmidt-
Lanterman incisures were linked to each other by E-cad-
herin-positive tracts (Fig. 5 A, arrowhead).
Most interestingly, anti-EcadEC5 strongly highlighted the
paranodal region (Fig. 5, B-D). To obtain a highly detailed
image of E-cadherin localization, a series of 44 confocal
scans through a "paranode-node-paranode" was analyzed
using three dimensional reconstructions and video anima¬
tion, and presented as a geometric plane projection (Fig. 5
B). E-Cadherin labeling is indicated in red and the axon,
demarcated by anti-neurofilament labeling, is shown in
green. The node of Ranvier is indicated by the arrowhead.
The high degree of color saturation in the EcadEC5 channel
results from an intense immunofluorescent signal and pho-
todetector settings optimized for low signal levels. These
conditions were used to ensure detection of all E-cadherin
positive structures. E-Cadherin immunofluorescence flanked
the narrowed paranodal axon, precisely terminating at the lo¬
cus where the axonal diameter enlarged (Fig. 5 B, open ar¬
rows). Enlargements of single scans of the nodal region
showed that E-cadherin was absent from the node of Ranvier
(Fig. 5 B, insets, arrowheads). One feature of E-cadherin lo¬
calization, which was revealed by three-dimensional imag¬
ing, was that E-cadherin helically encircled the narrowed
paranodal axon. This helicity is suggested in single optical
images (Fig. 5 B, right inset, arrows), and is depicted on the
cover of this issue. E-cadherin immunolabeling of the outer
loop is also apparent (Fig. 5 B, white arrows).
Another interesting feature of paranodal E-cadherin distri¬
bution was that at the limiting edge of some, but not all,
paranodes, E-cadherin completely encircled the axon form¬
ing a cylindrical collar. Fig. 5 C is a series of rotations
around the x axis of an anti-EcadEC5 immunolabeled
paranodal region. The left panel (0°) shows the paranodal re¬
gion in longitudinal section; the right panel (50°) shows the
paranodal region in a slightly oblique cross section. As the
Figure 5. E-cadherin is highly concentrated in Schmidt-Lanterman incisures and paranodes in sciatic nerve. (A) Confocal image of two
Schmidt-Lanterman incisures (arrows) labeled with anti-EcadEC5. A thin E-cadherin positive tract (arrowhead) appears to connect the
incisures. To reconstruct the incisures, two 0.27-/rm incremental scans in the z axis were merged into a single image. The scale at the
right indicates the glow scale labeling intensity. (B) Confocal image of a paranodal region immunolabeled with anti-EcadEC5 (red) and
anti-neurofilament (green). A geometric plane projection of the paranode was created by merging 44 0.l-/im incremental scans in the z
axis into a single image. The color saturation in the anti-EcadEC5 channel (red) was the result of an intense signal and photodetector
settings optimized for low signal levels. These conditions were used to ensure detection of all E-cadherin-positive structures. Signals from
each antibody were simultaneously collected as two separate data sets, and overlaid to produce a single image. Neurofilament immunolabel¬
ing demarcates the axon. Anti-EcadEC5 labeled paranodal regions (open arrows), and outer loops (white arrows) but did not label the
node of Ranvier (arrowhead). Note that yellow does not indicate regions of colocalization (see text). The left inset is an individual scan
(z axis, 0.1 pm) taken at the midpoint of the axon and shows that anti-EcadEC5 labeling is situated at the edge of the axon, not in the
axon. The right inset is an individual scan (z axis, 0.1 (im) taken in the top quarter of the nerve fiber and indicates that the adaxonal labeling
(arrows) is helically orientated around the axon. In both insets, the node of Ranvier is indicated by the arrowhead. (C) Rotations around
the x axis of an EcadEC5-labeled paranode. 29 scans of a longitudinally sectioned paranode, taken at 0.13-/jm increments in the z axis,
were merged into a single image to create a geometric plane projection of the paranodal region (0° left). The geometric plane projection
was computationally rotated around the x axis by 30° (middle) and by 50° (right). The disc indicated by the arrow (left) represents
anti-EcadEC5 paranodal labeling which completely encircles the axon and forms a paranodal collar. The paranodal collar is clearly evident
after rotating the image around the x axis (middle and right). In the right panel, the axon, which is devoid of E-cadherin labeling, is indicated
by the arrow. (See A for intensity scale.) (D) confocal images of a paranode labeled with rabbit anti-EcadC5 (left, red) and mouse anti-MAG
(middle, green). The overlay (right) shows regions of E-cadherin and MAG colocalization (yellow). Two confocal scans of a longitudinally
sectioned paranodal region, taken at 0.11-/im increments in the z axis, were merged into a geometric plane projection. The overlay (right)
indicates that both anti-EcadEC5 (red) and anti-MAG (green) demonstrate adaxonal labeling (open arrow, yellow), but only anti-EcadEC5
labels the paranodal collar (solid arrow). Bars: (A) 5 pm; (B) 2 pm; (insets, 1 pm; (C and D) 2 ^m.
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Figure 6. Stereo image of E-cadherin positive tracts in two sciatic
nerve fibers. Confocal scans were merged into geometric plane
projections which were then computationally rotated around the y
axis. The two images, differing by 5°, can be paired to produce a
stereo image. Bar, 2 (im.
fiber was rotated, the flattened disc in the left panel (Fig. 5
C, arrow), became a hollow E-cadherin positive ring encir¬
cling the axon (Fig. 5 C, right, arrow, see also Fig. 6, right
fiber). In most paranodes where collars were found, two col¬
lars, one at the limiting edge of each internode were ob¬
served.
In Schwann cells, E-cadherin distribution was remarkably
similar but not identical, to that of an IgCAM superfamily
protein, MAG (myelin-associated glycoprotein). While both
proteins were restricted to the cytoplasmic channels of
Schwann cells, they did not exhibit an exact colocalization.
For example, in the inner loop, MAG was evenly distributed
(Trapp et al., 1989) while E-cadherin was restricted to a sin¬
gle punctate site (see Fig. 4 A). In addition, in the paranodal
region, both E-cadherin and MAG flanked the paranodal
axon (Fig. 5 D, solid arrow, yellow), but E-cadherin, alone,
formed a paranodal collar (Fig. 5 D, open arrow, red).
Helical E-cadherin Tracts Are in Register Across
Adjacent Internodes
A distinguishing feature of E-cadherin distribution in the in¬
ternode was its organization into discontinuous longitudinal
tracts that wound helically along the periphery of the
Schwann cell in the outer loops (Fig. 6). Indeed, the punctate
fluorescence in the outer loop observed in cross sections (see
Fig. 4 A) corresponded to labeling of the tracts. As the
E-cadherin tracts wove among the outer loop, they criss¬
crossed and often extended from one Schmidt-Lanterman
incisure to the next (see also Fig. 5 A), indicating that
E-cadherin was part of a highly organized substructure
within the entire cytoplasmic channel network of Schwann
cells. Video animation revealed that the helical paths delin¬
eated by E-cadherin continued in register from internode to
Figure 7. /3-catenin and F-actin colocalize in peripheral nerve fibers. (A) Peripheral nerve, immunolabeled with anti-/3-catenin was analyzed
by confocal microscopy. Two scans, taken at 1.7-^m increments in the z axis, were merged into a geometric plane projection. The open
arrows demarcate labeling of Schmidt-Lanterman incisures and the solid arrows indicate labeling of the outer loops. (B) Confocal image
of a paranodal region immunolabeled with anti-EcadEC5 (left, red) and anti-/3-catenin (middle, green). The regions of colocalization are
indicated in yellow in the overlay (right). A single confocal scan was taken through the midpoint of an obliquely cut paranode. Both adaxonal
labeling (arrow) and paranodal collar labeling (arrowhead) were apparent with anti-/3-catenin (middle). The overlay (right) shows colocali¬
zation of E-cadherin and 0-catenin (yellow). (C) Confocal image of two nerve fibers immunolabeled with anti-EcadEC5 (left) and phalloidin
(middle) which binds to F-actin. Two scans, taken at 1.3-jum increments in the z axis, were merged into a geometric plane projection.
The graininess in this set of images is due to low averaging values used during data collection. F-Actin (middle) is found in the outer loop
(short arrows) and inner loop (long arrow). These regions colocalize with anti-EcadEC5 (right, yellow). (D) Confocal image of a Schmidt-
Lanterman incisure immunolabeled with E-cadherin (left) and phalloidin (middle). Nine confocal scans, taken at 0.54-^m increments in
the z axis, were merged into a geometric plane projection. The overlay (right) shows E-cadherin and F-actin colocalization (yellow) in
Schmidt-Lanterman incisures. Bars: (A) 10 /im; (B and C) 2 fim; (D) 1 pim.
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internode. This novel observation suggested, surprisingly,
that adjacent Schwann cells may be functionally associated
with one another. Thus the morphology of the E-cadherin
network revealed a previously unsuspected organization of
Schwann cells into what might be a globally interactive unit.
/3-Catenin and F-Actin Colocalize with E-Cadherin in
the Outer and Inner Loops and at Schmidt-Lanterman
Incisures and Paranodes
Low magnification confocal images of /3-catenin immunola-
beled peripheral nerve were similar to those observed for
E-cadherin labeled tissue (Fig. 7 A). Schmidt-Lanterman in¬
cisures (Fig. 7 A, open arrows) and labeling at the outer loop
(Fig. 7 A, white arrows) were clearly visible. At the para¬
nodes, /3-catenin flanked the axon (Fig. 7 B, middle) and
formed a paranodal collar (Fig. 7 B, arrowhead), thus
demonstrating a precise colocalization with E-cadherin (Fig.
7 B, right, yellow).
F-Actin, another protein which associates with E-cadhe-
rin, also localizes to E-cadherin positive regions (Fig. 7, C
and D). F-actin, labeled by phalloidin, had a punctate ap¬
pearance in the outer loop (Fig. 7 C, middle, short arrows)
which precisely colocalized with E-cadherin (Fig. 7 C,
right). In the inner loop, a single distinct spot of F-actin was
found (Fig. 7 C, long arrow), which co-distributed with
E-cadherin (Fig. 7 C, right, yellow). Finally F-actin (Fig. 7
D, middle) and E-cadherin (Fig. 7 D, left) colocalized in
Schmidt-Lanterman incisures (Fig. 7 D, right, yellow). The
graininess in Fig. 7 (C and D) is from statistical noise pro¬
duced when using low averaging values during data collec¬
tion, and is not due to a weak signal. Sciatic and trigeminal
nerves were also examined for the presence of vinculin, an¬
other protein which is associated with E-cadherin adhesion
complexes (Geiger and Ginsberg, 1991). Preliminary data
indicated that vinculin antibodies strongly labeled blood ves¬
sels in peripheral nerve but did not colocalize with E-cad-
herin (data not shown). The co-distributions of E-cadherin
with /3-catenin and F-actin provide strong evidence that these
proteins may organize into an adhesion complex that has
characteristics of adherens junctions and is integral to the
stability of the inner and outer loops, Schmidt-Lanterman in¬
cisures and the paranodes.
E-Cadherin Mediates Adhesion within an Individual
Schwann Cell
A striking finding was that by immunoelectron microscopy,
E-cadherin strongly labeled Schwann cell membranes as¬
sociated with cytoplasmic densities in the paranodes (Fig.
8), Schmidt-Lanterman incisures (Fig. 9) and outer mesaxons
(Fig. 10, B-D). No E-cadherin was observed at the Schwann
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Figure 8. E-cadherin localizes
to densities in the paranodal
channels. Immunoelectron
microscopy of sciatic nerve
from 7-d-old mice and rats
labeled with anti-P0 (A)
or anti-EcadEC5 (B-D).
Anti-EcadEC5 intensely la¬
bels densities in the paranode
(B, arrows). Note the exten¬
sive labeling of the densities in
C. In D, the narrowing of the
cytoplasm and the widening
of the intracellular space is
apparent. In a control Po-
labeled paranode (A) myelin
(arrows) is labeled, but the
densities (arrowheads) re¬
main unlabeled. Bars, 0.1 nm.
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cell-axonal interface, nor between the membranes of two
Schwann cells. Thus, in the PNS, E-cadherin is unusual in
that it mediates adhesion between membranes elaborated by
an individual cell.
In longitudinally sectioned paranodes, cytoplasmic densi¬
ties were strongly labeled with anti-EcadEC5 (Figs. 8,
B-D). In control sections, P0, the major glycoprotein of pe¬
ripheral nerve myelin localized specifically to compact my¬
elin (Fig. 8 A, arrows), and was absent from the densities
(Fig. 8 A, arrowheads). Loops extending from the innermost
myelin lamellae consistently contained the most well devel¬
oped densities (Fig. 8 B, arrows), while the outermost turns
(Fig. 8 B, asterisk) were often devoid of densities and E-cad¬
herin labeling. Since the tissue used for the immunoelectron
microscopy was obtained from 7-d-old animals, the preferen¬
tial labeling of the inner turns may have been related to a de-
velopmentally transient event. We did not observe im-
munogold labeling of structures which would correspond to
the collars seen in some paranodes by light microscopy (see
Figs. 5 C and 7). The absence of such labeling may be de-
velopmentally related and/or it could be due to the lower
sensitivity of immunoelectron microscopy. The arrangement
of the plaques across several turns of the paranodal channel
produced a large zonula-like junctional complex. Within the
junctional array, there was a distinct narrowing of the
cytoplasm from 85 to 45 nm (Fig. 8 D), accompanied by a
local widening of the extracellular space (see also Harkin,
1964). In addition the densities extended across the full
length of the cytoplasm, in effect dividing the paranodal
channel into two separate compartments.
E-Cadherin is also highly concentrated in densities found
in Schmidt-Lanterman incisures. Fig. 9 A is a transverse sec¬
tion of a developing myelin sheath showing what is likely to
be a forming Schmidt-Lanterman incisure. At the periphery
of the sheath, three densities are specifically labeled by
anti-EcadEC5 (Fig. 9 A, arrows). Two well-developed
Schmidt-Lanterman incisures and their associated densities
(Fig. 9 B, arrows) are shown in a P0-labeled control sec¬
tion. As in the paranodal channel, densities in the Schmidt-
Lanterman incisures are highly ordered and aligned in con¬
tiguous cytoplasmic wraps. E-Cadherin thus may have an
important role in the formation of Schmidt-Lanterman in¬
cisures.
At the outer loop, E-cadherin was associated with densi¬
ties that were either macular (Fig. 10 D, arrows) or reason¬
ably extensive (>350 nm, Fig. 10 C). E-cadherin was also
present at densities at the outer mesaxon (Fig. 10 B). The
presence of these profiles directly correlated with the punc¬
tate and linear E-cadherin fluorescence patterns we detected
along outer loops by confocal microscopy (see Figs. 4, 5 A,
and 6). The inner mesaxon was the only region that consis¬
tently showed E-cadherin localization in the absence of cyto¬
plasmic densities (Fig. 10 A, arrows). However, densities at
some inner mesaxons were noted by Bunge et al. (1989) in
sheaths that had only a few compact wraps. The labeled
inner mesaxons that we observed were in sheaths with
numerous turns of compact myelin. At the inner mesaxon,
it is possible that the appearance of these densities may be
transiently coordinated with the state of myelin bilayer com¬
paction. The presence of E-cadherin together with the ab¬
sence of densities suggests that only relatively weak adhesion
could be required at the inner mesaxon after compaction has
occurred. In contrast, the presence of dense plaques in the
paranodes and outer mesaxons is indicative of strong adhe¬
sive and mechanical stabilization in these regions.
Discussion
The data presented here reveal E-cadherin to be an important
component in the cytoarchitecture of individual Schwann
cells. In other cell types, cadherins mediate intercellular
adhesion. Even in peripheral nerve, it has been shown that
Figure 9. Distribution of cytoplasmic
plaques in Schmidt-Lanterman incisures.
Immunoelectron microscopy of Schmidt-
Lanterman incisures labeled with anti-
EcadEC5. In A, the arrows indicate three
labeled densities in a forming Schmidt-
Lanterman incisure. In a control Po-
labeled incisure (B ), labeling of myelin is
apparent, but the densities (arrows) re¬
main unlabeled. Bars, 0.1 fim.
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Figure 10. Distribution of E-cadherin in the inner and outer mesaxons and the outer loops of Schwann cells. Immunoelectron microscopy
of Schwann cells labeled with anti-EcadEC5. (A) E-cadherin is present at the inner mesaxon (arrows) in the absence of a well-developed
plaque. Conversely, at the outer mesaxon. E-cadherin is associated with well-developed densities (B). In the outer loop, anti-EcadEC5
localizes to large, extensive densities (C) and to macular densities (D, arrows). Bars, 0.1 #im.
satellite cells, which surround dorsal root ganglion cells, ex¬
press E-cadherin at cell to cell contact sites (Shimamura et
al., 1992; Uchiyama et al., 1994). However, in the Schwann
cell, E-cadherin is unique in that it mediates adhesion be¬
tween membranes elaborated by a single cell. E-cadherin
was not detected between two Schwann cells nor between
Schwann cells and the axon. In Schwann cells, E-cadherin
localizes to densities which we have designated as autotypic
adherens-type junctions, in contrast to homotypic (between
two similar cell types) and heterotypic (between two differ¬
ent cell types) junctions. To our knowledge this is the first
documentation of functional E-cadherin mediated adhesion
within an individual cell.
Densities in the paranodes (Harkin, 1964), mesaxons
(Bunge et al., 1989) and Schmidt-Lanterman incisures (Hall
and Williams, 1970) have been noted but infrequently dis¬
cussed. It is now clear that these densities are components
of an adherens junctional system that serves to anchor adja¬
cent membranes. The argument that these are adherens-type
junctions is based on their ultrastructural morphology as
well as the presence of E-cadherin, and likely /3-catenin and
F-actin, hallmark molecules of adherens junctions found in
other tissues (Boiler et al., 1985; Volk and Geiger, 1986a,
b\ Le Bivic et al., 1990; Geiger and Ginsberg, 1991; Geiger
and Ayalon, 1992). Despite the similarities with classical
junctions, Schwann cell adherens junctions are unusual in
that the subplasmalemmal plaque traverses the cytoplasmic
compartment and appears to fuse with the adjacent plaque.
E-Cadherin adhesion loci in the Schwann cell are dis¬
tributed throughout the cytoplasmic channel network, which
is most easily illustrated in an "unrolled" Schwann cell (Fig.
11A). The continuous channel network (light gray) borders
the compact myelin domains (dark gray) and consists of the
outer loop, paranodal channels, the inner loop and the
Schmidt-Lanterman incisures. The data in this study dem¬
onstrates that E-cadherin sites (black) have a restricted dis¬
tribution within the cytoplasmic network. Diagrammed in
situ (Fig. 11 B, bottom), E-cadherin loci become aligned in
contiguous cytoplasmic wraps, thus forming extended junc¬
tional complexes. This is most evident in the paranodal chan¬
nel (Fig. 11 B, top) where two helically oriented junctional
complexes (black) are depicted. Note that the orientation of






B Figure 11. Model for the dis¬
tribution of E-cadherin adher¬
ence sites in an "unrolled"
Schwann cell, in the parano-
dal channels and in a native
Schwann cell. (A) In an un¬
rolled Schwann cell, E-cad¬
herin adherence sites are
found in regions which form
the outer boundaries of the
cell. These include the outer
mesaxon, the outer loop, the
inner loop and the paranodal
channel. E-cadherin adher¬
ence sites are also found in the
internal portion of the cell in
the Schmidt-Lanterman in¬
cisures. Thus, E-cadherin loci
are restricted to a cytoplasmic
network which sequesters com¬
pact myelin into discrete do¬
mains. (5, bottom). In a
Schwann cell in its native ("rolled") conformation, E-cadherin adherence sites become aligned with each other, allowing the formation
of an extensive series of transcytoplasmic densities which contribute to the overall stability of the cell. The location of the E-cadherin
adherence sites in the outer mesaxon suggests that the outer mesaxon helically wraps around the cell and its orientation continues in register
in the adjacent cell. (B, top). In paranodal channels stripped of their myelin, E-cadherin containing densities form two helically oriented
complexes of transcytoplasmic densities in each paranode.
Inner Loop
these complexes is in register across the node of Ranvier.
This model for the organization of paranodal junctions is
based on confocal and immuno-electron microscopy (this
study), and serial electron microscopy (Harkin, 1964). In
the outer loop, E-cadherin loci are helically placed, which
gives the impression that the outer mesaxon twists along the
length of the internode (Fig. 115, lower) Attachment sites
at the outer mesaxon have been previously noted (Bunge et
al., 1989), and it is of great interest that freeze-fracture
studies reveal extensive linear arrays of particles on the P
face at the mesaxonal border (Peters et al., 1991). Some of
these particles may, in fact, correspond to E-cadherin loci.
We can speculate that adherens junctions in the Schwann
cell may assist in compensatory mechanisms during the
stretching and contraction of peripheral nerve. Mechanical
stresses on nerve fibers may perhaps be accommodated by
changing the degree of coiling of the helical E-cadherin
tracts. In this regard, it should be noted that expansion and
contraction of Schmidt-Lanterman incisures have been ob¬
served in situ (Singer and Bryant, 1969). The alignment of
the tracts in the outer loop and mesaxon from one internode
to the next suggests that responses may even be coordinated
along the entire length of an individual fiber. The adherens
junctions in the paranodes may locally supplement the re¬
sponse by maintaining a constant length at the node of Ran¬
vier. This is important since it is generally believed that to
ensure efficient saltatory conduction, sodium channels in the
nodal axon must be sequestered within relatively non-variant
membranous area (Rosenbluth, 1988; Joe and Angelides,
1992).
Autotypic adherens junctions in the Schwann cell may
have evolved to mediate rapid intracellular communication
which would bypass signaling around the spiral turns. Re¬
cent studies have demonstrated that some components of
adherens junctions, notably, /3-catenin and plakoglobin, are
homologues of the Drosophila protein, armadillo, which has
been shown to be involved in signal transduction pathways
(Nusse and Varmus, 1992). The fact that Schwann cell junc¬
tions completely straddle the cytoplasm suits their putative
function as efficient signal transducers, and is consistent with
the notion that adherens junctions are involved in cellular
communication (Gumbiner, 1993; Peifer, 1993).
E-Cadherin may also organize and polarize Schwann cell
plasma membrane proteins and other junctional compo¬
nents. Past studies have indicated that adherens junctions and
E-cadherin are involved in tissue morphogenesis (Wheelock
and Jensen, 1992) and are integral to the maintenance of a
polarized epithelium. In addition, E-cadherin seems to act
as an organizer of other cell adhesion molecules, and is in¬
volved in long-term assembly of the plasma membrane. In
the Schwann cell plasma membrane, there is, in effect, a
sharply polarized distribution of the two bona fide adhesion
molecules characterized in these cells to date: P0, a mem¬
ber of the Ig superfamily, is restricted to compact myelin,
and E-cadherin is restricted to the channel network. The
plasma membrane of the Schwann cell actually has four con¬
tact sites, three of which have been described as authentic
junctions. These include adherens junctions (this paper);
tight junctions, (also termed zonula occludens; Mugnaini
and Schnapp, 1974; Schnapp and Mugnaini, 1978; Peters et
al., 1991); and axoglial junctions, which bridge the parano¬
dal channel and the axonal membrane. The fourth contact
site is compact myelin which is a vast planar junction. These
junctions are stereotypically organized within the Schwann
cell, particularly within the paranodal loops. In fact E-cad-
herin may play an integral role in establishing Schwann cell
polarity in a manner that is analogous to, but certainly dis¬
tinct from, that in other epithelial cells.
The formation of autotypic junctions must have a crucial
role in myelinogenesis. During development of the sheath,
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there is both circumferential deposition of myelin lamellae
and longitudinal expansion of Schwann cell membrane that
proceeds in parallel with the lengthening of the axonal fiber
(Webster, 1971). In the establishment of the node of Ranvier,
each successive paranodal turn must guide itself around the
adjacent channel segment to establish axonal contact. Junc¬
tions in the paranodes, Schmidt-Lanterman incisures and
outer loops probably stabilize subsequent wraps of myelin
as the sheath enlarges. As each turn is completed, newly
formed plaques may link with those from previous wraps
and, thus, result in contiguously arranged transcytoplasmic
junctions. As the myelin sheath forms, E-cadherin mediated
adhesive bonds may be continually established, dissociated,
and re-established. This activity is likely to depend on inter¬
actions between E-cadherin and the actin cytoskeleton, and
it is worth noting in this regard that F-actin is localized in
peripheral nerve in a labeling pattern that is extraordinarily
congruent to E-cadherin distribution (this study; see also
Trapp et al., 1989). The adhesive interplay between non-
compacted membranes required during myelinogenesis may
be analogous to that found in epithelial compaction in which
E-cadherin seems to be the major mediator of adhesion
(Fleming and Johnson, 1988). During the compaction pro¬
cess, it is thought that E-cadherin induces submembranous,
transient changes that are labile and cell contact dependent.
Thus, E-cadherin is a good candidate for directing the tran¬
sient alterations in adhesivity which are likely to be involved
in the sequential laying down of the myelin spiral.
In the mature sheath the transcytoplasmic plaques may act
as a scaffolding, and perhaps serve to maintain a minimum
cytoplasmic width. The absence of a cytoplasmic undercoat-
ing at the inner mesaxon may be indicative of more labile
membrane-membrane interactions, although there is no di¬
rect experimental evidence to support this at present. The
relative lability of this interaction would be consistent with
one model for myelin membrane deposition that predicts that
the myelin sheath enlarges by addition of membrane at the
inner loop concurrent with the movement of the inner loop
around the axon (Bunge et al., 1989). However, addition of
myelin components at the inner loop is not likely to be the
only mechanism by which myelin components are deposited
in the sheath inasmuch as others have demonstrated that the
paranodal and outer loops are also sites of vigorous myelin-
related synthetic activity (Gould and Sinatra, 1981; Griffiths
et al., 1989), and probable membrane deposition.
In conclusion, E-cadherin is a major adhesion protein in
peripheral nerve Schwann cells and is unusual in that it medi¬
ates adhesion between membranes synthesized by a single
cell. E-cadherin localizes to unique adhesion specializa¬
tions, now identified as autotypic adherens junctions, that
are restricted to subdomains within the noncompacted
regions. The junctional complexes may be important stabili¬
zation sites in myelination and may mediate rapid signaling
across cytoplasmic compartments, which suggests special¬
ized functions in addition to those required for myelinogene¬
sis. Our findings also indicate that the orientations of cyto¬
plasmic networks in Schwann cells are in register across
adjacent internodes and this implies that contiguous Schwann
cells may have the capacity to act in concert with each other
as part of a globally interactive unit. Most importantly, be¬
cause E-cadherin is fundamentally involved in cellular orga¬
nization in other cell systems, our data allows us to adduce
that E-cadherin may have a similar role in organizing the
polarized distributions of Schwann cell proteins, such as Pn
and other components of the myelin sheath. Finally the local¬
ization of E-cadherin at the border of each compact myelin
domain, taken together with the known susceptibility of this
molecule to proteolyze under certain conditions, suggests
that failure of E-cadherin mediated adhesion may be one
means by which demyelination may proceed in certain
pathological states in peripheral nerve.
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Periaxin is a newly described protein that is expressed
exclusively by myelinating Schwann cells. In developing
nerves, periaxin is first detected as Schwann cells ensheathe
axons, prior to the appearance of the proteins that charac¬
terize the myelin sheath. Periaxin is initially concentrated
in the adaxonal membrane (apposing the axon) but, during
development, as myelin sheaths mature, periaxin becomes
predominately localized at the abaxonal Schwann cell
membrane (apposing the basal lamina). In permanently
axotomized adult nerves, periaxin is lost from the abaxonal
and adaxonal membranes, becomes associated with
degenerating myelin sheaths and is phagocytosed by
macrophages. In crushed nerves, in which axons regenerate
and are remyelinated, periaxin is first detected in the
adaxonal membrane as Schwann cells ensheathe regener¬
ating axons, but again prior to the appearance of other
myelin proteins. Periaxin mRNA and protein levels change
in parallel with those of other myelin-related genes after
permanent axotomy and crush. These data demonstrate
that periaxin is expressed by myelinating Schwann cells in
a dynamic, developmentally regulated manner. The shift in
localization of periaxin in the Schwann cell after completion
of the spiralization phase of myelination suggests that
periaxin participates in membrane-protein interactions that
are required to stabilize the mature myelin sheath.
Key words: Wallerian degeneration, peripheral nerve, axotomy,
nerve growth factor receptor, myelin. Schwann cell, rat
INTRODUCTION
Myelin is a multi-lamellar structure that surrounds axons and
increases axonal conduction velocity. It is formed by the spiral
wrapping of the cell membrane of Schwann cells (in the PNS)
and oligodendrocytes (in the CNS). Compact myelin is chiefly
composed of lipids, but also contains a unique set of proteins;
in the PNS, these are Pq, myelin basic protein (MBP), and
peripheral myelin protein-22 kD (PMP-22) (Lemke, 1992;
1993). Other membrane proteins are excluded from compact
myelin even though their expression is characteristic of myeli¬
nating Schwann cells. Their discrete localization emphasizes
that myelinating Schwann cells appear to be polarized epi¬
thelial cells, whose plasma membrane contains several distinct
domains, each of which has its own distinct repertoire of
proteins. Thus, myelin-associated glycoprotein (MAG), the
gap junction protein connexin32, oligodendrocyte-myelin gly¬
coprotein and E-cadherin are all found in the perinodal regions
and the Schmidt-Lanterman incisures (Trapp and Quarles,
1982; Bergoffen et al., 1993; Apostolski et al., 1994; Fannon
et ah, 1995; Scherer et al., 1995) In contrast, the integrins a6
and (34 are localized to the (abaxonal) surface of myelinating
Schwann cells, which apposes their basal laminae (Einheber et
ah, 1993; Feltri et ah, 1994). The adaxonal surface and its asso¬
ciated periaxonal rim of cytoplasm, which appose the axon, are
characterized by the expression of MAG, spectrin and F-actin
(Trapp et ah, 1989). This complex organization of the Schwann
cell-axon unit is presumed to contribute to the structural basis
required for the formation and stabilization of the myelin
sheath.
In addition to myelin-forming Schwann cells, mature periph¬
eral nerve also contains non-myelinating Schwann cells. They
ensheathe one or more axons without forming a myelin sheath
around any of them (Peters et ah, 1991). In addition to these
morphological distinctions, non-myelinating and myelinating
Schwann cells have different molecular phenotypes. Non-
myelinating Schwann cells express glial fibrillary acid protein
(GFAP), p75/low-affinity nerve growth factor receptor
(NGFR), growth-associated protein 43 kD (GAP-43), neural
cell adhesion molecule (N-CAM), and the cell adhesion
molecule LI, but not Po. MBP. PMP-22 and MAG (Mirsky and
Jessen, 1990; Snipes et ah, 1992; Curtis et ah. 1992; Scherer
et ah, 1994b). Conversely, myelinating Schwann cells do not
express GFAP. NGFR. GAP-43, N-CAM and LI. In spite of
these differences, the phenotype of Schwann cells depends on
their association with axons, and can be experimentally altered.
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so that non-myelinating Schwann cells can become myelinat¬
ing Schwann cells and vice versa. Thus, previously non-myeli-
nating Schwann cells can form myelin sheaths if they are trans¬
planted into a nerve that normally contains many myelinating
Schwann cells (Langley and Anderson, 1903; Simpson and
Young, 1945; Aguayo et ah, 1976b; Weinberg and Spencer,
1976). This finding demonstrates that axons, and not the
Schwann cells themselves, determine whether a Schwann cell
has a myelinating or a non-myelinating phenotype.
The maintenance of the myelinating phenotype requires con¬
tinuous axon-Schwann cell interactions, as illus¬
trated by the sequence of events that follow
axotomy, which causes axons to degenerate distal
to the lesion. Within a few days of axotomy, the
axons and myelin sheaths begin to degenerate, but
the Schwann cells survive and even proliferate.
Myelinating Schwann cells cease expressing high
levels of myelin-related proteins and their
mRNAs, and begin expressing ones that are more
characteristic of non-myelinating Schwann cells,
such as the NGFR and GAP-43 (Taniuchi et ah,
1988; Curtis et al., 1992; Plantinga et ah, 1993;
Scherer et ah, 1994b). However, if axons regener¬
ate and are remyelinated, the pattern of gene
expression reverses: the expression of myelin-
related genes increases and the expression of
NGFR and GAP-43 falls (Taniuchi et ah, 1988;
Plantinga et ah, 1993; Scherer et ah, 1994b). The
coordinate increase in myelin-related genes occurs
in a manner that appears quite similar to that seen
during the onset of myelination in developing
nerves. The levels of myelin-related proteins and
mRNAs increase, probably because the rate of
their transcription increases (Wood and Engel,
1976; Uyemura et ah, 1979; Stahl et ah, 1990;
Wiktorowicz and Roach, 1991). Thus, there is a
coordinate program of myelin gene expression,
regulated at the level of transcription, which
accompanies the synthesis of myelin during both
development and regeneration.
In this paper, we have investigated the
expression and localization of a newly described
protein, periaxin (Gillespie et ah, 1994), which is
probably the same protein previously identified as
P170 and SAG (Shuman et ah, 1986; Dieperink et
ah, 1992). In adult nerve, we find that periaxin is
expressed exclusively by myelinating Schwann
cells and is predominately localized to their
abaxonal surface. In developing and regenerating
nerves, however, periaxin is predominately
localized to the adaxonal surface of Schwann cells
as they begin to form compact myelin. Periaxin
immunoreactivity is seen before those of MAG,
MBP or Po, which is consistent with the electron
microscopic evidence that it is expressed by
ensheathing Schwann cells (Gillespie et ah, 1994).
Periaxin mRNA levels change in parallel with
those of other myelin-related genes in permanently
axotomized and regenerating nerves. These data
show that periaxin is a myelin-related protein, and
the dynamic changes in its localization during
ensheathment and myelination suggest that it may play ar
important role in these processes.
MATERIALS AND METHODS
Sciatic nerve transection and crush
Using aseptic technique, the sciatic nerves of anesthetized (50 mg/kg
pentobarbital i.p.), adult (10-13 week old) Sprague-Dawley rats were



















Fig. 1. Immunohistochemical analysis of periaxin in the adult rat PNS.
(A-D) Transverse sections of the lumbar dorsal roots, double-labeled for periaxin
(fluorescein; A.C) and MAG (rhodamine; B.D). Some incisures are indicated by
double-arrowheads and a few axons are labeled (a). At the dorsal root entry zone
(A.B). periaxin is expressed by myelinating Schwann cells (left side), but not by
oligodendrocytes (right side), whereas MAG is found in a adaxonal distribution
in both PNS and CNS myelin sheaths. (C.D) Periaxin immunoreactivity of
myelinating Schwann cells is greater on the abaxonal surface (arrowheads) than
on the adaxonal surface, in contrast to the adaxonal localization of MAG.
(E) Longitudinal section of sciatic nerve that had been treated for 1 hour in 100%
Triton-X to better reveal periaxin immunoreactivity in the incisures (arrowheads)
and paranodes (arrows) of myelinated axons (a). (F) Transverse section of
cervical sympathetic trunk, demonstrating periaxin immunoreactivity is
associated with myelinating, but not non-myelinating, Schwann cells. Scale bar:
10 pin.
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Fig. 2. Immunohistochemical analysis of periaxin
expression in Wallerian degeneration. These are
longitudinal sections of the distal nerve stump of an
adult rat sciatic nerve at 8 (E), 12 (A.B), and 24
(C,D) days post-transection. Periaxin
immunoreactivity is green (fluorescein); the
rhodamine is either S-100(3 (B), MBP (D) or ED-1
(E). Pairs of photomicrographs (A.B and C.D) were
taken from the same field; (E) is a confocal image.
(A,B) Periaxin-immunoreactive material (p) is found
in both S-100fS-positive (Schwann cells) and S-l()0(3-
negative cells (macrophages). (C.D) Periaxin-
immunoreactive material (p) is associated with MBP-
positive myelin ovoids. (E) Periaxin-immunoreactive
material (p) is found within both ED-1-positive
(macrophages) and ED-1-negative cells (Schwann
cells). Scale bar: 10 pm.
Fig. 3. Immunohistochemical analysis of periaxin in
regenerating adult rat sciatic nerve. Longitudinal
sections from the distal nerve stump at 12 days (A-D)
and transverse sections at 24 days (E,F) postcrush
were double-labeled for periaxin (A,C,E; fluorescein)
and either Po (B) or MAG (D.F). The periaxin-positive
Schwann cells that are associated with regenerating
axons form long strands that run between clumps of
degenerating periaxin-positive debris (A.C). Two
periaxin-positive. MAG-negative Schwann cells are
indicated by arrowheads (C.D), whereas most of the
periaxin-positive cells are Po-negative (A.B). In
transverse sections, many myelinating Schwann cells
have a double ring of periaxin labeling; an inner
(adaxonal) ring that superimposes with MAG
immunoreactivity (arrows), and an outer ring that
marks the abaxonal surface (arrowheads). Scale bars:
50 pm (A-D); 10 pm (E.F).
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sected with iridectomy scissors, and the two nerve stumps were
sutured at least 1 cm apart; this technique prevents axonal regenera¬
tion to the distal nerve stump for at least 2 months. Nerve crush was
produced by tightly compressing the sciatic nerve at the sciatic notch
with flattened forceps twice, each time for 10 seconds; this technique
causes all of the axons to degenerate, but allows axonal regeneration.
At varying times after nerve injury, the animals were killed by CO2
inhalation, the distal nerve stumps were removed, and the most
proximal 2-3 mm were trimmed off. For transected nerves, the entire
distal nerve stump was taken from just below the lesion to the ankle
(about 4 cm long). For crushed nerves, the distal nerve stump was
divided into two equal segments, termed the proximal and distal
segments, each about 2 cm long. The nerves were immediately frozen
in liquid nitrogen and stored at -80°C. Unlesioned sciatic nerves were
obtained from animals of varying ages, from PI (the day after birth)
to P90. All animal protocols were approved by the Institutional
Animal Care and Use Committee of The University of Pennsylvania.
Northern blotting
RNA was isolated from rat sciatic nerves and Schwann cells by CsCb
gradient centrifugation (Chirgwin et ah. 1979). Equal samples (10 pg)
of total RNA were electrophoresed in 1% agarose, 2.2 M formalde¬
hyde gels, transferred to nylon membranes (Duralon. Stratagene) in
6x SSC. and u.v. cross-linked (0.12 joules). Blots were prehybridized,
hybridized and washed using standard techniques; the final stringency
of the wash was 0.2x SSC at 65°C for 30 minutes (Sambrook et al.,
1989). The following cDNAs were utilized as probes, a 1.1 kb
fragment of rat periaxin (Gillespie et al., 1994), a full-length cDNA
of rat Po (Lentke and Axel. 1985), a 0.7 kb BamHI fragment of rat
NGFR (Radeke et al., 1987) and a full-length cDNA of glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH; (Fort et al., 1985).
Plasmid inserts were isolated after restriction endonuclease digestion,
separated by agarose gel electrophoresis and purified by electrolution.
32P-labeled cDNA probes with specific activities of 2-5xl09
cts/minute/pg were prepared by primer extension with random
hexamers using the Prim-a-gene kit (Promega) according to the man¬
ufacturer's instructions.
Immunohistochemistry and immunocytochemistry
The distal nerve stumps of transected and crushed rat sciatic nerves,
as well as unlesioned nerves and spinal cords, were fixed for 24 hours
in Bouins solution or 4% paraformaldehyde, cryoprotected in 20%
sucrose and embedded in OCT (Miles). Fixation in Bouins solution
gave the best periaxin immunoreactivity, but fixation in paraformalde¬
hyde better preserved the structure of the myelin sheaths. Both trans¬
verse and longitudinal sections of the nerves, 6-8 pm thick were
obtained and mounted on glass slides. The sections were treated with
acetone for 10 minutes at room temperature, blocked for at least 1
hour in 10% fish skin gelatin containing 0.1% Triton-X, and incubated
24-48 hours at 4°C with a various combinations of a primary anti¬
bodies. To better visualize periaxin immunoreactivity in the Schmidt-
Lanterman incisures, some sections were initially treated with 100%
Triton-X for 1 hour. We used a rabbit polyclonal antibody (1:2000
final dilution) against a full-length fusion protein of rat periaxin
(Gillespie et al., 1994), as well as guinea pig and rabbit antisera
against P170 (Shuman et al., 1986). These antibodies were used in
various combinations with a rabbit polyclonal antibody against
purified bovine S-100(3 (East Acres Biologicals), as well as mouse
monoclonal antibodies against purified rat GAP-43 (Schreyer and
Skene, 1991), bovine myelin basic protein (Serotec clone 2), rat MAG
(Boehringer-Manheim), purified bovine S-100(3 (East Acres Biologi¬
cals), rat Po (Archelos et al.. 1993), or rat macrophages (EDI. Serotec;
Dijkstra et al.. 1985). After incubating with the primary antibodies,
the sections were washed, then incubated with a fluorescein- and
rhodamine-conjugated donkey anti-rabbit and anti-mouse secondary
antibodies (Jackson ImmunoResearch Laboratories), respectively.
Non-immune rabbit serum, diluted to have the same protein concen¬
tration as the primary antibodies, was used to control for the sped
ficity of the primary antibodies. Sections were photographed on ;
Leitz microscope equipped for epifluorescence or scanning lasei
confocal microscopy.
Electron microscopy
P28 Wistar rats were anaesthetized and perfused with 4% formalde¬
hyde (freshly prepared from paraformaldehyde) in 0.01 M periodate
0.075 M lysine, 0.1 M phosphate buffer at pH 7.4 (McLean anc
Nakane, 1974). The sciatic and trigeminal nerves were removed and
fixed for another 2-3 hours at room temperature. Sciatic nerves were
removed and fixed by immersion in the same fixative for 2-3 hours al
room temperature. The tissues were processed according to the
method of Berryman et al. (1992). Briefly, tissues were washed
several times with 0.1 M phosphate buffer containing 3.5% sucrose
and stained with 0.2% tannic acid in the same buffer for 1 hour at 4°C
(subsequent steps were performed at 4°C). After several washes,
aldehydes were quenched in 50 ntM NH4CI in the same buffer. The
tissues were then washed four times in 0.1 M maleate buffer (pH 6.2)
containing 4% sucrose, followed by 1% uranyl acetate in maleate -
sucrose buffer for 1 hour. The tissues were dehydrated to 90% ethanol
(from 70% ethanol onward all steps were at -20°C), absolute ethanol
for 15 minutes then infiltrated with a 1:1 ratio of LR Gold (Agar Sci¬
entific Ltd, Stanstead. Essex) and ethanol. followed by a 7:3 ratio of
LR Gold and ethanol, and two changes of LR Gold for 1 hour and
overnight. The tissues were infiltrated in two changes of LR Gold con¬
taining 0.5% benzoin methyl ether, for 1 hour and then overnight, and
embedded in gelatin capsules. Polymerization was by u.v. irradiation
at a wavelength of 365 nin for 48 hours at -20°C.
Sections were collected on nickel grids that were coated with
formvar and carbon, blocked (1% BSA.0.5% fish skin gelatin. 0.05%
Triton-X 100, 0.05% Tween 20, 500 mM NaCl, in lO^mM Tris. pH
7.4) for 30 minutes at room temperature and incubated overnight at
4°C with affinity-purified rabbit anti-periaxin antiserum (Gillespie et
al, 1994) in the same buffer. Grids were rinsed with the above buffer,
incubated for I hour with goat anti-rabbit IgG conjugated to 10 nm
gold particles (1:20, Amersham), washed on drops of distilled water,
fixed with 2.5% aqueous glutaraldehyde and rinsed in a stream of
distilled water. After postfixing for 15 minutes with 2% aqueous
OsO-t. the grids were stained with lead citrate and examined at 80 kV
in a JEOL 100CX electron microscope.
RESULTS
Periaxin is expressed by myelinating Schwann cells
Since periaxin has only been found in myelinating Schwann
cells (Gillespie et al, 1994), we compared its localization to
those of other Schwann cell markers in the adult rat PNS. As
shown in Fig. 1 A, periaxin immunoreactivity stopped abruptly
at the interface of the PNS and CNS, demonstrating that it is
not expressed by oligodendrocytes. Po and PMP-22 immuno-
reactivities were also confined to myelinating Schwann cells
(data not shown), whereas MAG (Fig. IB), MBP (data not
shown), and S-100(3 immunoreactivities (data not shown) were
found in both the PNS and the CNS. In both the nerve roots
and the sciatic nerve of adult rats, periaxin was predominately
localized to the abaxonal surface of myelinating Schwann
cells, which apposes their basal laminae (Fig. 1A,C,E). There
was also distinct staining of the adaxonal surface, which
apposes the axon, as well as of the incisures and paranodes
(Fig. 1A,C,E), but compact myelin was not labeled. We
compared the localization of periaxin with that of MAG (Fig.
1B.D), which was localized at the adaxonal membrane of
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Schwann cells and oligodendrocytes (Sternberger et al., 1979),
and even more prominently in the incisures and paranodes
(Trapp and Quarles, 1982). To determine whether periaxin was
expressed by non-myelinating Schwann cells, we examined the
cervical sympathetic trunk, which is mostly composed of
unmyelinated axons and their (non-myelinating) Schwann cells
(Aguayo et al., 1976a). Periaxin immunoreactivity was found
only around the thinly myelinated axons (Fig. IF), which was
confirmed by double-labeling for Po and MBP (data not
shown). Thus, in the mature PNS, periaxin is exclusively found
in myelinating Schwann cells, predominately at the abaxonal
surface.
Periaxin has a similar mobility by SDS-polyacrylamide gel
electrophoresis to two proteins previously isolated from
peripheral nerve myelin, PI70 and SAG (Shuman et al., 1986;
Dieperink et al., 1992). When sections of adult spinal cord
were labeled with two rabbit and three guinea pig antisera
against PI70 (kindly provided by Dr David Pleasure), all
stained myelinating Schwann cells in an identical pattern to
that of the periaxin antiserum. As this pattern of staining is
essentially the same as described for SAG (Dieperink et al.,
1992), periaxin, PI70 and SAG are probably the same protein.
Periaxin expression in degenerating and
regenerating nerves
It was of interest to learn what happens to periaxin after nerve
injury, since most myelin-related proteins disappear after
axotomy, as the distal nerve stump undergoes Wallerian
degeneration (Mirsky and Jessen, 1990; Scherer and Salzer,
1995). Thus, we examined the distal nerve stumps after both
permanent axotomy (transection) and nerve crush, which also
causes Wallerian degeneration, but allows axonal regeneration.
By 4 days postlesion, the smooth rim of abaxonal periaxin
immunoreactivity was largely gone; focal aggregates of
periaxin were seen in the Schwann cell cytoplasm, but separate
from the degenerating myelin sheaths. After 4 days, most of
periaxin immunoreactivity was found in large aggregates, often
associated with the degenerating myelin sheaths, the so-called
myelin ovoids, which contained the myelin proteins Po, MBP
and MAG (Fig. 2C,D). The amount of periaxin-positive
material, as well as myelin debris, fell progressively after 8
days postinjury, but was still found here and there even at 58
days postlesion. The periaxin aggregates were initially found
mostly in Schwann cells and not in macrophages, but by 58
days postlesion, most of the periaxin-immunoreactive material
was found in macrophages (Fig. 2A.B.E). Thus, even though
periaxin is not present in compact myelin, it is degraded along
with the components of the myelin sheath by Schwann cells
and macrophages (Stoll et al., 1989).
Since regenerating axons are remyelinated after nerve crush
(Ramon y Cajal, 1928), we could evaluate further how axon-
Schwann cell interactions regulate periaxin expression. In
crushed nerves, the periaxin that was previously associated
with myelinating Schwann cells appeared to be degraded as in
transected nerves but, in addition, periaxin was re-expressed as
Schwann cells ensheathed and myelinated regenerating axons
(Fig. 3). Schwann cells with periaxin-positive sheaths
ensheathing regenerating axons, which were labeled by a rat
monoclonal antibody against neurofilaments, were seen in the
proximal segment of distal nerve stumps at 8 days. By 12 days,
these Schwann cells were much more numerous and extended
much further into the distal nerve stump and, by 24 and 58 days
postcrush, they were found through the full extent of the distal
nerve stump. As the temporal and spatial gradient of periaxin-
expressing Schwann cells is consistent with the idea that
Schwann cells re-express periaxin as they remyelinate axons,
we performed double labeling for periaxin and MAG, Po or
MBP to determine whether these proteins were co-expressed.
At 8 days (data not shown) and 12 days postcrush (Fig. 3C,D),
most periaxin-positive cells were also MAG-positive, although
a few were MAG-negative. In contrast, at these early stages of
regeneration, many periaxin-positive (and MAG-positive) cells
were Po- (Fig. 3A.B) and MBP-negative (not shown). At 24
(Fig. 3E,F) and 58 days (not shown) most of the periaxin-
positive Schwann cells also expressed MAG. Po and MBP.
These data demonstrate that periaxin and MAG are re-
expressed by Schwann cells as they ensheathe axons, and prior
to the onset of Po and MBP expression.
We also noted a change in the distribution of periaxin
immunoreactivity during remyelination. Between 12 and 24
days postcrush, it was difficult to determine whether the
periaxin immunoreactivity was abaxonal or adaxonal, owing
to the thinness of the myelin sheath. At the level of the
Schwann cell nucleus, where the nucleus and perinuclear
cytoplasm separated the abaxonal and adaxonal surfaces, it was
possible to determine that there was both abaxonal and
adaxonal periaxin immunoreactivity, and that the latter
typically predominated (Fig. 3E,F). By 58 days postcrush,
most of the periaxin immunoreactivity was found abaxonally
(data not shown), as in normal adult nerve. Thus, the localiza¬
tion of periaxin changes dynamically as Schwann cells
ensheathe and remyelinate axons.
To confirm that the amount of periaxin protein changed as
predicted by the above immunohistochemistry, we performed
western blot analysis using the rabbit polyclonal serum against
rat periaxin fusion protein. After transection, the amount of
periaxin protein decreased to a low level by 24 days and
remained at this level until at least 60 days post-transection
(data not shown). In crushed nerves, the amount of periaxin
decreased to a nadir at 28 days, then returned to nearly normal
levels at 60 days postcrush (data not shown). Thus, the level
of periaxin protein changed in parallel with the immunohisto-
chemical changes in periaxin expression in both transected and
crushed nerves. These results show that the expression of
periaxin, like other myelin-related proteins, depends on axon-
Schwann cell interactions (Mirsky and Jessen, 1990; Scherer
and Salzer, 1995).
Periaxin expression in developing peripheral nerve
The shift in the subcellular localization of periaxin during
remyelination probably reconciles the contrasting immunohis-
tochemical data from adult and neonatal nerves. In adult
nerves, periaxin is predominately abaxonally localized (Fig.
1 A), whereas we previously reported that periaxin was mostly
adaxonal, which was based on our observations of neonatal
nerves (Gillespie et al., 1994). To confirm that periaxin is redis¬
tributed during development, we analyzed PI, P6 and PI5
sciatic nerves, spanning the most active period of myelination
(Webster and Favilla, 1984). As expected, the number of
periaxin-positive, as well as MAG-, MBP- and Po-positive
Schwann cells increased dramatically during this period (Hahn
et al., 1987). While there were numerous Schwann cells that
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had robust periaxin staining both adaxonally and abaxonally in
PI and P6 nerves, by PI5 abaxonal staining predominated in
most myelinating Schwann cells. To determine whether
periaxin was expressed prior to MAG, MBP and Po, we
performed double-labeling. At PI, most of the periaxin-
positive Schwann cells were also MAG-positive, but there
were many periaxin-positive and MBP- or Po-negative cells
(Fig. 4C-F). These data suggest that periaxin expression in
developing nerves is similar to that in regenerating nerves: the
expression of periaxin immunoreactivity precedes that of
MAG, Po and MBP, and that the predominant localization of
periaxin changes from adaxonal to abaxonal.
This shift in localization during development was confirmed
by immunoelectron microscopy. In P3 sciatic nerve, periaxin
was found to be localized both adaxonally and abaxonally (Fig.
5A). In P28 trigeminal nerve, however, the amount of adaxonal
labeling was considerably diminished, whereas the
abaxonal surface remained heavily labeled (Fig.
5B). Although adult trigeminal nerve is illustrated,
the localization of periaxin was identical in adult
sciatic nerve (data not shown).
Periaxin mRNA levels depend on axon-
Schwann cell interactions
The above data, taken together, show that periaxin
is expressed in concert with the other myelin-
related genes in Schwann cells. Since the mRNA
levels of these genes are exquisitely sensitive to the
disruption of axon-Schwann cell interactions
(Scherer and Salzer, 1995), we analyzed the levels
of periaxin mRNA after permanent axotomy (tran¬
section) and nerve crush by northern blot analysis.
To better illustrate the changes in gene expression
in crushed nerves, we divided the distal nerve
stumps into a proximal and a distal segment, as
axons regenerate in a proximal-to-distal manner.
As shown in Fig. 6A. the steady state level of
periaxin mRNA fell dramatically by 4 days post-
transection and did not return even by 58 days.
After nerve crush, the level of periaxin mRNA also
fell over a similar time course, but began to return
by 12 days in the proximal segment and by 24 days
in the distal nerve segment (Fig. 6B). The level of
periaxin mRNA in both segments continued to
increase until at least 58 days postcrush. We
compared the changes in periaxin mRNA with that
of Po, NGFR and GAPDH. by reprobing the same
blots. The changes in the levels of periaxin and Po
mRNA were strikingly similar in both transected
and crushed nerves. The level of NGFR mRNA. in
contrast, was reciprocally related to those of
periaxin and Po, both in transected and in crushed
nerves. The level of GAPDH mRNA did not
change significantly after transection or crush.
These data indicate that axon-Schwann cell
interactions are necessary to maintain the high level
of periaxin mRNA, and that the increase in the
expression of myelin-related genes, including
periaxin, in regenerating nerves is mediated by
axon-Schwann cell interactions. To demonstrate
directly that regenerating axons were required for
the return of periaxin mRNA in crushed nerves, we transected
regenerating nerves at 24 days postcrush, when periaxin levels
had begun to return. As shown in Fig. 6C, 2 days after tran¬
section of the regenerating nerve, the level of periaxin mRNA
fell in the distal nerve stump. The blot was reprobed for Po and
NGFR mRNA, thereby demonstrating a fall in the expression
of other myelin-related mRNAs, and an increase in the
expression of genes expressed by denervated Schwann cells,
respectively (Gupta et al., 1993; Scherer et al., 1994a).
DISCUSSION
Periaxin is a protein whose deduced amino acid sequence
predicts a cytoplasmic protein (Gillespie et al., 1994). We have







Fig. 4. Immunohistoehemical analysis of periaxin in developing rat sciatic nerve.
These are photomicrographs of the same field of P6 (A.B; transverse sections)
and PI (C-F; longitudinal sections) sciatic nerves. Periaxin immunoreactivity is
green (fluorescein); the rhodamine is either MAG (B), Po (D) or MBP (F).
(A.B) Note that many myelinating Schwann cells have a double ring of periaxin
labeling: an inner (adaxonal) ring that superimposes with MAG
immunoreactivity (arrows) and an outer ring that marks the abaxonal surface
(arrowheads). (C-F) Note that some periaxin-positive cells are Po- and MBP-
negative (arrows). Scale bars: 10 pm.
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Fig. 5. Comparison of periaxin localization
in longitudinal sections of P3 sciatic nerve
(A) and P28 (B) rat trigeminal nerve by
immunoelectron microscopy. A basal
lamina (between arrowheads) surrounds
compact myelin (m), which in turn,
surrounds the axon (a). The axolemma is
indicated by arrows. Gold particles (10 nm)
are abundantly detected in at both the
adaxonal and abaxonal myelin membranes
at P3 (A), whereas by P28 the shift to a
predominantly abaxonal localization has
become apparent. Scale bar: 200 nm.
:ells, and that its localization changes dynamically during
insheathment and myelination. Since PI70 and SAG have the
tame molecular weight and insolubility in Triton-X as
oeriaxin, as well as the same immunohistochemical localiza-
:ion, all three are probably the same protein (Shuman et al.,
1986; Dieperink et al., 1992; Gillespie et al., 1994). Futher-
nore, like other myelin-related proteins, the expression
reriaxin mRNA and protein is tightly regulated by axon-
Schwann cell interactions (Scherer and Salzer, 1995). These
lata suggest that periaxin has a specific function in myelinat-
ng Schwann cells.
3eriaxin is expressed in ensheathing Schwann cells
n both developing and regenerating nerves, we found that
reriaxin is initially found predominately in the adaxonal
Schwann cell membrane. At the ultrastructural level, periaxin
s expressed as soon as Schwann cells ensheathe axons in a 1:1
relationship, which corresponds to the onset of MAG
expression (Gillespie et al., 1994; Martini and Schachner,
1986, 1988). The onset of Po expression is slightly later, as it
is first expressed after a few lamellae of compact myelin are
formed (Hahn et al., 1987; Lamperth et al., 1990; Martini et
al., 1988). Although periaxin, MAG, and Po all appear to be
expressed at roughly the same time, we found a few Schwann
cells were periaxin-positive and MAG-negative, and many that
were periaxin-positive and Po- and MBP-negative (see also
Owens and Bunge, 1989), indicating that periaxin, MAG and
Po are expressed in that order in individual, myelinating
Schwann cells. The earlier onset of periaxin and MAG
immunoreactivities, however, do not necessarily mean that
their corresponding mRNAs are expressed earlier than those of
Po and MBP. In oligodendrocytes, the onset of proteolipid
protein (PLP) expression is delayed by as much as 3 days
relative to other MBP, whereas the onset of PLP and MBP
A. Transected B. Crushed






Fig. 6. Northern blot analysis of normal and
lesioned adult rat sciatic nerves. Each lane
contains an equal amount (10 pg) of total RNA
isolated from the distal stumps of sciatic nerves
that had been transected (A), crushed (B) or
transected 24 days after nerve crush and allowed
to degenerate for an additional 2 days (C). The
number of days after each of these lesions in
indicated; the '0' time point is from unlesioned
nerves. In crushed nerves (B), the distal nerve
stumps were divided into proximal (P) and distal
(D) segments of equal lengths. The blots were
successively hybridized with a radiolabeled
cDNA probe for periaxin (A). NGFR (C),
GAPDH (D) and Po (B). The films were exposed
for the following times: periaxin, 2 weeks; Po, 2
hours; NGFR, 1 day; GAPDH. 3 days. The
periaxin signal is composed of two transcripts
that are similar in size (data not shown): these
two bands are difficult to discern on these blots,
rhe identity of the band recognized by the periaxin probe in the 24 day transected sample is not known, but is probably due to cross-
lybridization with a plasmid that contaminated this sample of RNA.
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mRNA expression is the same (Dubois-Dalcq et al., 1987;
Grinspan et al., 1993).
The localization of periaxin is developmentally
regulated
We found that periaxin was predominately localized to the
adaxonal Schwann membrane during ensheathment and early
myelination, then predominately to the abaxonal membrane as
myelination continued. These data reconcile previous reports
on the localization of periaxin, SAG and P170 in peripheral
nerve. Like the ultrastructural study of Gillespie et al. (1994),
we find that periaxin is abundant in the adaxonal Schwann cell
membrane in early postnatal rat sciatic nerves. SAG was
localized to the adaxonal and abaxonal Schwann cell
membranes of myelinated axons in human neurofibromas
(Dieperink et al., 1992), which agrees with our localization in
adult nerves. Finally, although PI70 was initially reported to
be in compact myelin (Shuman et al., 1986), we have repeated
this experiment using the same antibodies and find that it is
predominantly localized to the abaxonal membrane in adult
nerve.
The developmental regulation of periaxin localization may
reflect the reorganization of the Schwann cell membrane
during myelination. There is a growing body of evidence that,
as Schwann cells ensheathe axons, they become polarized. In
axon-Schwann cell co-cultures, Schwann cells need to interact
with axons in order to assemble a basal lamina (Clark and
Bunge, 1989), and Schwann cells need a basal lamina in order
to properly ensheathe and myelinate axons and to express
MAG and Po (Eldridge et al., 1987, 1989; Fernandez-Valle et
al., 1993). The redistribution of periaxin from the adaxonal to
the abaxonal Schwann cell membrane may mark the polariza¬
tion of myelinating Schwann cells. Periaxin is not the only
protein to be redistributed, since MAG becomes restricted to
the adaxonal surface as Schwann cells ensheathe axons
(Martini and Schachner, 1986, 1988). Finally, the integrin
subunits a6 and (34 are found only on the abaxonal surface
(Einheber et al., 1993; Feltri et al., 1994), even as they first
appear in the rat sciatic nerve (about P6, Scherer, unpublished
observations). Thus, periaxin, MAG and Ct6p4 integrin are all
restricted with respect to the adaxonal and abaxonal Schwann
cell membrane. The spatial restriction of these molecules is
presumably important for their function in myelinating
Schwann cells, although to date this has been shown directly
only for MAG (Owens and Bunge, 1989; Li et al., 1994;
Montag et al., 1994). Analysis of the molecular basis by which
the polarization of periaxin distribution is accomplished during
the maturation of the myelin sheath is likely to foster a better
understanding of the cell biology of myelination in the periph¬
eral nerve.
This work was supported by NS-01565 and NS-08075 to S. S. S.,
and by a grant from the Medical Research Council to P. J. B.. We
thank Drs D. Pleasure, D. Schreyer, D. Colman, V. M.-Y. Lee, and J.
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Periaxin was first described as a 147-kDa protein that
was suggested to have a potential role in the initiation of
myelin deposition in peripheral nerves based upon its
abundance, cell type specificity, pattern of develop¬
mental expression, and localization (Gillespie, C. S.,
Sherman, D. L., Blair, G. E., and Brophy. P. J. (1994)
Neuron 12, 497-508). Here we show that the murine peri¬
axin gene spans 20.6 kilobases and encodes two mRNAs
of 4.6 and 5.2 kilobases that encode two periaxin iso-
forms, L-periaxin and S-periaxin of 147 and 16 kDa re¬
spectively. The larger mRNA is produced by a retained
intron mechanism that introduces a stop codon and re¬
sults in a truncated protein with an intron-encoded C
terminus of 21 amino acids. Both proteins possess a PDZ
domain at the N terminus; nevertheless, they are tar¬
geted differently in Schwann cells. Like other proteins
that contain PDZ domains, L-periaxin is localized to the
plasma membrane ofmyelinating Schwann cells: in con¬
trast, S-periaxin is expressed diffusely in the cytoplasm.
This suggests that proteins that contain this protein-
binding module may also participate in protein-protein
interactions at sites other than the cell cortex.
Periaxin was first identified as a relatively abundant 146-
kDa protein of myelinating Schwann cells in a screen for novel
cytoskeleton-associated proteins with a role in peripheral nerve
myelination (1). Like P0, the major integral membrane protein
of peripheral nervous system myelin, periaxin is detectable at
an early stage of peripheral nervous system development (2).
However, in contrast to P0, periaxin is not incorporated into
compact myelin (1), but is initially concentrated in the plasma
membrane, the abaxonal membrane (apposing the basal lami¬
na), and the adaxonal membrane (apposing the axon). As my¬
elin sheaths mature periaxin becomes concentrated in the ab¬
axonal membrane and plasma membrane (2). This shift in the
localization of the protein in the Schwann cell after completion
of the spiralization phase of axon ensheathment suggests that
periaxin may participate in the membrane-protein interactions
that are required to stabilize the mature sheath. To shed light
on the protein's function, we were particularly interested to
determine if modular protein-binding domains might be repre¬
sented in the periaxin amino acid sequence. Although no such
domains were identified from initial data base comparisons (1),
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Sciences Research Council, the Medical Research Council, and the
Wellcome Trust. The costs of publication of this article were defrayed in
part by the payment of page charges. This article must therefore be
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here we report that the periaxin gene does encode one of the
most interesting of these protein-binding motifs to emerge over
recent years, namely the PDZ domain.
The PDZ domain was named after the three proteins in
which it was first identified, namely post-synaptic density pro¬
tein PSD-95, Drosophila discs large (dig) tumor suppressor
gene, and the tight junction-associated protein ZO-1 (3). It
consists of an approximately 90-amino acid protein-binding
motif found in proteins that interact with the cytoplasmic tail
of plasma membrane proteins and with the cortical cytoskele-
ton (4). Although the binding site for some PDZ domains is the
simple peptide sequence (S/TXXV found at the C terminus of
certain plasma membrane proteins (5), PDZ-containing pro¬
teins can recognize somewhat different sequences and can even
form homophilic clusters with the PDZ domains of other pro¬
teins (6, 7) . So far, two major functions have been ascribed to
PDZ domains on the basis of their interactions with plasma
membrane proteins and their presence in known signaling
molecules such as dig (6). First, they may organize and recruit
proteins to the plasma membrane as has been proposed for
PSD-95 (3). Secondly, they may link transmembrane proteins
with the actin cytoskeleton via actin-binding proteins such as
protein 4.1 (8-10).
Here we report the structure of the murine periaxin gene,
which reveals that there are two periaxin isoforms, L-periaxin
and S-periaxin. The smaller protein, S-periaxin, is generated
by a relatively rare retained intron mechanism (11), which is
probably favored by the presence of suboptimal 5'- and 3'-splice
sites in the final intron together with a downstream putative
exonic splicing enhancer (12, 13). Although both are PDZ pro¬
teins, L- and S-periaxin are targeted differently in the
Schwann cell, indicating that the PDZ domain is not the sole
determinant of their subcellular localization. To our knowledge
this is the first example of the differential localization of two
protein isoforms with the same PDZ domain.
EXPERIMENTAL PROCEDURES
Isolation and Characterization of Genomic Clones—A 129SV murine
genomic library (gift from Dr W. Skarnes, Center for Genome Research,
Edinburgh University) in the bacteriophage Lambda Dash II (Strat-
agene, Cambridge, UK) was screened by plaque hybridization (14) with
a 32P-labeled probe comprising nucleotides 1-3000 of rat periaxin cDNA
(1). Hybridization was at 60 °C in QuikHyb (Stratagene, Cambridge,
UK), and the filters were washed in 2 x SSC (300 mM NaCl, 30 mM
sodium citrate, pH 7), 0.1% (w/v) SDS at room temperature and finally
at 60 °C in 0.2 X SSC, 0.1% SDS. From 1 X 106 clones, twelve positive
plaques were identified after three rounds of screening, and EcoRl
fragments of each insert were subcloned into the pIBI30 plasmid (IBI,
Cambridge, UK) for analysis. The ends of each clone were sequenced by
the dideoxy chain termination method (15) using a T7 DNA polymerase
kit (Pharmacia LKB Biotech, Uppsala, Sweden), which showed that the
twelve clones comprised three groups of sequences that overlapped (HI,
F2, and II). Oligonucleotide primers designed from these sequences
were used to determine the order of the EcoRI fragments within the
5794 This paper is available on line at http://www.jbc.org
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gene by PCR1 using purified bacteriophage DNA (1 pi of 1:500 dilution)
as template (first cycle of 94 °C for 5 min, 60 °C for 1 min, and then
72 °C for 1 min; 36 cycles of 94 °C for 1 min, 60 °C for 1 min, and then
72 °C for 1 min, 7 min during the last cycle). The reactions (50 p.1)
included primers (5 p.M) and Dynazyme DNA polymerase (5 units)
(Flowgen Ltd., Sittingbourne, UK). Periaxin sequence was mapped to
the EcoRI fragments by Southern blot with regional periaxin probes.
Briefly, ficoRI-digested plasmid DNA from each ScoRI subclone was
electrophoresed on a 1% agarose gel and vacuum blotted to Magma
nylon membrane (Micron Separations Inc., Westborough, MA). The
membrane was hybridized with 32P-labeled rat periaxin cDNA frag¬
ments covering the entire rat cDNA, and the order of the genomic clones
was determined. The cDNA and genomic sequences were compared
using the University of Wisconsin GCG software package. Analysis of
the three clone types from the first screening revealed the absence of
sequence corresponding to the first 297 bases of the rat cDNA, which
includes the initiation codon and the 5'-untranslated region. Therefore
a further 6 X 105 plaques were screened with a probe corresponding to
nucleotides 50—297 of the rat sequence (1), which was generated by
reverse transcription-PCR of the 5'-end of mouse periaxin mRNA (see
below). Two clones were isolated and characterized as described above
and were shown to be identical. This sequence (HH1) did not overlap
with the 5'-end of HI. However HH1 and HI were shown to be contig¬
uous by PCR performed on 129SV genomic DNA. as template (first cycle
of 94 °C for 5 min, 60 °C for 1 min, and then 72 °C for 1 min; 36 cycles
of 94 °C for 1 min, 60 °C for 1 min, and then 72 °C for 1 min, 7 min
during the last cycle). The reactions (50 pi) contained genomic DNA
(200 ng) primers (5 pM) and Dynazyme DNA polymerase (5 units)
(Flowgen Ltd.). The PCR product was isolated from an agarose gel with
the QIAEX II gel extraction kit (Qiagen Ltd, Crawley, UK) cloned into
the pGEM-T vector (Promega Ltd., Southampton, UK) according to the
manufacturer's instructions and sequenced using a T7 sequencing kit,
with T7 and M13(R) primers (Pharmacia).
Reverse Transcription-PCR—To obtain a probe for the 5'-end of the
mouse periaxin mRNA, total RNA was isolated from the sciatic nerves
of 15-day-old mice with RNAznl B (Biogenesis, Bournemouth, TJK)
according to the manufacturer's instructions Reverse transcriptions
(20 pi) contained RNA (2 pg), random hexamers (150 ng), dithiothreitol
(10 mM), dNTPs (0.5 mil), and Superscript reverse transcriptase (400
units) (Life Technologies Inc., Paisley, Scotland) in first, strand synthe¬
sis buffer and were incubated at 42 °C for 1 h. The reactions were
terminated by heating at 80 °C, and 1 pi of this reaction was used as a
template for PCR using primers corresponding to nucleotides 50—71
and 631-650 of the published rat periaxin cDNA sequence (1). PCR
conditions were* five cycles of94 °0 for 1 min, 55 °C for 1 min, and 79 °C
for 1 min followed by 26 cycles of 94 °C for 40 s, 55 °C for 1 min, and
72 °C for 1 min (4 min during last cycle). Reactions (50 pi) contained
primers (5 pM) and Dynazyme DNA polymerase (1 unit) (Flowgen Ltd.).
The product was subcloned into the pGEM-T (Promega Ltd., Southamp¬
ton, TJK) vector according to the manufacturer's instructions and se¬
quenced with a T7 DNA polymerase kit (Pharmacia).
Determination ofPeriaxin Transcriptional Initiation Site—An oligo-
nucleotide complementary to nucleotides 50-71 of the rat periaxin
cDNA (1) was end-labeled with [*y-32P]ATP and T4 polynucleotide ki¬
nase. Total RNA (10 pg) from the trigeminal nerves of 13-day-old mice
was hybridized to labeled oligonucleotide (5 pmol) and reverse tran¬
scribed for 10 min at 80 °C followed by 18 h at 42 °C. Reverse transcrip¬
tion employed Superscript, reverse transcriptase (Life Technologies
Inc.) in a buffer supplied by the manufacturer and included 50 pg/ml
actinomycin D. Extended products were resolved on a 6% polyacryl-
amide DNA sequencing gel adjacent to a dideoxy sequencing ladder
comprising the 5'-end of periaxin primed using an oligonucleotide com¬
plementary to nucleotides 103—122 of mouse periaxin cDNA.
Isolation of cDNA Clones Encoding Two Periaxin Isoforms—Two
periaxin mRNAs of 5.2 and 4.6 kb were detected in mouse and rat
sciatic nerve. We had previously cloned the cDNA for the smaller
mRNA (1). To identify how the larger mRNA differed from the 4.6-kb
mRNA, 3 x 105 clones of a 15-day-old rat sciatic nerve cDNA library
constructed in EcoRI-digested Agtll (Promega Ltd., Southampton, UK)
according to the manufacturer's instructions were screened with a
probe comprising nucleotides 1-597 of the rat periaxin cDNA previously
described (1). Screening was carried out essentially as for the genomic
library, and 24 positive plaques were purified DNA from each of these
phage clones was digested with Notl, and the inserts were subclonod
1 The abbreviations used are: PCR, polymerase chain reaction; kb,
kilobase pair(s); bp, base pair(s); PBS, phosphate-buffered saline.
. Clone II (18.3 kb) ..
I 77i
| Clone F2 (15.0 kb) ^
. Clone HI (22.4 kb)
I : 7rH
. yjf Clone HH1 (13.5 kb)^~7s — 1
EE EE E
1 H—I—I—1—-!■ '~32kb
I II-IV V VI VII
20.6 kb
Fig. 1. Structure of the murine periaxin gene. Exons are num¬
bered and indicated by solid rectangles. Introno arc Ghown no 3olid lines
between the exons, except for intron 6, which ia depicted no a hatched
box between exons VI and VII. FcoRI (E) restriction sites are indicated
and were used to subclone the genomic clones F2, HI, and II (from the
first screen) and HH1 (from the second screen).
into the pGEMllzf plasmid (Promega Ltd., Southampton, UK) and
sequenced. Of 11 clones that included a sequence homologous to exon 6
of the mouse gene, five included a sequence corresponding to the intron
between exons 6 and 7. Total RNA from both rat and mouse sciatic
norvoG was subsequently Northern blotted with a PCR generated probe
for this intronic sequence with identical results.
Northern Blotting—Total RNA from 15-day-old mouse sciatic nerves was
electrophoresed on 0.8% agarose formaldehyde gels and transferred to
Magna nylon membrane (Micron Separations Inc., Westborough, MA) by
vacuum blotting in 20 X SSC. Filters were probed for 1.5 h in Rapid Hyb
buffer (Amersham) at 65 °C with an exon 7-specific probe, a 1.3-kb restric¬
tion fragment corresponding to nucleotides 1-1324 of the rat periaxin cDNA
sequence, or a PCR product homologous to the intron 6 of the mouse gene
labeled with [a-32P]dCTP by random priming (Life Technologies Inc.) and
were washed to a final stringency of 0.2 X SSC at 65 °C. The intron probe
was prepared using one of the five rat cDNA clones isolated as described
above as templatewith primorG that flanked 400 bp of intron sequence. The
PCR conditions used for the preparation of this intronic probe were: first
cycle of 94 °C for 1 min, 55 °C for 1 min, and then 72 °C for 1 min; 28 cycles
of 94 °C for 40 s, 55 °C for 1 min, and then 72 °C for 1 min, 4 min during the
last cyclo. Reactions (50 pi) contained primers (5 pM) and Dynazymc DNA
polymerase (0.5 unit) (Flowgen Ltd.).
Antibody Production—The anti-SPeri and anti-NTerm antibodies
were raised in rabbits against the synthetic peptides AKLVRVL-
SPVPVQDSPSDRVAAAC and EARSRSAEELRRAEC, respectively,
which wore gonerous gifts from Prof. N. Croome, Department of Biol¬
ogy, Oxford Brookes University. The former peptide corresponded to the
C-terminal 23 amino acids of mouse S-periaxin, and the latter com¬
prised the N-terminal 14 amino acids of mouse periaxin ,which is
identical in L-periaxin and S-periaxin. The C-terminal cysteine residue
of each peptide was coupled to Keyhole Limpet hemocyanin by standard
techniques and used to immunize rabbits. Anti-SPeri antibody was
affinity purified by immunoabsorption to a column of peptide coupled to
Sepharose (Sigma Chemical Company, Poole, UK).
Immunofluorescence Microscopy—20-day-old mice were perfused in-
tracardially with a 4% solution of paraformaldehyde in 0.1 M sodium
phosphate, pH 7.4. Sciatic nerves were then removed and fixed for a
furthor 2 h at room temperature. After washing, nerves were cryopro
tected by immersion for 15 min in 5% (w/v) and then 10% (w/v) sucrose
in 0.1 M phosphate, pH 7.4, followed by overnight incubation in a 20%
(w/v) solution at 4 °C. Cryoprotected nerves were subsequently frozen
in OCT embedding compound (Tissue TEK) using isopentane. Trans¬
verse sections (7 pm) were collected on 3-aminopropyltriethoxysilane-
subbed glass slides. Following removal of OCT by washing in phos¬
phate-buffered saline (PBS) (Sigma), sections were blocked for 3 h at
room temperature in a solution of 10% (v/v) goat serum (Scottish Anti¬
body Production Unit, Law Hospital, Carluke, Scotland), 0.2% (w/v)
gelatin, and 0.3% (v/v) Triton X-100 in PBS. Blocked sections were
incubated overnight with rabbit anti-170pepl (1) (diluted 1:3000) or
affinity-purified anti-SPeri (diluted 1:200) with mouse anti-myelin ba¬
sic protein (diluted 1:200) (from Prof. N. Groome, Department of Biol¬
ogy, Oxford Brookes University) in 4% (v/v) goat serum, 0.2% (w/v)
gelatin and 0.3% (v/v) Triton X-100 (in PBS) under humid conditions at
room tomporaturo. Slides were washed in blocking buffer minus goat
acrum and then incubated with the occondary antibodies fluorescein
isothiocyanate-labeled goat anti rabbit (Cappcl, Durham, NC) (diluted
1:200) and biotinylated goat anti-mouse (Kirkegaard and Perry) (dilut¬
ed 1:500). Both antibodies were in 4% (v/v) goat serum, 0.2% (w/v)
gelatin, and 0.3% (v/v) Triton X-100 (in PBS) and incubated for 1 h at
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Table I
Exonlintron position, size, and junction sequence structure of the mouse periaxin gene
The intronic 5'-splice donor GT and 3'-splice acceptor AG are in bold type. The exonic sequences are capitalized. The interruption of codons by
introns is indicated by the phase. A phase of 0 indicates no interruption, and insertion of an intron after the first nucleotide of the codon is indicated
by phase 1. All numbering is relative to the deduced cDNA sequence of the mouse 4.6-kb periaxin message.
Exon no.
(size in bp)
cDNA position 5'-Splice donor
Intron no.
(size in bp) 3'-Splice acceptor




































Fig. 2. Alternative splicing of a retained intron generates two
mRNAs. Sciatic nerve RNA from 15-day-old mice was electrophoresed
on a 0.8% agarose formaldehyde gel (2 pg/lane), transferred to nylon
membrane and probed in lane A with a 1.3-kb restriction fragment of
nucleotides 1-1324 of the rat periaxin cDNA and in lane B with a PCR
product comprising intron 6 of the mouse gene. Both probes were
labeled with [a-32P]dCTP by random priming as described under "Ex¬
perimental Procedures." Autoradiography was for 48 h.
A GT C P
i75
Fig. 3. Determination of the periaxin transcription initiation
site by primer extension. An oligonucleotide complementary to nu
cleotides 50—71 of rat periaxin cDNA (1) was end-labeled with
[y_32p]ATP and T4 polynucleotide kinase. Total RNA (10 pg) from the
trigeminal nerves of 13-day-old mice was hybridized to labeled oligonu¬
cleotide (5 pmol) and reverse transcribed. Extended products were
resolved on a 6% polyacrylamide sequencing gel adjacent to a sequenc¬
ing ladder comprising the 5' end of pcriaxin primed using an oligonu¬
cleotide complementary to nucleotides 103—122 of mouse periaxin
cDNA. (lane P).
-491 ACAAC CTTCA AGAGG TAAGC ATTCT TACTA CTACT ATTTC AAAGA CAAAG
-441 AACTG AGGGC CCAGT GATGC CCTGT GATTG CTGAA GTTCC CGGAG CCAGG
-391 AATGC CTGAG CTGGG ACTTG AACCC AAATT CTCAA GGAGA CAGTG TAAGA
GCRE
-341 GGTTG TTTTG AGAGT CTCAG GGACT ATGTG GGCTA GGCCT GGGTC CAGGA
-291 GCCCA GAGAT GATGG GGGTG GGGTG CTGAG TATTC GAATG GGGGT GGTAT
SCIP/Oct- 6
-241 GCAAA TTCTT GAACT AAGGC TGGGG TGGAG GTCTG GGCTC TGGCA AGGGA
-191 GAGGT TCATG TTTCC ACATC CCCAC GCCCT TGCAG ATGGA TGTAG TGCAC
-141 AGAAG GGGAT GTTTG TTTCC CCACC ACCCA CCCTT TGGGT GACAT CACAG
CAAT BOX
-91 CAGGA CAGCC AATGG CCAGG GTCCC CCTTC TGCCC CCCCC TTCCC ATTCC
+ 1
-41 TTTTC CCTCC CAGCC CAAGG CTAGG ACTAA ACAGA CAGAC CAAGG AGCTC
+10 TGGAG GTGTC TGGAG GCCCA CCGgt
Fig. 4. Nucleotide sequence of the transcriptional initiation
site and consensus sequences of transcription factor-binding
elements in the putative core promoter. Exon 1, which comprises
32 (positive numbers) and 491 bp of the putative core promoter (negative
numbers) are shown relative to the transcriptional intiation site ( + 1)
determined by primer extension. The sequences recognized by STAT
proteins (29), SCIP/Oct-6 (18-20), SREBP1 (30), and NF-Y (31) to¬
gether with the consensus glial cAMP response element (GCRE) (21)
are underlined. The CAAT box is double-underlined.
room temperature. Further washes in blocking buffer minus serum
were followed by a 1-h incubation with streptavidin-Texas red (Vector
laboratories) (diluted 1:1500) and several washes in PBS. Sections were
subsequently examined with a Leica TCS4D confocal microscope.
Western Blot Analysis—Sciatic nerve homogenates (10 pg) were re¬
solved by SDS-polyacrylamide gel electrophoresis on 4-20% gradient
polyacrylamide gels, and Western blotting was performed as described
previously (1). Rabbit anti-170pepl (1) was diluted 1:2000, affinity-
purified rabbit anti-SPeri was diluted 1:200, and rabbit anti-NTerm
was diluted 1:1000. Goat anti-rabbit IgG-horseradish peroxidase con¬
jugate (Scottish antibody production unit) was used at a dilution of
1:500. The peroxidase reaction was stopped by the addition of SDS to
2% (v/v).
RESULTS
Intron-Exon Structure of Murine Periaxin Gene—Three dif¬
ferent clones were isolated from a murine 129SV genomic li¬
brary using a rat periaxin cDNA as a hybridization probe. A
fourth, which included the 5'-end of the gene, was isolated
using a murine cDNA probe that had been generated by reverse
transcription-PCR. The clones were digested with A'coKl and
subcloned into pIBI30. These clones were analyzed by PCR and
Southern blot and were sequenced, which demonstrated that
they encompassed the entire periaxin gene. The gene is divided
into seven exons, and the coding region spans were approxi¬
mately 20.6 kb (Fig. 1). Exons 1-6 range in size from 32 (exon
1) to 197 bp (exon 6). Exon 7 is the largest by far at 4002 bp. The
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Fig. 5. Comparison of the amino acid sequences ofmouse and rat periaxin. Alignment of the deduced amino acid sequence ofmouse and
rat L-periaxin (A) and S-periaxin (B) using the single-letter code. Identity is depicted by an asterisk, and dashes indicate gaps introduced for
optimal alignment. The point at which L- and S-periaxin diverge in sequence is shown by the arrows in A and B.
sizes of the introns were estimated by restriction mapping and
PCR and range from 88 (intron 2) to 7500 bp (intron 5). The
exon-intron boundaries were sequenced and the splice donor
(GT) and acceptor (AG) sites were identified. This information
is summarized in Table I.
Two distinct periaxin mRNAs are expressed in the rat pe¬
ripheral nervous system (1), and the murine gene also encodes
two mRNAs of 4.6 and 5.2 kb of approximately equal abun¬
dance (Fig. 2A). Of eleven cDNA clones isolated from a rat
cDNA library, five included intron 6 (Fig. 1). Confirmation that
the murine 5.2-kb mRNA differed from the 4.6-kb mRNA by the
inclusion of this 592-bp intron was obtained by Northern blot¬
ting (Fig. 2).
Identification of Transcriptional Initiation Site and Core
Promoter—The transcriptional initiation site was determined
by primer extension and was found to be 75 bp upstream of a
primer complementary to a region comprising the final nucle¬
otide of exon 2 and the 5'-end of exon 3 in the murine gene (Fig.
3). This site lay in the sequence YYA+1AGGA, which has some
similarity to the sequence YYA+1N(A/T)YY believed to be the
consensus transcriptional initiator for RNA polymerase II tran¬
scripts (16). An identical transcriptional initiation site was
found for the rat mRNA (data not shown). Approximately 500
bp of the putative core promoter was sequenced (Fig. 4). Al¬
though it lacks a TATA box, the promoter does possess a CAAT
box, and between this motif and the initiator the sequence is
relatively GC-rich (68%), which is commonly the case in TATA-
less promoters (17). A sequence motif corresponding to the
SCIP/Oct-6 binding site (position —241) is ofparticular interest
owing to the role that Oct-6 is believed to play in Schwann cell
maturation (18-20). An element (GCRE) at position -360 has
previously been identified as mediating the induction of several
myelin protein genes by forskolin (21). The presence of this
sequence would help to explain the ability of cAMP to mimic
some of the axonal signals that regulate the expression of
differentiation-specific genes in Schwann cells (22, 23).
Deduced Amino Acid Sequence of L-Periaxin and S-Peri-
axin—The deduced amino acid sequence of the protein encoded
by the 4.6-kb mRNA is depicted in Fig. 5A. This isoform,
termed L-periaxin, is 93% identical to rat periaxin and has a
size of 147.500 kDa, slightly larger than the rat protein (1). The
presence of a retained intron in the larger 5.2-kb mRNA intro¬
duces a stop codon preceded by a sequence that encodes a
unique 21-amino acid C terminus. This truncated isoform,
termed S-periaxin, has a size of 16.2 kDa (Fig. 5B). Eccept for
two differences at the extreme C terminus, the rat and murine
S-periaxins are identical. Anti-peptide antibodies recognizing
the N terminus of L- and S-periaxin (anti-NTerm), the repeat
region unique to L-periaxin (anti-170pepl (1)), or the C termi¬
nus unique to S-periaxin (anti-SPeri) confirmed the structural
relationship between the two isoforms (Fig. 6).
A PDZ Domain at the N Terminus ofL- and S-Periaxin—The
similarity between mouse and rat periaxin is particularly strik¬
ing in the N-terminal 127 amino acids up to the point where the
sequences of L- and S-periaxin diverge. Within this region the
rat and mouse polypeptides are identical. This prompted us to
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examine this sequence very carefully for conserved motifs that
might illuminate the function of these proteins, despite the fact
that previous searches of the complete L-periaxin polypeptide
had not been informative (1). A degree of sequence similarity
with a portion of the PDZ domain of the junction-associated
protein ZO-1 provided the necessary clue. Comparison of the N
terminus sequence from amino acids 13 to 97 with several well
characterized PDZ domains in other proteins confirmed that
this region comprises a PDZ domain common to both L- and
S-periaxin (Fig. 7).
Because proteins that contain PDZ domains are believed to
associate with the plasma membrane (3, 6), it was of consider¬
able interest to compare the subcellular locations of L- and
S-periaxin in the Schwann cell. In transverse sections of sciatic
/ ff
<? $
Fig. 6. Western blot of mouse periaxin with domain-specific
antibodies. Mouse sciatic nerves from 15-day-old mice were homoge¬
nized and immunoblotted using antibodies raised against peptide se¬
quences comprising either the N terminus of L- and S-periaxin (anti-
NTerm), the repeat region unique to L-periaxin (anti-170pepl (1)) or
the C terminus unique to S-periaxin (anti-SPeri). The sizes of L- and
S-periaxin are indicated in kDa.
nerves from 20-day-old mice L-periaxin was detected in a typ¬
ical annular pattern that reflected its concentration in the
periaxonal and abaxonal myelin lamellae (Fig. 8, A and C). In
contrast to myelin basic protein, L-periaxin was also present at
the plasma membrane of the Schwann cell, consistent with the
possession of a PDZ domain. As found before, L-periaxin is not
present in compact myelin where myelin basic protein is abun¬
dant (Fig. 8, B and C) (1, 2). In contrast, S-periaxin was not
concentrated at the interface between the plasma membrane
and cytoplasm of the Schwann cell or the myelin sheath (Fig. 8,
D-F). Instead, this protein seemed to be distributed fairly
evenly throughout the cytoplasm. There also appeared to be
some S-periaxin in the nucleus of the Schwann cell. Appar¬
ently, the presence of a PDZ domain may not be sufficient to
direct the association of S-periaxin with either the Schwann
cell plasma membrane or its product, the myelin sheath.
DISCUSSION
One of the most interesting aspects of the expression of the
periaxin gene is the fact that alternative splicing involves the
retention of an intron. There are approximately equal propor¬
tions of two mRNAs that either lack or include the last intron.
The factors that determine the retention of introns have been
studied in detail by Rottman and colleagues, and a key feature
is the "weakness" of the splice sites at the 5'- and 3'-ends of the
intron, i.e. the extent to which they differ from the consensus
sequences that are known to promote splicing (12, 24). These
weak splice sites would not normally support splicing without
an additional sequence in the downstream exon called the
exonic splicing enhancer (13). The main distinguishing feature
of exonic splicing enhancers is their high content of purines
(13). In support of this model, the splice sites in the last intron
of the periaxin gene are divergent from the consensus se¬
quences, and there is a domain downstream in exon 7 that is
highly purine-rich. The sequences of these 5'- and 3'-splice
sites are CTGgtacgc and tcagA, respectively (intron sequences
in lowercase), which are significantly different from the corre¬
sponding consensus donor and acceptor sequences of CAG-
gtragt and ncagG (24). Downstream of the acceptor site and 24
bases into exon 7 there is a 14-base sequence GAAGAAGAA-
GAAGA, which is an excellent candidate for an exonic splicing
enhancer (1, 13).
Of those genes that are typically expressed by myelin-form-
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Fig. 7. Identification of a PDZ domain at the N terminus of L- and S-periaxin. The sequence ofmouse L- and S-periaxin between amino
acids 14 and 98 was compared with PDZ domains in the Caenorhabditis elegans protein CET19B10 (residues 232-316) (32), PSD-95 (residues
309-393) (33), Discs-Large (dig) (residues 482-566) (34), SAP97 (residues 461-545) (35), ZO-1 (residues 408-491) (36), ZO-2 (residues 93-176)
(37), and inaD (residues 361-447) (38). The eight segments within the domain comprising six 0 strands and two a-helices are as determined and
described by Doyle et al. (5). The sequences have been arranged to maximize their similarity. Solid blocks show amino acid identity, and shading
indicates conservative substitutions.




Fig. 8. Immunofluorescence localization of L- and S-periaxin in mouse Schwann cells. A-C, transverse section of a sciatic nerve from
a 20-day-old mouse, double-labeled with anti-170pepl to detect L-periaxin (fluorescein isothiocyanate, A) and antibodies against myelin basic
protein (MBP) (tetramethyl rhodamine isothiocyanate, B). The combined image is shown in C. L-periaxin is localized to the plasma membrane
{arrow) and the abaxonal and adaxonal surfaces (arrowheads) ofmyelinating Schwann cells. Myelin basic protein is restricted to the myelin sheath.
D-F, transverse section of the same sciatic nerve double labeled with anti-SPeri to detect S-periaxin (fluorescein isothiocyanate, D) and anti-myelin
basic protein (tetramethyl rhodamine isothiocyanate, E). The combined image is shown in F. S-periaxin is restricted to the cytoplasm of
myelinating Schwann cells. Preincubation of the anti-SPeri with 1 mg/ml of peptide completely abolished staining with this antibody (data not
shown).
become transcriptionally active (2). The means by which the
gene is regulated is therefore of considerable interest in eval¬
uating how the expression of those genes required for axon
ensheathment and myelination is coordinated. The SCIP/Oct-6
transcription factor is known to play a part in Schwann cell
maturation, and the presence of a binding site for this protein
in the periaxin promoter is intriguing (18-20). However, the
timing of expression of periaxin expression in SCIP/Oct-6 null
mutants appears to be relatively normal, despite the fact that
peripheral myelination is disrupted (20). The presence of a site
that bears considerable similarity to the consensus GCRE bind¬
ing site found in other genes that are characteristically ex¬
pressed in myelin-forming glia indicates that the the periaxin
gene may respond to common signaling mechanisms, in which
cAMP can mimic to some extent the inductive interactions of
the axon (21). Certainly axonal contact has been shown to be
vital to maintain periaxin expression in Schwann cells in vivo
(2).
So far, two major functions have been ascribed to PDZ do¬
mains on the basis of their interactions with plasma membrane
proteins and their presence in known signaling molecules such
as dig (6). First, they may act as organizers of cortical trans¬
duction complexes. In this model the PDZ protein acts as a
scaffold on which the macromolecular signaling complex is
assembled. These complexes have been termed transduci-
somes, within which PDZ proteins are key elements (25). Sec¬
ondly, they may link transmembrane proteins with the actin
cytoskeleton via actin-binding proteins such as protein 4.1 (8,
9). Indeed, the insolubilty of periaxin (actually L-periaxin) in
Triton X-100 was a key feature in the initial identification of
this protein as a potential cytoskeleton-associated protein (1,
3).
The discovery of a PDZ domain in the periaxin proteins is
certain to provide exciting new ways of interpreting the func¬
tion not only of periaxin but also of PDZ domain-containing
proteins in general. The PDZ motif in periaxin may either
participate in the membrane-protein interactions that are re¬
quired to promote spiralization or act to recruit proteins to a
cortical scaffold important in transmembrane signaling, at
least for L-periaxin. The fact that S-periaxin is not concen¬
trated at the membrane-cytoplasm interface but is distributed
throughout the cytoplasm of the Schwann cell suggests that
this protein has a quite distinct function and that the PDZ
domain may not be sufficient to ensure cortical targeting. It is
also possible that the unique C terminus of S-periaxin might
target the protein away from the plasma membrane. Although
most PDZ proteins are localized to the cell cortex, there is an
increasing recognition that they do not always function at the
plasma membrane (26). The possibility that they play a part in
nuclear signaling has been suggested by the fact that the tight
junction-associated protein Z0-1 localizes to the nucleus before
it is recruited to sites of cell-cell contact (27). Furthermore, a
nuclear binding partner for the transcriptional factor SRY is a
PDZ protein that is thought to participate in a macromolecular
transcription complex (28).
In conclusion, we have shown that two periaxin isoforms,
both of which contain the same PDZ domain, are generated in
approximately equal amounts by an alternative retained intron
mechanism. Furthermore, these PDZ proteins are uniquely
targeted to different localizations in myelinating Schwann
cells, which suggests that the presence of a PDZ motifmay not
be the dominant determinant in the selection of binding part¬
ners for L- and S-periaxin in myelinating Schwann cells.
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